<?xml version="1.0" encoding="UTF-8"?>
<patent-document ucid="EP-2314712-B1" country="EP" doc-number="2314712" kind="B1" date="20140108" family-id="27662934" file-reference-id="311089" date-produced="20180826" status="corrected" lang="EN"><bibliographic-data><publication-reference fvid="146588633" ucid="EP-2314712-B1"><document-id><country>EP</country><doc-number>2314712</doc-number><kind>B1</kind><date>20140108</date><lang>EN</lang></document-id></publication-reference><application-reference ucid="EP-10180603-A" is-representative="NO"><document-id mxw-id="PAPP154850825" load-source="docdb" format="epo"><country>EP</country><doc-number>10180603</doc-number><kind>A</kind><date>20021107</date><lang>EN</lang></document-id><document-id mxw-id="PAPP168019492" load-source="docdb" format="original"><country>EP</country><doc-number>10180603.2</doc-number><date>20021107</date></document-id></application-reference><priority-claims><priority-claim mxw-id="PPC140550273" ucid="EP-02806695-A" linkage-type="3" load-source="docdb"><document-id format="epo"><country>EP</country><doc-number>02806695</doc-number><kind>A</kind><date>20021107</date></document-id></priority-claim><priority-claim mxw-id="PPC140553184" ucid="US-33696801-P" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>33696801</doc-number><kind>P</kind><date>20011107</date></document-id></priority-claim></priority-claims><dates-of-public-availability><intention-to-grant-date><date>20130724</date></intention-to-grant-date></dates-of-public-availability><technical-data><classifications-ipcr><classification-ipcr mxw-id="PCL1989326187" load-source="docdb">A61K  39/00        20060101ALI20110314BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1989326188" load-source="docdb">C07K  14/18        20060101ALI20110314BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1989326189" load-source="docdb">C07K  14/47        20060101ALI20110314BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1989326190" load-source="docdb">C12Q   1/37        20060101AFI20110314BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1989629401" load-source="docdb">A61K  39/12        20060101A I20051008RMEP        </classification-ipcr><classification-ipcr mxw-id="PCL1989635392" load-source="docdb">A61P  31/00        20060101A I20060521RMWO        </classification-ipcr><classification-ipcr mxw-id="PCL1989643116" load-source="docdb">C12N  15/85        20060101A I20051008RMEP        </classification-ipcr><classification-ipcr mxw-id="PCL1989643181" load-source="docdb">A61P  35/00        20060101A I20060521RMWO        </classification-ipcr><classification-ipcr mxw-id="PCL1989648369" load-source="docdb">G01N  33/68        20060101A I20051008RMEP        </classification-ipcr></classifications-ipcr><classifications-cpc><classification-cpc mxw-id="PCL-2068547420" load-source="docdb" scheme="CPC">C12N2840/203       20130101 LA20150420BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2068548150" load-source="docdb" scheme="CPC">A61K  39/00        20130101 LI20150420BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2068548588" load-source="docdb" scheme="CPC">A61K2039/53        20130101 LA20150420BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2068548892" load-source="docdb" scheme="CPC">G01N  33/6845      20130101 LI20150420BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2068550883" load-source="docdb" scheme="CPC">G01N  33/6848      20130101 FI20150420BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2068551345" load-source="docdb" scheme="CPC">C12N2760/16122     20130101 LA20150420BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2068551489" load-source="docdb" scheme="CPC">A61K  39/0011      20130101 LI20150420BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2068552298" load-source="docdb" scheme="CPC">C07K2319/00        20130101 LA20150420BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2068552888" load-source="docdb" scheme="CPC">C12N  15/85        20130101 LI20150420BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2068553039" load-source="docdb" scheme="CPC">C07K  14/4748      20130101 LI20150420BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2068553237" load-source="docdb" scheme="CPC">C07K  14/47        20130101 LI20150420BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2068554067" load-source="docdb" scheme="CPC">G01N2500/00        20130101 LA20150420BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2068555512" load-source="docdb" scheme="CPC">G01N  33/68        20130101 LI20150420BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2073252230" load-source="docdb" scheme="CPC">A61K2039/6075      20130101 LA20150417BHEP        </classification-cpc></classifications-cpc><invention-title mxw-id="PT132370532" lang="DE" load-source="patent-office">Für Epitope von Antigenen kodierende Expressionsvektoren sowie Verfahren zu deren Konzeption</invention-title><invention-title mxw-id="PT132370533" lang="EN" load-source="patent-office">Expression vectors encoding epitopes of antigens and methods for their design</invention-title><invention-title mxw-id="PT132370534" lang="FR" load-source="patent-office">Vecteurs d´expression codant pour des épitopes d´antigènes et procédés permittant leur conception</invention-title></technical-data><related-documents><relation type="division"><child-doc ucid="EP-10180603-A"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>10180603</doc-number><kind>A</kind><date>20021107</date></document-id></child-doc><parent-doc ucid="EP-02806695.9"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>02806695.9</doc-number><date>20021107</date></document-id></parent-doc></relation></related-documents><parties><applicants><applicant mxw-id="PPAR919521010" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>MANNKIND CORP</last-name><address><country>US</country></address></addressbook></applicant><applicant mxw-id="PPAR919525742" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>MANNKIND CORPORATION</last-name></addressbook></applicant></applicants><inventors><inventor mxw-id="PPAR919528153" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>SIMARD JOHN J L</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR919523146" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>SIMARD, JOHN J.L.</last-name></addressbook></inventor><inventor mxw-id="PPAR919024001" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>SIMARD, JOHN J.L.</last-name><address><street>1340 Patterson Road</street><city>Austin, TX 78733</city><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR919511641" load-source="docdb" sequence="2" format="epo"><addressbook><last-name>QUI ZHIYONG</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR919535743" load-source="docdb" sequence="2" format="intermediate"><addressbook><last-name>QUI, ZHIYONG</last-name></addressbook></inventor><inventor mxw-id="PPAR919024004" load-source="patent-office" sequence="2" format="original"><addressbook><last-name>QUI, ZHIYONG</last-name><address><street>941 South Gladys Avenue K</street><city>San Gabriel, Ca 91776</city><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR919517771" load-source="docdb" sequence="3" format="epo"><addressbook><last-name>DIAMOND DAVID C</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR919545565" load-source="docdb" sequence="3" format="intermediate"><addressbook><last-name>DIAMOND, DAVID C.</last-name></addressbook></inventor><inventor mxw-id="PPAR919024002" load-source="patent-office" sequence="3" format="original"><addressbook><last-name>DIAMOND, DAVID C.</last-name><address><street>23135 Schoenborn Street</street><city>West Hills, CA 91304</city><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR919509599" load-source="docdb" sequence="4" format="epo"><addressbook><last-name>LEI XIANG-DONG</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR919536928" load-source="docdb" sequence="4" format="intermediate"><addressbook><last-name>LEI, XIANG-DONG</last-name></addressbook></inventor><inventor mxw-id="PPAR919024003" load-source="patent-office" sequence="4" format="original"><addressbook><last-name>LEI, XIANG-DONG</last-name><address><street>6940 Newgate Road</street><city>West Hills, CA 91307</city><country>US</country></address></addressbook></inventor></inventors><assignees><assignee mxw-id="PPAR919024005" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Mannkind Corporation</last-name><iid>100171836</iid><address><street>28903 North Avenue Paine</street><city>Valencia, California 91355</city><country>US</country></address></addressbook></assignee></assignees><agents><agent mxw-id="PPAR919024006" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Lasar, Andrea Gisela</last-name><iid>101219626</iid><address><street>Maiwald Patentanwalts GmbH Elisenhof Elisenstrasse 3</street><city>80335 München</city><country>DE</country></address></addressbook></agent></agents></parties><international-convention-data><designated-states><ep-contracting-states><country mxw-id="DS549872340" load-source="docdb">AT</country><country mxw-id="DS549787418" load-source="docdb">BE</country><country mxw-id="DS549924885" load-source="docdb">BG</country><country mxw-id="DS549882202" load-source="docdb">CH</country><country mxw-id="DS549788642" load-source="docdb">CY</country><country mxw-id="DS549788643" load-source="docdb">CZ</country><country mxw-id="DS549804511" load-source="docdb">DE</country><country mxw-id="DS549787419" load-source="docdb">DK</country><country mxw-id="DS549787420" load-source="docdb">EE</country><country mxw-id="DS549895020" load-source="docdb">ES</country><country mxw-id="DS549924886" load-source="docdb">FI</country><country mxw-id="DS549924887" load-source="docdb">FR</country><country mxw-id="DS549804516" load-source="docdb">GB</country><country mxw-id="DS549787425" load-source="docdb">GR</country><country mxw-id="DS549882203" load-source="docdb">IE</country><country mxw-id="DS549924888" load-source="docdb">IT</country><country mxw-id="DS549787426" load-source="docdb">LI</country><country mxw-id="DS549872341" load-source="docdb">LU</country><country mxw-id="DS549804517" load-source="docdb">MC</country><country mxw-id="DS549872346" load-source="docdb">NL</country><country mxw-id="DS549895025" load-source="docdb">PT</country><country mxw-id="DS549872347" load-source="docdb">SE</country><country mxw-id="DS549882204" load-source="docdb">SK</country><country mxw-id="DS549787427" load-source="docdb">TR</country></ep-contracting-states></designated-states></international-convention-data></bibliographic-data><description mxw-id="PDES63961053" lang="EN" load-source="patent-office"><!-- EPO <DP n="1"> --><heading id="h0001"><b><u>Background of the Invention</u></b></heading><heading id="h0002"><u>Field of the Invention</u></heading><p id="p0001" num="0001">The invention disclosed herein is directed to methods for the design of epitope-encoding vectors for use in compositions, including for example, pharmaceutical compositions capable of inducing an immune response in a subject to whom the compositions are administered. The invention is further directed to the vectors themselves. The epitope(s) expressed using such vectors can stimulate a cellular immune response against a target cell displaying the epitope(s),</p><heading id="h0003"><u>Description of the Related Art</u></heading><p id="p0002" num="0002">The immune system can be categorized into two discrete effector arms. The first is innate immunity, which involves numerous cellular components and soluble factors that respond to all infectious challenges. The other is the adaptive immune response, which is customized to respond specifically to precise epitopes from infectious agents. The adaptive immune response is further broken down into two effector arms known as the humoral and cellular immune systems. The humoral arm is centered on the production, of antibodies by B-lymphocytes while the cellular arm involves the killer cell activity of cytotoxic T Lymphocytes.</p><p id="p0003" num="0003">Cytotoxic T Lymphocytes (CTL) do not recognize epitopes on the infectious agents themselves. Rather, CTL detect fragments of antigens derived from infectious agents that are displayed on the surface of infected cells. As a result antigens are visible to CTL only after they have been processed by the infected cell and thus displayed on the surface of the cell</p><p id="p0004" num="0004">The antigen processing and display system on the surface of cells has been well established. CTL recognize short peptide antigens, which arc displayed on the surface in noncovalent association with class I major histocompatibility complex molecules (MHC). These class I peptides are in turn derived from the degradation of cytosolic proteins</p><heading id="h0004">Summary of the invention</heading><p id="p0005" num="0005">Disclosed herein are expression cassettes, for example, for use in vaccine vectors, which encode one or more embedded housekeeping epitopes, and methods for designing and testing such expression cassettes. Housekeeping epitopes can be liberated from the translation product of such cassettes through proteolytic processing by the immunoproteasome of professional antigen presenting cells (pAPC). In one embodiment, sequences flanking the housekeeping epitope(s) can be altered to promote cleavage by the immunoproteasome at the desired location(s), Housekeeping epitopes, their uses, and identification are described in <patcit id="pcit0001" dnum="US6861234B"><text>U.S. Patent No. 6,861,234</text></patcit>.</p><p id="p0006" num="0006">Examples of housekeeping epitopes are disclosed in <patcit id="pcit0002" dnum="US20030220239A"><text>U.S. Application No. 2003/0220239</text></patcit>.</p><p id="p0007" num="0007">In other embodiments, the housekeeping epitope(s) can be flanked by arbitrary sequences or by sequences incorporating residues known to be favored in immunoproteasome cleavage sites. As used herein the term "arbitrary sequences" refers to sequences chosen without reference to the native sequence context of the epitope, their ability to promote processing, or immunological function. In further embodiments of the invention multiple epitopes can be arrayed head-to-tail. These arrays can be made up entirely of housekeeping epitopes. Likewise, the arrays can include alternating housekeeping and immune epitopes. Alternatively, the arrays can include housekeeping epitopes flanked by immune epitopes, whether complete or distally truncated. Further, the arrays can be of any other similar arrangement. There is no restriction on placing a housekeeping epitope at the terminal positions of the array. The vectors can additionally contain authentic protein coding sequences or segments thereof containing epitope clusters at a source of immune epitopes. The term "authentic" refers to natural protein sequences.</p><p id="p0008" num="0008">Epitope clusters and their uses are described in <patcit id="pcit0003" dnum="US2003021545A"><text>U.S. Patent application No. 2003/021545</text></patcit>.</p><p id="p0009" num="0009">Embodiments can encompass screening the constructs to determine whether the housekeeping epitope is liberated. In constructs containing multiple housekeeping epitopes, embodiments can include screening to determine which epitopes are liberated. Also disclosed herein is a vector containing an embedded epitope that can be<!-- EPO <DP n="2"> --> used to immunise HLA transgenic mice and the resultant CTL can be tested for their ability to recognize target cells presenting the mature epitope. In another embodiment, target cells expressing immunoproteasome can be transformed with the vector. The target cell may express immunoproteasome either constitutively, because of treatment with interferon or through genetic manipulation, for example. CTL that recognize the mature epitope can be tested for their ability to recognize these target cells. In yet another embodiment, the embedded epitope can be prepared as a synthetic peptide. The synthetic peptide then can be subjected to digestion by an immunoproteasome preparation <i>In vitro</i> and the resultant fragments can be analysed to determine the sites of cleavage. Such polypeptides, recombinant or synthetic, from which embedded epitopes can be successfully liberated, can also be incorporated into immunogenic compositions.</p><p id="p0010" num="0010">The invention disclosed herein relates to the identification of a polypeptide suitable for epitope liberation. One embodiment relates to a method of identifying a polypeptide suitable for epitope liberation inducing, for example, the steps of identifying an epitope of interest, providing a substrate polypeptide sequence including the epitope, wherein the substrate polypeptide permits processing by a proteasome; contacting the substrate polypeptide with a composition including the protaesome, under conditions that support processing of the substrate polypeptide by the proteasome; and assaying for liberation of the epitope.</p><p id="p0011" num="0011">The epitope can be embedded in the substrate polypeptide, and in some aspects the substrate polypeptide can include more than one epitope, for example. Also, the epitopes can be a housekeeping epitope.</p><p id="p0012" num="0012">It is disclosed that the substrate polypeptide can be a synthetic peptide. Optionally, the substrate polypeptide can be included in a formulation promoting protein transfer. Alternatively, the substrate polypeptide can be a fusion protein. The fusion protein can further include a protein domain possessing protein transfer activity. Further, the contacting step can include immunization with the substrate polypeptide.</p><p id="p0013" num="0013">In one aspect, the substrate polypeptide can be encoded by a polynucleotide. The contacting step can include immunization with a vector including the polynucleotide, for example. The immunization can be carried out in can HLA-transgenic mouse or any other suitable animal, for example. Alternatively, the contacting step can include transforming a cell with a vector including the polynucleotide. In some embodiments the transformed cell can be a target cell that is targeted by CTL for purposes of assaying for proper liberation of epitope.</p><p id="p0014" num="0014">The proteasome processing can take place intracellularly, either <i>in vitro</i> or <i>in vivo</i>. Further, the proteasome processing can take place in a cell-free system.</p><p id="p0015" num="0015">The assaying step can include a technique selected from the group including, but not limited to, mass spectrometry, N-terminal pool sequencing, HPLC, and the like. Also, the assaying step can include a T cell target recognition assay. The T cell target recognition assay can be selected from the group including, but not limited to, a cytolytic activity assay, a chromium release assay, a cytokine assay, an ELISPOT assay, tetramer analysis, and the like.</p><p id="p0016" num="0016">It is disclosed that the amino acid sequence of the substrate polypeptide including the epitope can be arbitrary. Also, the substrate polypeptide in which the epitope is embedded can be derived from an authentic sequence of a target-associated antigen. Further, the substrate polypeptide in which the epitope is embedded can be conformed to a preferred immune proteasome cleavage site flanking sequence.</p><p id="p0017" num="0017">It is disclosed that the substrate polypeptide can include an array of additional epitopes. Members of the array can be arranged head-to-tail, for example. The array can include more than one housekeeping epitope. The more than one housekeeping epitope can include copies of the same epitope, The array can include a housekeeping and an immune epitope, or alternating housekeeping and immune epitopes, for example. Also, the array can include a housekeeping epitope positioned between two immune epitopes in an epitope battery, The array can include multiple epitope batteries, so that there arc two immune epitopes between each housekeeping epitope in the interior of the array. Optionally, at least one of the epitopes can be truncated distally to its junction with an adjacent epitope. The truncated epitopes can be immune epitopes, for example. The truncated epitopes can have lengths selected from the group including, but not limited to, 9, 8, 7, 8, 5, 4 amino acids, and the like.</p><p id="p0018" num="0018">It is disclosed that the substrate polypeptide can include an array of epitopes and epitope clusters. Members of the array can be arranged head-to-tail, for example.</p><p id="p0019" num="0019">It is disclosed that the proteasome can be an immune proteasome.</p><p id="p0020" num="0020">Also described are vectors including a housekeeping epitope expression cassette. The housekeeping epitope(s) can be derived from a target-associated antigen, and the housekeeping epitope can be liberatable, that is capable of liberation, from a translation product of the cassette by immunoprateasome processing.</p><p id="p0021" num="0021">The expression cassette can encode an array of two or more epitopes or at least one epitope and at least one epitope cluster. The members of the array can be arranged head-to-tail, for example. Also, the members of the array can be arranged head-to-tail separated by spacing sequences, for example. Further, the array can include a plurality of housekeeping epitopes. The plurality of housekeeping epitopes can include more than one copy of the same epitopes or single copies of distinct epitopes, for example. The array can include at least one housekeeping epitope and at least one immune epitopes. Also, the array can include alternating housekeeping and immune epitopes. Further, the array includes a housekeeping epitope sandwiched between two immune epitopes so that there<!-- EPO <DP n="3"> --> are two immune topes between each housekeeping epitope in the interior of the array. The immune epitopes can be truncated distally to their junction with the adjacent housekeeping epitope.</p><p id="p0022" num="0022">It is described herein that the expression cassette further encodes an authentic protein sequence, or segment thereof, including at least one immune epitope. Optionally, the segment can include at least one epitope cluster. The housekeeping epitope expression cassette and the authentic sequence including at least one immune epitope can be encoded in a single reading frame or transcribed as a single mRNA species, for example. Also, the housekeeping epitope expression. cassette and the authentic sequence including at least one immune epitope may not be transcribed as a single mRNA species.</p><p id="p0023" num="0023">In yet another aspect, the vector can include a DNA molecule or an RNA molecule. The vector can encode, SEQ ID NO. 17, or SEQ ID NO. 20.</p><p id="p0024" num="0024">Also, the vector can include SEQ ID NO. 21.</p><p id="p0025" num="0025">Also, the vector can encode SEQ ID NO. 18.</p><p id="p0026" num="0026">It is described herein that the target-associated antigen can be an antigen derived from or associated with a tumor or an intracellular parasite, and the intracellular parasite can be, for example, a virus, a bacterium, a protozoan, or the like.</p><p id="p0027" num="0027">Also described herein are vectors including a housekeeping epitope identified according to any of the methods disclosed herein, claimed or otherwise. For example, described is a vector encoding a substrate polypeptide that includes a housekeeping epitope by any of the methods described herein.</p><p id="p0028" num="0028">It is described herein that the housekeeping epitope can be liberated from the cassette translation product by immune proteasome processing</p><p id="p0029" num="0029">Also described herein are methods of activating a T cell. The methods can include, for example, the steps of contacting a vector including a housekeeping epitope expression cassette with an APC. The housekeeping epitope can be derived from a target-associated antigen, for example, and the housekeeping epitope can be liberatable from a translation product of the cassette by immunoproteasome processing. The methods can further include contacting the APC with a T cell. The contacting of the vector with the APC can occur <i>In vitro</i> or in vivo.</p><p id="p0030" num="0030">Also described herein is a substrate polypeptide including a housekeeping epitope wherein the housekeeping epitope can be liberated by immunoproteasome processing in a pAPC.</p><p id="p0031" num="0031">Also described herein is a method of activating a T cell comprising contacting a substrate polypeptide including a housekeeping epitope with an APC wherein the housekeeping epitope can be liberated by immunoproteasome processing and contacting the APC with a. T cell.</p><heading id="h0005"><u>Brief Description of the Drawing</u></heading><p id="p0032" num="0032"><ul><li><figref idrefs="f0001">Figure 1</figref>. An illustrative drawing depicting pMA2M.</li><li><figref idrefs="f0002">Figure 2</figref>. Assay results showing the % of specific lysis of ELAGIGILTV pulsed and unpulsed T2 target cells by mock immunized CTL.</li><li><figref idrefs="f0003">Figure 3</figref>. Assay results showing the % of specific lysis of ELAGIGILTV pulsed and impulsed T2 target cells by pVAXM3 immunized CTL.</li><li><figref idrefs="f0004">Figure 4</figref>. Assay results showing the % of specific lysis of ELAGIGILTV pulsed and impulsed T2 target cells by pVAXM2 immunized CTL.</li><li><figref idrefs="f0005">Figure 5</figref>. Assay results showing the % of specific lysis of ELAGIGILTV pulsed and unpulsed T2 target cells by pVAXM1 immunized CTL.</li><li><figref idrefs="f0006">Figure 6</figref>. illustrates a sequence of SEQ ID NO. 22 from which the NY-ESO-1<sub>157-165</sub> epitope is liberated by immunoproteasomal processing.</li><li><figref idrefs="f0007">Figure 7</figref>. Shows the differential processing by immunoproteasome and housekeeping proteasome of the SLLM-WITQC epitope (SEQ ID NO. 12) in its native context where the cleavage following the C is more efficiently produced by housekeeping than immunoproteasome,</li><li><figref idrefs="f0008 f0009">Figure 8</figref>. <figref idrefs="f0008">8A</figref>: Shows the results of the human immunoproteasome digest of SEQ ID NO. 31. 8B: Shows the comparative results of mouse versus human immunoproteasome digestion of SEQ ID NO. 31.</li><li><figref idrefs="f0010">Figure 9</figref>. Shows the differential processing of SSX-2<sub>31-68</sub> by housekeeping and immunoproteasome.</li></ul></p><heading id="h0006"><u>Detailed Descritption of the Preferred Embodiment</u></heading><heading id="h0007">Definitions</heading><p id="p0033" num="0033">Unless otherwise clear from the context of the use of a term herein, the following listed terms shall generally have the indicated meanings for purposes of this description.</p><p id="p0034" num="0034">PROFESSIONAL ANTIGEN-PRESENTING CELL (pAPC)-acell that possesses Tcell costimulatory molecules and is able to induce a T cell response. Well characterized pAPCs include dendritic cells, B cells, and macrophages.<!-- EPO <DP n="4"> --></p><p id="p0035" num="0035">PERIPHERAL CELL - a cell that is not a pAPC.</p><p id="p0036" num="0036">HOUSEKEEPING PROTEASOME -a proteasome normally active in peripheral cells, and generally not present or not strongly active in pAPCs.</p><p id="p0037" num="0037">IMMUNOPROTEASOME - a proteasome normally active in pAPCs; the immunoproteasome is also active in some peripheral cells in infected tissues or following exposure to interferon.</p><p id="p0038" num="0038">EPITOPE - a molecule or substance capable of stimulating an immune response. In preferred embodiments, epitopes according to this definition include but are not necessarily limited to a polypeptide and a nucleic acid encoding a polypeptide, wherein the polypeptide is capable of stimulating an immune response. In other preferred embodiments; epitopes according to this definition include but are not necessarily limited to peptides presented on the surface of cells, the peptides being non-covalently bound to the binding cleft of class I MHC, such that they can interact with T cell receptors (TCR). Epitopes presented by class I MHC may be in immature or mature form. "Mature" refers to an MHC epitope in distinction to any precursor ("Immature") that may include or consist essentially of a housekeeping epitope, but also includes other sequences in a primary translation product that are removed by processing, including without limitation, alone or in any combination, proteasomal digestion, N-terminal trimming, or the action of exogenous enzymatic activities. Thus, a mature epitope may be provided embedded in a somewhat longer polypeptide, the immunological potential of which is due, at least in part, to the embedded epitope; or in its ultimate form that can bind in the MHC binding cleft to be recognized by TCR, respectively.</p><p id="p0039" num="0039">MHC EPITOPE - a polypeptide having a known or predicted binding affinity for a mammalian class I or class II major histocompatibility complex (MHC) molecule.</p><p id="p0040" num="0040">HOUSEKEEPING EPITOPE- in a preferred embodiment, a housekeeping epitope is defined as a polypeptide fragment that is an MHC epitope, and that is displayed on a cell in which housekeeping proteasomes are predominantly active. In another preferred embodiment, a housekeeping epitope is defined as a polypeptide containing a housekeeping epitope according to the foregoing definition, that is flanked by one to several additional amino acids. In another preferred embodiment, a housekeeping epitope is defined as a nucleic acid that encodes a housekeeping epitope according to the foregoing definitions. Exemplary housekeeping epitopes are provide in <patcit id="pcit0004" dnum="US11793702A"><text>U.S. Application No. 10/117,937, filed on April 4, 2002</text></patcit>; and <patcit id="pcit0005" dnum="US28221101P"><text>U.S. Provisional Application Nos. 60/282,211, filed on April 6, 2001</text></patcit>; <patcit id="pcit0006" dnum="US60337017P"><text>60/337,017, filed on November 7, 2001</text></patcit>; <patcit id="pcit0007" dnum="US60363210P"><text>60/363210 filed 3/7/02</text></patcit>; and <patcit id="pcit0008" dnum="US60409123P"><text>60/409,123, filed on September 5, 2002</text></patcit>; all of which are entitled EPITOPE SEQUENCES.</p><p id="p0041" num="0041">IMMUNE EPITOPE- In a preferred embodiment, an immune epitope is defined as a polypeptide fragment that is an MHC epitope, and that is displayed on a cell in which immunoproteasomes are predominantly active. In another preferred embodiment, an immune epitope is defined as a polypeptide containing an immune epitope according to the foregoing definition, that is flanked by one to several additional amino acids, in another preferred embodiment, an immune epitope is defined as a polypeptide including an epitope cluster sequence, having at least two polypeptide sequences having a known or predicted affinity for a class I MHC. In yet another preferred embodiment, an immune epitope is defined as a nucleic acid that encodes an immune epitope according to any of the foregoing definitions.</p><p id="p0042" num="0042">TARGET CELL -a cell to be targeted by the vaccines and methods of the invention. Examples of target cells according to this definition include but are not necessarily limited to: a neoplastic cell and a cell harboring an intracellular parasite, such as, for example, a virus, a bacterium, or a protozoan. Target cells can also include cells that are targeted by CTL as a part of assays to determine or confirm proper epitope liberation and processing by a cell expressing immunoproteasome, to determine T cell specify or immunogenicity for a desired epitope. Such cells may be transformed to express the substrate or liberation sequence, or the cells can simply be pulsed with peptide/epitope.</p><p id="p0043" num="0043">TARGET-ASSOCIATED ANTIGEN (TAA) -a protein or polypeptide present in a target cell.</p><p id="p0044" num="0044">TUMOR-ASSOCIATED ANTIGENS (TuAA)- a TAA, wherein the target cell is a neoplastic cell.</p><p id="p0045" num="0045">HLA EPITOPE -a polypeptide having a known or predicted binding affinity for a human class I or class 11 HLA complex molecule.</p><p id="p0046" num="0046">ANTIBODY-natural immunoglobulin (Ig), poly- or monoclonal, or any molecule composed in whole or in part of an lg binding domain, whether derived biochemically or by use of recombinant DNA. Examples include <i>Inter alia</i>, F (ab), single chain Fv, and if, variable region-phage coat protein fusions.</p><p id="p0047" num="0047">ENCODE -an open-ended term such that a nucleic acid encoding a particular amino acid sequence can consist of codons specifying that (poly)peptide, but can also comprise additional sequences either translatable, or for the control of transcription, translation, or replication, or to facilitate manipulation of some host nucleic add construct.</p><p id="p0048" num="0048">SUBSTANTIAL SIMILARITY -this term is used to refer to sequences that differ from a reference sequence in an inconsequential way as judged by examination of the sequence. Nucleic add sequences encoding the same amino add sequence are substantially similar despite differences in degenerate positions or modest differences in length or composition of any non-coding regions. Amino acid sequences differing only by conservative substitution or minor length variations are substantially similar. Additionally, amino add sequences comprising housekeeping epitopes that differ in the number of N-terminal flanking residues, or immune epitopes and epitope clusters that differ in the number of flanking residues at either terminus, arc substantially similar. Nucleic acids that encode substantially similar amino acid sequences<!-- EPO <DP n="5"> --> are themselves also substantially similar.</p><p id="p0049" num="0049">FUNCTIONAL SIMILARITY-this term is used to refer to sequences that differ from a reference sequence in an inconsequential way as judged by examination of a biological or biochemical property, although the sequences may not be substantially similar. For example, two nucleic acids can be useful as hybridization probes for the same sequence but encode differing amino acid sequences. Two peptides that induce cross-reactive CTL responses are functionally similar even if they differ by non-conservative amino add substitutions (and thus do not meet the substantial similarity definition). Pairs of antibodies, or TCRs, that recognize the epitope can be functionally similar to each other despite whatever structural differences exist. In testing for functional similarity of immunogenicity one would generally immunize with the "altered" antigen and test the ability of the elicited response (Ab, CTL, cytokine production, etc.) to recognize the target antigen. Accordingly, two sequences may be designed to differ in certain respects while retaining the same function. Such designed sequence variants are among the embodiments of the present invention.</p><p id="p0050" num="0050">EXPRESSION CASSETTE-a polynucleotide sequence encoding a polypeptide, operably linked to a promoter and other transcription and translation control elements, including but not limited to enhancers, termination codons, internal ribosome entry sites, and polyadenylation sites. The cassette can also include sequences that facilitate moving it from one host molecule to another.</p><p id="p0051" num="0051">EMBEDDED EPITOPE -an epitope contained within a longer polypeptide, also can include an epitope in which either the N- terminus or the C-terminus is embedded such that the epitope is not in an interior position,</p><p id="p0052" num="0052">MATURE EPITOPE -a peptide with no additional sequence beyond that present when the epitope is bound in the MHC peptide-binding cleft.</p><p id="p0053" num="0053">EPITOPE CLUSTER - a polypeptide, or a nucleic acid sequence encoding it, that is a segment of a native protein sequence comprising two or more known or predicted epitopes with binding affinity for a shared MHC restriction element, wherein the density of epitopes within the cluster is greater than the density of all known, or predicted epitopes with binding affinity for the shared MHC restriction element within the compete protein sequence, and as disclosed in <patcit id="pcit0009" dnum="US561571A"><text>U.S. Patent Application No. 09/561,571</text></patcit> entitled EPITOPE CLUSTERS.</p><p id="p0054" num="0054">Substrate or liberation sequence-a designed or engineered sequence comprising or encoding a housekeeping epitope (according to the first of the definitions offered above) embedded in a larger sequence that provides a context allowing the housekeeping epitope to be liberated by immunoproteasomal processing, directly or in combination with N-terminal trimming or other processes.</p><p id="p0055" num="0055">Degradation, of cytosolic proteins takes place via the ubiquity-dependent multi-catalytic multi-subunit protease system known as the proteasome. The proteasome degrades cytosolic proteins generating fragments that can then be translocated from the cytosol into the endoplasmic reticulum (ER) for loading onto class I MHC. Such protein fragments shall be referred to as class I peptides. The peptide loaded MHC are subsequently transported to the cell surface where they can be detected by CTL.</p><p id="p0056" num="0056">The multi-catalytic activity of the proteasome is the result of its multi-subunit structure. Subunits are expressed from different genes and assembled post-translationally into the proteasome complex. A key feature of the proteasome is its bimodal activity, which enables it to exert its protease, or cleavage function, with two discrete kinds of cleavage patterns. This bimodal action of the proteasome is extremely fundamental to understanding how CTL are targeted to recognize peripheral cells in the body and how this targeting requires synchronization between the immune system and the targeted cells.</p><p id="p0057" num="0057">The housekeeping proteasome is constitutively active in all peripheral cells and tissues of the body. The first mode of operation for the housekeeping proteasome is to degrade cellular protein, recycling it into amino acids. Proteasome function is therefore a necessary activity for cell life. As a corollary to its housekeeping protease activity, however, class I peptides generated by the housekeeping proteasome are presented on all of the peripheral cells of the body.</p><p id="p0058" num="0058">The proteasome's second mode of function is highly exclusive and occurs specifically in pAPCs or as a consequence of a cellular response to interferons (IFNs). In its second mode of activity the proteasome incorporates unique subunits, which replace the catalytic subunits of the constitutive housekeeping proteasome. This "modified" proteasome has been called the immunoproteasome, owing to its expression in pAPC and as a consequence of induction by IFN in body cells.</p><p id="p0059" num="0059">APC define the repertoire of CTL that recirculate through the body and are potentially active as killer cells. CTL are activated by interacting with class I peptide presented on the surface of a pAPC. Activated CTL are induced to proliferate and caused to recirculate through the body in search of diseased cells, This is why the CTL response in the body is defined specifically by the class I peptides produced by the pAPC. It is important to remember that pAPCs express the immunoproteasome, and that as a consequence of the bimodal activity of the proteasome, the cleavage pattern of proteins (and the resultant class I peptides produced) are different from those in peripheral body cells which express housekeeping proteasome. The differential proteasome activity in pAPC and peripheral body cells, therefore, is important to consider during natural infection and with therapeutic CTL vaccination strategies.</p><p id="p0060" num="0060">All cells of the body are capable of producing IFN In the event that they are infected by a pathogen such as a virus. IFN production in turn results in the expression of the immunoproteasome in the infected cell. Viral antigens are<!-- EPO <DP n="6"> --> thereby processed by the immunoproteasome of the Infected cell and the consequent peptides are displayed with class I MHC on the cell surface. At the same time, pAPC are sequestering virus antigens and are processing class I peptides with their immunoproteasome activity, which is normal for the pAPC cell type. The CTL response in the body is being stimulated specifically by the class I peptides produced by the pAPC. Fortunately, the infected cell is also producing class I peptides from the immunoproteasome, rather than the normal housekeeping proteasome. Thus, virus-related class I peptides are being produced that enable detection by the ensuing CTL response. The CTL immune response is induced by pAPC, which normally produce different class I peptides compared to peripheral body cells, owing to different proteasome activity. Therefore, during infection there is epitope synchronization betweenthe infected cell and the immune system.</p><p id="p0061" num="0061">This is not the case with tumors and chronic viruses, which block the interferon system. For tumors there is no infection in the tumor cell to induce the immunoproteasome expression, and chronic virus infection either directly or indirectly blocks immunoproteasome expression. In both cases the diseased cell maintains its display of class I peptides derived from housekeeping proteasome activity and avoids effective surveillance by CTL.</p><p id="p0062" num="0062">In the case of therapeutic vaccination to eradicate tumors or chronic Infections, the bimodal function of the proteasome and its differential activity in APC and peripheral cells of the body is significant Upon vaccination with protein antigen, and before a CTL response can occur, the antigen must be acquired and processed into peptides that are subsequently presented on class I MHC on the pAPC surface. The activated CTL recirculate in search of cells with similar class I peptide on the surface. Cells with this peptide will be subjected to destruction by the cytolytic activity of the CTL. If the targeted diseased cell does not express the immunoproteasome, which is present in the pAPC, then the epitopes are not synchronized and CTL fail to find the desired peptide target on the surface of the diseased cell.</p><p id="p0063" num="0063">Preferably, therapeutic vaccine design takes into account the class 1 peptide that, is actually present on the target tissue. That is, effective antigens used to stimulate CTL to attack diseased tissue are those that are naturally processed and presented on the surface of the diseased tissue. For tumors and chronic infection this generally means that the CTL epitopes are those that have been processed by the housekeeping proteasome. In order to generate an effective therapeutic vaccine, CTL epitopes arc identified based on the knowledge that such epitopes are, in fact, produced by the housekeeping proteasome system. Once identified, these epitopes, embodied as peptides, can be used to successfully immunize or induce therapeutic CTL responses against housekeeping proteasome expressing target cells in the host.</p><p id="p0064" num="0064">However, in the case of DNA vaccines, there can be an additional consideration. The immunization with DNA requires that APCs take up the DNA. and express the encoded proteins or peptides, It is possible to encode a discrete class I peptide on the DNA. By immunizing with this construct, APCs can be caused to express a housekeeping epitope, which is then displayed on class I MHC on the surface of the cell for stimulating an appropriate CTL response. Constructs for generation of proper termini of housekeeping epitopes have been, described in <patcit id="pcit0010" dnum="US561572A"><text>U.S. Patent application No. 09/561,572 </text></patcit> entitled EXPRESSION VECTORS ENCODING EPITOPES OF TARGET-ASSOCIATED ANTIGENS, filed on April 28, 2000.</p><p id="p0065" num="0065">Disclosed herein are expression cassettes that encode one or more embedded housekeeping epitopes, and methods for designing and testing such expression cassettes. The expression cassettes and constructs can encode epitopes, including housekeeping epitope, derived from antigens that are associated with targets. Housekeeping epitopes can be liberated from the translation product(s) of the cassettes. It is described that the housekeeping epitope(s) can be flanked by arbitrary sequences or by sequences Incorporating residues known to be favored in immunoproteasome cleavage sites. It is described that multiple epitopes can be arrayed head-to-tell. It is described that these arrays can be made up entirely of housekeeping epitopes. Likewise, the arrays can include alternating housekeeping and Immune epitopes. Alternatively, the arrays can include housekeeping epitopes flanked by immune epitopes, whether complete or distally truncated. It is described that each housekeeping epitope can be flanked on either side by an immune epitope, such that an array of such arrangements has two immune epitopes between each housekeeping epitope. Further, the arrays can be of any other similar arrangement. There is no restriction on placing a housekeeping epitope at the terminal positions of the array. The vectors can additionally contain authentic protein coding sequences or segments thereof containing epitopes clusters as a source of immune epitopes.</p><p id="p0066" num="0066">Several disclosures make reference to polyepitopes orstring-of-bead arrays. See, for example, <patcit id="pcit0011" dnum="WO0119408A1"><text>WO0119408A1, March 22, 2001</text></patcit>; <patcit id="pcit0012" dnum="WO9955730A2"><text>WO9955730A2, November 4,1999</text></patcit>; <patcit id="pcit0013" dnum="WO0040261A2"><text>WO0040261 A2, July 13, 2000</text></patcit>; <patcit id="pcit0014" dnum="WO9603144A1"><text>WO9603144A1, February 8, 1996</text></patcit>; <patcit id="pcit0015" dnum="EP1181314A1"><text>EP1181314A1, February 27,2002</text></patcit>; <patcit id="pcit0016" dnum="WO0123577A"><text>W00123577A.3, April 5</text></patcit>; <patcit id="pcit0017" dnum="US6074817A"><text>US6074817, June 13,2000</text></patcit>; <patcit id="pcit0018" dnum="US5965381A"><text>US5965381</text></patcit>, October 1.2, 1999; <patcit id="pcit0019" dnum="WO9741440A1"><text>WO9741440A1, November 6, 1997</text></patcit>; <patcit id="pcit0020" dnum="US6130066A"><text>US6130066, October 10, 2000</text></patcit>; <patcit id="pcit0021" dnum="US6004777A"><text>US6004777, December 21, 1999</text></patcit>; <patcit id="pcit0022" dnum="US5990091A"><text>US5990091, November23,1999</text></patcit>; <patcit id="pcit0023" dnum="WO9840501A1"><text>WO9840501A1, September 177,1998</text></patcit>; <patcit id="pcit0024" dnum="WO9840500A1"><text>WO9840500A1, September 17,1998</text></patcit>; <patcit id="pcit0025" dnum="WO0118035A2"><text>WO0118035A2, March 15, 2001</text></patcit>; <patcit id="pcit0026" dnum="WO02068654A2"><text>WO02068654A2, September 6, 2002</text></patcit>; <patcit id="pcit0027" dnum="WO0189281A2"><text>WO0189281A2, November 29, 2001</text></patcit>; <patcit id="pcit0028" dnum="WO0158478A"><text>WO0158478A, August 16, 2001</text></patcit>; <patcit id="pcit0029" dnum="EP1118860A1"><text>EP1118860A1, July 25, 2001</text></patcit>; <patcit id="pcit0030" dnum="WO0111040A1"><text>WO0111040A1, February 15, 2001</text></patcit>; <patcit id="pcit0031" dnum="WO0073438A1"><text>WO0073438A1, December 7, 2000</text></patcit>; <patcit id="pcit0032" dnum="WO0071158A1"><text>WO0071158A1, November 30, 2000</text></patcit>; <patcit id="pcit0033" dnum="WO0066727A1"><text>WO0066727A1, November 9, 2000</text></patcit>; <patcit id="pcit0034" dnum="WO0052451A1"><text>WO0052451A1, September 8. 2000</text></patcit>; <patcit id="pcit0035" dnum="WO0052157A1"><text>WO0052157A1, September 8, 2000</text></patcit>; <patcit id="pcit0036" dnum="WO0029008A2"><text>WO0029008A2, May 25, 2000</text></patcit>; <patcit id="pcit0037" dnum="WO0006723A1"><text>WO0006723A1, February 10, 2000</text></patcit>. Additional disclosures, include<!-- EPO <DP n="7"> --> <nplcit id="ncit0001" npl-type="s"><text>Palmowski MJ, et al -J Immunol 2002; 168(9):4391-8</text></nplcit>;<nplcit id="ncit0002" npl-type="s"><text> Fang ZY, et al - Virology 2001 ;291 (2):272-84</text></nplcit>;<nplcit id="ncit0003" npl-type="s"><text> Firat H, et al - J Gene Med 2002;4(1):38-45</text></nplcit>; <nplcit id="ncit0004" npl-type="s"><text>Smith SG, et al - Clin Cancer Res 2001;7(12):4253-61</text></nplcit>; <nplcit id="ncit0005" npl-type="s"><text>Vonderheide RH, et a1- Clin Cancer Res 2001; 7(11):3343-8</text></nplcit>; <nplcit id="ncit0006" npl-type="s"><text>Firat H, et al- Eur J Immunol 2001;31(10):3084-74</text></nplcit>; <nplcit id="ncit0007" npl-type="s"><text>Le TT, et el Vaccine 2001;19(32):4669.75</text></nplcit>; <nplcit id="ncit0008" npl-type="s"><text>Fayolle C, et al - J virol 2001;75(16):7330-8</text></nplcit>; <nplcit id="ncit0009" npl-type="s"><text>Smith. SG - Curr Opin Mol Ther 1999,1(1);10-5</text></nplcit>); <nplcit id="ncit0010" npl-type="s"><text>Firat H, et al - Eur J Immunol 1999;29(10):3112.-21</text></nplcit>; <nplcit id="ncit0011" npl-type="s"><text>Mateo L, et al -J Immmol 1999;163(7):4058-63</text></nplcit>; <nplcit id="ncit0012" npl-type="s"><text>Heemskerk MH, et al - Cell Immunol 1999;195(1): 10-7</text></nplcit>; <nplcit id="ncit0013" npl-type="s"><text>Woodberry T, et al - J Virol 1999;73(7):5320-5</text></nplcit>; <nplcit id="ncit0014" npl-type="s"><text>Hanke T, et al - Vaccine 1998;16(4):426-35</text></nplcit>; <nplcit id="ncit0015" npl-type="s"><text>Thomson SA, et al - J Immunol 1998,160(4):1717-23</text></nplcit>; <nplcit id="ncit0016" npl-type="s"><text>Toes RE, et al -Proc Natl Acad Sci USA. 1997;94(26):14660-5</text></nplcit>; <nplcit id="ncit0017" npl-type="s"><text>Thomson SA, et al -J Immunol 1996;157(2):822-6</text></nplcit>; <nplcit id="ncit0018" npl-type="s"><text>Thomson SA, et al - Proc Natl Acad sci USA 199S;92(13):5M5-9</text></nplcit>; <nplcit id="ncit0019" npl-type="s"><text>Street MD, et al - Immunology 2002;106(4):526-36</text></nplcit>; <nplcit id="ncit0020" npl-type="s"><text>Hirano K, et al Histochem Cell Biol 2002;117(1):41-53</text></nplcit>; <nplcit id="ncit0021" npl-type="s"><text>Ward SM, et al virus Genes 2001;23(I):97-104</text></nplcit>; <nplcit id="ncit0022" npl-type="s"><text>Liu WJ, et al - Virology 2000;273(2):374-82</text></nplcit>; <nplcit id="ncit0023" npl-type="s"><text>Gariglio P, et al - Arch Med Res 1998;29(4): 279-84</text></nplcit>; <nplcit id="ncit0024" npl-type="s"><text>Suhrbler A - Immunol Cell Biol 1997;75(4);402-8</text></nplcit>; <nplcit id="ncit0025" npl-type="s"><text>Fomsgaard A, at al - Vaccine 1999;18(7-8):681-91</text></nplcit>; <nplcit id="ncit0026" npl-type="s"><text>An LL, et al - J Virol 1997;71 (3):2292-302</text></nplcit>; <nplcit id="ncit0027" npl-type="s"><text>Whitton JL, et al - J Virol 1993;67(1):348-52</text></nplcit>; <nplcit id="ncit0028" npl-type="s"><text>Ripalti A, et al - J Clin Microbiol 1994;32 (2):358-63</text></nplcit>; and <nplcit id="ncit0029" npl-type="s"><text>Gilbert, S.C., et al., Nat. Biotech. 15:1280-1284, 1997</text></nplcit>.</p><p id="p0067" num="0067">One important feature that the disclosures In the preceding paragraph all share is their lack of appreciation for the desirability of regenerating housekeeping epitopes when the construct is expressed in a pAPC. This understanding was not apparent until the present invention. Embodiments of the invention include sequences, that when processed by an immune proteasome, liberate or generate a housekeeping epitope. Embodiments also can liberate or generate such epitopes in immunogenically effective amounts. Accordingly, while the preceding references contain disclosures relating to polyepitope arrays, none is enabling of the technology necessary to provide or select a polyepitope capable of liberating a housekeeping epitopes by action of an immunoproteasome in a pAPC. In contrast, embodiments are based upon a recognition of the desirability of achieving this result. Accordingly, embodiments include any nucleic acid construct that encodes a polypeptide containing at least one housekeeping epitopes provided in a context that promotes its generation via immunoproteasomal activity, whether the housekeeping epitope is embedded in a string-of-beads array or some other arrangement. Some embodiments include uses of one or more of the nucleic acid constructs or their products that are specifically disclosed in any one or more of the above-listed references. Such uses include, for example, screening a polyepitope for proper liberation context of a housekeeping epitope and/or an immune epitope, designing an effective immunogen capable of causing presentation of a housekeeping epitope and/or an immune epitope on a pAPC, immunizing a patient, and the like. Alternative embodiments include use of only a subset of such nucleic acid constructs or a single such construct, while specifically excluding one or more other such constructs, for any of the purposes disclosed herein.</p><p id="p0068" num="0068">Embodiments also include methods, uses, therapies, and compositions directed to verious types of targets. Such targets can Include, for example, neoplastic cells such as those listed below, for example; and cells infected with any virus, bacterium, protozoan, fungus, or other agents, examples of which are listed below, in Tables 1-5, or which are disclosed In any of the references listed above. Alternative embodiments include the use of only a subset of such neoplastic cells and infected cells listed below, in Tables 1-5, or in any of the references disclosed herein, or a single one of the neoplastic cells or infected cells, while specifically excluding one or more other such neoplastic cells or infected cells, for any of the purposes disclosed herein. The following are examples of neoplastic cells that can be targeted: human sarcomas and carcinomas, e.g., fibrosarcoma, myxosarcoma, liposarcoma, chondrosarcoma, osteogenic sarcoma, chordoma, angiosancoma, endotheliosarcoma, lymphanglosarcoma, lymphangioendothellosarcoma, synovioma, mesothelioma, Ewing's tumor, leiomyosarcoma, rhabdomyosarcoma, colon carcinoma, pancreatic cancer, breast cancer, ovarian cancer, prostate cancer, squamous cell carcinoma, basal cell carcinoma, adenocarcinoma, sweat gland carcinoma, sebaceous gland carcinoma, papillary carcinoma, papillary adenocarcinomas, cystadenocarcinoma, medullary carcinoma, bronchogenic carcinoma, renal cell carcinoma, hepatoma, bile duct carcinoma, chonocarcinoma, seminoma, embryonal carcinoma, Wilms' tumor, cervical cancer, testicular tumor, lung carcinoma, small cell lung carcinoma, bladder carcinoma, epithelial carcinoma, glioma, astrocytoma, medulloblastoma, craniopharyngloma,<!-- EPO <DP n="8"> --> ependymoma, pinealoma, hemangloblastoma, acoustic neuroma, oligodendroglioma, meningioma, melanoma, neuroblastoma, retinoblastoma; leukemias, e.g., acute lymphocytic leukemia and acute myelocytic leukemia (mycloblastic, promyelocytic, myelomonocytic, monocytic and crythrolaukemia); chronic leukemia (chronic myelocytic (granulocytic) leukemia and chronic lymphocytic leukemia); and polycythemia vera, lymphoma (Hodgkin's disease and non Hodgkin's disease), multiple myeloma, Waldenstrom's macroglobulinemia, heavy chain disease, hepatocellular cancer, brain cancer, stomach cancer, liver cancer, and the like. Examples of infectious agents that infect the target cells can include the following: adenovirus, cytomegalovirus, Epstem-Barr virus, herpes simplex virus 1 herpes simplex virus 2, human herpesvirus 6, varicella-zoster virus, hepatitis B virus, hepatitis D virus, papilloma Virus, parvovirus B19, polyomavirus BK, polyomavirus JC, hepatitis C virus, measles virus, rubella virus, human immunodeficiency virus (HIV), human Tcell leukemia virus I, human T cell leukemia virus II, <i>Chlamydia, Listeria, Salmonella, Legionella, Brucella, Coxiella, Rickettsia, Mycobacterium, Leishmania, Trypanasoma, Toxoplasma, Plasmodium,</i> and the like. Exemplary infectious agents and neoplastic cells are also included in Tables 1-5 below.</p><p id="p0069" num="0069">Furthermore the targets can include neoplastic cells described in or cells infected by agents that are described in any of the following references: <nplcit id="ncit0030" npl-type="s"><text>Jäger, E. et al., "Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo," Int. J Cancer, 67:54-62 (1996</text></nplcit>); <nplcit id="ncit0031" npl-type="s"><text>Kündig, T.M., Althage, A., Hengartner, H. &amp; Zinkemagel, R.M., "A skin test to assess CD8+ cytotoxic T cell activity," Proc. Natl. Acad Sci. USA, 89: 7757-76 (1992</text></nplcit>); <nplcit id="ncit0032" npl-type="s"><text>Bachmann, M.F. &amp; Kundig, T.M., "In vitro vs, in vivo assays for the assessment of T- and B-cell function," Curr. Opin. Immunol., 6:320-326 (1994</text></nplcit>), <nplcit id="ncit0033" npl-type="s"><text>Kundig et al., "On the role of antigen in maintaining cytotoxic T cell memory." Proceedings of the National Academy of Sciences of the United States of America, 93:9716-23 (1996</text></nplcit>); <nplcit id="ncit0034" npl-type="s"><text>Steinmann, R.M., "The dendritic cells system and its role in immunogenicity," Annual Review of Immunology 9:271-96 (1991</text></nplcit>); <nplcit id="ncit0035" npl-type="s"><text>Inaba, K. et al., "Identification of proliferating dendritic cell precursors in mouse blood," Journal of Experimental Medicine, 175: 1157-67 (1992</text></nplcit>); <nplcit id="ncit0036" npl-type="s"><text>Young, J.W. &amp; Inaba, K., "Dendritic cells as adjuvants for class I major histocompatibility complex-restricted anti-tumor immunity," Journal of Experimental Medicine, 183:7-1. (1996</text></nplcit>); <nplcit id="ncit0037" npl-type="b"><text>Kuby, Janis, Immunology, Second Edition, Chapter 15, W.H. Freeman and Company (1991</text></nplcit>); <nplcit id="ncit0038" npl-type="b"><text>Austenst, E., Stahl, T., and de Gruyter, Walter, Insulin Pump Therapy, Chapter 3, Berlin, New York (1990</text></nplcit>); <nplcit id="ncit0039" npl-type="b"><text>Remington, The Science and Practice of Pharmacy, Nineteenth Edition, Chapters 86-88; Cleland, Jeffery L. and Lanker, Robert (Editor), "Formulation and delivery of proteins and peptides," American Chemical Society (ACS Symposium Series, No. 567) (1994</text></nplcit>); Dickinson, Becton, which is fixed usingTegadenn transparent dressing Tegaderm™ 1624, 3M, St. Paul, MN 55144, USA; Santus, <nplcit id="ncit0040" npl-type="s"><text>Giancario and Baker, Richard, "Osmotic drug delivery: A. review of the patent literature," Journal of Controlled Release, 35:121 (1995</text></nplcit>); <patcit id="pcit0038" dnum="US5747269A"><text>Rammensee, U.S. Patent No. 5,747,269, issued May 05, 1998</text></patcit>; <patcit id="pcit0039" dnum="US5059423A"><text>Magruder, U.S. Patent No. 5,059,423, issued October 22, 1991</text></patcit>; <patcit id="pcit0040" dnum="US4552651A"><text>Sandbrook, U.S. Patent No. 4,552,651, issued November 25, 1985</text></patcit>; <patcit id="pcit0041" dnum="US33987790B"><text>Eckenhoff et al., U.S. Patent No.3 3,987,790, issued October 26, 1976</text></patcit>; <patcit id="pcit0042" dnum="US4455145A"><text>Theeuwes, U.S. Patent No. 4,455,145, issued June 19, 1984</text></patcit>, <patcit id="pcit0043" dnum="US4929233A"><text>Roth et al. U.S. Patent No. 4,929,233, issued May 29 1990</text></patcit>; <patcit id="pcit0044" dnum="US5554506A"><text>van der Bruggen et al., U.S. Patent No. 5,554,506, issued September 10, 1996</text></patcit>; <patcit id="pcit0045" dnum="US5698396A"><text>Pfreundschuh, U.S. Patent No. 5,698,396, issued December 16, 1997</text></patcit>; <patcit id="pcit0046" dnum="US5110596A"><text>Magruder, U.S, Patent. No. 5,110,596, issued May 5, 1992</text></patcit>; <patcit id="pcit0047" dnum="US4619652A"><text>Eckenhoff, U.S. Patent. No. 4,619,652, issued October 28, 1986</text></patcit>; <patcit id="pcit0048" dnum="US3995631A"><text>Higuchi et al., U.S. Patent No. 3,995,631, issued December07, 1976</text></patcit>; <patcit id="pcit0049" dnum="US5017381A"><text>Maruyama, U.S. Patent No, 5,017,381, issued May 21, 1991</text></patcit>; <patcit id="pcit0050" dnum="US4963141A"><text>Eckenhoff, U.S. Patent No. 4,963,141, issued October 16, 1990</text></patcit>; <patcit id="pcit0051" dnum="US5558995A"><text>van der Bruggen et al., U.S. Patent No. 5,558,995, issued September 24, 1996</text></patcit>; <patcit id="pcit0052" dnum="US3604417A"><text>Stolzenberg et al. U.S. Patent No. 3,604,417, issued September 14, 1971</text></patcit>; <patcit id="pcit0053" dnum="US5110597A"><text>Wong et al., US. Patent No. 5,110,597, issued May 05, 1992</text></patcit>; <patcit id="pcit0054" dnum="US4753651A"><text>Eckenhoff, U.S. Patent No. 4,753,651, issued June 28, 1988</text></patcit>; <patcit id="pcit0055" dnum="US4203440A"><text>Theeuwes, U.S. Patent No. 4,203,440, issued May 20, 1980</text></patcit>; <patcit id="pcit0056" dnum="US5023088A"><text>Wong et al. U.S. Patent No. 5,023,088, issued June 11, 1991</text></patcit>; <patcit id="pcit0057" dnum="US4976966A"><text>Wong et al., U.S. Patent. No. 4,976,966, issued December 11, 1990</text></patcit>; <patcit id="pcit0058" dnum="US5648226A"><text>Van den Eynde et al., U.S. Patent No. 5,648,226, issued July 15, 1997</text></patcit>; <patcit id="pcit0059" dnum="US4838862A"><text>Baker et al., U.S. Patent No. 4,838,862, issued June 13, 1989</text></patcit>; <patcit id="pcit0060" dnum="US5135523A"><text>Magruder, U.S. Patent No. 5,135,523, issued August 04, 1992</text></patcit>; <patcit id="pcit0061" dnum="US3732865A"><text>Higuchi et al., U.S. Patent No. 3,732,865, issued May 15, 1975</text></patcit>, ; <patcit id="pcit0062" dnum="US4286067A"><text>Theeuwes, U.S. Patent No. 4,286,067, issued August, 25 1981</text></patcit>; <patcit id="pcit0063" dnum="US5030216A"><text>Theeuwes et al., U.S. Patent No. 5,030,216, issued July 09, 1991</text></patcit>;<patcit id="pcit0064" dnum="US5405940A"><text> Boon et al., U.S. Patent No. 5,405,940, issued April 11, 1995</text></patcit>; <patcit id="pcit0065" dnum="US4898582A"><text>Faste, U.S. Patent No. 4,898,582, issued February 06, 1990</text></patcit>; <patcit id="pcit0066" dnum="US5137727A"><text>Eckenhoff, U.S. Patent No. 5,137,727, issued August 11, 1992</text></patcit>; <patcit id="pcit0067" dnum="US3760804A"><text>Higuchi et al., U.S. Patent No. 3,760,804, issued September 25, 1973</text></patcit>; <patcit id="pcit0068" dnum="US4300558A"><text>Eckenhoff et al., U.S. Patent No. 4,300,558, issued November 12, 1981</text></patcit>; <patcit id="pcit0069" dnum="US5034229A"><text>Magruder et al., U.S. Patent No. 5,034,229, issued July 23, 1991</text></patcit> <patcit id="pcit0070" dnum="US5487974A"><text>Boon et al., U.S. Patent No. 5,487,974, issued January 30, 1996</text></patcit>; <patcit id="pcit0071" dnum="US5135498A"><text>Kam et al., U.S. Patent No. 5,135,498, issued August 04, 1992</text></patcit>; <patcit id="pcit0072" dnum="US5174999A"><text>Magruder et al., U.S. Patent No. 5,174,999, issued December 29, 1992</text></patcit>; <patcit id="pcit0073" dnum="US3760805A"><text>Higuchi, U.S. Patent No. 3,760,805, September 25, 1973</text></patcit>; <patcit id="pcit0074" dnum="US4304232A"><text>Michaels, U.S. Patent No. 4,304,232, issued December 08, 1981</text></patcit>; <patcit id="pcit0075" dnum="US5037420A"><text>Magruder et al., U.S. Patent No. 5,037,420, issued October 15, 1991</text></patcit>; <patcit id="pcit0076" dnum="US5530096A"><text>Wolfel et al., U.S. Patent No. 5,530,096, issued June 25, 1996</text></patcit>; <patcit id="pcit0077" dnum="US5169390A"><text>Athadye et al., U.S. Patent No. 5,169,390, issued December 08, 1992</text></patcit>; <patcit id="pcit0078" dnum="US5209746A"><text>Balaban et al., U.S. Patent No. 5,209,746, issued May 11, 1993</text></patcit>; <patcit id="pcit0079" dnum="US3929132A"><text>Higuchi, U.S. Patent No. 3,929,132, issued December 30,1975</text></patcit>; <patcit id="pcit0080" dnum="US4340054A"><text>Michaels, U.S, Patent No. 4,340,054, issued July 20,1982</text></patcit>; <patcit id="pcit0081" dnum="US0057318A"><text>Magruder et al., U.S. Patent No. 0,057,318, issued October 15, 1991</text></patcit>; <patcit id="pcit0082" dnum="US5519117A"><text>Wolfel et al., U.S. Patent No. 5,519,117, issued May 21, 1996</text></patcit>; <patcit id="pcit0083" dnum="US5257987A"><text>Athadye et al., U.S. Patent. No. 5,257,987, issued November 02, 1993</text></patcit>; <patcit id="pcit0084" dnum="US5221278A"><text>Linkwitz et al., U.S. Patent No. 5,221,278, issued June 22,1993</text></patcit>; <patcit id="pcit0085" dnum="US3995632A"><text>Nakano et al., U.S. Patent No. 3,995,632, issued December 07,1976</text></patcit>; <patcit id="pcit0086" dnum="US4367741A"><text>Michaels, U.S. Patent No. 4,367,741, issued January 11, 1983</text></patcit>; <patcit id="pcit0087" dnum="US4865598A"><text>Eckenhoff, U.S. Patent No. 4,865,598, issued September 12, 1989</text></patcit>;<patcit id="pcit0088" dnum="US5774316A"><text> Eat al., U.S. Patent No. 5,774,316., issued April 28, 1998</text></patcit>; <patcit id="pcit0089" dnum="US4340048A"><text>Eckenhoff, U.S. Patent No. 4,340,048, issued July 20, 1982</text></patcit>; <patcit id="pcit0090" dnum="US5223265A"><text>Wong, U.S.<!-- EPO <DP n="9"> --> Patent No. 5,223,265, issued June 29, 1993</text></patcit>; <patcit id="pcit0091" dnum="US4034756A"><text>Higuchi et al., U.S. Patent No. 4,034,756, issued July 12, 1977</text></patcit>; <patcit id="pcit0092" dnum="US4450198A"><text>Michaels, U.S. Patent No. 4,450,198, issued May 22, 1984</text></patcit>; <patcit id="pcit0093" dnum="US4865845A"><text>Eckenhoff et al., U.S. Patent No. 4,865,845, issued September 12, 1989</text></patcit>; <patcit id="pcit0094" dnum="US5554724A"><text>Melief et al., U.S. Patent No. 5.554,724, issued September to, 1996</text></patcit>; <patcit id="pcit0095" dnum="US4474575A"><text>Eckenhoff et al., U.S. Patent No. 4,474,575, issued October 02, 1984</text></patcit>; <patcit id="pcit0096" dnum="US3760984A"><text>Theeuwes, U.S. Patent No. 3,760,984, issued September 25, 1983</text></patcit>; <patcit id="pcit0097" dnum="US4350271A"><text>Eckenhoff, U.S. Patent No. 4,350,271, issued September 21, 1982</text></patcit>; <patcit id="pcit0098" dnum="US4855141A"><text>Eckenhoff et al., U.S. Patent No. 4,855,141, issued August 08, 1989</text></patcit>; <patcit id="pcit0099" dnum="US4872873A"><text>Zingerman, U.S. Patent No. 4,872,873, issued October 10, 1989</text></patcit>; <patcit id="pcit0100" dnum="US5585461A"><text>Townsend at al., U.S. Patent No. 5,585,461, issued December 17, 1996</text></patcit>; <nplcit id="ncit0041" npl-type="s"><text>Carulli. J.P. et al., J. Cellular Biochem Suppl., 30/31:286-96 (1998</text></nplcit>); <nplcit id="ncit0042" npl-type="s"><text>Türeci, Ö., Sahin, U., and Pfreundschuh, M., "Serological analysis of human tumor antigens; molecular definition and implications," Molecular Medicine Today, 3:342 (1997</text></nplcit>); <nplcit id="ncit0043" npl-type="b"><text>Rammensee et al., MHC Ligands and Peptide Motifs Landes Bioscience Austin, TX, 224-27, (1997</text></nplcit>); <nplcit id="ncit0044" npl-type="s"><text>Parker et al., "Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains," J. Immunol, 152:163-175</text></nplcit>; <nplcit id="ncit0045" npl-type="s"><text>Kido &amp; Ohshita, Anal. Biochem., 230:41-47 (1995</text></nplcit>); <nplcit id="ncit0046" npl-type="s"><text>Yamada et al., J. Biochem, (Tokyo), 95:1155-60 (1984</text></nplcit>); <nplcit id="ncit0047" npl-type="s"><text>Kawashima et al., Kidney Int., 54:275.8 (1998</text></nplcit>); <nplcit id="ncit0048" npl-type="s"><text>Nakabayshi &amp; Ikezawa, Biochem. Int. 16:1119.-25 (1988</text></nplcit>); <nplcit id="ncit0049" npl-type="s"><text>Kanaseki &amp; Ohkuma, J. Biochem. (Tokyo), 110:541-7 (1991</text></nplcit>); <nplcit id="ncit0050" npl-type="s"><text>Wattiaux et al., J. Cell Biol., 78:349-68 (1978</text></nplcit>);<nplcit id="ncit0051" npl-type="s"><text> Lisman et al., Biochem, J., 178:79-87 (1979</text></nplcit>); <nplcit id="ncit0052" npl-type="s"><text>Dean, B., Arch. Blochem. Blophys., 227:154-63 (1983</text></nplcit>); <nplcit id="ncit0053" npl-type="s"><text>Overdijk et al., Adv. Exp. Med. Biol., 101:601-10 (1978</text></nplcit>); <nplcit id="ncit0054" npl-type="s"><text>Stromhaug et al., Biochem. J., 335:217-24 (1998</text></nplcit>); <nplcit id="ncit0055" npl-type="s"><text>Escola et al., J. Biol. Chem., 271:27360-05 (1996</text></nplcit>); <nplcit id="ncit0056" npl-type="s"><text>Hammond et al., Am. J. Physiol.,267:F516-27 (1994</text></nplcit>); <nplcit id="ncit0057" npl-type="s"><text>Williams &amp; Smith, Arch. Biochem. Biophys., 305:298-306 (1993</text></nplcit>); <nplcit id="ncit0058" npl-type="s"><text>Marsh, M., Methods Cell Biol., 31:319.34 (1989</text></nplcit>); <nplcit id="ncit0059" npl-type="s"><text>Schmid &amp; Mellman, Prog. Clin. Biol. Res., 270:35-49 (1988</text></nplcit>); <nplcit id="ncit0060" npl-type="s"><text>Falk, K. et at., Nature, 351:290, (1991</text></nplcit>); <nplcit id="ncit0061" npl-type="b"><text>Ausubel et al., Short Protocols in Molecular Biology, Third Edition, Unit 11.2 (1997); hypertext transfer protocol address 134.2.96.221/scripts/hlaserver.dil/EpPredict.htm</text></nplcit>; <nplcit id="ncit0062" npl-type="s"><text>Levy, Morel, S. et al., Immunity 12:107-117 (2000</text></nplcit>); <nplcit id="ncit0063" npl-type="s"><text>Seipelt et Virus Research, 62:159-68, 1999</text></nplcit>; <patcit id="pcit0101" dnum="US5989565A"><text>Storkus et al., U.S. Patent No. 5,989,565, issued November 23, 1999</text></patcit>; <patcit id="pcit0102" dnum="US5993828A"><text>Morton, U.S. Patent No. 5,993,828, issued November 30, 1999</text></patcit>; <nplcit id="ncit0064" npl-type="s"><text>Virus Research 62:159-168, (1999</text></nplcit>); <patcit id="pcit0103" dnum="US20030215425A"><text>U.S. Patent Application No. 2003/0215425 </text></patcit> <patcit id="pcit0104" dnum="WO9901283A"><text>Miura et al., WO 99/01283, January 14, 1999</text></patcit>; <patcit id="pcit0105" dnum="US6861234B"><text>Simard et al., U.S. Patent 6,861,234</text></patcit>, U.S. Patent Application, U.S. Patent <patcit id="pcit0106" dnum="US6861234B"><text>US 6,861,234</text></patcit>.</p><p id="p0070" num="0070">Also disclosed herein are methods, uses, therapies, and compositions relating to a particular antigen, whether the antigen is derived from, for example, a target cell or an infective agent, such as those mentioned above. Some preferred embodiments employ the antigens listed herein, in Tables 1-5, or in the list below, alone, as subsets, orin any combination. For example, some embodiments exclude use of one or more ofthose antigens. Other embodiments may exclude any combination or all of those antigens. Several examples of such antigens include MelanA (MART-1), gp100 (Pmel 17), tyrosinase, TRP-1, TRP-2, MAGE-1, MAGE-3, BAGE, GAGE-1, GAGE-2, CEA, RAGE, NY-ESO, SCP-1, Hom/Mel-40, FRAME, p53, H-Ras, HER-2/neu, BCR-ABL, E2A-PRL, H4-RET, IGH-IGK, MYL-RAR, Epstein Barr virus antigens, EBNA, human papillomavirus (HPV) antigens E6 and E7, TSP-180, MAGE-4, MAGE-5, MAGE-6, p185erbB2, p180erbB-3, c-met, nm-23HL PSA, TAG-72.4, CAM 17,1, NuMa, K-ras, β-Catenin, CDK4, Mum-1, p16, as well as any of those set forth in the above mentioned references. Other antigens are included in Tables 1-4 below.</p><p id="p0071" num="0071">Also disclosed herein are methods, uses, compositions, and therapies relating to epitopes, including, for example those epitopes listed in Tables 1-5. These epitopes can be useful to flank housekeeping epitopes in screening vectors, for example. Some embodiments include one or more epitopes from Tables 1-5, while other embodiments specifically exclude one or more of such epitopes or combinations thereof.
<tables id="tabl0001" num="0001"><table frame="all"><title><u>Table 1</u></title><tgroup cols="5"><colspec colnum="1" colname="col1" colwidth="36mm"/><colspec colnum="2" colname="col2" colwidth="26mm"/><colspec colnum="3" colname="col3" colwidth="25mm"/><colspec colnum="4" colname="col4" colwidth="49mm"/><colspec colnum="5" colname="col5" colwidth="31mm"/><thead><row><entry valign="top">Virus</entry><entry valign="top">Protein</entry><entry valign="top">AA Position</entry><entry valign="top">T cell epitope MHC ligand (Antigen)</entry><entry valign="top">MHC molecule</entry></row></thead><tbody><row><entry>Adenovirus 3</entry><entry>E3 9Kd</entry><entry>30-38</entry><entry>LIVIGILIL</entry><entry>HLA-A *0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:44)</entry><entry/></row><row><entry>Adenovirus 5</entry><entry>EIA</entry><entry>234-243</entry><entry>SGPSNTPPEI</entry><entry>H2-Db</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:45)</entry><entry/></row><row><entry>Adenovirus 5</entry><entry>EIB</entry><entry>192-200</entry><entry>VNIRNCCYI</entry><entry>H2-Db</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 46)</entry><entry/></row><row><entry>Adenovirus 5</entry><entry>EIA</entry><entry>234-243</entry><entry>SGPSNIPPEI (T&gt;I)</entry><entry>H2-Db</entry></row><!-- EPO <DP n="10"> --><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:47)</entry><entry/></row><row><entry>CSFV</entry><entry>NS polyprotein</entry><entry>2276-2284</entry><entry>ENALLVALF</entry><entry>SLA,haplotype d/d</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:48)</entry><entry/></row><row><entry>Dengue virus 4</entry><entry>NS3</entry><entry>500-508</entry><entry>TPEGIIPTL</entry><entry>HLA-B*3501</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:49)</entry><entry/></row><row><entry>EBV</entry><entry>LMP-2</entry><entry>426-434</entry><entry>CLGGLLTMV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:50)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA.-1</entry><entry>480-484</entry><entry>NIAEGLRAL</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:51)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA.1.</entry><entry>519-527</entry><entry>NLRRGTALA</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:52)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-1</entry><entry>525-533</entry><entry>ALAIPQCRL</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:53)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-1</entry><entry>575-582</entry><entry>VLKDAIKDL</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:54)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-1</entry><entry>562-570</entry><entry>FMVFLQTHI</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:55)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-2</entry><entry>15-23</entry><entry>HLIVDTDSL</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:56)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-2</entry><entry>22-30</entry><entry>SLGNPSLSV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:57)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-2</entry><entry>126-134</entry><entry>PLASAMRML</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:58)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-2</entry><entry>132-140</entry><entry>RMLWMANYI</entry><entry>HLA-A*020</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:59)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-2</entry><entry>133-141</entry><entry>MLWMANYIV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:60)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-2</entry><entry>151-159</entry><entry>ILPQGPQTA</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:61)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-2</entry><entry>171-179</entry><entry>PLRPTAPTI</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:62)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-2</entry><entry>205-213</entry><entry>PLPPATLTV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:63)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-2</entry><entry>246-254</entry><entry>RMHLPVLHV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:64)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-2</entry><entry>287-295</entry><entry>PMPLPPSQL</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:65)</entry><entry/></row><!-- EPO <DP n="11"> --><row><entry>EBV</entry><entry>EBNA-2</entry><entry>294..302</entry><entry>QLPPPAAPA</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:66)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-2</entry><entry>381-389</entry><entry>SMPELSPVL</entry><entry>HLA-A *020</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:67)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-2</entry><entry>453-461</entry><entry>DLDESWDYI</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:68)</entry><entry/></row><row><entry>EBV</entry><entry>BZLFI</entry><entry>43-51</entry><entry>PLPCVLWPV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:69)</entry><entry/></row><row><entry>EBV</entry><entry>BZLF1</entry><entry>167-175</entry><entry>SLEECDSEL</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:70)</entry><entry/></row><row><entry>EBV</entry><entry>BZLFI</entry><entry>176-184</entry><entry>EIKRYKNRV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:71)</entry><entry/></row><row><entry>EDV</entry><entry>BZLF1</entry><entry>195-203</entry><entry>QLLQHYREV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:72)</entry><entry/></row><row><entry>EBV</entry><entry>BZLFI</entry><entry>196-204</entry><entry>LLQHYREVA</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SFQ. ID NO.:73)</entry><entry/></row><row><entry>EBV</entry><entry>BZLFI</entry><entry>217-225</entry><entry>LLKQMCPSL</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:74)</entry><entry/></row><row><entry>EBV</entry><entry>BZLFI</entry><entry>229-237</entry><entry>SIIPRTPDV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:75)</entry><entry/></row><row><entry>EBV</entry><entry>ETNA-6</entry><entry>284-293</entry><entry>LLDFVRFMGV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ ID NO.:76)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-3</entry><entry>464-472</entry><entry>SVRDRLARL</entry><entry>HLA-A*0203</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO:77)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-4</entry><entry>416-424</entry><entry>IVTDFSVIK</entry><entry>HLA-A*1101</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:78)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-4</entry><entry>399-408</entry><entry>AVFDRKSDAK</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:79)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-3</entry><entry>246-253</entry><entry>RYSIFFDY</entry><entry>HLA-A24</entry></row><row><entry/><entry/><entry/><entry>(SEQ ID NO.: 80)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-6</entry><entry>881-889</entry><entry>QPRAPIRPI</entry><entry>HLA-B7</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:81)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-3</entry><entry>379-387</entry><entry>RPPIFIRRI.</entry><entry>HLA-B7</entry></row><row><entry/><entry/><entry/><entry>(SEQ ID NO.:82)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-1</entry><entry>426-434</entry><entry>EPDVPPGAI</entry><entry>HLA-B7</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:83)</entry><entry/></row><row><entry>EBV</entry><entry>EDNA-1</entry><entry>228-236</entry><entry>IPQCRLTPL</entry><entry>HLA-B7</entry></row><!-- EPO <DP n="12"> --><row><entry/><entry/><entry/><entry>(SEQ ID NO.:84)</entry><entry/></row><row><entry>EBV</entry><entry>EDNA-1</entry><entry>546-554</entry><entry>GPGPQPGPL</entry><entry>HLA-B7</entry></row><row><entry/><entry/><entry/><entry>(SEQ ID NO.:85)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-1</entry><entry>550-558</entry><entry>QPGPLRESI</entry><entry>HLA-B7</entry></row><row><entry/><entry/><entry/><entry>(SEQ, ID NO.:86)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-1</entry><entry>72-80</entry><entry>R.PQKRPSCI</entry><entry>HLA-B7</entry></row><row><entry/><entry/><entry/><entry>(SEQ ID NO.:87)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-2</entry><entry>224-232</entry><entry>PPTPLLTVL</entry><entry>HLA-B7</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:88)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-2</entry><entry>241-249</entry><entry>TFPSPPRMHL</entry><entry>HLA-B7</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:89) (SEQ. ID NO.:89)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-2</entry><entry>244-252</entry><entry>PPRMHLPVL</entry><entry>HLA-B7</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 90)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-2</entry><entry>254-262</entry><entry>VPDQSMHPL</entry><entry>HLA-B7</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO,: 91)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-2</entry><entry>446-454</entry><entry>PPSIDPADL</entry><entry>HLA-B7</entry></row><row><entry/><entry/><entry/><entry>(SEQ, ID NO.:92)</entry><entry/></row><row><entry>EBV</entry><entry>BZLFI</entry><entry>44-52</entry><entry>LPCVEWPVL</entry><entry>HLA-B7</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:93)</entry><entry/></row><row><entry>EBV</entry><entry>BZLFI</entry><entry>222-231</entry><entry>CPSLDVDSII</entry><entry>HLA-B7</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:94)</entry><entry/></row><row><entry>EBV</entry><entry>BZLFI</entry><entry>234-242</entry><entry>TPDVLHEDL</entry><entry>HLA-B7</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:95)</entry><entry/></row><row><entry>EBV</entry><entry>ETNA-3</entry><entry>339-347</entry><entry>FLIIGRAYGL</entry><entry>HLA-B8</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:96)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-3</entry><entry>26-34</entry><entry>QAKWRLQTL</entry><entry>HLA-B8</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:97)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-3</entry><entry>325-333</entry><entry>AYPLHEQHG</entry><entry>HLA-B8</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:98)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-3</entry><entry>158-166</entry><entry>YIKSFVSDA</entry><entry>HLA-B8</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:99)</entry><entry/></row><row><entry>EBV</entry><entry>LMP-2</entry><entry>236-244</entry><entry>RRRWRRLTV</entry><entry>HLA-B*2704</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 100)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-6</entry><entry>258-266</entry><entry>RRIYDLIEL</entry><entry>HLA-B*2705</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:101)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-3</entry><entry>458-466</entry><entry>YPLHEQHGM</entry><entry>HLA-B*3501</entry></row><!-- EPO <DP n="13"> --><row><entry/><entry/><entry/><entry>(SEQ. U) NO.: 102)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-3</entry><entry>458-466</entry><entry>YPLHEQHGM</entry><entry>HLA-B*3503</entry></row><row><entry/><entry/><entry/><entry>(SEQ.IDNO.:103)</entry><entry/></row><row><entry>HBV</entry><entry>NS3</entry><entry>389-397</entry><entry>HSKKKCDEL</entry><entry>HLA-B8</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 104)</entry><entry/></row><row><entry>HCV</entry><entry>env E</entry><entry>44-51</entry><entry>ASRCWVAM</entry><entry>HLA-B*3501</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 105)"°</entry><entry/></row><row><entry>HCV</entry><entry>core protein</entry><entry>27-35</entry><entry>GQIVGGVYL</entry><entry>HLA-B*40012</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 106)</entry><entry/></row><row><entry>HCV</entry><entry>NSI</entry><entry>77-85</entry><entry>PPLTDFDQGW</entry><entry>HLA-B*5301</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 107)</entry><entry/></row><row><entry>HCV</entry><entry>core protein</entry><entry>18-27</entry><entry>LMGYIPLVGA</entry><entry>H2-Dd</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 108)</entry><entry/></row><row><entry>HCV</entry><entry>core protein</entry><entry>16-25</entry><entry>ADLMGY1 PLV</entry><entry>H2-Dd</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 109)</entry><entry/></row><row><entry>HCV</entry><entry>NS5</entry><entry>409-424</entry><entry>MSYSWTGALVTPCAEE</entry><entry>H2-Dd</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 110)</entry><entry/></row><row><entry>HCV</entry><entry>NS1</entry><entry>205-213</entry><entry>KHPDATYSR</entry><entry>Papa-A06</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:111)</entry><entry/></row><row><entry>HCV-1</entry><entry>NS3</entry><entry>400-409</entry><entry>KLVALGINAV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 112)</entry><entry/></row><row><entry>HCV-1</entry><entry>NS3</entry><entry>440-448</entry><entry>GDFDSVIDC</entry><entry>Patr-B16</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 113)</entry><entry/></row><row><entry>HCV-1</entry><entry>env E</entry><entry>118-126</entry><entry>GNASRCWVA</entry><entry>Patr-B16</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 114)</entry><entry/></row><row><entry>HCV-1</entry><entry>NSI</entry><entry>159-167</entry><entry>TRPPLGNWF</entry><entry>Patr-B13</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 115)</entry><entry/></row><row><entry>HCV-1</entry><entry>NS3</entry><entry>351-359</entry><entry>VPHPNIEEV</entry><entry>Patr-B13</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 116)</entry><entry/></row><row><entry>HCV-1</entry><entry>NS3</entry><entry>438-446</entry><entry>YTGDFDSVI</entry><entry>Patr-B01</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:117)</entry><entry/></row><row><entry>HCV-1</entry><entry>NS4</entry><entry>328-335</entry><entry>SWAIKWEY</entry><entry>Patr-A11</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:118)</entry><entry/></row><row><entry>HCV-1</entry><entry>NSI</entry><entry>205-213</entry><entry>KHPDATYSR</entry><entry>Patr-A04</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:119)</entry><entry/></row><row><entry>HCV-1</entry><entry>NS3</entry><entry>440-448</entry><entry>GDFDSVIDC</entry><entry>Patr-A04</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:120)</entry><entry/></row><!-- EPO <DP n="14"> --><row><entry>HIV</entry><entry>gp41</entry><entry>583-591</entry><entry>RYLKDQQLL</entry><entry>HLA A24</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:121)</entry><entry/></row><row><entry>HIV</entry><entry>gagp24</entry><entry>267-275</entry><entry>IVGLNKIVR</entry><entry>HLA-A*3302</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:122)</entry><entry/></row><row><entry>HIV</entry><entry>gagp24</entry><entry>262-270</entry><entry>EIYKRWIIL</entry><entry>HLA-B8</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:123)</entry><entry/></row><row><entry>HIV</entry><entry>gagp24</entry><entry>261-269</entry><entry>GEIYKRWII</entry><entry>HLA-B8</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:124)</entry><entry/></row><row><entry>HIV</entry><entry>gagp17</entry><entry>93-101</entry><entry>EIKDTKEAL</entry><entry>HLA-B8</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:125)</entry><entry/></row><row><entry>HIV</entry><entry>gp41</entry><entry>586-593</entry><entry>YLKDQQLL</entry><entry>HLA-B8</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:126)</entry><entry/></row><row><entry>HIV</entry><entry>gagp24</entry><entry>267-277</entry><entry>ILGLNKIVRMY</entry><entry>HLA-B*1501</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:127)</entry><entry/></row><row><entry>HIV</entry><entry>gp41</entry><entry>584-592</entry><entry>ERYLKDQQL</entry><entry>HLA-B14</entry></row><row><entry/><entry/><entry/><entry>(SEQ.IDNO.:128)</entry><entry/></row><row><entry>HIV</entry><entry>nef</entry><entry>115-125</entry><entry>YHTQGYFPQWQ</entry><entry>HLA-B17</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:129)</entry><entry/></row><row><entry>HIV</entry><entry>nef</entry><entry>117-128</entry><entry>TQGYFPQWQNYT</entry><entry>HLA-B17</entry></row><row><entry/><entry/><entry/><entry>(SEQ, ID NO.:130)</entry><entry/></row><row><entry>HIV</entry><entry>gp120</entry><entry>314-322</entry><entry>GRAFVTIGK</entry><entry>HL-A-B*2705</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 131</entry><entry/></row><row><entry>HIV</entry><entry>gagp24</entry><entry>263-271</entry><entry>KRWIILGLN</entry><entry>HLA-B*2702</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:132)</entry><entry/></row><row><entry>HIV</entry><entry>nef</entry><entry>72-82</entry><entry>QVPLRPMTYK</entry><entry>HLA-B*3501</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:133)</entry><entry/></row><row><entry>HIV</entry><entry>nef</entry><entry>117-125</entry><entry>TQGYFPQWQ</entry><entry>HLA-B*3701</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:134)</entry><entry/></row><row><entry>HIV</entry><entry>gagp24</entry><entry>143-151</entry><entry>HQAISPRTI,</entry><entry>HLA-Cw*0301</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:135)</entry><entry/></row><row><entry>HIV</entry><entry>gagp24</entry><entry>140-151</entry><entry>QMVHQAISPRTL</entry><entry>HLA-Cw*0301</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:136)</entry><entry/></row><row><entry>HIV</entry><entry>gp120</entry><entry>431-440</entry><entry>MYAPPIGGQI</entry><entry>H2-Kd</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:137)</entry><entry/></row><row><entry>HIV</entry><entry>gp160</entry><entry>318-327</entry><entry>RGPGRAFVTI</entry><entry>H2-Dd</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:138)</entry><entry/></row><row><entry>HIV</entry><entry>gp120</entry><entry>17-29</entry><entry>MPGRAFVTI</entry><entry>H2-Ld</entry></row><!-- EPO <DP n="15"> --><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:139)</entry><entry/></row><row><entry>HIV-1</entry><entry>RT</entry><entry>476-484</entry><entry>ILKEPVHGV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:140)</entry><entry/></row><row><entry>HIV-1</entry><entry>nef</entry><entry>190-198</entry><entry>AFHHVAREL</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:141)</entry><entry/></row><row><entry>HIV-1</entry><entry>gp160</entry><entry>120-128</entry><entry>KLTPLCVTL</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:142)</entry><entry/></row><row><entry>HIV-1</entry><entry>gp]60</entry><entry>814-823</entry><entry>SLLNATDIAV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:143)</entry><entry/></row><row><entry>HIV-1</entry><entry>RT</entry><entry>179-187</entry><entry>VIYQYMDDL</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:144)</entry><entry/></row><row><entry>HIV-1</entry><entry>gagp 17</entry><entry>77-85</entry><entry>SLYNTVATL</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:145)</entry><entry/></row><row><entry>HIV-1</entry><entry>gp160</entry><entry>315-329</entry><entry>RGPGRAFVT1</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:146)</entry><entry/></row><row><entry>HIV-1</entry><entry>gp41</entry><entry>768-778</entry><entry>RLRDLLLIVTR</entry><entry>HLA-A3</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:147)</entry><entry/></row><row><entry>HIV-1</entry><entry>nef</entry><entry>73-82</entry><entry>QVPLRPMTYK</entry><entry>HLA-A3</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:148)</entry><entry/></row><row><entry>HIV-1</entry><entry>gp120</entry><entry>36-45</entry><entry>TVYYGVPVWK</entry><entry>HLA-A3</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:149)</entry><entry/></row><row><entry>HIV-1</entry><entry>gagp17</entry><entry>20-29</entry><entry>RLRPGGKKK</entry><entry>HLA-A3</entry></row><row><entry/><entry/><entry/><entry>(SEQ. 1D NO.:150)</entry><entry/></row><row><entry>HIV-1</entry><entry>gp120</entry><entry>38-46</entry><entry>VYYGVPVWK</entry><entry>HLA-A3</entry></row><row><entry/><entry/><entry/><entry>(SEQ.1D NO.:151)</entry><entry/></row><row><entry>HIV-1</entry><entry>nef</entry><entry>74-82</entry><entry>VPLRPMTYK</entry><entry>HLA-a*1101</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:152)</entry><entry/></row><row><entry>HIV-1</entry><entry>gagp24</entry><entry>325-333</entry><entry>AIFQSSMTK</entry><entry>HLA-A*1101</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:153)</entry><entry/></row><row><entry>HIV-1</entry><entry>nef</entry><entry>73-82</entry><entry>QVPLRPMTYK</entry><entry>HLA-A*1101</entry></row><row><entry/><entry/><entry/><entry>(SEG. ID NO.:154)</entry><entry/></row><row><entry>HIV-1</entry><entry>nef</entry><entry>83-94</entry><entry>AAVDLSHFLKEK</entry><entry>HLA-A*1101</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:155)</entry><entry/></row><row><entry>HIV-1</entry><entry>gagp24</entry><entry>349-359</entry><entry>ACQGVGGPGGHK</entry><entry>HLA-A*1101</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:156)</entry><entry/></row><row><entry>HIV-1</entry><entry>gagp24</entry><entry>203-212</entry><entry>ETINEEAAEW</entry><entry>HLA-A25</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:157)</entry><entry/></row><!-- EPO <DP n="16"> --><row><entry>HIV-1</entry><entry>nef</entry><entry>128-137</entry><entry>TPGPGVRYPL</entry><entry>HLA-B7</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO:158)</entry><entry/></row><row><entry>HIV-1</entry><entry>gagp 17</entry><entry>24-31</entry><entry>GGKKKYKL</entry><entry>HLA-B8</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID. NO.:159)</entry><entry/></row><row><entry>HIV-1</entry><entry>gpl20</entry><entry>2-10</entry><entry>RVKEKYQHL</entry><entry>HLA-B8</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID. NO.:160)</entry><entry/></row><row><entry>HIV-1</entry><entry>gagp24</entry><entry>298-306</entry><entry>DRFYKTLRA</entry><entry>HLA-B 14</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:161)</entry><entry/></row><row><entry>HIV-1</entry><entry>NEF</entry><entry>132-147</entry><entry>GVRYPLTFGWCYKLVP</entry><entry>HLA-B18</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:162)</entry><entry/></row><row><entry>HIV-1</entry><entry>gagp24</entry><entry>205-24</entry><entry>KRWIILGLNK</entry><entry>HLA-B*2705</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:163)</entry><entry/></row><row><entry>HIV-1</entry><entry>nef</entry><entry>190-198</entry><entry>AFHHVAREL</entry><entry>HLA-B*5201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:164)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-6</entry><entry>335-343</entry><entry>KEHVIQNAF</entry><entry>HLA-B44</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:165)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-8</entry><entry>130-139</entry><entry>EENLLDFVRF</entry><entry>HLA-B*4403</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 166)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-2</entry><entry>42-51</entry><entry>DTPLIPLTIF</entry><entry>HLA-B51</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:167)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-6</entry><entry>213-222</entry><entry>QNGALAINTF</entry><entry>HLA-1362</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:168)</entry><entry/></row><row><entry>EBV</entry><entry>EBNA-3</entry><entry>603-611</entry><entry>RLRAEAGVK</entry><entry>HLA-A3</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:169)</entry><entry/></row><row><entry>HBV</entry><entry>sAg</entry><entry>348-357</entry><entry>GLSPTVWLSV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 170)</entry><entry/></row><row><entry>HBV</entry><entry>SAg</entry><entry>335-343</entry><entry>WLSLLVPFV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:171)</entry><entry/></row><row><entry>HBV</entry><entry>cAg</entry><entry>18-27</entry><entry>FLPSDFFPSV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 172)</entry><entry/></row><row><entry>HBV</entry><entry>cAg</entry><entry>18-27</entry><entry>FLPSDFFPSV</entry><entry>HLA-A*0202</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:173)</entry><entry/></row><row><entry>HBV</entry><entry>cAg</entry><entry>18-27</entry><entry>FLPSDFFPSV</entry><entry>HLA-A*0205</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:174)</entry><entry/></row><row><entry>HBV</entry><entry>cAg</entry><entry>18-27</entry><entry>FLPSDFFPSV</entry><entry>HLA-A*0206</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:175)</entry><entry/></row><row><entry>HBV</entry><entry>pol</entry><entry>575-583</entry><entry>FLLSLOIHL</entry><entry>HLA-A*0201</entry></row><!-- EPO <DP n="17"> --><row><entry/><entry/><entry/><entry>(SEQ. ID NO:176)</entry><entry/></row><row><entry>HBV</entry><entry>pol</entry><entry>816-824</entry><entry>SLYADSPSV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:177)</entry><entry/></row><row><entry>HBV</entry><entry>pol</entry><entry>455-463</entry><entry>GLSRYVARL</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:178)</entry><entry/></row><row><entry>HBV</entry><entry>env</entry><entry>338-347</entry><entry>LLVPFVQWFV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:179)</entry><entry/></row><row><entry>HBV</entry><entry>pol</entry><entry>642-650</entry><entry>ALMPLYACI</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:180)</entry><entry/></row><row><entry>HBV</entry><entry>env</entry><entry>378-387</entry><entry>LLPIFFCLWV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:181)</entry><entry/></row><row><entry>HBV</entry><entry>pol</entry><entry>538-546</entry><entry>YMDDVVLGA</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:182)</entry><entry/></row><row><entry>HBV</entry><entry>env</entry><entry>250-258</entry><entry>LLLCLIFLL</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:183)</entry><entry/></row><row><entry>HBV</entry><entry>env</entry><entry>260-269</entry><entry>LLDYQGMLPV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:184)</entry><entry/></row><row><entry>HBV</entry><entry>env</entry><entry>370-379</entry><entry>SIVSPFIPLL</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:185)</entry><entry/></row><row><entry>HBV</entry><entry>env</entry><entry>183-191</entry><entry>FLLTMILTI</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 186)</entry><entry/></row><row><entry>HBV</entry><entry>cAg</entry><entry>88-96</entry><entry>YVMVNMGLK</entry><entry>HLA-A*1101</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:187)</entry><entry/></row><row><entry>HBV</entry><entry>cAg</entry><entry>141-151</entry><entry>STLPETTVVRR</entry><entry>HLA-A*3101</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 188)</entry><entry/></row><row><entry>HBV</entry><entry>can</entry><entry>141-151</entry><entry>STLPETTVVRR</entry><entry>HLA-A*6801</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:189)</entry><entry/></row><row><entry>HBV</entry><entry>cAg</entry><entry>18-27</entry><entry>FLPSDFFPSV</entry><entry>HLA-A*6801</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 190)</entry><entry/></row><row><entry>HBV</entry><entry>sAg</entry><entry>28-39</entry><entry>IPQSLDSWWTSL</entry><entry>H2-Ld</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:191)</entry><entry/></row><row><entry>HBV</entry><entry>cAg</entry><entry>93-100</entry><entry>MGLKFRQL</entry><entry>H2-Kb</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:192)</entry><entry/></row><row><entry>HBV</entry><entry>preS</entry><entry>141-149</entry><entry>STBXQSGXQ</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ.ID NO.: 193)</entry><entry/></row><row><entry>HCMV</entry><entry>gp B</entry><entry>618-628</entry><entry>FIAGNSAYEYV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 194)</entry><entry/></row><!-- EPO <DP n="18"> --><row><entry>HCMV</entry><entry>E1</entry><entry>978-989</entry><entry>SDEEFAIVAYTL</entry><entry>HLA-B18</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 195)</entry><entry/></row><row><entry>HCMV</entry><entry>pp65</entry><entry>397-411</entry><entry>DDVWTSGSDSDEELV</entry><entry>HLA-b35</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 196)</entry><entry/></row><row><entry>HCMV</entry><entry>pp65</entry><entry>123-131</entry><entry>IPSINVHHY</entry><entry>HLA-B*3501</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:197)</entry><entry/></row><row><entry>HCMV</entry><entry>pp65</entry><entry>495-504</entry><entry>NLVPMVATVO</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 198)</entry><entry/></row><row><entry>HCMV</entry><entry>pp65</entry><entry>415-429</entry><entry>RKTPRVTOGGAMAGA</entry><entry>HLA-B7</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:199)</entry><entry/></row><row><entry>HCV</entry><entry>MP</entry><entry>17-25</entry><entry>DLMGYIPLV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:200)</entry><entry/></row><row><entry>HCV</entry><entry>MP</entry><entry>63-72</entry><entry>LLALLSCLTV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 201)</entry><entry/></row><row><entry>HCV</entry><entry>MP</entry><entry>105-112</entry><entry>ILHTPGCV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 202)</entry><entry/></row><row><entry>HCV</entry><entry>env E</entry><entry>66-75</entry><entry>QLRRHIDLLV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:203)</entry><entry/></row><row><entry>HCV</entry><entry>end E</entry><entry>88-96</entry><entry>DLCGSVFLV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:204)</entry><entry/></row><row><entry>HCV</entry><entry>env E</entry><entry>172-180</entry><entry>SMVGNWAKV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:205)</entry><entry/></row><row><entry>HCV</entry><entry>NSI</entry><entry>308-316</entry><entry>HLHQNIVDV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:206)</entry><entry/></row><row><entry>HCV</entry><entry>NSI</entry><entry>340-348</entry><entry>FLLLADARV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:207)</entry><entry/></row><row><entry>HCV</entry><entry>NS2</entry><entry>234-246</entry><entry>GLRDLAVAVEPVV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:208)</entry><entry/></row><row><entry>HCV</entry><entry>NSI</entry><entry>18-28</entry><entry>SLLAPGAKQNV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:209)</entry><entry/></row><row><entry>HCV</entry><entry>NSI</entry><entry>19-28</entry><entry>LLAPGAKQNV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ.ID NO.:210)</entry><entry/></row><row><entry>HCV</entry><entry>NS4</entry><entry>199-201</entry><entry>LLFNILGGWV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO. :211)</entry><entry/></row><row><entry>HCV</entry><entry>NS3</entry><entry>579-587</entry><entry>YLVAYQATV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:212)</entry><entry/></row><row><entry>HCV</entry><entry>core protein</entry><entry>34-43</entry><entry>YLLPRRGPRL</entry><entry>HLA-A*0201</entry></row><!-- EPO <DP n="19"> --><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:213)</entry><entry>HLA-A*0201</entry></row><row><entry>HCV</entry><entry>MP</entry><entry>63-72</entry><entry>LLALLSCLTI</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:214)</entry><entry/></row><row><entry>HCV</entry><entry>NS4</entry><entry>174-182</entry><entry>SLMAFTAAV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:215)</entry><entry/></row><row><entry>HCV</entry><entry>NS3</entry><entry>67-75</entry><entry>CINGVCWTV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:216)</entry><entry/></row><row><entry>HCV</entry><entry>NS3</entry><entry>163-171</entry><entry>LLCPAGHAV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:217)</entry><entry/></row><row><entry>HCV</entry><entry>NS5</entry><entry>239-247</entry><entry>ILDSFDPLV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:218)</entry><entry/></row><row><entry>HCV</entry><entry>NS4A</entry><entry>236-244</entry><entry>ILAGYGAGV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:219)</entry><entry/></row><row><entry>HCV</entry><entry>NS5</entry><entry>714-722</entry><entry>GLQDCTMLV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:220)</entry><entry/></row><row><entry>HCV</entry><entry>NS3</entry><entry>281-290</entry><entry>TGAPVTYSTY</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:221)</entry><entry/></row><row><entry>HCV</entry><entry>NS4A</entry><entry>149-157</entry><entry>HMWNFISGI</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:222)</entry><entry/></row><row><entry>HCV</entry><entry>NS5</entry><entry>575-583</entry><entry>RVCEKMALY</entry><entry>HLA-A*0201-A3</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:223)</entry><entry/></row><row><entry>HCV</entry><entry>NS1</entry><entry>238-246</entry><entry>TINYTIFK</entry><entry>HLA-A*1101</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:224)</entry><entry/></row><row><entry>HCV</entry><entry>NS2</entry><entry>109-116</entry><entry>YISWCLWW</entry><entry>HLA-A23</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:225)</entry><entry/></row><row><entry>HCV</entry><entry>core protein</entry><entry>40-48</entry><entry>GPRLGVRAT</entry><entry>HLA-B7</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:226)</entry><entry/></row><row><entry>HIV-1</entry><entry>gp120</entry><entry>380-388</entry><entry>SFNCGGEFF</entry><entry>HLA-Cw*0401</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:227)</entry><entry/></row><row><entry>HIV-1</entry><entry>RT</entry><entry>206-214</entry><entry>TEMEKBGKI</entry><entry>H2-Kk</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:228)</entry><entry/></row><row><entry>HIV-1</entry><entry>p17</entry><entry>18-26</entry><entry>KIRLRPGGK</entry><entry>HLA-A*0301</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:229)</entry><entry/></row><row><entry>HIV-1</entry><entry>P17</entry><entry>20-29</entry><entry>RLRPGGKKKY</entry><entry>HLA-A*0301</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:230)</entry><entry/></row><row><entry>HIV-1</entry><entry>RT</entry><entry>325-333</entry><entry>AIFQSSMTK</entry><entry>HLA-A*0301</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:231)</entry><entry/></row><!-- EPO <DP n="20"> --><row><entry>HIV-1</entry><entry>p17</entry><entry>84-92</entry><entry>TLYCVHQRI</entry><entry>HLA-A11</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:232)</entry><entry/></row><row><entry>HIV-1</entry><entry>RT</entry><entry>508-517</entry><entry>IYQEPFKNLK</entry><entry>HLA-A11</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:233)</entry><entry/></row><row><entry>HIV-1</entry><entry>p17</entry><entry>28-36</entry><entry>KYKLKHIVW</entry><entry>HLA-A24</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:234)</entry><entry/></row><row><entry>HIV-1</entry><entry>gp120</entry><entry>53-62</entry><entry>LFCASDAKAY</entry><entry>HLA-A24</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:235)</entry><entry/></row><row><entry>HIV-1</entry><entry>gagp24</entry><entry>145-155</entry><entry>QAISPRTLNAW</entry><entry>HLA-A25</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.236)</entry><entry/></row><row><entry>HIV-1</entry><entry>gagp24</entry><entry>167-175</entry><entry>EVIMFSAL</entry><entry>HLA-A26</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:237)</entry><entry/></row><row><entry>HIV-1</entry><entry>RT</entry><entry>593-603</entry><entry>ETFYVDGAANR</entry><entry>HLA-A26</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:238)</entry><entry/></row><row><entry>HIV-1</entry><entry>gp41</entry><entry>775-785</entry><entry>RLRDLLLIVTR</entry><entry>HLA-A31</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:239)</entry><entry/></row><row><entry>HIV-1</entry><entry>RT</entry><entry>559-568</entry><entry>PIQKETWETW</entry><entry>HLA-A32</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:240)</entry><entry/></row><row><entry>HIV-1</entry><entry>gp120</entry><entry>419-427</entry><entry>RIKQIINMW</entry><entry>HLA-A32</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:241)</entry><entry/></row><row><entry>HIV-1</entry><entry>RT</entry><entry>71-79</entry><entry>ITLWQRPLV</entry><entry>HLA-A*6802</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:242)</entry><entry/></row><row><entry>HIV-1</entry><entry>RT</entry><entry>85-93</entry><entry>DTVLEEMNL</entry><entry>HLA-A*6802</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:243)</entry><entry/></row><row><entry>HIV-1</entry><entry>RT</entry><entry>71-79</entry><entry>ITLWQRPLV</entry><entry>HLA-A*7401</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:244)</entry><entry/></row><row><entry>HIV-1</entry><entry>gag p24</entry><entry>148-156</entry><entry>SPRTLNAWV</entry><entry>HLA-B7</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:245)</entry><entry/></row><row><entry>HIV-1</entry><entry>gagp24</entry><entry>179-187</entry><entry>ATPQDLNTM</entry><entry>HLA-B7</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:246)</entry><entry/></row><row><entry>HIV-1</entry><entry>gp120</entry><entry>303-312</entry><entry>RPNNNTRKSI</entry><entry>HLA-B7</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:247)</entry><entry/></row><row><entry>HIV-1</entry><entry>gp41</entry><entry>843-851</entry><entry>HIRRIRQGL</entry><entry>HLA-B7</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:248)</entry><entry/></row><row><entry>HIV-1</entry><entry>p17</entry><entry>74-82</entry><entry>ELRSLYNTY</entry><entry>HLA-B8</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:249)</entry><entry/></row><row><entry>HIV-1</entry><entry>nef</entry><entry>13-20</entry><entry>WPTVRERM</entry><entry>HLA-B8</entry></row><!-- EPO <DP n="21"> --><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:250)</entry><entry/></row><row><entry>HIV-1</entry><entry>nef</entry><entry>90-97</entry><entry>FLKEKGGL</entry><entry>HLA-B8</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:251)</entry><entry/></row><row><entry>HIV-1</entry><entry>gag p24</entry><entry>183-191</entry><entry>DLNTMLNTV</entry><entry>HLA-B14</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:252)</entry><entry/></row><row><entry>HIV-1</entry><entry>P17</entry><entry>18-27</entry><entry>KIRLRPGGKK</entry><entry>HLA-B27</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:253)</entry><entry/></row><row><entry>HIV-1</entry><entry>p17</entry><entry>19-27</entry><entry>IRLRPGGKK</entry><entry>HLA-B27</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 254)</entry><entry/></row><row><entry>HIV-1</entry><entry>gp41</entry><entry>791-799</entry><entry>GRRGWEALKY</entry><entry>HLA-B27</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:255)</entry><entry/></row><row><entry>HIV-1</entry><entry>nef</entry><entry>73-82</entry><entry>QVPLRPMTYK</entry><entry>HLA-B27</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:256)</entry><entry/></row><row><entry>HIV-1</entry><entry>GP41</entry><entry>590-597</entry><entry>RYLKDQQL</entry><entry>HLA-B27</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:257)</entry><entry/></row><row><entry>HIV-1</entry><entry>nef</entry><entry>105-114</entry><entry>RRQDILDLWI</entry><entry>HLA-B*2705</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:258)</entry><entry/></row><row><entry>HIV-1</entry><entry>nef</entry><entry>134-141</entry><entry>RYPLTFGW</entry><entry>HLA-B*2705</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:259)</entry><entry/></row><row><entry>HIV-1</entry><entry>p17</entry><entry>36-44</entry><entry>WASRELERF</entry><entry>HLA-B35</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:260)</entry><entry/></row><row><entry>HIV-1</entry><entry>GAG P24</entry><entry>262-270</entry><entry>TVLDVGDAY</entry><entry>HLA-B35</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:261)</entry><entry/></row><row><entry>HIV-1</entry><entry>gp120</entry><entry>42-52</entry><entry>VPVWKEATTTL</entry><entry>HLA-B35</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:262)</entry><entry/></row><row><entry>HIV-1</entry><entry>P17</entry><entry>36-44</entry><entry>NSSKVSQNY</entry><entry>HLA-B35</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:263)</entry><entry/></row><row><entry>HIV-1</entry><entry>gag p24</entry><entry>254-262</entry><entry>PIPVGDIY</entry><entry>HLA-835</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:264)</entry><entry/></row><row><entry>HIV-1</entry><entry>RT</entry><entry>342-350</entry><entry>HPDIVIYQY</entry><entry>HLA-B35</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:265)</entry><entry/></row><row><entry>HIV-1</entry><entry>gp41</entry><entry>611-619</entry><entry>TAVPWNASW</entry><entry>HLA-B35</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:266)</entry><entry/></row><row><entry>HIV-1</entry><entry>gag</entry><entry>245-253</entry><entry>NPVPVGNIY</entry><entry>HLA-B35</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:267)</entry><entry/></row><row><entry>HIV-1</entry><entry>net</entry><entry>120-128</entry><entry>YFPDWQNYT</entry><entry>HLA-B37</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:268)</entry><entry/></row><!-- EPO <DP n="22"> --><row><entry>HIV-1</entry><entry>gag p24</entry><entry>193-201</entry><entry>GHQAAMQML</entry><entry>HLA-B42</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:269)</entry><entry/></row><row><entry>HIV-1</entry><entry>p17</entry><entry>20-29</entry><entry>RLRPGGKKKY</entry><entry>HLA-B42</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:270)</entry><entry/></row><row><entry>HIV-1</entry><entry>RT</entry><entry>438-446</entry><entry>YPGIKVRQL</entry><entry>HLA-B42</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:271)</entry><entry/></row><row><entry>HIV-1</entry><entry>RT</entry><entry>591-600</entry><entry>GAETFYVDGA</entry><entry>HLA-B45</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:272)</entry><entry/></row><row><entry>HIV-1</entry><entry>gag p24</entry><entry>325-333</entry><entry>NANPDCKTI</entry><entry>HLA-B51</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:273)</entry><entry/></row><row><entry>HIV-1</entry><entry>gag p24</entry><entry>275-282</entry><entry>RMYSPTSI</entry><entry>HLA-B52</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:274)</entry><entry/></row><row><entry>HIV-1</entry><entry>gyp120</entry><entry>42-51</entry><entry>VPVWKEATTT</entry><entry>HLA-B*5501</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:275)</entry><entry/></row><row><entry>HIV-1</entry><entry>gag p24</entry><entry>147-155</entry><entry>ISPRTLNAW</entry><entry>HLA-B57</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:276)</entry><entry/></row><row><entry>HIV-1</entry><entry>gag p24</entry><entry>240-249</entry><entry>TSTLOEQIGW</entry><entry>HLA-B57</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:277)</entry><entry/></row><row><entry>HIV-1</entry><entry>gag p24</entry><entry>162-172</entry><entry>KAFSPEVIPMF</entry><entry>HLA-B57</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:278)</entry><entry/></row><row><entry>HIV-1</entry><entry>gag p24</entry><entry>311-319</entry><entry>QASQEVKNW</entry><entry>HLA-B57</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:279)</entry><entry/></row><row><entry>HIV-1</entry><entry>gag p24</entry><entry>311-319</entry><entry>QASQDVKNW</entry><entry>HLA-B57</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:280)</entry><entry/></row><row><entry>HIV-1</entry><entry>nef</entry><entry>116-125</entry><entry>HTQGYFPDWQ</entry><entry>HLA-B57</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:281)</entry><entry/></row><row><entry>HIV-1</entry><entry>nef</entry><entry>120-128</entry><entry>YFPDWQNYT</entry><entry>HLA-B57</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:282)</entry><entry/></row><row><entry>HIV-1</entry><entry>gag p24</entry><entry>240-249</entry><entry>TSTLQEQIGW</entry><entry>HLA-B58</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:283)</entry><entry/></row><row><entry>HIV-1</entry><entry>p17</entry><entry>20-29</entry><entry>RLRPGGKKKY</entry><entry>HLA-B62</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:284)</entry><entry/></row><row><entry>HIV-1 p24</entry><entry>p24</entry><entry>268-277</entry><entry>LGLNKJVRMY</entry><entry>HLA-B62</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:285)</entry><entry/></row><row><entry>HIV-1</entry><entry>RT</entry><entry>415-426</entry><entry>LVGKLNWASQIY</entry><entry>HLA-B62</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:286)</entry><entry/></row><row><entry>HIV-1</entry><entry>RT</entry><entry>476-485</entry><entry>ILKEPVHGVY</entry><entry>HLA-B62</entry></row><!-- EPO <DP n="23"> --><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:287)</entry><entry/></row><row><entry>HIV-1</entry><entry>nef</entry><entry>117-127</entry><entry>TQGYFPDWQNY</entry><entry>HLA-B62</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:288)</entry><entry/></row><row><entry>HIV-1</entry><entry>net</entry><entry>84-91</entry><entry>AVDLSHFL</entry><entry>HLA-B62</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:289)</entry><entry/></row><row><entry>HIV-1</entry><entry>gag p24</entry><entry>168-175</entry><entry>VIPMFSAL</entry><entry>HLA-Cw*0102</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:290)</entry><entry/></row><row><entry>HIV-1</entry><entry>gp120</entry><entry>376-384</entry><entry>FNCGGEFFY</entry><entry>HLA-A29</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:291</entry><entry/></row><row><entry>HIV-1</entry><entry>gp120</entry><entry>375-383</entry><entry>SFNCGGEFF</entry><entry>HLA-B15</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:292)</entry><entry/></row><row><entry>HIV-1</entry><entry>nef</entry><entry>136-145</entry><entry>PLTFGWCYKL</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:293)</entry><entry/></row><row><entry>HIV-1</entry><entry>nef</entry><entry>180-189</entry><entry>VLEWRFDSRL</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:294)</entry><entry/></row><row><entry>HIV-1</entry><entry>nef</entry><entry>68-77</entry><entry>FPVTPQVPLR</entry><entry>HLA-B7</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:295)</entry><entry/></row><row><entry>HIV-1</entry><entry>nef</entry><entry>128-137</entry><entry>TPGPGVRYPL</entry><entry>HLA-B7</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:296)</entry><entry/></row><row><entry>HIV-1</entry><entry>gag p24</entry><entry>308-316</entry><entry>QASQEVKNW</entry><entry>HLA-Cw*0401</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:297)</entry><entry/></row><row><entry>HIV-1 IIIB</entry><entry>RT</entry><entry>273-282</entry><entry>VPLDEDFRKY</entry><entry>HLA-B35</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:298)</entry><entry/></row><row><entry>HIV-1 IIIB</entry><entry>RT</entry><entry>25-33</entry><entry>NPDIVFYQY</entry><entry>HLA-B35</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:299)</entry><entry/></row><row><entry>HIV-1 IIIB</entry><entry>gp41</entry><entry>557-565</entry><entry>RAIEAQAHL</entry><entry>HLA-B51</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:300)</entry><entry/></row><row><entry>HIV-1 IIIB</entry><entry>RT</entry><entry>231-238</entry><entry>TAFTIPSI</entry><entry>HLA-B51</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:301)</entry><entry/></row><row><entry>HIV-1 IIIB</entry><entry>p24</entry><entry>215-223</entry><entry>VHPVHAGPIA</entry><entry>HLA-B*5501</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:302)</entry><entry/></row><row><entry>HIV-1 IIIB</entry><entry>gp120</entry><entry>156-165</entry><entry>NCSFNISTSI</entry><entry>HLA-Cw8</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:303)</entry><entry/></row><row><entry>HIV-1 IIIB</entry><entry>gp120</entry><entry>241-249</entry><entry>CTNVSTVQC</entry><entry>HLA-Cw8</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:304)</entry><entry/></row><row><entry>HIV-1 5F2</entry><entry>gp120</entry><entry>312-320</entry><entry>IGPGRAFHT</entry><entry>H2-Dd</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:305)</entry><entry/></row><!-- EPO <DP n="24"> --><row><entry>HIV-1 5F2</entry><entry>pol</entry><entry>25-33</entry><entry>NPDIVIYQY</entry><entry>HLA-B*3501</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:306)</entry><entry/></row><row><entry>HIV-1 5F2</entry><entry>pol</entry><entry>432-441</entry><entry>EPIVGAETFY</entry><entry>HLA-B*3501</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:307)</entry><entry/></row><row><entry>HIV-1 5F2</entry><entry>pol</entry><entry>432-440</entry><entry>EPIVGAETF</entry><entry>HLA-B*3501</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:308)</entry><entry/></row><row><entry>HIV-1 5F2</entry><entry>pol</entry><entry>6-14</entry><entry>SPAHFQSSM</entry><entry>HLA-B*3501</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:309)</entry><entry/></row><row><entry>HIV-1 5F2</entry><entry>pol</entry><entry>59-68</entry><entry>VPLDKDFRKY</entry><entry>HLA-B*3501</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:310)</entry><entry/></row><row><entry>HIV-1 5F2</entry><entry>pol</entry><entry>6-14</entry><entry>IPLTEEAEL</entry><entry>HLA-B*3501</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:311)</entry><entry/></row><row><entry>HIV-1 5F2</entry><entry>nef</entry><entry>69-79</entry><entry>RPQVPLRMTY</entry><entry>HLA-B*3501</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:312)</entry><entry/></row><row><entry>HIV-1 5F2</entry><entry>nef</entry><entry>66-74</entry><entry>FPVRPQVPL</entry><entry>HLA-B*3501</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:313)</entry><entry/></row><row><entry>HIV-1 5F2</entry><entry>env</entry><entry>10-18</entry><entry>DPNPQEVVL</entry><entry>HLA-B*3501</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:314)</entry><entry/></row><row><entry>HIV-1 5F2</entry><entry>env</entry><entry>7-15</entry><entry>RPIVSTQLL</entry><entry>HLA-B*3501</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:315)</entry><entry/></row><row><entry>HIV-1 5F2</entry><entry>pol</entry><entry>6-14</entry><entry>IPLTEEAEL</entry><entry>HLA-B51</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:316)</entry><entry/></row><row><entry>HIV-1 5F2</entry><entry>env</entry><entry>10-18</entry><entry>DPNPQEVVL</entry><entry>HLA-B51</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:317)</entry><entry/></row><row><entry>HIV-1 5F2</entry><entry>gagp24</entry><entry>199-207</entry><entry>AMQMLKETI</entry><entry>H2-Kd</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:318)</entry><entry/></row><row><entry>HIV-2</entry><entry>gagp24</entry><entry>182-190</entry><entry>TPYDrNQML,</entry><entry>HLA-B*5301</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:319)</entry><entry/></row><row><entry>HIV-2</entry><entry>gag</entry><entry>260-269</entry><entry>RRWIQLGLQKV</entry><entry>HLA-B*2703</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:320)</entry><entry/></row><row><entry>HIV-1 5F2</entry><entry>gp41</entry><entry>593-607</entry><entry>GIWGCSGKLICTTAV</entry><entry>HLA-B17</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:321)</entry><entry/></row><row><entry>HIV-1 5F2</entry><entry>gp41</entry><entry>753-767</entry><entry>ALIWEDLRSLCLFSY</entry><entry>HLA-B22</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:322)</entry><entry/></row><row><entry>HPV 6b</entry><entry>E7</entry><entry>21-30</entry><entry>GLHCYEQLV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:323)</entry><entry/></row><row><entry>HPV 6b</entry><entry>E7</entry><entry>47-55</entry><entry>PLKQHFQIV</entry><entry>HLA-A*0201</entry></row><!-- EPO <DP n="25"> --><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:324)</entry><entry/></row><row><entry>HIV11</entry><entry>E7</entry><entry>4-12</entry><entry>RLVTLKDIV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:325)</entry><entry/></row><row><entry>HPV16</entry><entry>E7</entry><entry>86-94</entry><entry>TLGIVCPIC</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:326)</entry><entry/></row><row><entry>HPV16</entry><entry>E7</entry><entry>85-93</entry><entry>GTLGIVCPI</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:327)</entry><entry/></row><row><entry>HPV16</entry><entry>E7</entry><entry>12-20</entry><entry>MLDLQPETT</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:328)</entry><entry/></row><row><entry>HPV16</entry><entry>E7</entry><entry>11-20</entry><entry>YMLDLQPETT</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:329)</entry><entry/></row><row><entry>HPV-16</entry><entry>E6</entry><entry>15-22</entry><entry>RPRKLPQL</entry><entry>HLA-B7</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:330)</entry><entry/></row><row><entry>HPV16</entry><entry>E6</entry><entry>49-57</entry><entry>RAHYNIVTF</entry><entry>HW-Db</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:331)</entry><entry/></row><row><entry>HSV</entry><entry>gpB</entry><entry>498-505</entry><entry>SSIEFARL</entry><entry>H2-Kb</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:332)</entry><entry/></row><row><entry>HSV-1</entry><entry>gpC</entry><entry>480-488</entry><entry>GIGIGVLAA</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:333)</entry><entry/></row><row><entry>HSV-1</entry><entry>ICP27</entry><entry>448-456</entry><entry>DYATLGVGV</entry><entry>H2-Kd</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:334)</entry><entry/></row><row><entry>Virus</entry><entry>Protein</entry><entry/><entry>T cell epitope MHC ligand</entry><entry>MHC molecule</entry></row><row><entry/><entry/><entry/><entry>(Antigen)</entry><entry/></row><row><entry>HSV-1</entry><entry>ICP27</entry><entry>322-332</entry><entry>LYRTFAGNPRA</entry><entry>H2-Kd</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:335)</entry><entry/></row><row><entry>HSV-1</entry><entry>UI.39</entry><entry>822-829</entry><entry>QTFDFGRL</entry><entry>H2-Kd</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:336)</entry><entry/></row><row><entry>HSV-2</entry><entry>gpC</entry><entry>446-454</entry><entry>GAGIGVAVL</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:337)</entry><entry/></row><row><entry>HLTV-1</entry><entry>TAX</entry><entry>11-19</entry><entry>LLFGYPVYV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:338)</entry><entry/></row><row><entry>Influenza</entry><entry>MP</entry><entry>58-66</entry><entry>GILGFVFTL</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:339)</entry><entry/></row><row><entry>Influenza</entry><entry>MP</entry><entry>59-68</entry><entry>ILGFVFTLTV</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:340)</entry><entry/></row><row><entry>Influenza</entry><entry>NP</entry><entry>265-273</entry><entry>ILROSVAHK</entry><entry>HLA-A3</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:341)</entry><entry/></row><!-- EPO <DP n="26"> --><row><entry>Influenza</entry><entry>NP</entry><entry>91-99</entry><entry>KTGGPIYKR</entry><entry>HLA-A*6801</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:342)</entry><entry/></row><row><entry>Influenza</entry><entry>NP</entry><entry>380-388</entry><entry>ELRSRYWAI</entry><entry>HLA-B8</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:343)</entry><entry/></row><row><entry>Influenza</entry><entry>NP</entry><entry>381-388</entry><entry>LRSRYWAI</entry><entry>HLA-B*2702</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:344)</entry><entry/></row><row><entry>Influenza</entry><entry>NP</entry><entry>339-347</entry><entry>EDLRVLSFI</entry><entry>HLA-B*3701</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 345)</entry><entry/></row><row><entry>Influenza</entry><entry>NSI</entry><entry>158-166</entry><entry>GEISPLPSL</entry><entry>HLA-B44</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO..:346)</entry><entry/></row><row><entry>Influenza</entry><entry>NP</entry><entry>338-346</entry><entry>FEDLRVLSF</entry><entry>HLA-B44</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 347)</entry><entry/></row><row><entry>Influenza</entry><entry>NSI</entry><entry>158-166</entry><entry>GEISPLPSL</entry><entry>HLA-B*4402</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:348)</entry><entry/></row><row><entry>Influenza</entry><entry>NP</entry><entry>338-346</entry><entry>FEDLRVLSP</entry><entry>HLA-B*4402</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:349)</entry><entry/></row><row><entry>Influenza</entry><entry>PBI</entry><entry>591-599</entry><entry>VSDGGPKLY</entry><entry>HLA-A1</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 3 50)</entry><entry/></row><row><entry>Influenza A</entry><entry>NP</entry><entry>44-52</entry><entry>CTELKLSDY</entry><entry>HLA-A1</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:351)</entry><entry/></row><row><entry>Influenza</entry><entry>NSI</entry><entry>122-130</entry><entry>AIMDKNIIL</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:352)</entry><entry/></row><row><entry>Influenza A</entry><entry>NSI</entry><entry>123-132</entry><entry>MDKNIILKA</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>SEQ. ID NO.:353)</entry><entry/></row><row><entry>Influenza A</entry><entry>NP</entry><entry>383:391</entry><entry>SRYWAIRTR</entry><entry>HLA-B*2705</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:354)</entry><entry/></row><row><entry>Influenza A</entry><entry>NP</entry><entry>147-155</entry><entry>TYQRTRALV</entry><entry>112-Kd</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 355)</entry><entry/></row><row><entry>Influenza A</entry><entry>HA</entry><entry>210-219</entry><entry>TYVSVSTSTL</entry><entry>H2-Kd</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:356)</entry><entry/></row><row><entry>Influenza A</entry><entry>HA</entry><entry>518-526</entry><entry>IYSTVASSL</entry><entry>H2-Kd</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:357)</entry><entry/></row><row><entry>Influenza A.</entry><entry>HA</entry><entry>259-266</entry><entry>FEANGNLI</entry><entry>H2-Kk</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:358)</entry><entry/></row><row><entry>Influenza A</entry><entry>HA</entry><entry>10-18</entry><entry>IEGGWTGMI</entry><entry>H2-Kk</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:359)</entry><entry/></row><row><entry>Influenza A</entry><entry>NP</entry><entry>50-57</entry><entry>SDYEGRLI</entry><entry>H2-Kk</entry></row><!-- EPO <DP n="27"> --><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:360)</entry><entry/></row><row><entry>Influenza a</entry><entry>NSI</entry><entry>152-160</entry><entry>EEGAIVGEI</entry><entry>H2-Kk</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO,:361)</entry><entry/></row><row><entry>Influenza A34</entry><entry>NP</entry><entry>336-374</entry><entry>ASNENMETM</entry><entry>H2Db</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID N'O.:362)</entry><entry/></row><row><entry>Influenza A68</entry><entry>NP</entry><entry>366-374</entry><entry>ASNENMDAM</entry><entry>H2Db</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:363)</entry><entry/></row><row><entry>Influenza B</entry><entry>NP</entry><entry>85-94</entry><entry>KLGEFYNQMM</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:364)</entry><entry/></row><row><entry>Influenza B</entry><entry>NP</entry><entry>85-94</entry><entry>KAGEFYNQMM</entry><entry>HLA-A*0201</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:365)</entry><entry/></row><row><entry>Influenza JAP</entry><entry>HA</entry><entry>204-212</entry><entry>LYQNVGTYV</entry><entry>H2-Kd</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:366)</entry><entry/></row><row><entry>Influenza JAP</entry><entry>HA</entry><entry>210-219</entry><entry>TYVSVGTSTL</entry><entry>H2-Kd</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID No.:367)</entry><entry/></row><row><entry>Influenza JAP</entry><entry>HA</entry><entry>523-531</entry><entry>VYQILATYA</entry><entry>H2-Kd</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:368)</entry><entry/></row><row><entry>Influenza JAP</entry><entry>HA</entry><entry>529-537</entry><entry>IYATVAGSL</entry><entry>H2-Kd</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:369)</entry><entry/></row><row><entry>Influenza JAP</entry><entry>HA</entry><entry>210-219</entry><entry>TYVSVCYfSTI(L&gt;I)</entry><entry>H2-Kd</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:370)</entry><entry/></row><row><entry>Influenza JAP</entry><entry>HA</entry><entry>255-262.</entry><entry>FESTGNLI</entry><entry>H2-Kk</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 371)</entry><entry/></row><row><entry>JHMV</entry><entry>cAg</entry><entry>318-326</entry><entry>APTAGAFFF</entry><entry>H2-Ld</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:372)</entry><entry/></row><row><entry>LCMV</entry><entry>NP</entry><entry>118-126</entry><entry>RPQASGVYM</entry><entry>H2-Ld</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:373)</entry><entry/></row><row><entry>LCMV</entry><entry>NP</entry><entry>396-404</entry><entry>FQPQNGQFI</entry><entry>H2-Db</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:374)</entry><entry/></row><row><entry>LCMV</entry><entry>GP</entry><entry>276-286</entry><entry>SGVENPGGYCL</entry><entry>H2-Db</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:375)</entry><entry/></row><row><entry>LCMV</entry><entry>GP</entry><entry>33-42</entry><entry>KAVYNFATCG</entry><entry>H2-Db</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:376)</entry><entry/></row><row><entry>MCMV</entry><entry>pp89</entry><entry>168-176</entry><entry>YPHFMPTNL</entry><entry>H2-Ld</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:377)</entry><entry/></row><row><entry>MHV</entry><entry>spike protein</entry><entry>510-518</entry><entry>CLSWNGPHL</entry><entry>H2-Db</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO,:378)</entry><entry/></row><!-- EPO <DP n="28"> --><row><entry>MMTV</entry><entry>env gp 36</entry><entry>474-482</entry><entry>SFAVATTAL</entry><entry>H2-Kd</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:379)</entry><entry/></row><row><entry>MMTV</entry><entry>gag p27</entry><entry>425-433</entry><entry>SYETFISRL</entry><entry>H2-Kd</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:380)</entry><entry/></row><row><entry>MMTV</entry><entry>env gp73</entry><entry>544-551</entry><entry>ANYDFICV</entry><entry>H2-Kb</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 381)</entry><entry/></row><row><entry>MuLV</entry><entry>env p15E</entry><entry>574-581</entry><entry>KSPWFTTL</entry><entry>H2-Kb</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 382) °</entry><entry/></row><row><entry/><entry>env gp70</entry><entry>189-196</entry><entry>sswDFrrv</entry><entry>H2-Kb</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:383)</entry><entry/></row><row><entry>MuLV</entry><entry>gag 75K</entry><entry>75-83</entry><entry>CCLCLTVFL</entry><entry>H2-Db</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:384)</entry><entry/></row><row><entry>MuLV</entry><entry>env gp70</entry><entry>423-431</entry><entry>SPSYVYHQP</entry><entry>H2Ld</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:385)</entry><entry/></row><row><entry>MV</entry><entry>F protein</entry><entry>437-447</entry><entry>SRRYPDAVYLH</entry><entry>HLA-B*2705</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:386)</entry><entry/></row><row><entry>Mv</entry><entry>F protein</entry><entry>438-446</entry><entry>RRYPDAVYL</entry><entry>HLA-B*2705</entry></row><row><entry/><entry/><entry/><entry/><entry/></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:387)</entry><entry/></row><row><entry>Mv</entry><entry>NP</entry><entry>281-289</entry><entry>YPALGLHEF</entry><entry>H2-Ld</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO..388)</entry><entry/></row><row><entry>Mv</entry><entry>HA</entry><entry>343-351</entry><entry>DPVIDRLYL</entry><entry>H2-Ld</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:389)</entry><entry/></row><row><entry>MV</entry><entry>HA</entry><entry>544-552</entry><entry>SPGRSFSYF</entry><entry>H2-Ld</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:390)</entry><entry/></row><row><entry>Pollovirus</entry><entry>VPI</entry><entry>111-118</entry><entry>TYKDTVQL</entry><entry>H2-Kd</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:391)</entry><entry/></row><row><entry>Pollovirus</entry><entry>VPI</entry><entry>208-217</entry><entry>FYDGFSKVPL</entry><entry>H2-Kd</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID) NO.: 392)</entry><entry/></row><row><entry>Pseudorabies Virus gp</entry><entry>G111</entry><entry>455-463</entry><entry>IAGIGILAI</entry><entry>HLA-A*020</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:393)</entry><entry/></row><row><entry>Rabiesvirus</entry><entry>NS</entry><entry>197-205</entry><entry>VEAEIAHQI</entry><entry>H2-Kk</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:394)</entry><entry/></row><row><entry>Rotavirus</entry><entry>VP7</entry><entry>33-40</entry><entry>IIYRFLLI</entry><entry>H2-Kb</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:395)</entry><entry/></row><row><entry>Rotavirus</entry><entry>VP6</entry><entry>376-384</entry><entry>VGPVFPPGM</entry><entry>H2-Kb</entry></row><!-- EPO <DP n="29"> --><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:396)</entry><entry/></row><row><entry>Rota vims</entry><entry>VP3</entry><entry>585-593</entry><entry>YSGYIFRDL</entry><entry>H2-Kb</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:397)</entry><entry/></row><row><entry>RSV</entry><entry>M2</entry><entry>82-90</entry><entry>SYIGSINNI</entry><entry>H2-Kb</entry></row><row><entry/><entry/><entry/><entry>(SEQ, ID NO.:398)</entry><entry/></row><row><entry>SIV</entry><entry>gagp11c</entry><entry>179-190</entry><entry>EGCTPYDTNQML</entry><entry>Mamu-A*01</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:399)</entry><entry/></row><row><entry>SV</entry><entry>NP</entry><entry>324-332</entry><entry>FAPGNYPAL</entry><entry>H2-Db</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:400)</entry><entry/></row><row><entry>SV</entry><entry>NP</entry><entry>324-332</entry><entry>FAPCTNYPAL</entry><entry>H2-Kb</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:401)</entry><entry/></row><row><entry>SV40</entry><entry>T</entry><entry>404-411</entry><entry>VVYDFLKC</entry><entry>H2-Kb</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.: 402)</entry><entry/></row><row><entry>SV40</entry><entry>T</entry><entry>206-215</entry><entry>SAINNYAQKL</entry><entry>H2-Db</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:403)</entry><entry/></row><row><entry>SV40</entry><entry>T</entry><entry>223-231</entry><entry>CKGVNKEYL</entry><entry>H2-Db</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:404)</entry><entry/></row><row><entry>SV40</entry><entry>T</entry><entry>489-497</entry><entry>QGINNLDNI,</entry><entry>H2-Db</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:405)</entry><entry/></row><row><entry>SV40</entry><entry>T</entry><entry>492-500 (501)</entry><entry>NNLDNLRDY(L)</entry><entry>H2-Db</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:406)</entry><entry/></row><row><entry>SV40</entry><entry>T</entry><entry>560-568</entry><entry>SEFLLEKRI</entry><entry>H2-Kk</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:407)</entry><entry/></row><row><entry>VSV</entry><entry>NP</entry><entry>52-59</entry><entry>RGYVYQGL</entry><entry>H2-Kb</entry></row><row><entry/><entry/><entry/><entry>(SEQ. ID NO.:408)</entry><entry/></row></tbody></tgroup></table></tables>
<tables id="tabl0002" num="0002"><table frame="all"><title><u>Table2</u></title><tgroup cols="3"><colspec colnum="1" colname="col1" colwidth="26mm"/><colspec colnum="2" colname="col2" colwidth="33mm"/><colspec colnum="3" colname="col3" colwidth="77mm"/><thead><row><entry align="center" valign="top"><b>HLA-A1</b></entry><entry align="center" valign="top"><b>Position (Antigen)</b></entry><entry align="center" valign="top"><b>Source</b></entry></row></thead><tbody><row><entry>T cell epitopes</entry><entry>EADPTGHSY</entry><entry>MAGE-1 161-169</entry></row><row><entry/><entry>(SEQ. ID NO.:409)</entry><entry/></row><row><entry/><entry>VSDGGPNLY</entry><entry>Influenza A PB 1591-599</entry></row><row><entry/><entry>(SEQ. ID NO.:410)</entry><entry/></row><row><entry/><entry>CTELKLSDY</entry><entry>Influenza A NP 44-52</entry></row><row><entry/><entry>(SEQ. ID NO.:411)</entry><entry/></row><row><entry/><entry>EVDPIGHLY</entry><entry>MAGE-3168-176</entry></row><row><entry/><entry>(SEQ. ID NO.:412)</entry><entry/></row><row><entry>HLA-A201</entry><entry>MLLSYPLLLG</entry><entry>Calreticulin signal sequence 1-10</entry></row><!-- EPO <DP n="30"> --><row><entry/><entry>(SEQ. ID NO,: 413)</entry><entry/></row><row><entry/><entry>STBXQSGXQ</entry><entry>HBV PRE-S PROTEIN 141-149</entry></row><row><entry/><entry>(SEQ. ID NO.:414)</entry><entry/></row><row><entry/><entry>YMDGTMSQV</entry><entry>Tyrosinase 369-377</entry></row><row><entry/><entry>(SEQ. ID NO.:41 5)</entry><entry/></row><row><entry/><entry>ILKEPVHGV</entry><entry>HIV-.IRT 476-484</entry></row><row><entry/><entry>(SEQ. ID NO.:416)</entry><entry/></row><row><entry/><entry>LLGFYFTLTV</entry><entry>Influenza MP 59-68</entry></row><row><entry/><entry>(SEQ. ID NO.:417)</entry><entry/></row><row><entry/><entry>LLFGYPYYVV</entry><entry>HTVL-1 tax 11-19</entry></row><row><entry/><entry>(SEQ. ID NO.:418)</entry><entry/></row><row><entry/><entry>GLSPTVWLSV</entry><entry>HBV sAg 348-357</entry></row><row><entry/><entry>(SEQ. ID NO.:419)</entry><entry/></row><row><entry/><entry>WLSLLVPFV</entry><entry>HBY sAg 335-343</entry></row><row><entry/><entry>(SEQ. ID NO.:420)</entry><entry/></row><row><entry/><entry>FLPSDFFPSV</entry><entry>HBV cAg 18-27</entry></row><row><entry/><entry>SEQ. ID.:421)</entry><entry/></row><row><entry/><entry>CLG0LITMV</entry><entry>B8V LMP-2 426-434</entry></row><row><entry/><entry>(SEQ. ID NO.:422)</entry><entry/></row><row><entry/><entry>FLAGNSAVEYV</entry><entry>HCMV gp 618-628B</entry></row><row><entry/><entry>(SEQ. ID NO.:423)</entry><entry/></row><row><entry/><entry>KLGEFYNQMM</entry><entry>Influenza BNP 85-94</entry></row><row><entry/><entry>(SEQ. ID NO.:424)</entry><entry/></row><row><entry/><entry>KLVALGMAV</entry><entry>HCV-1 NS3 400..409</entry></row><row><entry/><entry>(SEQ. ID NO.425)</entry><entry/></row><row><entry/><entry>DLMGYDILV</entry><entry>HCV-1 MP 17-.25</entry></row><row><entry/><entry>(SEQ. ID NO.:426)</entry><entry/></row><row><entry/><entry>RLVTLKDIV</entry><entry>HCV 11 EZ 4-12</entry></row><row><entry/><entry>(SEQ. ID NO.:427)</entry><entry/></row><row><entry/><entry>MLLAVLYCL</entry><entry>Tyrosinase. 1-9</entry></row><row><entry/><entry>(SEQ. ID NO.:428)</entry><entry/></row><row><entry/><entry>AAGIGILTV</entry><entry>Melan A\Mart-.127.-35</entry></row><row><entry/><entry>(SEQ. ID NO.:429)</entry><entry/></row><row><entry/><entry>YLEPGPYTA</entry><entry>Pmel 17/gp 100 480-488</entry></row><row><entry/><entry>(SEQ. ID NO.:430)</entry><entry/></row><row><entry/><entry>ILDGTATLRL</entry><entry>Pmel17/ gp 100 457-466</entry></row><row><entry/><entry>(SEQ. ID NO.:431)</entry><entry/></row><row><entry/><entry>LLDGTATLRL</entry><entry>Pmel gp100 457-466</entry></row><!-- EPO <DP n="31"> --><row><entry/><entry>(SEQ. ID NO.:432)</entry><entry/></row><row><entry/><entry>ITDQVPFSV</entry><entry>Pmel gp 100 209-217</entry></row><row><entry/><entry>(SEQ. ID NO,:433)</entry><entry/></row><row><entry/><entry>KTWGQYWQV</entry><entry>Pmel gp 100 154-162</entry></row><row><entry/><entry>(SEQ. ID NO.:434)</entry><entry/></row><row><entry/><entry>TITDQVPFSV</entry><entry>Pmel gp 100 208-217</entry></row><row><entry/><entry>(SEQ. ID NO.:435)</entry><entry/></row><row><entry/><entry>AFHIIVAREL</entry><entry>HIV-Inef 190-198</entry></row><row><entry/><entry>(SEQ. ID NO.:436)</entry><entry/></row><row><entry/><entry>YLNKIQNSL</entry><entry>P. falciparum CSP 334-342</entry></row><row><entry/><entry>(SEQ. ID NO.:437)</entry><entry/></row><row><entry/><entry>MMRKLA11.SV</entry><entry>P. falciparum CSP 1-10</entry></row><row><entry/><entry>(SEQ. ID NO,:438)</entry><entry/></row><row><entry/><entry>KAGEFYMQMM.</entry><entry>Influenza BNP 85-94</entry></row><row><entry/><entry>(SEQ. NO.:439)</entry><entry/></row><row><entry/><entry>NIAEGLRAL</entry><entry>EBNA-1 480-48</entry></row><row><entry/><entry>(SEQ. NO 440)</entry><entry/></row><row><entry/><entry>NLRRGTALA</entry><entry>EBNA-1 519-527</entry></row><row><entry/><entry>(SEQ. NO 441)</entry><entry/></row><row><entry/><entry>ALAIPQCRL</entry><entry>EBNA-1 525-533</entry></row><row><entry/><entry>(SEQ. ID NO.:442)</entry><entry/></row><row><entry/><entry>VLKDAIKDL</entry><entry>EBNA-1 575-582</entry></row><row><entry/><entry>(SEQ. ID NO.:443)</entry><entry/></row><row><entry/><entry>FMVFLQTHI</entry><entry>EBNA-1 562-570)</entry></row><row><entry/><entry>(SEQ. ID NO.:444)</entry><entry/></row><row><entry/><entry>HLIVDTDS,</entry><entry>EBNA-2 15-23</entry></row><row><entry/><entry>(SEQ. ID NO.:445)</entry><entry/></row><row><entry/><entry>SLGNPSLSV</entry><entry>EBNA-2 22-30</entry></row><row><entry/><entry>(SEQ. ID NO.:446)</entry><entry/></row><row><entry/><entry>PLASAMRML</entry><entry>EBNA-2 126-134</entry></row><row><entry/><entry>(SEQ. ID NO.:447)</entry><entry/></row><row><entry/><entry>RMLWMANYI</entry><entry>EBNA-2 132-140</entry></row><row><entry/><entry>(SEQ. ID NO.:448)</entry><entry/></row><row><entry/><entry>MLWMANYIV</entry><entry>EBNA-2 133-141</entry></row><row><entry/><entry>(SEQ. ID NO.:449)</entry><entry/></row><row><entry/><entry>ILPQGPQIA</entry><entry>EBNA-2151-159</entry></row><row><entry/><entry>(SEQ. ID NO.:450)</entry><entry/></row><row><entry/><entry>PLRPTAPTTI</entry><entry>EBNA-2171-179</entry></row><!-- EPO <DP n="32"> --><row><entry/><entry>(SEQ. ID NO.:451)</entry><entry/></row><row><entry/><entry>PLRPTAPTTV</entry><entry>EBNA-2 205-213</entry></row><row><entry/><entry>(SEQ. ID NO.:452)</entry><entry/></row><row><entry/><entry>R M H L P V L H V</entry><entry>EBNA-2 246-254</entry></row><row><entry/><entry>(SEQ- ID NO.:453)</entry><entry/></row><row><entry/><entry>PMPLPPSQL</entry><entry>EBNA-2 287-295</entry></row><row><entry/><entry>(SEQ. ID NO.:454)</entry><entry/></row><row><entry/><entry>QLPPPAAPA</entry><entry>EBNA-2 294-302</entry></row><row><entry/><entry>(SEQ. ID NO.:455)</entry><entry/></row><row><entry/><entry>SMPELSPVL</entry><entry>EBNA-2 381-389</entry></row><row><entry/><entry>(SEQ. ID NO.:456)</entry><entry/></row><row><entry/><entry>DLDESWDYI</entry><entry>EBNA-2 453-46</entry></row><row><entry/><entry>(SEQ. ID NO.:457)</entry><entry/></row><row><entry/><entry>PLPCVLWPW</entry><entry>BZLF1 43-51</entry></row><row><entry/><entry>(SEQ. ID NO.:458)</entry><entry/></row><row><entry/><entry>SLEECDSEL</entry><entry>BZLF1167-175</entry></row><row><entry/><entry>(SEQ, ID NO.:459)</entry><entry/></row><row><entry/><entry>EIKRYKNRV</entry><entry>BZLFH176-184</entry></row><row><entry/><entry>(SEQ. ID NO.:460)</entry><entry/></row><row><entry/><entry>QLLQFIY1-LEV</entry><entry>BZLF1 195-203</entry></row><row><entry/><entry>(SEQ.ID NO.:461)</entry><entry/></row><row><entry/><entry>LLQHYREVA</entry><entry>BZLFI 196-204</entry></row><row><entry/><entry>(SEQ. ID NO.:462)</entry><entry/></row><row><entry/><entry>LLKQMCPSL</entry><entry>BZLFI 217-225</entry></row><row><entry/><entry>(SEQ. ID NO.:463)</entry><entry/></row><row><entry/><entry>SUPRTPDV</entry><entry>BZLFI 229-237</entry></row><row><entry/><entry>(SEQ.ID NO.:464)</entry><entry/></row><row><entry/><entry>AIMDKNHL</entry><entry>Influenza ANSI 122-130</entry></row><row><entry/><entry>(SEQ. ID NO.:465)</entry><entry/></row><row><entry/><entry>IMDKNIILKA</entry><entry>Influenza A NSI 123-132</entry></row><row><entry/><entry>(SEQ.ID NO.:466)</entry><entry/></row><row><entry/><entry>LLALLSCLTV</entry><entry>HCV MP 63-72</entry></row><row><entry/><entry>(SEQ.ID NO.:467)</entry><entry/></row><row><entry/><entry>ILHTPGCV</entry><entry>HCV MP 105-112</entry></row><row><entry/><entry>(SEQ.ID NO.:468)</entry><entry/></row><row><entry/><entry>QLRRHIDLLV</entry><entry>HCV env E 66-75</entry></row><row><entry/><entry>(SEQ, ID NO.:469)</entry><entry/></row><row><entry/><entry>DLCGSVFLV</entry><entry>HCV en E 88-96</entry></row><!-- EPO <DP n="33"> --><row><entry/><entry>(SEQ. ID NO.:470)</entry><entry/></row><row><entry/><entry>SMVGNWAKV</entry><entry>HCV env E 172-180</entry></row><row><entry/><entry>(SEQ. ID NO.:471)</entry><entry/></row><row><entry/><entry>HLHQNIVDV</entry><entry>HCV NSI 308-316</entry></row><row><entry/><entry>(SEQ.ID NO.:472)</entry><entry/></row><row><entry/><entry>FLLLADAR V</entry><entry>HCV NSI 340-348</entry></row><row><entry/><entry>(SEQ.ID NO.:473)</entry><entry/></row><row><entry/><entry>GLRDLAVAVEPV</entry><entry>HCV NSI234-246</entry></row><row><entry/><entry>(SEQ. ID NO.:474)</entry><entry/></row><row><entry/><entry>SLLAPGAKQNV</entry><entry>HCV NSI 18-28</entry></row><row><entry/><entry>(SEQ.ID NO.:475)</entry><entry/></row><row><entry/><entry>LLAPGAKQNV</entry><entry>HCV NSI19-28</entry></row><row><entry/><entry>(SEQ. ID NO.:476)</entry><entry/></row><row><entry/><entry>FLLSLGIHL</entry><entry>HBV pol 575-583</entry></row><row><entry/><entry>(SEQ. ID NO.:477)</entry><entry/></row><row><entry/><entry>SLYADSPSV</entry><entry>B16-B24</entry></row><row><entry/><entry>(SEQ. ID NO.:478)</entry><entry/></row><row><entry/><entry>GLSRYVARL</entry><entry>HBV POL 455 463</entry></row><row><entry/><entry>(SEQ. ID NO.:479)</entry><entry/></row><row><entry/><entry>KIFGSLAFL</entry><entry>HER-2 369-377</entry></row><row><entry/><entry>(SEQ. ID NO.:480)</entry><entry/></row><row><entry/><entry>ELVSEFSRM</entry><entry>HER-2 971-979</entry></row><row><entry/><entry>(SEQ. ID NO.:481)</entry><entry/></row><row><entry/><entry>KLTPLCVTL</entry><entry>HIV-1 gp 160 120-128</entry></row><row><entry/><entry>(SEQ. ID NO.:482)</entry><entry/></row><row><entry/><entry>SLLNATDIAV</entry><entry>HIV-I GP 160 814-823</entry></row><row><entry/><entry>(SEQ. ID.NO.:483)</entry><entry/></row><row><entry/><entry>VLYRYGSFSV</entry><entry>PmeI gp100 476-485</entry></row><row><entry/><entry>(SEQ. ID NO.:484)</entry><entry/></row><row><entry/><entry>YIGEVLVSV</entry><entry>Non-filament forming class 1 myosin family (HA.-2)**</entry></row><row><entry/><entry>(SEQ. ID NO.:485)</entry><entry/></row><row><entry/><entry>LLFNILGGWV</entry><entry>HCV NS4 192-201</entry></row><row><entry/><entry>(SEQ. ID NO.486)</entry><entry/></row><row><entry/><entry>LLVPFVQWPW</entry><entry>HBV env 338-347</entry></row><row><entry/><entry>(SEQ. ID NO. :487)</entry><entry/></row><row><entry/><entry>ALMPLYACI</entry><entry>HBV pol 642-G.Sb</entry></row><row><entry/><entry>(SEQ. ID NO.:4S8)</entry><entry/></row><row><entry/><entry>YLVAYQATV</entry><entry>HCV NS3 579-587</entry></row><!-- EPO <DP n="34"> --><row><entry/><entry>(SEQ. ID NO.:489)</entry><entry/></row><row><entry/><entry>TLGFVCPIC</entry><entry>HIPV 16 E7 86-94</entry></row><row><entry/><entry>(SEQ. ID NO.:490)</entry><entry/></row><row><entry/><entry>YLLPRRGPRL</entry><entry>HCV core protein 34-43</entry></row><row><entry/><entry>(SEQ.ID NO.:491)</entry><entry/></row><row><entry/><entry>LLPIFFCLWV</entry><entry>HBV env 378-387</entry></row><row><entry/><entry>(SEQ. ID NO.:492)</entry><entry/></row><row><entry/><entry>YMDDVVLGA</entry><entry>HBV Pol 538-546</entry></row><row><entry/><entry>(set. ID NO.:493)</entry><entry/></row><row><entry/><entry>GTLGIVCPI</entry><entry>HPV16 E7 85-93</entry></row><row><entry/><entry>(SEQ. ID NO. :494)</entry><entry/></row><row><entry/><entry>LLALLSCLTI</entry><entry>HCV MP 63-72</entry></row><row><entry/><entry>(SEQ. ID NO,:495)</entry><entry/></row><row><entry/><entry>MLDLQPETT</entry><entry>HPV 1 E712-20</entry></row><row><entry/><entry>(SEQ. ID NO.:496)</entry><entry/></row><row><entry/><entry>SLMAFTAAV</entry><entry>HCV NS4174-182</entry></row><row><entry/><entry>(SEQ. ID NO.:497)</entry><entry/></row><row><entry/><entry>CINGVCWTV</entry><entry>HCV NS3 67-75</entry></row><row><entry/><entry>(SEQ. ID NO.:498)</entry><entry/></row><row><entry/><entry>VMNILLQYVV</entry><entry>Glutamic acid decarboxylase 114-123</entry></row><row><entry/><entry>(SEQ. ID NO.:499)</entry><entry/></row><row><entry/><entry>ILTVILGVL</entry><entry>Man A/Mart-32, 40</entry></row><row><entry/><entry>(SEQ.ID NO.:500)</entry><entry/></row><row><entry/><entry>FLWGPRALV</entry><entry>MAGE-3 271-279</entry></row><row><entry/><entry>(SEQ.ID NO.:501)</entry><entry/></row><row><entry/><entry>LLCPAGHAV</entry><entry>HCV NS3 163-171</entry></row><row><entry/><entry>(SEQ. ID NO.:502)</entry><entry/></row><row><entry/><entry>ILDSFDPLV</entry><entry>HCV NSS 239-247</entry></row><row><entry/><entry>(SEQ. ID NO.:503)</entry><entry/></row><row><entry/><entry>LLLCLIFLL</entry><entry>HBV env 250-258</entry></row><row><entry/><entry>(SEQ. ID NO.:504)</entry><entry/></row><row><entry/><entry>LIDYQGMLPV</entry><entry>HBV env 260-269</entry></row><row><entry/><entry>(SEQ. ID NO.:505)</entry><entry/></row><row><entry/><entry>SIVSPFIPLL</entry><entry>HBV env 370-379</entry></row><row><entry/><entry>(SEQ. ID NO.:506)</entry><entry/></row><row><entry/><entry>FLLTRILTI</entry><entry>HBV env 183-191</entry></row><row><entry/><entry>(SEQ. ID NO.:507)</entry><entry/></row><row><entry/><entry>HLGNVKYLV</entry><entry>P. faciparum TRAP 3-11</entry></row><!-- EPO <DP n="35"> --><row><entry/><entry>(SEQ. ID NO.:508)</entry><entry/></row><row><entry/><entry>GIAGGLALL</entry><entry>P. faciparum TRAP 500-508</entry></row><row><entry/><entry>(SEQ. ID NO.:509)</entry><entry/></row><row><entry/><entry>ILAGYGAGV</entry><entry>HCV NS S4A 236-244</entry></row><row><entry/><entry>(SEQ. ID NO.:510)</entry><entry/></row><row><entry/><entry>GLQDCTMLV</entry><entry>HCV NS5 714-722</entry></row><row><entry/><entry>(SEQ. ID NO.:511)</entry><entry/></row><row><entry/><entry>TGAPVTYSTY</entry><entry>HCV NS3 281-290</entry></row><row><entry/><entry>(SEQ. ID NO.:512)</entry><entry/></row><row><entry/><entry>VIYQYMDDLV</entry><entry>HIV-IRT 179-187</entry></row><row><entry/><entry>(SEQ. ID NO.:513)</entry><entry/></row><row><entry/><entry>VLPDVFIRCV</entry><entry>N-acetylglucosaminyltransferase V</entry></row><row><entry/><entry/><entry>Gnt-V intron</entry></row><row><entry/><entry>(SEQ. ID NO.:514)</entry><entry/></row><row><entry/><entry>VLPDVFIRC</entry><entry>N-acetylglucosaminyltransferase V</entry></row><row><entry/><entry/><entry>Gnt-V intron</entry></row><row><entry/><entry>(SEQ. ID NO.:515)</entry><entry/></row><row><entry/><entry>AVGIGIAVV</entry><entry>Human CD9</entry></row><row><entry/><entry>(SEQ. ID NO.:516)</entry><entry/></row><row><entry/><entry>LWLGLLAV</entry><entry>Human glutamyltransferase</entry></row><row><entry/><entry>(SEQ. ID NO.:517)</entry><entry/></row><row><entry/><entry>ALGLGLLPV</entry><entry>Human G protein coupled receptor</entry></row><row><entry/><entry>(SEQ. ID NO.:518)</entry><entry/></row><row><entry/><entry>164-172</entry><entry/></row><row><entry/><entry>GIGIGVLAA</entry><entry>HSV-I gp C 480-488</entry></row><row><entry/><entry>(SEQ. ID NO.:519)</entry><entry/></row><row><entry/><entry>GAGIGVAVL</entry><entry>HSV-2 gp C 446-454</entry></row><row><entry/><entry>(SEQ. ID NO.:520)</entry><entry/></row><row><entry/><entry>IAGIGILAI</entry><entry>Pseudorabies gpGIN 455-463</entry></row><row><entry/><entry>(SEQ. ID NO.:521)</entry><entry/></row><row><entry/><entry>LIVIGILIL</entry><entry>Adenovirus 3 E3 9kD 30-38</entry></row><row><entry/><entry>(SEQ. ID NO.:522)</entry><entry/></row><row><entry/><entry>LAGIGLIAA</entry><entry>S. Lincolnensis ImrA</entry></row><row><entry/><entry>(SEQ. ID NO.:523)</entry><entry/></row><row><entry/><entry>VDGIGILTI</entry><entry>Yeast ysa-1 77-85</entry></row><row><entry/><entry>(SEQ. ID NO.:524)</entry><entry/></row><row><entry/><entry>GAGIGVLTA</entry><entry>B. polymyxa, βendoxylanase 149-157</entry></row><row><entry/><entry>(SEQ. ID NO.:525)</entry><entry/></row><!-- EPO <DP n="36"> --><row><entry/><entry>157</entry><entry/></row><row><entry/><entry>AAGIGIIQI</entry><entry>E. coli methionine synthase 590-598</entry></row><row><entry/><entry>(SEQ. ID NO.:526)</entry><entry/></row><row><entry/><entry>QAGIGILLA</entry><entry>E. coli hypothetical protein 4-12</entry></row><row><entry/><entry>(SEQ. ID NO.:527)</entry><entry/></row><row><entry/><entry>KARDPHSGHFV</entry><entry>CDK4wl 22.32</entry></row><row><entry/><entry>(SEQ. ID NO.:528)</entry><entry/></row><row><entry/><entry>KACDPI-ISGIIFV</entry><entry>CDK4-R24C 22-32</entry></row><row><entry/><entry>(SEQ. ID NO.:529)</entry><entry/></row><row><entry/><entry>ACDPFISGHFV</entry><entry>CDK4-R24C 23-32</entry></row><row><entry/><entry>(SEQ. ID NO.:530)</entry><entry/></row><row><entry/><entry>SLYNTVATL</entry><entry>HIV-I gag p 17 77-85</entry></row><row><entry/><entry>(SEQ. ID NO.:531)</entry><entry/></row><row><entry/><entry>ELVSEFSRV</entry><entry>HER-2, m&gt;V substituted 971-979</entry></row><row><entry/><entry>(SEQ. ID NO.:532)</entry><entry/></row><row><entry/><entry>RGPGRAFVTI</entry><entry>HIV-1 I gp 160 315-329</entry></row><row><entry/><entry>(SEQ. ID NO.:533)</entry><entry/></row><row><entry/><entry>HMWNFISGI</entry><entry>HCVNS4A 149-157</entry></row><row><entry/><entry>(SEQ. ID NO.:534)</entry><entry/></row><row><entry/><entry>NLVPMVATVQ</entry><entry>HCMV pp65 495-504</entry></row><row><entry/><entry>(SEQ. ID NO.:535)</entry><entry/></row><row><entry/><entry>GLHCYEQLV</entry><entry>HPV 6b E7 21-30</entry></row><row><entry/><entry>(SEQ. ID NO.:536)</entry><entry/></row><row><entry/><entry>PLKQHFQIV</entry><entry>HPV 6b E7 47-55</entry></row><row><entry/><entry>(SEQ. ID NO.:537)</entry><entry/></row><row><entry/><entry>LLDFYRFMGV</entry><entry>EBNA-6 284-293</entry></row><row><entry/><entry>(SEQ. ID NO.:538)</entry><entry/></row><row><entry/><entry>AIMEKNIML</entry><entry>Influenza Alaska NS 1 122-130</entry></row><row><entry/><entry>(SEQ. ID NO.:539)</entry><entry/></row><row><entry/><entry>YLKTIQNSL</entry><entry>P. falciparum cp36 CSP</entry></row><row><entry/><entry>(SEQ. ID NO.:540)</entry><entry/></row><row><entry/><entry>YLNKIQNSL</entry><entry>P. falclparum cp39 CSP</entry></row><row><entry/><entry>(SEQ. ID NO.: 541)</entry><entry/></row><row><entry/><entry>YMLDLQPETT</entry><entry>HPV 16 E7 11-20*</entry></row><row><entry/><entry>(SEQ. ID NO.:542)</entry><entry/></row><row><entry/><entry>LLMGTLGIV</entry><entry>HPV16 E7 82-90**</entry></row><row><entry/><entry>(SEQ. ID NO.:543)</entry><entry/></row><row><entry/><entry>TLGIVCPI</entry><entry>HPV 16 E7 86-93</entry></row><!-- EPO <DP n="37"> --><row><entry/><entry>(SEQ. ID NO.:544)</entry><entry/></row><row><entry/><entry>TLTSCNTSV</entry><entry>HIV-1 gp120 197-205</entry></row><row><entry/><entry>(SEQ. ID NO.:545)</entry><entry/></row><row><entry/><entry>KLPQLCTEL</entry><entry>HPV 16 E6 18-26</entry></row><row><entry/><entry>(SEQ. ID NO.:546)</entry><entry/></row><row><entry/><entry>TIHDIILEC</entry><entry>HPV16 E6 29-37</entry></row><row><entry/><entry>(SEQ. ID NO.:547)</entry><entry/></row><row><entry/><entry>LGIVCPICS</entry><entry>HPV16 E7 87-95</entry></row><row><entry/><entry>(SEQ. ID NO.:548)</entry><entry/></row><row><entry/><entry>VILGVLLLI</entry><entry>Melan A/Mart-1 35-43</entry></row><row><entry/><entry>(SEQ. ID NO.:549)</entry><entry/></row><row><entry/><entry>ALMDKSLHV</entry><entry>Melan A/Mart-1 56-64</entry></row><row><entry/><entry>(SEQ. ID NO.:550)</entry><entry/></row><row><entry/><entry>GILTVILGV</entry><entry>Melan A/Mart-1 31-39</entry></row><row><entry/><entry>(SEQ. ID NO.:551)</entry><entry/></row><row><entry>T cell epitopes,</entry><entry>MINAYLDKL</entry><entry>P. Falciparum STARP 523-531</entry></row><row><entry/><entry>(SEQ. ID NO.:552)</entry><entry/></row><row><entry/><entry>AAGIGILTV</entry><entry>Melan A/Mart- 127-35</entry></row><row><entry/><entry>(SEQ. ID NO.:553)</entry><entry/></row><row><entry/><entry>FLPSDFFPSV</entry><entry>HBV cAg 18-27</entry></row><row><entry/><entry>(SEQ. ID NO.:554)</entry><entry/></row><row><entry>Motif unknown</entry><entry>SVRDRLARL</entry><entry>EBNA-3 464-472</entry></row><row><entry>T cell epitopes</entry><entry>(SEQ. ID NO.:555)</entry><entry/></row><row><entry>T cell epitopes</entry><entry>AAGIGILTV</entry><entry>Melan A/Mart-1 27-35</entry></row><row><entry/><entry>(SEQ. ID NO.:556)</entry><entry/></row><row><entry/><entry>FAYDGKDYI</entry><entry>Human MHC I-ot 140-148</entry></row><row><entry/><entry>(SEQ. ID NO.:557)</entry><entry/></row><row><entry>T cell epitopes</entry><entry>AAGIGILTV</entry><entry>Melan A/Mart-1 27-35</entry></row><row><entry/><entry>(SEQ. ID NO.:558)</entry><entry/></row><row><entry/><entry>FLPSDFFPSV</entry><entry>HBV cAg 18-27</entry></row><row><entry/><entry>(SEQ. ID NO.:559)</entry><entry/></row><row><entry>Motif unknown</entry><entry>AAGMILTV</entry><entry>Meland A/Mart-1 27-35</entry></row><row><entry>T cell epitopes</entry><entry>(SEQ. ID NO.:560)</entry><entry/></row><row><entry/><entry>FLPSDFFPSV</entry><entry>HBV cAg 18-27</entry></row><row><entry/><entry>(SEQ. ID NO.:561)</entry><entry/></row><row><entry/><entry>AAGIGILTV</entry><entry>Melan A/Mart-1 27-35</entry></row><row><entry/><entry>(SEQ. ID NO.:562)</entry><entry/></row><row><entry/><entry>ALLAVGATK</entry><entry>Pmell7 gp 100 17-25</entry></row><!-- EPO <DP n="38"> --><row><entry/><entry>(SEQ. ID NO.:563)</entry><entry/></row><row><entry>T cell epitopes</entry><entry>RLRDLLLIVTR</entry><entry>HIV-1 gp41 768-778</entry></row><row><entry/><entry>(SEQ. ID NO.: 564)</entry><entry/></row><row><entry/><entry>QVPLRPMTYK</entry><entry>HIV-1 nef 73-82</entry></row><row><entry/><entry>(SEQ. ID NO.:565)</entry><entry/></row><row><entry/><entry>TVYYGVPVWK</entry><entry>HIV-1 gp120-36-45</entry></row><row><entry/><entry>(SEQ. ID NO.:566)</entry><entry/></row><row><entry/><entry>RLRPGGKKK</entry><entry>HIV- 1 gag p 17 20-29</entry></row><row><entry/><entry>(SEQ. ID NO.:567)</entry><entry/></row><row><entry/><entry>ILRGSVAHK</entry><entry>Influenza NP 265-273</entry></row><row><entry/><entry>(SEQ. ID NO.:668)</entry><entry/></row><row><entry/><entry>RLRAEAGVK</entry><entry>EBNA-3 603-611</entry></row><row><entry/><entry>(SEQ. ID NO.:569)</entry><entry/></row><row><entry/><entry>RLRDLLLIVTR</entry><entry>HIV-1 gp41 770-780</entry></row><row><entry/><entry>(SEQ. ID NO.:570)</entry><entry/></row><row><entry/><entry>VYYGVPVWK</entry><entry>HIV-1 GP 120 38-46</entry></row><row><entry/><entry>(SEQ. ID NO.:571)</entry><entry/></row><row><entry/><entry>RVCEKMALY</entry><entry>HCV NS5 575-583</entry></row><row><entry/><entry>(SEQ. ID NO.:572)</entry><entry/></row><row><entry>Motif unknown</entry><entry>KIFSEVTLK</entry><entry>Unknown; muta melanoma peptide ted</entry></row><row><entry/><entry/><entry>(p I 83L) 175-183</entry></row><row><entry>T cell epitope</entry><entry>(SEQ. ID NO.:573)</entry><entry/></row><row><entry/><entry>YVNVNMGLK*</entry><entry>HBV cAg 88-96</entry></row><row><entry/><entry>(SEQ. ID NO.:574)</entry><entry/></row><row><entry>T cell epitopes</entry><entry>IVTDFSVIK</entry><entry>EBNA-4 416-424</entry></row><row><entry/><entry>(SEQ. ID NO.:575)</entry><entry/></row><row><entry/><entry>ELNEALELK</entry><entry>P53 343-351</entry></row><row><entry/><entry>(SEQ. ID NO.:576)</entry><entry/></row><row><entry/><entry>VPLRPMTYK</entry><entry>HIV- 1 NEF 74-82</entry></row><row><entry/><entry>(SEQ. ID NO.:577)</entry><entry/></row><row><entry/><entry>AIFQSSMTK</entry><entry>HIV- I gag p24 325-333</entry></row><row><entry/><entry>(SEQ. ID NO.:578)</entry><entry/></row><row><entry/><entry>QVPLRPMTYK</entry><entry>HIV-1 nef 73-82</entry></row><row><entry/><entry>(SEQ. ID NO.:579)</entry><entry/></row><row><entry/><entry>TRNYTIFK HCV</entry><entry>NSI 238-246</entry></row><row><entry/><entry>(SEQ. ID NO.:580)</entry><entry/></row><row><entry/><entry>AAVDLSHFLKEK</entry><entry>HIV-1 nef 83-94</entry></row><row><entry/><entry>(SEQ. ID NO.:581)</entry><entry/></row><!-- EPO <DP n="39"> --><row><entry/><entry>ACQGVGGPGGHK</entry><entry>HIV-1 II 1B p24 349.-359</entry></row><row><entry/><entry>(SEQ. ID NO.:581)</entry><entry/></row><row><entry>HLA-A24</entry><entry>SYLDSGIHF*</entry><entry>β-catenin, mutated (proto-onocogen)</entry></row><row><entry/><entry/><entry>29-37</entry></row><row><entry/><entry>(SEQ. ID NO.:582)</entry><entry/></row><row><entry>T cell epitopes</entry><entry>RYLKDQQLL</entry><entry>HIV GP 41 583-591</entry></row><row><entry/><entry>(SEQ. ID NO.:583)</entry><entry/></row><row><entry/><entry>AYGLDPYIL</entry><entry>P 15 melanoma Ag 10-18</entry></row><row><entry/><entry>(SEQ. ID NO.: 5 84)</entry><entry/></row><row><entry/><entry>AFLPWHRLFL</entry><entry>Tyrosinase 206-215</entry></row><row><entry/><entry>(SEQ. ID NO.:585)</entry><entry/></row><row><entry/><entry>AFLPWHRLF</entry><entry>Tyrosinase 206-214</entry></row><row><entry/><entry>(SEQ. ID NO.:586)</entry><entry/></row><row><entry/><entry>RYSIFFDY</entry><entry>Ebna-3 246-253</entry></row><row><entry/><entry>(SEQ. ID NO.:587)</entry><entry/></row><row><entry>T cell epitope</entry><entry>ETINEEAAEW</entry><entry>HIV-1 gag p24 203-212</entry></row><row><entry/><entry>(SEQ. ID NO.:588)</entry><entry/></row><row><entry>T cell epitopes</entry><entry>STLPETTVVRR</entry><entry>HBV cAg 141 -151</entry></row><row><entry/><entry>(SEQ. ID NO.:589)</entry><entry/></row><row><entry/><entry>MSLQRQFLR</entry><entry>ORF 3P-gp75 294-321 (bp)</entry></row><row><entry/><entry>(SEQ. ID NO.:590)</entry><entry/></row><row><entry/><entry>LLPGGRPYR</entry><entry>TRP (tyrosinase rel.) 197-205</entry></row><row><entry/><entry>(SEQ. ID NO.:591)</entry><entry/></row><row><entry>T cell epitope</entry><entry>IVGLNKIVR</entry><entry>HIV gag p24 267-267-275</entry></row><row><entry/><entry>(SEQ. ID NO.:592)</entry><entry/></row><row><entry/><entry>AAGIGILTV</entry><entry>Melan A/Mart- 127 35</entry></row><row><entry/><entry>(SEQ. ID NO.:593)</entry><entry/></row></tbody></tgroup></table></tables>
Table 3 sets forth additional antigens useful in the invention that are available from the Ludwig Cancer Institute. The Table refers to patents in which the identified antigens can be found. TRA refers to the tumor-related antigen and the LUD No. refers to the Ludwig Institute number.
<tables id="tabl0003" num="0003"><table frame="all"><title>Table 3</title><tgroup cols="6"><colspec colnum="1" colname="col1" colwidth="21mm"/><colspec colnum="2" colname="col2" colwidth="18mm"/><colspec colnum="3" colname="col3" colwidth="21mm"/><colspec colnum="4" colname="col4" colwidth="33mm"/><colspec colnum="5" colname="col5" colwidth="56mm"/><colspec colnum="6" colname="col6" colwidth="20mm"/><thead><row><entry valign="top">TRA</entry><entry valign="top">LUD No.</entry><entry valign="top">Patent No.</entry><entry valign="top">Date Patent Issued</entry><entry valign="top">Peptide (Antigen)</entry><entry valign="top">HLA</entry></row></thead><tbody><row><entry>MAGE-4</entry><entry>5293</entry><entry>5,405,940</entry><entry>11 April 1995</entry><entry>EVDPASNTY</entry><entry>HLA-AI</entry></row><row><entry/><entry/><entry/><entry/><entry>(SEQ. ID NO.:532)</entry><entry/></row><row><entry>MAGE-41</entry><entry>5293</entry><entry>5,405,940</entry><entry>11 April 1995</entry><entry>EVDPTSNTY</entry><entry>HLA-A1</entry></row><row><entry/><entry/><entry/><entry/><entry>(SEQ ID NO.:533)</entry><entry/></row><row><entry>MAGE-5</entry><entry>5293</entry><entry>5,405,940</entry><entry>11 April 1995</entry><entry>EADPTSNTY</entry><entry>HLA-A 1</entry></row><!-- EPO <DP n="40"> --><row><entry/><entry/><entry/><entry/><entry>(SEQ ID NO:534)</entry><entry/></row><row><entry>MAGE-51</entry><entry>5293</entry><entry>5,405,940</entry><entry>11 April 1995</entry><entry>EADPTSNTY</entry><entry>HLA-A 1</entry></row><row><entry/><entry/><entry/><entry/><entry>(SEQ ID NO:534)</entry><entry/></row><row><entry>MAGE-6</entry><entry>5294</entry><entry>5,405,940</entry><entry>11 April 1995</entry><entry>EVDPIGHVY</entry><entry>HLA-A1</entry></row><row><entry/><entry/><entry/><entry/><entry>(SEQ ID NO:535)</entry><entry/></row><row><entry/><entry>5299.2</entry><entry>5,487,974</entry><entry>30 January 1996</entry><entry>MLLAVLYCLL</entry><entry>HLA-A2</entry></row><row><entry/><entry/><entry/><entry/><entry>(SEQ ID NO:536)</entry><entry/></row><row><entry/><entry>5360</entry><entry>5,530,096</entry><entry>25 June 1996</entry><entry>MLLAVLYCL</entry><entry>HLA-B44</entry></row><row><entry/><entry/><entry/><entry/><entry>(SEQ ID NO:537)</entry><entry/></row><row><entry>Tyrosinase</entry><entry>5360.1</entry><entry>5,519,11</entry><entry>21 May 1996</entry><entry>SEIWRDIDFA</entry><entry>HLA-B44</entry></row><row><entry/><entry/><entry/><entry/><entry>(SEQ ID NO:538)</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>SEIWRDIDF</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>(SEQ ID NO:539)</entry><entry/></row><row><entry>Tyrosinase</entry><entry>5431</entry><entry>5,774,316</entry><entry>28 April 1998</entry><entry>XEIWRDIDF</entry><entry>HLA-B44</entry></row><row><entry/><entry/><entry/><entry/><entry>(SEQ ID NO:540)</entry><entry/></row><row><entry>MAGE-2</entry><entry>5340</entry><entry>5,554,724</entry><entry>10 September 1996</entry><entry>STLVEVTLGEV</entry><entry>HLA-A2</entry></row><row><entry/><entry/><entry/><entry/><entry>(SEQ ID NO:541)</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>LVEVTLGEV</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>(SEQ ID NO:542)</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>VIFSKASEYL</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>(SEQ ID NO:543)</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>IIVL-AIIAI</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>(SEQ ID NO:544)</entry><entry/></row><row><entry>(Continued)</entry><entry/><entry/><entry/><entry>KIWEELSMLEV</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>(SEQ ID NO:.545)</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>LIETSYVKV</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>(SEQ ID NO:546)</entry><entry/></row><row><entry/><entry>5327</entry><entry>5,585,461</entry><entry>17 December 1996</entry><entry>FLWGPRALV</entry><entry>HLA-A2</entry></row><row><entry/><entry/><entry/><entry/><entry>(SEQ ID NO: 547)</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>TLVEVTLGEV</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>(SEQ ID NO:548)</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>ALVETSYVKV</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>(SEQ ID NO:549)</entry><entry/></row><row><entry>MAGE-3</entry><entry>5344</entry><entry>5,554,506</entry><entry>10 September 1996</entry><entry>KIWEELSVL</entry><entry>HLA-A2</entry></row><row><entry/><entry/><entry/><entry/><entry>(SEQ ID NO:550)</entry><entry/></row><row><entry>MAGE-3</entry><entry>5393</entry><entry>5,405,940</entry><entry>11 April 1995</entry><entry>EVDPIGHLY</entry><entry>HLA-A1</entry></row><row><entry/><entry/><entry/><entry/><entry>(SEQ ID NO:551)</entry><entry/></row><!-- EPO <DP n="41"> --><row><entry>MAGE</entry><entry>5293</entry><entry>5,405,940</entry><entry>11 April 1995</entry><entry>EXDX5Y</entry><entry>HLA-A1</entry></row><row><entry/><entry/><entry/><entry/><entry>(SEQ. ID NO.:552)</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>(but not EADPTGHSY)</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>(SEQ. ID NO.:553)</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>E (A/V) D X5 Y</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>(SEQ. ID NO.:554)</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>E(A/V)DPX4Y</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>(SEQ. ID NO.:555)</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>E (A/V) D P (I/A/T) X3 Y</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>(SEQ. ID NO.:556)</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>E (A/V) D P (I/A/T) (G/S) X2 Y</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>(SEQ. ID NO.:557)</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>E (A/V) D P (I/A/T) (G/S) (H/N) X Y</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>E (A/V) DP (I/A/T) (G/S) (H/N) (L/T/V) Y</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>(SEQ. ID NO.:559)</entry><entry/></row><row><entry>MAGE-1</entry><entry>5361</entry><entry>5,558.995</entry><entry>24 September 1996</entry><entry>ELHSAYGEPRKLLTQD</entry><entry>HLA-C</entry></row><row><entry/><entry/><entry/><entry/><entry>(SEQ ID NO:560)</entry><entry>Clone 10</entry></row><row><entry/><entry/><entry/><entry/><entry>EHSAYGEPRKLL</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>(SEQ ID NO:561)</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>SAYGEPRKL</entry><entry/></row><row><entry/><entry/><entry/><entry/><entry>(SEQ ID NO:562)</entry><entry/></row><row><entry>MAGE-1</entry><entry>5253.4</entry><entry>TBA</entry><entry>TBA</entry><entry>EADPTGHSY</entry><entry>HLA-A 1</entry></row><row><entry/><entry/><entry/><entry/><entry>(SEQ ID NO:563)</entry><entry/></row><row><entry>BAGE</entry><entry>5310.1</entry><entry>TBA</entry><entry>TBA</entry><entry>MAARAVFLALSAQLLQARLMKE</entry><entry>HLA-C</entry></row><row><entry/><entry/><entry/><entry/><entry>(SEQ ID NO:564)</entry><entry>Clone 10</entry></row><row><entry/><entry/><entry/><entry/><entry>MAARAVFLALSAQLLQ</entry><entry>HLA-C</entry></row><row><entry/><entry/><entry/><entry/><entry>(SEQ ID NO:565)</entry><entry>Clone 10</entry></row><row><entry/><entry/><entry/><entry/><entry>AARAVFLAL</entry><entry>HLA-C</entry></row><row><entry/><entry/><entry/><entry/><entry>(SEQ ID NO:566)</entry><entry>Clone 10</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry/></row><row><entry>GAGE</entry><entry>5323.2</entry><entry>5,648,226</entry><entry>15 July 1997</entry><entry>YRPRPRRY</entry><entry>HLA-CW6</entry></row><row><entry/><entry/><entry/><entry/><entry>(SEQ. ID NO:567)</entry><entry/></row></tbody></tgroup></table></tables><!-- EPO <DP n="42"> -->
<tables id="tabl0004" num="0004"><table frame="all"><title><u>Table 4</u></title><tgroup cols="6"><colspec colnum="1" colname="col1" colwidth="28mm"/><colspec colnum="2" colname="col2" colwidth="25mm"/><colspec colnum="3" colname="col3" colwidth="21mm"/><colspec colnum="4" colname="col4" colwidth="22mm"/><colspec colnum="5" colname="col5" colwidth="42mm"/><colspec colnum="6" colname="col6" colwidth="30mm"/><thead><row><entry align="center" valign="top"><b>Source</b></entry><entry align="center" valign="top"><b>Protein</b></entry><entry align="center" valign="top"><b>AA Position</b></entry><entry align="center" valign="top"><b>MHC molecules</b></entry><entry align="center" valign="top"><b>T cell epitope MHC ligand (Antigen)</b></entry><entry align="center" valign="top"><b>Ref.</b></entry></row></thead><tbody><row><entry>synthetic peptides</entry><entry>synthetic peptides</entry><entry>synthetic peptides</entry><entry align="center">HLA-A2</entry><entry>ALFAAAAAV</entry><entry><nplcit id="ncit0065" npl-type="s"><text>Parker, et al., "Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptides sidechains," J. Immunol. 152: 163-175</text></nplcit></entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GIFGGVGGV</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GLDKGGGV</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GLFGGFGGV</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GLFGGGAGV</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GLFGGGEGV</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GLFGGGFGV</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GLFGGGGGL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GLFGGGGGV</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GLFGGGVGV</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GLFGGVGGV</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GLFGGVGKV</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GLFKGVGGV</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GLGGGGFGV</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GLLGGGVGV</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GLYGGGGGV</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GMFGGGGGV</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GMFGGVGGV</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GQFGGVGGV</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GVFGGVGGV</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>KLFGGGGGV</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>KLFGGVGGV</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>AILGFVFTL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GAIGFVFTL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GALGFVFTL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GELGFVFTL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GIAGFVFTL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GIEGFVFTL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GILAFVFTL</entry><entry align="center">"</entry></row><!-- EPO <DP n="43"> --><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GILGAVFTL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GILGEVFTL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GILFGAFTL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GILGFEFTL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GILGFKFTL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GILGFVATL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GILGFVETL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GILGFVFAL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GILGFVFEL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GILGFVFKL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GILGFVFTA</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GILGFVFTL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GILGFVFVL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GILGFVKTL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GILGKVFTL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GILKFVFTL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GILPFVFTL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GIVGFVFTL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GKLGFVFTL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GLLGFVFTL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>GQLGFVFTL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>KALGFVFTL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>KILGFVFTL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>KILGKVFRL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>AILLGVFML</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>AIYKRWIIL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>ALFFFDIDL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>ATVELLSEL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>CLFGYPVYV</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>FIFPNYTIV</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>IISLWDSQL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>ILASLFAAV</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>ILESLFAAV</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>KLGEFFNQM</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>KLGEFYNQM</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>LLFGYPVYV</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>LLWKGEGAV</entry><entry align="center">"</entry></row><!-- EPO <DP n="44"> --><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>LMFGYPVYV</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>LNFGYPVYV</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>LQFGYPVYV</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>NIVAKRFKV</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>NLPMVATV</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>QMLLAIARL</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>QMWQARLTV</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>RLLQTGIHV</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>RLVNGSLAL</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>SLYNTVATL</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>TLNAWVKVV</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>WLYRETCNL</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>YLFKRMIDL</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GAFGGVGGV</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GAFGGVGGY</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GEFGGVGGV</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GGFGGVGGV</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GIFGGGGGV</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GIGGFGGGL</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GIGGGGGGL</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GLDGGGGGV</entry><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GLDGKGGGV</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GLDKKGGGV</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GLFGGGFGF</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GLFGGGFGG</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GLFGGGFGN</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GLFGGGFGS</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GLFGGGGGI</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GLFGGGGGM</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GLFGGGGGT</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GLFGGGGGY</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GLGFGGGGV</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GLGGFGGGV</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GLGGGFGGV</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GLGGGGGFV</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GLGGGGGGY</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GLGGGVGGV</entry><entry align="center">"</entry></row><!-- EPO <DP n="45"> --><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GLLGGGGGV</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GLPGGGGGV</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GNFGGVGGV</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GSFGGVGGV</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GTFGGVGGV</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>AGNSAYEYV</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GLFPGQFAY</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>HILLGVFML</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>ILESLFFRAV</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>KKKYKLKHI</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>MLASIDLKY</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>MLERELVRK</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>KLFGFVFTV</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>ILDKKVEKV</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>ILKEPVHGV</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>ALFAAAAAY</entry><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GIGFGGGGL</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GKTGGVGGV</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GLFGGGGGK</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>EILGFVFTL</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GIKGFVFTL</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>GQLGFVFTK</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>ILGFVFTLT</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>KILGFVFTK</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>KKLGFVFTL</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>KLFEKVYNY</entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry>LRFGYPVYV</entry><entry align="center">"</entry></row><row><entry>Human</entry><entry>HSP60</entry><entry>140-148</entry><entry align="center">HLA-B27</entry><entry>IRRGVMLAV</entry><entry>Rammensee et al. 1997</entry></row><row><entry/><entry/><entry/><entry align="center"/><entry/><entry align="center">160</entry></row><row><entry>"</entry><entry>"</entry><entry>369-377</entry><entry align="center">"</entry><entry>KRIQEHEQ</entry><entry align="center">"</entry></row><row><entry/><entry>"</entry><entry>469-477</entry><entry align="center">"</entry><entry>KRTLKIPAM</entry><entry align="center">"</entry></row><row><entry>Yersinia</entry><entry>HSP60</entry><entry>35-43</entry><entry align="center">"</entry><entry>GRNVVLDKS</entry><entry align="center">"</entry></row><row><entry>"</entry><entry>"</entry><entry>117-125</entry><entry align="center">"</entry><entry>KRGIDKAVI</entry><entry align="center">"</entry></row><row><entry>"</entry><entry>"</entry><entry>420-428</entry><entry align="center">"</entry><entry>IRAASAITA</entry><entry align="center">"</entry></row><row><entry/><entry>HSP 60</entry><entry>284-292</entry><entry align="center">HLA-B*2705</entry><entry>RRKAMFEDI</entry><entry align="center">169</entry></row><row><entry>P.falciparum</entry><entry>LSA-1</entry><entry>1850-1857</entry><entry align="center">HLA-B3501</entry><entry>KPKDELDY</entry><entry align="center">170</entry></row><!-- EPO <DP n="46"> --><row><entry>Influenza NP</entry><entry/><entry>379-387</entry><entry align="center">HLA-B*4402</entry><entry>LELRSRYWA</entry><entry align="center">183</entry></row><row><entry/><entry>Tum-P35B</entry><entry>4-13</entry><entry align="center">HLA-D<sup>d</sup></entry><entry>GPPHSNNFGY</entry><entry align="center">230</entry></row><row><entry>Rotavirus</entry><entry>VP7</entry><entry>33-40</entry><entry align="center"/><entry>IIYRFLLI</entry><entry align="center">262</entry></row><row><entry/><entry>OGDH (F108Y)</entry><entry>104-112</entry><entry align="center">H2-L<sup>d</sup></entry><entry>QLSPYPFDL</entry><entry align="center">253</entry></row><row><entry/><entry>TRP-2</entry><entry>181-188</entry><entry align="center">p287</entry><entry>VYDFFVWL</entry><entry align="center">284</entry></row><row><entry/><entry>DEAD box</entry><entry>547-554</entry><entry align="center">p287</entry><entry>SNFVFAGI</entry><entry align="center">283</entry></row><row><entry/><entry>p 68</entry><entry/><entry align="center"/><entry/><entry align="center"/></row><row><entry/><entry>Vector "artefact"</entry><entry/><entry align="center">p287</entry><entry>SVVEFSSL</entry><entry align="center">260</entry></row><row><entry/><entry>Epiopemimic of tumor Ag</entry><entry/><entry align="center">p287</entry><entry>AHYLFRNL</entry><entry align="center">278</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>THYLFRNL</entry><entry align="center"/></row><row><entry/><entry>Epitope mimic of H-3 miHAg<sup>■</sup></entry><entry/><entry align="center">"</entry><entry>LIVIYNTL</entry><entry align="center">279</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>LIYEFNTL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>IPYIYNTL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center"/><entry>IIYIYHRL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>LIYIFNTL</entry><entry align="center"/></row><row><entry/><entry>HBV cAg</entry><entry>93-100</entry><entry align="center">"</entry><entry>MGLKFRQL</entry><entry align="center">280</entry></row><row><entry>Human</entry><entry>autoantigen LA</entry><entry>51-58</entry><entry align="center">"</entry><entry>IMIKFRNRL</entry><entry align="center">281</entry></row><row><entry>Mouse</entry><entry>UTY protein</entry><entry/><entry align="center">H2D<sup>b</sup></entry><entry>WMHHNMDLI</entry><entry align="center">303</entry></row><row><entry>Mouse</entry><entry>p53</entry><entry>232-240</entry><entry align="center">"</entry><entry>KYMCNSSCM</entry><entry align="center">302</entry></row><row><entry>MURINE</entry><entry>MDM2</entry><entry>441-449</entry><entry align="center">"</entry><entry>GRPKNGCIV</entry><entry align="center">277</entry></row><row><entry/><entry>Epitope mimic of natural</entry><entry/><entry align="center">"</entry><entry>AQHPNAELL</entry><entry align="center">278</entry></row><row><entry/><entry>MuLV gag75K</entry><entry>75-83</entry><entry align="center">"</entry><entry>CCLCLTVFL</entry><entry align="center">301</entry></row><row><entry>P. Falciparum</entry><entry>CSP</entry><entry>375-383</entry><entry align="center">p290</entry><entry>YENDIEKK</entry><entry align="center">315</entry></row><row><entry>"</entry><entry>"</entry><entry>371-379</entry><entry align="center">"</entry><entry>DELDYENDI</entry><entry align="center">315</entry></row><row><entry>HIV</entry><entry>-IRT</entry><entry>206-214</entry><entry align="center">"</entry><entry>TEMEKEGKI</entry><entry align="center">316</entry></row><row><entry>Rabies</entry><entry>NS</entry><entry>197-205</entry><entry align="center"/><entry>VEAEIAHQI</entry><entry align="center">309,310</entry></row><row><entry>Influenza A</entry><entry>NSI</entry><entry>152-160</entry><entry align="center">"</entry><entry>EEGAIVGEI</entry><entry align="center">304</entry></row><row><entry>Murine</entry><entry>SMCY</entry><entry/><entry align="center">p291</entry><entry>TENSGKDI</entry><entry align="center">317</entry></row><row><entry/><entry>MHC class I leader</entry><entry>3-11</entry><entry align="center">p293</entry><entry>AMAPRTLLL</entry><entry align="center">318</entry></row><!-- EPO <DP n="47"> --><row><entry/><entry>ND1 alpha</entry><entry>1-12</entry><entry align="center">p293</entry><entry>FFINILTLLVP</entry><entry align="center">323</entry></row><row><entry/><entry>ND Beta</entry><entry>1-12</entry><entry align="center">p293</entry><entry>FFINILTLLVP</entry><entry align="center">323</entry></row><row><entry/><entry>ND alpha</entry><entry>1-17</entry><entry align="center">"</entry><entry>FFNILTLLVPILIAM</entry><entry align="center">324</entry></row><row><entry/><entry>ND Beta</entry><entry>1-17</entry><entry align="center">"</entry><entry>FFINALTLLVPILIAM</entry><entry align="center">"</entry></row><row><entry/><entry>COI mitochondrial</entry><entry>1-6</entry><entry align="center">"</entry><entry>FINRW</entry><entry align="center">325</entry></row><row><entry>L. monocytogenes</entry><entry>LemA</entry><entry>1-6</entry><entry align="center">"</entry><entry>IGWII</entry><entry align="center">326</entry></row><row><entry/><entry>SIV gag p11C</entry><entry>179-190</entry><entry align="center">Mamu-A*01</entry><entry>EGCTPYDINQML</entry><entry align="center">334</entry></row><row><entry/><entry/><entry/><entry align="center"/><entry/><entry align="center"/></row><row><entry/><entry>MAGE-3</entry><entry/><entry align="center">HLA-A2</entry><entry>ALSRKVAEL</entry><entry align="center">5,554,506</entry></row><row><entry/><entry/><entry/><entry align="center"/><entry>IMPKAGLLI</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>KIWEELSVL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry>ALVETSYVKV</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry><img id="ib0001" file="imgb0001.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center"/></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry><img id="ib0002" file="imgb0002.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry><img id="ib0003" file="imgb0003.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry><img id="ib0004" file="imgb0004.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry><img id="ib0005" file="imgb0005.tif" wi="33" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center"/><entry/><entry align="center"/></row><row><entry/><entry>peptides which bind to MHCs</entry><entry/><entry align="center">HLA-A2</entry><entry><img id="ib0006" file="imgb0006.tif" wi="35" he="10" img-content="dna" img-format="tif"/></entry><entry align="center">5,989,565</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry><img id="ib0007" file="imgb0007.tif" wi="36" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry><img id="ib0008" file="imgb0008.tif" wi="36" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry><img id="ib0009" file="imgb0009.tif" wi="34" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry><img id="ib0010" file="imgb0010.tif" wi="36" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry><img id="ib0011" file="imgb0011.tif" wi="35" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry><img id="ib0012" file="imgb0012.tif" wi="36" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><!-- EPO <DP n="48"> --><row><entry/><entry/><entry/><entry align="center">"</entry><entry><img id="ib0013" file="imgb0013.tif" wi="34" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry><img id="ib0014" file="imgb0014.tif" wi="35" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry><img id="ib0015" file="imgb0015.tif" wi="35" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry><img id="ib0016" file="imgb0016.tif" wi="36" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center"/><entry/><entry align="center"/></row><row><entry/><entry>Peptides from MAGE-1</entry><entry/><entry align="center">HLA-C clone 10</entry><entry><img id="ib0017" file="imgb0017.tif" wi="33" he="13" img-content="dna" img-format="tif"/></entry><entry align="center">5,558,995</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry><img id="ib0018" file="imgb0018.tif" wi="33" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry><img id="ib0019" file="imgb0019.tif" wi="34" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center"/><entry/><entry align="center"/></row><row><entry/><entry>GAGE</entry><entry/><entry align="center">HLA-Cw6</entry><entry><img id="ib0020" file="imgb0020.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">5,648,226</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry><img id="ib0021" file="imgb0021.tif" wi="33" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry><img id="ib0022" file="imgb0022.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry><img id="ib0023" file="imgb0023.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry><img id="ib0024" file="imgb0024.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry><img id="ib0025" file="imgb0025.tif" wi="32" he="12" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">"</entry><entry><img id="ib0026" file="imgb0026.tif" wi="33" he="13" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><!-- EPO <DP n="49"> --><row><entry align="center"/><entry align="center">MAGE</entry><entry align="center"/><entry align="center">HLA-A1, primarily</entry><entry>Isolated nonapeptide having Glu at its N terminal, Tyr at its C-terminal, and Asp at the third residue from its N terminal, with the proviso that said isolated nonapeptide is not Glu Ala Asp Pro Thr Gly His Ser Tyr (SEQ ID NO: 1), and wherein aid isolated nonapeptide binds to a human leukocyte antigen molecule on a cell to form a complex, said complex provoking lysis of said</entry><entry align="center">5,405,940</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center"/><entry>cell by a cytolytic T cell specific to said complex</entry><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry><img id="ib0027" file="imgb0027.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry><img id="ib0028" file="imgb0028.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry><img id="ib0029" file="imgb0029.tif" wi="33" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry><img id="ib0030" file="imgb0030.tif" wi="31" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry><img id="ib0031" file="imgb0031.tif" wi="33" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry><img id="ib0032" file="imgb0032.tif" wi="33" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry><img id="ib0033" file="imgb0033.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry><img id="ib0034" file="imgb0034.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry><img id="ib0035" file="imgb0035.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry><img id="ib0036" file="imgb0036.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry><img id="ib0037" file="imgb0037.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry><img id="ib0038" file="imgb0038.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry><img id="ib0039" file="imgb0039.tif" wi="33" he="9" img-content="dna" img-format="tif"/></entry><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry><img id="ib0040" file="imgb0040.tif" wi="32" he="8" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><!-- EPO <DP n="50"> --><row><entry/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry><img id="ib0041" file="imgb0041.tif" wi="33" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry><img id="ib0042" file="imgb0042.tif" wi="30" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry align="center"/><entry align="center"/><entry align="center">"</entry><entry><img id="ib0043" file="imgb0043.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry align="center">MAGE peptides</entry><entry align="center"/><entry align="center">HLA-A2</entry><entry><img id="ib0044" file="imgb0044.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">5,554,724</entry></row><row><entry/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0045" file="imgb0045.tif" wi="30" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0046" file="imgb0046.tif" wi="31" he="9" img-content="dna" img-format="tif"/></entry><entry align="center"/></row><row><entry/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0047" file="imgb0047.tif" wi="33" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0048" file="imgb0048.tif" wi="31" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0049" file="imgb0049.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0050" file="imgb0050.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center"/></row><row><entry/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry>llelleValLeuAlallelleAlalle</entry><entry align="center">"</entry></row><row><entry/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0051" file="imgb0051.tif" wi="33" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0052" file="imgb0052.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0053" file="imgb0053.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0054" file="imgb0054.tif" wi="31" he="9" img-content="dna" img-format="tif"/></entry><entry align="center"/></row><row><entry/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0055" file="imgb0055.tif" wi="30" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0056" file="imgb0056.tif" wi="30" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0057" file="imgb0057.tif" wi="30" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0058" file="imgb0058.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0059" file="imgb0059.tif" wi="32" he="8" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0060" file="imgb0060.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0061" file="imgb0061.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><!-- EPO <DP n="51"> --><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0062" file="imgb0062.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0063" file="imgb0063.tif" wi="31" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0064" file="imgb0064.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center"/><entry><img id="ib0065" file="imgb0065.tif" wi="30" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0066" file="imgb0066.tif" wi="30" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0067" file="imgb0067.tif" wi="31" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0068" file="imgb0068.tif" wi="30" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0069" file="imgb0069.tif" wi="31" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center"/><entry><img id="ib0070" file="imgb0070.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0071" file="imgb0071.tif" wi="33" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0072" file="imgb0072.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0073" file="imgb0073.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0074" file="imgb0074.tif" wi="34" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0075" file="imgb0075.tif" wi="31" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0076" file="imgb0076.tif" wi="30" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0077" file="imgb0077.tif" wi="30" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0078" file="imgb0078.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0079" file="imgb0079.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0080" file="imgb0080.tif" wi="30" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0081" file="imgb0081.tif" wi="30" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0082" file="imgb0082.tif" wi="30" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0083" file="imgb0083.tif" wi="30" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><!-- EPO <DP n="52"> --><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0084" file="imgb0084.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0085" file="imgb0085.tif" wi="31" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0086" file="imgb0086.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0087" file="imgb0087.tif" wi="34" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0088" file="imgb0088.tif" wi="32" he="10" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0089" file="imgb0089.tif" wi="31" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0090" file="imgb0090.tif" wi="33" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0091" file="imgb0091.tif" wi="34" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0092" file="imgb0092.tif" wi="34" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0093" file="imgb0093.tif" wi="34" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0094" file="imgb0094.tif" wi="34" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0095" file="imgb0095.tif" wi="35" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0096" file="imgb0096.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0097" file="imgb0097.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0098" file="imgb0098.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0099" file="imgb0099.tif" wi="30" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0100" file="imgb0100.tif" wi="31" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0101" file="imgb0101.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0102" file="imgb0102.tif" wi="31" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0103" file="imgb0103.tif" wi="33" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry align="center"/><entry align="center">"</entry><entry align="center"/><entry align="center">"</entry><entry><img id="ib0104" file="imgb0104.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><!-- EPO <DP n="53"> --><row><entry/><entry align="center">Mage-3 peptides</entry><entry/><entry align="center">HLA-A2</entry><entry><img id="ib0105" file="imgb0105.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">5,585,461</entry></row><row><entry/><entry align="center">"</entry><entry/><entry align="center">"</entry><entry><img id="ib0106" file="imgb0106.tif" wi="33" he="8" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry align="center">"</entry><entry/><entry align="center">"</entry><entry><img id="ib0107" file="imgb0107.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry align="center">"</entry><entry/><entry align="center">"</entry><entry><img id="ib0108" file="imgb0108.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry align="center">"</entry><entry/><entry align="center">"</entry><entry><img id="ib0109" file="imgb0109.tif" wi="33" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry align="center">"</entry><entry/><entry align="center">"</entry><entry><img id="ib0110" file="imgb0110.tif" wi="33" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry align="center"/><entry/><entry align="center"/><entry/><entry align="center"/></row><row><entry/><entry align="center">Tyrosinase</entry><entry/><entry align="center">HLA-A2</entry><entry><img id="ib0111" file="imgb0111.tif" wi="33" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">5,487,974</entry></row><row><entry/><entry align="center">"</entry><entry/><entry align="center">"</entry><entry><img id="ib0112" file="imgb0112.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry align="center"/><entry/><entry align="center"/><entry/><entry align="center"/></row><row><entry/><entry align="center">Tyrosinase</entry><entry/><entry align="center">HLA-A2</entry><entry><img id="ib0113" file="imgb0113.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">5,530,096</entry></row><row><entry/><entry align="center">"</entry><entry/><entry align="center">"</entry><entry><img id="ib0114" file="imgb0114.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry align="center">Tyrosinase</entry><entry/><entry align="center">HLA-A2 and HLA-B44</entry><entry><img id="ib0115" file="imgb0115.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">5,519,117</entry></row><row><entry/><entry align="center">"</entry><entry/><entry align="center">"</entry><entry><img id="ib0116" file="imgb0116.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry align="center">"</entry><entry/><entry align="center">"</entry><entry><img id="ib0117" file="imgb0117.tif" wi="32" he="9" img-content="dna" img-format="tif"/></entry><entry align="center">"</entry></row><row><entry/><entry align="center">Melan</entry><entry/><entry align="center"/><entry>EAAGIGILTV</entry><entry align="center">Jäger, E. et al.</entry></row><row><entry/><entry align="center">A/MART-1</entry><entry/><entry align="center"/><entry/><entry>Granulocyte-macrophage-colony-stimulating Factor Enhances Immune Responses To Melanoma-associated Peptides in vivo Int. J Cancer 67, 54-62 (1996)</entry></row><row><entry/><entry align="center">Tyrosinase</entry><entry/><entry align="center"/><entry>MLLAVLYCL</entry><entry align="center"/></row><row><entry/><entry align="center">"</entry><entry/><entry align="center"/><entry>YMDGTMSQV</entry><entry align="center">"</entry></row><row><entry/><entry align="center">gp 100/Pmel 17</entry><entry/><entry align="center"/><entry>YLEPGPVTA</entry><entry align="center">"</entry></row><!-- EPO <DP n="54"> --><row><entry/><entry align="center">"</entry><entry/><entry align="center"/><entry>LLDGTATLRL</entry><entry align="center">"</entry></row><row><entry/><entry align="center">Influenza matrix</entry><entry/><entry align="center"/><entry>GILGFVFTL</entry><entry align="center">"</entry></row><row><entry/><entry align="center">MARGE-1</entry><entry/><entry align="center"/><entry>EADPTGHSY</entry><entry align="center">"</entry></row><row><entry/><entry align="center">"</entry><entry/><entry align="center"/><entry/><entry align="center"/></row><row><entry/><entry align="center">MAGE.-1</entry><entry/><entry align="center">HLA-A1</entry><entry>EADPTGHSY</entry><entry align="center">DIRECTLY FROM DAVID'S LIST</entry></row><row><entry/><entry align="center">BAGE</entry><entry/><entry align="center">HLA-C</entry><entry>MAARAVFLALSAQL LQARLMKE</entry><entry align="center">"</entry></row><row><entry/><entry align="center">"</entry><entry/><entry align="center"/><entry>MAARAVFLALSAQL LQ</entry><entry align="center">"</entry></row><row><entry/><entry align="center">"</entry><entry/><entry align="center"/><entry>AARAVFLAL</entry><entry align="center">"</entry></row><row><entry>Influenza</entry><entry align="center">PR8 NP</entry><entry>147-154</entry><entry align="center">K<sup>d</sup></entry><entry>IYQIURALV</entry><entry align="center">Falk et al., Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules</entry></row><row><entry>SELF</entry><entry align="center">P815</entry><entry/><entry align="center">"</entry><entry>SYFPETHI</entry><entry align="center">"</entry></row><row><entry>PEPTIDE</entry><entry align="center">"</entry><entry/><entry align="center">"</entry><entry/><entry align="center">"</entry></row><row><entry>Influenza</entry><entry align="center">Jap HA 523-549</entry><entry/><entry align="center">"</entry><entry>IVATVAGSL</entry><entry align="center">"</entry></row><row><entry/><entry align="center">"</entry><entry/><entry align="center">"</entry><entry>VYQILAIYA</entry><entry align="center">"</entry></row><row><entry/><entry align="center">"</entry><entry/><entry align="center">"</entry><entry>IYSTVASSL</entry><entry align="center">"</entry></row><row><entry/><entry align="center">JAP HA 202-221</entry><entry/><entry align="center">"</entry><entry>LYQNVGTYV</entry><entry align="center">"</entry></row><row><entry/><entry align="center">HLA-A24</entry><entry/><entry align="center">"</entry><entry>RYLENQKRT</entry><entry align="center">"</entry></row><row><entry/><entry align="center">HLA-Cw3</entry><entry/><entry align="center">"</entry><entry>RYLKNGKET</entry><entry align="center">"</entry></row><row><entry/><entry align="center">P815</entry><entry/><entry align="center">"</entry><entry>KYQAVTTTL</entry><entry align="center">"</entry></row><row><entry>Plasmodium berghen</entry><entry align="center">CSP</entry><entry/><entry align="center">"</entry><entry>SYIPSAEKI</entry><entry align="center">"</entry></row><row><entry>Plasmodium yoelli</entry><entry align="center">CSP</entry><entry/><entry align="center">"</entry><entry>SYVPSAFQI</entry><entry align="center">"</entry></row><row><entry>Vesicular stomatitis viruse</entry><entry align="center">NP 52-59</entry><entry/><entry align="center">K<sup>b</sup></entry><entry>RGYVYQGL</entry><entry align="center">"</entry></row><row><entry>Ovalbumin</entry><entry align="center"/><entry/><entry align="center">"</entry><entry>SIINFEKL</entry><entry align="center">"</entry></row><row><entry>Sandal Virus</entry><entry align="center">NP 321-332</entry><entry/><entry align="center">"</entry><entry>APGNYPAL</entry><entry align="center">"</entry></row><!-- EPO <DP n="55"> --><row><entry/><entry/><entry align="center"/><entry align="center"/><entry>VPYGSFKHV</entry><entry align="center">Morel et al., Processing of some antigens by the standard proteasome but not by the Immunoproteaso me results in poor presentation by dendritic cells, Immunity, vol.12: 107-117,2000.</entry></row><row><entry/><entry/><entry align="center"/><entry align="center">MOTIFS</entry><entry/><entry align="center"/></row><row><entry>Iinfluenza</entry><entry>PR8 NP</entry><entry align="center"/><entry align="center">K<sup>d</sup> restricted peptide motif</entry><entry>TYQRTRALV</entry><entry align="center">5,747,269</entry></row><row><entry>self peptide</entry><entry>P815</entry><entry align="center"/><entry align="center">"</entry><entry>SYFPEITHI</entry><entry align="center">"</entry></row><row><entry>influenza</entry><entry>JAP HA</entry><entry align="center"/><entry align="center">"</entry><entry>IYATVAGSL</entry><entry align="center">"</entry></row><row><entry>influenza</entry><entry>JAP HA</entry><entry align="center"/><entry align="center">"</entry><entry>VYQILAIYA</entry><entry align="center">"</entry></row><row><entry>influenza</entry><entry>FR8 HA</entry><entry align="center"/><entry align="center">"</entry><entry>IYSTVASSL</entry><entry align="center">"</entry></row><row><entry>Iinfluenza</entry><entry>JAP HA</entry><entry align="center"/><entry align="center">"</entry><entry>LYQNVGTYV</entry><entry align="center">"</entry></row><row><entry/><entry/><entry align="center"/><entry align="center">HLA-A24</entry><entry>RYLENGKETL</entry><entry align="center">"</entry></row><row><entry/><entry/><entry align="center"/><entry align="center">HLA-Cw3</entry><entry>RYLKNGKETL</entry><entry align="center">"</entry></row><row><entry/><entry>P815 tumour antigen</entry><entry align="center"/><entry align="center">"</entry><entry>KY4AVTTTL</entry><entry align="center">"</entry></row><row><entry>Plasmodium berghei</entry><entry>CSP</entry><entry align="center"/><entry align="center">"</entry><entry>SYILPSAEKI</entry><entry align="center">"</entry></row><row><entry>Plasmodium yoeli</entry><entry>CSP</entry><entry align="center"/><entry align="center">"</entry><entry>SYVPSAEQI</entry><entry align="center">"</entry></row><row><entry>influenza</entry><entry>NP</entry><entry align="center"/><entry align="center">D<sup>b</sup> - restricted peptides motif</entry><entry>ASNENMETM</entry><entry align="center">"</entry></row><row><entry>adenovirus</entry><entry>E1A</entry><entry align="center"/><entry align="center">"</entry><entry>SGPSNTPPEI</entry><entry align="center">"</entry></row><row><entry>lymphocytic choriomenin gitis</entry><entry/><entry align="center"/><entry align="center">"</entry><entry>SGVENPGGYCL</entry><entry align="center">"</entry></row><row><entry>simian virus</entry><entry>40 T</entry><entry align="center"/><entry align="center">"</entry><entry>SAINNY ...</entry><entry align="center">"</entry></row><row><entry>HIV</entry><entry>reverse transcriptase</entry><entry align="center"/><entry align="center">HLA-A2.1-restricted peptide motif</entry><entry>ILKEPVHGV</entry><entry align="center">"</entry></row><row><entry/><entry>influenza matrix protein</entry><entry align="center"/><entry align="center">"</entry><entry>GILGFVFRL</entry><entry align="center">"</entry></row><row><entry>influenza</entry><entry>influenza matrix protein</entry><entry align="center"/><entry align="center">"</entry><entry>ILG FV FTLTV</entry><entry align="center">"</entry></row></tbody></tgroup><!-- EPO <DP n="56"> --><tgroup cols="6"><colspec colnum="1" colname="col1" colwidth="28mm"/><colspec colnum="2" colname="col2" colwidth="25mm"/><colspec colnum="3" colname="col3" colwidth="21mm"/><colspec colnum="4" colname="col4" colwidth="22mm"/><colspec colnum="5" colname="col5" colwidth="42mm"/><colspec colnum="6" colname="col6" colwidth="30mm"/><thead><row><entry valign="top"/><entry valign="top"/><entry valign="top"/><entry align="center" valign="top"><b>MOTIFS</b></entry><entry valign="top"/><entry align="center" valign="top"/></row></thead><tbody><row><entry>HIV</entry><entry>Gag protein</entry><entry/><entry/><entry>FLQSRPEPT</entry><entry align="center">"</entry></row><row><entry>HIV</entry><entry>Gag protein</entry><entry/><entry/><entry>AMQMLKE</entry><entry align="center">"</entry></row><row><entry>HIV</entry><entry>Gag protein</entry><entry/><entry/><entry>PIAPGQMRE</entry><entry align="center">"</entry></row><row><entry>HIV</entry><entry>Gag protein</entry><entry/><entry/><entry>QMKDCTERQ</entry><entry align="center">"</entry></row><row><entry/><entry/><entry/><entry align="center">HLA-A*0205-restricted peptide motif</entry><entry>VYGVIQK</entry><entry align="center">"</entry></row></tbody></tgroup></table></tables>
<tables id="tabl0005" num="0005"><table frame="all"><title><u>Tablet 5</u></title><tgroup cols="1" colsep="0"><colspec colnum="1" colname="col1" colwidth="57mm" colsep="1"/><tbody><row><entry>VSV-NP peptide (49-62)</entry></row><row><entry>LCMV-NP peptide (118-132)</entry></row><row><entry>LCMV glycoprotein peptide. 33-41</entry></row><row><entry>ISNQLTLDSNTKYFHKLN</entry></row><row><entry>ISNQLTLDSNTKYFHKL</entry></row><row><entry>ISNALTLDSNTKYFHK</entry></row><row><entry>VDTFLEDVKNLYHSEA</entry></row><row><entry>KPRAIWDPVHGFMY</entry></row><row><entry>KQTISPDYRNMI</entry></row><row><entry>Y[DFIMDPKEKDKV</entry></row><row><entry>NIQLINDQEVARFD</entry></row><row><entry>LLSFVRDLNQYRADI</entry></row><row><entry>LPKPPKPVSKMRMATPL</entry></row><row><entry>LPKPPKPVSKMRMATPLLMQALP</entry></row><row><entry>LPKPPKPVSKMRMATPLLMQALPM</entry></row><row><entry>PKPPKPVSKMRMATPL</entry></row><row><entry>PKPPKPVSKMRMATPLLMQA</entry></row><row><entry>KPPKPVSKMRMATPLLMQ</entry></row><row><entry>KPPKPVSKMRMATPLLMQALPM</entry></row><row><entry>VDDTQFVRFDSDAASQ</entry></row><row><entry>ATKYGNMTEDHVMHLLQNA</entry></row><row><entry>VFLLLLADKVPETSLS</entry></row><row><entry>LNKILLDEQAQWK</entry></row><row><entry>GPPKLDIRKEEKQIMUDIFH</entry></row><row><entry>GPPKLDIRKEEKQIMIDIFHP</entry></row><row><entry>GFKAIRPDKKSNPIIRTV</entry></row><row><entry>YANILLDRRVPQTDMTF</entry></row><row><entry>NLFLKSDGRIKYTLNKNSLK</entry></row><row><entry>IPDNLFLKSDGRIKYTLNKN</entry></row><!-- EPO <DP n="57"> --><row><entry>IPDNLFLKSDGRIKYTLNK</entry></row><row><entry>IPDNLFLKSDGRIKYTLN</entry></row><row><entry>IPDNLFLKSDGRIKYTL</entry></row><row><entry>NLFLKSDGRIKYTLNK</entry></row><row><entry>NLFLKSDGRIKYTLNK</entry></row><row><entry>VTTLNSDLKYNALDLTN</entry></row><row><entry>VGSDWRFLRGYHC1YA</entry></row></tbody></tgroup></table></tables></p><p id="p0072" num="0072">Also described herein are methods, uses, therapies and compositions rotated to epitopes with specificity for MHC, including, for example, those listed in Tables 6-10. Also described herein are the MHCs listed in Tables 6-10, including combinations of the same, while other embodiments specifically exclude any one or more of the MHCs or combinations thereof. Tables 8-10 include frequencies for the listed HLA. antigens.
<tables id="tabl0006" num="0006"><table frame="none"><title><u>Table 6</u></title><tgroup cols="1" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="45mm"/><thead><row><entry align="center" valign="top"><b>Class I MHC Molecules</b></entry></row><row><entry valign="top"><b>Class I</b></entry></row><row><entry valign="top"><b>Human</b></entry></row></thead><tbody><row><entry>HLA-A1</entry></row><row><entry>HLA-A*0101</entry></row><row><entry>HLA-A*0201</entry></row><row><entry>HIA-A*0202</entry></row><row><entry>HLA-A*0203</entry></row><row><entry>HLA-A *0204</entry></row><row><entry>HLA-A *0205</entry></row><row><entry>HLA-A *0206</entry></row><row><entry>HLA-A *0207</entry></row><row><entry>HLA-A *0209</entry></row><row><entry>HLA-A *0214</entry></row><row><entry>HLA-A3</entry></row><row><entry>HLA-A*0301</entry></row><row><entry>HLA-A*1101</entry></row><row><entry>HLA-A23</entry></row><row><entry>HLA-A24</entry></row><row><entry>HLA-A25</entry></row><row><entry>HLA-A*2902</entry></row><row><entry>HLA-A*3101</entry></row><row><entry>HIA-A *3302</entry></row><row><entry>HLA-A*6801</entry></row><row><entry>HLA-A*6901</entry></row><row><entry>HLA-B7</entry></row><row><entry>HLA-B*0702</entry></row><row><entry>HLA- B'0703</entry></row><row><entry>HLA-B*0704</entry></row><row><entry>HLA-B *0705</entry></row><row><entry>HLA-B8</entry></row><row><entry>HLA-B13</entry></row><row><entry>HLA-B14</entry></row><row><entry>HLA-B-1501 (B62)</entry></row><row><entry>HLA-B17</entry></row><!-- EPO <DP n="58"> --><row><entry>HLA-B18</entry></row><row><entry>HLA-B22</entry></row><row><entry>HLA-B27</entry></row><row><entry>HLA-B*2702</entry></row><row><entry>BLA-B*2704</entry></row><row><entry>HLA-B*2705</entry></row><row><entry>HLA-B*2709</entry></row><row><entry>HLA-B35</entry></row><row><entry>HLA-B*3501</entry></row><row><entry>HLA-B*3502</entry></row><row><entry>HLA-B*3701</entry></row><row><entry>HLA-B*3801</entry></row><row><entry>HLA-B*39011</entry></row><row><entry>HLA-B*3902</entry></row><row><entry>HLA-B40</entry></row><row><entry>HLA-B*40012 (B60)</entry></row><row><entry>HIA-13*4006 (B61)</entry></row><row><entry>HLA-B44</entry></row><row><entry>HLA-B*4402</entry></row><row><entry>HLA-B*4403</entry></row><row><entry>HLA-B*4501</entry></row><row><entry>HLA-B*4601</entry></row><row><entry>HLA-B51</entry></row><row><entry>HLA-B*5101</entry></row><row><entry>HLA-B*5102</entry></row><row><entry>HLA-B*5103</entry></row><row><entry>HLA-B*5201</entry></row><row><entry>HLA-B*5301</entry></row><row><entry>HLA-B*5401</entry></row><row><entry>HLA-B*5501</entry></row><row><entry>HLA-B*5502</entry></row><row><entry>HLA-B*5601</entry></row><row><entry>HLA-B*6801</entry></row><row><entry>HLA-B*6701</entry></row><row><entry>HLA-B*7301</entry></row><row><entry>HLA-B*7801</entry></row><row><entry>HLA-Cw*0102</entry></row><row><entry>HLA-Cw*030</entry></row><row><entry>HLA-Cw*0304</entry></row><row><entry>HLA-Cw*0401</entry></row><row><entry>HLA-Cw*0601</entry></row><row><entry>HLA-Cw*0602</entry></row><row><entry>HLA-Cw*0702</entry></row><row><entry>HLA-Cw8</entry></row><row><entry>HLA-Cw*1601 M</entry></row><row><entry>HLA-G</entry></row></tbody></tgroup><!-- EPO <DP n="59"> --><tgroup cols="1" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="45mm"/><thead><row><entry valign="top"><b>Murine</b></entry></row></thead><tbody><row><entry>H2-K<sup>d</sup></entry></row><row><entry>H2-D<sup>d</sup></entry></row><row><entry>H2-L<sup>d</sup></entry></row><row><entry>H2-K<sup>b</sup></entry></row><row><entry>H2-D<sup>b</sup></entry></row><row><entry>H2-K<sup>k</sup></entry></row><row><entry>H2-K<sup>kml</sup></entry></row><row><entry/></row><row><entry>Qa-1<b><sup>a</sup></b> Qa-2</entry></row><row><entry>H2-M3</entry></row></tbody></tgroup><tgroup cols="1" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="45mm"/><thead><row><entry valign="top">Rat</entry></row></thead><tbody><row><entry>RT1.A<sup>n</sup></entry></row><row><entry>RT1.A<sup>l</sup></entry></row></tbody></tgroup><tgroup cols="1" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="45mm"/><thead><row><entry valign="top"><b>Bovine</b></entry></row></thead><tbody><row><entry>Bota-Al</entry></row><row><entry>Bota-A20</entry></row></tbody></tgroup><tgroup cols="1" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="45mm"/><thead><row><entry valign="top"><b>Chicken</b></entry></row></thead><tbody><row><entry>B-F4</entry></row><row><entry>B-F12</entry></row><row><entry>B-F15</entry></row><row><entry>B-F19</entry></row></tbody></tgroup><tgroup cols="1" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="45mm"/><thead><row><entry valign="top"><b>Chimpanzee</b></entry></row></thead><tbody><row><entry>Patr-A*04</entry></row><row><entry>Patr-A*11</entry></row><row><entry>Patr-B*01</entry></row><row><entry>Patr-B*13</entry></row><row><entry>Patr-B*16</entry></row></tbody></tgroup><tgroup cols="1" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="45mm"/><thead><row><entry valign="top"><b>Baboon</b></entry></row></thead><tbody><row><entry>Papa..A*06</entry></row></tbody></tgroup><tgroup cols="1" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="45mm"/><thead><row><entry valign="top"><b>Macaque</b></entry></row></thead><tbody><row><entry>Mamu-A*01</entry></row></tbody></tgroup><tgroup cols="1" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="45mm"/><thead><row><entry valign="top"><b>Swine</b></entry></row></thead><tbody><row><entry>SLA (haplotype d/d)</entry></row></tbody></tgroup><tgroup cols="1" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="45mm"/><thead><row><entry valign="top"><b>Virus homolog</b></entry></row></thead><tbody><row><entry>hCMV class I homolog UL18</entry></row></tbody></tgroup></table></tables>
<tables id="tabl0007" num="0007"><table frame="none"><title><u>Table 7</u></title><tgroup cols="1" colsep="0"><colspec colnum="1" colname="col1" colwidth="45mm"/><thead><row><entry align="center" valign="top"><b>Class I MHC Molecules</b></entry></row><row><entry valign="top"><b>Class 1</b></entry></row><row><entry valign="top"><b>Human</b></entry></row></thead><tbody><row><entry>HLA-A1</entry></row><row><entry>HLA-A*0101</entry></row><row><entry>HLA-A*0201</entry></row><row><entry>HLA-A*0202</entry></row><row><entry>HLA-A*0204</entry></row><row><entry>HLA-A*0205</entry></row><row><entry>HLA-A*0206</entry></row><row><entry>HLA-A *0207</entry></row><row><entry>HLA-A*0214</entry></row><!-- EPO <DP n="60"> --><row><entry>HLA-A3</entry></row><row><entry>HLA-A*1101</entry></row><row><entry>HLA-A24</entry></row><row><entry>HLA-A*2902</entry></row><row><entry>HLA-A*3101</entry></row><row><entry>HLA-A*3302</entry></row><row><entry>HLA-A*6801</entry></row><row><entry>HLA-A*6901</entry></row><row><entry>HLA-B7</entry></row><row><entry>HLA-B*0702</entry></row><row><entry>HLA-B*0703</entry></row><row><entry>HLA-B*0704</entry></row><row><entry>HLA-B*0705</entry></row><row><entry>HLA-B8</entry></row><row><entry>HLA-B14</entry></row><row><entry>HLA-B*1501 (B62)</entry></row><row><entry>HLA-B27</entry></row><row><entry>HLA-B*2702</entry></row><row><entry>HLA-B*2705</entry></row><row><entry>HLA-B35</entry></row><row><entry>HLA-B*3501</entry></row><row><entry>HLA-B*3502</entry></row><row><entry>HLA-B*3701</entry></row><row><entry>HLA-B*3801</entry></row><row><entry>HLA-B*39011</entry></row><row><entry>HLA-B*3902</entry></row><row><entry>HLA-B40</entry></row><row><entry>HLA-B*40012(B60)</entry></row><row><entry>HLA-B*4006(B61)</entry></row><row><entry>HLA-B44</entry></row><row><entry>HLA.B*4402</entry></row><row><entry>HLA-B*4403</entry></row><row><entry>HLA-B*4601</entry></row><row><entry>HLA-B51</entry></row><row><entry>HLA-B*5101</entry></row><row><entry>HLA-B*5102</entry></row><row><entry>HLA-B*5103</entry></row><row><entry>HLA-B*5201</entry></row><row><entry>HLA-B*5301</entry></row><row><entry>HLA-B*5401</entry></row><row><entry>HLA-B*5501</entry></row><row><entry>HLA-B*5502</entry></row><row><entry>HLA-B*5601</entry></row><row><entry>HLA-B*5801</entry></row><row><entry>HLA-B*6701</entry></row><row><entry>HLA-B*7301</entry></row><row><entry>HLA-B*7801</entry></row><row><entry>HLA-Cw*0102</entry></row><!-- EPO <DP n="61"> --><row><entry>HLA-Cw*0301</entry></row><row><entry>HLA-Cw*0304</entry></row><row><entry>HLA-Cw*0401</entry></row><row><entry>HLA-Cw*0601</entry></row><row><entry>HLA-Cw*0802</entry></row><row><entry>HLA-Cw*0702</entry></row><row><entry>HLA-G</entry></row></tbody></tgroup><tgroup cols="1" colsep="0"><colspec colnum="1" colname="col1" colwidth="45mm"/><thead><row><entry valign="top"><b>Murine</b></entry></row></thead><tbody><row><entry>H2-K<sup>d</sup></entry></row><row><entry>H2-D<sup>d</sup></entry></row><row><entry>H2-L<sup>d</sup></entry></row><row><entry>H2-K<sup>b</sup></entry></row><row><entry>H2-D<sup>b</sup></entry></row><row><entry>H2-K<sup>k</sup></entry></row><row><entry>H2-K<sup>kml</sup></entry></row><row><entry>Qa-2</entry></row></tbody></tgroup><tgroup cols="1" colsep="0"><colspec colnum="1" colname="col1" colwidth="45mm"/><thead><row><entry valign="top"><b>Rat</b></entry></row></thead><tbody><row><entry>RT1.A<sup>a</sup></entry></row><row><entry>RT1.A<sup>1</sup></entry></row></tbody></tgroup><tgroup cols="1" colsep="0"><colspec colnum="1" colname="col1" colwidth="45mm"/><thead><row><entry valign="top"><b>Bovine</b></entry></row></thead><tbody><row><entry>Bota-A11</entry></row><row><entry>Bota-A20</entry></row></tbody></tgroup><tgroup cols="1" colsep="0"><colspec colnum="1" colname="col1" colwidth="45mm"/><thead><row><entry valign="top"><b>Chicken</b></entry></row></thead><tbody><row><entry>B-F4</entry></row><row><entry>B-F12</entry></row><row><entry>B-F15</entry></row><row><entry>B-F19</entry></row></tbody></tgroup><tgroup cols="1" colsep="0"><colspec colnum="1" colname="col1" colwidth="45mm"/><thead><row><entry valign="top"><b>Virus homolog</b></entry></row></thead><tbody><row><entry>hCMV class I homolog UL 18</entry></row></tbody></tgroup></table></tables><!-- EPO <DP n="62"> -->
<tables id="tabl0008" num="0008"><table frame="all"><title>Table 8</title><tgroup cols="11"><colspec colnum="1" colname="col1" colwidth="16mm"/><colspec colnum="2" colname="col2" colwidth="16mm"/><colspec colnum="3" colname="col3" colwidth="15mm"/><colspec colnum="4" colname="col4" colwidth="16mm"/><colspec colnum="5" colname="col5" colwidth="15mm"/><colspec colnum="6" colname="col6" colwidth="16mm"/><colspec colnum="7" colname="col7" colwidth="15mm"/><colspec colnum="8" colname="col8" colwidth="16mm"/><colspec colnum="9" colname="col9" colwidth="15mm"/><colspec colnum="10" colname="col10" colwidth="16mm"/><colspec colnum="11" colname="col11" colwidth="15mm"/><thead><row><entry namest="col1" nameend="col11" align="center" valign="middle">Estimated gene frequencies of HLA-A antigens</entry></row><row><entry morerows="1" valign="middle">Antigen</entry><entry namest="col2" nameend="col3" align="center" valign="middle">CAU</entry><entry namest="col4" nameend="col5" align="center" valign="middle">AFR</entry><entry namest="col6" nameend="col7" align="center" valign="middle">ASI</entry><entry namest="col8" nameend="col9" align="center" valign="middle">LAT</entry><entry namest="col10" nameend="col11" align="center" valign="middle">NAT</entry></row><row><entry valign="middle">Gf<sup>a</sup></entry><entry valign="middle">SE<sup>b</sup></entry><entry valign="middle">Gf</entry><entry valign="middle">SE</entry><entry valign="middle">Gf</entry><entry valign="middle">SE</entry><entry valign="middle">Gf</entry><entry valign="middle">SE</entry><entry valign="middle">Gf</entry><entry valign="middle">SE</entry></row></thead><tbody><row><entry valign="middle">A1</entry><entry valign="middle">15.1843</entry><entry valign="middle">0.0489</entry><entry valign="middle">5.7256</entry><entry valign="middle">0.0771</entry><entry valign="middle">4.4818</entry><entry valign="middle">0.0846</entry><entry valign="middle">7.4007</entry><entry valign="middle">0.0978</entry><entry valign="middle">12.0316</entry><entry valign="middle">0.2533</entry></row><row><entry valign="middle">A2</entry><entry valign="middle">28.6535</entry><entry valign="middle">0.0619</entry><entry valign="middle">18.8849</entry><entry valign="middle">0.1317</entry><entry valign="middle">24.6352</entry><entry valign="middle">0.1794</entry><entry valign="middle">28.1198</entry><entry valign="middle">0.1700</entry><entry valign="middle">29.3408</entry><entry valign="middle">0.3585</entry></row><row><entry valign="middle">A3</entry><entry valign="middle">13.3890</entry><entry valign="middle">0.0463</entry><entry valign="middle">8.4406</entry><entry valign="middle">0.0925</entry><entry valign="middle">2.6454</entry><entry valign="middle">0.0655</entry><entry valign="middle">8.0789</entry><entry valign="middle">0.1019</entry><entry valign="middle">11.0293</entry><entry valign="middle">0.2437</entry></row><row><entry valign="middle">A28</entry><entry valign="middle">4.4652</entry><entry valign="middle">0.0280</entry><entry valign="middle">9.9269</entry><entry valign="middle">0.0997</entry><entry valign="middle">1.7657</entry><entry valign="middle">0.0537</entry><entry valign="middle">8.9446</entry><entry valign="middle">0.1067</entry><entry valign="middle">5.3856</entry><entry valign="middle">0.1750</entry></row><row><entry valign="middle">A36</entry><entry valign="middle">0.0221</entry><entry valign="middle">0.0020</entry><entry valign="middle">1.8836</entry><entry valign="middle">0.0448</entry><entry valign="middle">0.0148</entry><entry valign="middle">0.0049</entry><entry valign="middle">0.1584</entry><entry valign="middle">0.0148</entry><entry valign="middle">0.1545</entry><entry valign="middle">0.0303</entry></row><row><entry valign="middle">A23</entry><entry valign="middle">1.8287</entry><entry valign="middle">0.0181</entry><entry valign="middle">10.2086</entry><entry valign="middle">0.1010</entry><entry valign="middle">0.3256</entry><entry valign="middle">0.0231</entry><entry valign="middle">2.9269</entry><entry valign="middle">0.0628</entry><entry valign="middle">1.9903</entry><entry valign="middle">0.1080</entry></row><row><entry valign="middle">A24</entry><entry valign="middle">9.3251</entry><entry valign="middle">0.0395</entry><entry valign="middle">2.9668</entry><entry valign="middle">0.0560</entry><entry valign="middle">22.0391</entry><entry valign="middle">0.1722</entry><entry valign="middle">13.2610</entry><entry valign="middle">0.1271</entry><entry valign="middle">12.6613</entry><entry valign="middle">0.2590</entry></row><row><entry valign="middle">A9 unsplit</entry><entry valign="middle">0.0809</entry><entry valign="middle">0.0038</entry><entry valign="middle">0.0367</entry><entry valign="middle">0.0063</entry><entry valign="middle">0.0858</entry><entry valign="middle">0.0119</entry><entry valign="middle">0.0537</entry><entry valign="middle">0.0086</entry><entry valign="middle">0.0356</entry><entry valign="middle">0.0145</entry></row><row><entry valign="middle">A9 total</entry><entry valign="middle">11.2347</entry><entry valign="middle">0.0429</entry><entry valign="middle">13.2121</entry><entry valign="middle">0.1128</entry><entry valign="middle">22.4505</entry><entry valign="middle">0.1733</entry><entry valign="middle">16.2416</entry><entry valign="middle">0.1382</entry><entry valign="middle">14.6872</entry><entry valign="middle">0.2756</entry></row><row><entry valign="middle">A25</entry><entry valign="middle">2.1157</entry><entry valign="middle">0.0195</entry><entry valign="middle">0.4329</entry><entry valign="middle">0.0216</entry><entry valign="middle">0.0990</entry><entry valign="middle">0.0128</entry><entry valign="middle">1.1937</entry><entry valign="middle">0.0404</entry><entry valign="middle">1.4520</entry><entry valign="middle">0.0924</entry></row><row><entry valign="middle">A26</entry><entry valign="middle">3.8795</entry><entry valign="middle">0.0262</entry><entry valign="middle">2.8284</entry><entry valign="middle">0.0547</entry><entry valign="middle">4.6628</entry><entry valign="middle">0.0862</entry><entry valign="middle">3.2612</entry><entry valign="middle">0.0682</entry><entry valign="middle">2.4292</entry><entry valign="middle">0.1191</entry></row><row><entry valign="middle">A34</entry><entry valign="middle">0.1508</entry><entry valign="middle">0.0052</entry><entry valign="middle">3.5228</entry><entry valign="middle">0.0810</entry><entry valign="middle">1.3529</entry><entry valign="middle">0.0470</entry><entry valign="middle">0.4928</entry><entry valign="middle">0.0260</entry><entry valign="middle">0.3150</entry><entry valign="middle">0.0432</entry></row><row><entry valign="middle">A43</entry><entry valign="middle">0.0018</entry><entry valign="middle">0.0006</entry><entry valign="middle">0.0334</entry><entry valign="middle">0.0060</entry><entry valign="middle">0.0231</entry><entry valign="middle">0.0062</entry><entry valign="middle">0.0055</entry><entry valign="middle">0.0028</entry><entry valign="middle">0.0059</entry><entry valign="middle">0.0059</entry></row><row><entry valign="middle">A66</entry><entry valign="middle">0.0173</entry><entry valign="middle">0.0018</entry><entry valign="middle">0.2233</entry><entry valign="middle">0.0155</entry><entry valign="middle">0.0478</entry><entry valign="middle">0.0089</entry><entry valign="middle">0.0399</entry><entry valign="middle">0.0074</entry><entry valign="middle">0.0534</entry><entry valign="middle">0.0178</entry></row><row><entry valign="middle">A10 unsplit</entry><entry valign="middle">0.0790</entry><entry valign="middle">0.0038</entry><entry valign="middle">0.0939</entry><entry valign="middle">0.0101</entry><entry valign="middle">0.1255</entry><entry valign="middle">0.0144</entry><entry valign="middle">0.0647</entry><entry valign="middle">0.0094</entry><entry valign="middle">0.0298</entry><entry valign="middle">0.0133</entry></row><row><entry valign="middle">A10 total</entry><entry valign="middle">6.2441</entry><entry valign="middle">0.0328</entry><entry valign="middle">7.1349</entry><entry valign="middle">0.0850</entry><entry valign="middle">6.3111</entry><entry valign="middle">0.0993</entry><entry valign="middle">5.0578</entry><entry valign="middle">0.0816</entry><entry valign="middle">4.2853</entry><entry valign="middle">0.1565</entry></row><row><entry valign="middle">A29</entry><entry valign="middle">3.5796</entry><entry valign="middle">0.0252</entry><entry valign="middle">3.2071</entry><entry valign="middle">0.0582</entry><entry valign="middle">1.1233</entry><entry valign="middle">0.0429</entry><entry valign="middle">4.5156</entry><entry valign="middle">0.0774</entry><entry valign="middle">3.4345</entry><entry valign="middle">0.1410</entry></row><row><entry valign="middle">A30</entry><entry valign="middle">2.5067</entry><entry valign="middle">0.0212</entry><entry valign="middle">13.0969</entry><entry valign="middle">0.1129</entry><entry valign="middle">2.2025</entry><entry valign="middle">0.0598</entry><entry valign="middle">4.4873</entry><entry valign="middle">0.0772</entry><entry valign="middle">2.5314</entry><entry valign="middle">0.1215</entry></row><row><entry valign="middle">A31</entry><entry valign="middle">2.7386</entry><entry valign="middle">0.0221</entry><entry valign="middle">1.6556</entry><entry valign="middle">0.0420</entry><entry valign="middle">3.6005</entry><entry valign="middle">0.0761</entry><entry valign="middle">4.8328</entry><entry valign="middle">0.0800</entry><entry valign="middle">6.0881</entry><entry valign="middle">0.1855</entry></row><row><entry valign="middle">A32</entry><entry valign="middle">3.6956</entry><entry valign="middle">0.0256</entry><entry valign="middle">1.5384</entry><entry valign="middle">0.0405</entry><entry valign="middle">1.0331</entry><entry valign="middle">0.0411</entry><entry valign="middle">2.7064</entry><entry valign="middle">0.0604</entry><entry valign="middle">2.5521</entry><entry valign="middle">0.1220</entry></row><row><entry valign="middle">A33</entry><entry valign="middle">1.2080</entry><entry valign="middle">0.0148</entry><entry valign="middle">6.5607</entry><entry valign="middle">0.0822</entry><entry valign="middle">9.270</entry><entry valign="middle">0.1191</entry><entry valign="middle">2.6593</entry><entry valign="middle">0.0599</entry><entry valign="middle">1,0754</entry><entry valign="middle">0.0796</entry></row><row><entry valign="middle">A74</entry><entry valign="middle">0.0277</entry><entry valign="middle">0.0022</entry><entry valign="middle">1.9949</entry><entry valign="middle">0.0461</entry><entry valign="middle">0.0561</entry><entry valign="middle">0.0096</entry><entry valign="middle">0.2027</entry><entry valign="middle">0.0167</entry><entry valign="middle">0.1068</entry><entry valign="middle">0.0252</entry></row><row><entry valign="middle">A19 unsplit</entry><entry valign="middle">0.0567</entry><entry valign="middle">0.0032</entry><entry valign="middle">0.2057</entry><entry valign="middle">0.0149</entry><entry valign="middle">0.0990</entry><entry valign="middle">0.0128</entry><entry valign="middle">0.1211</entry><entry valign="middle">0.0129</entry><entry valign="middle">0.0475</entry><entry valign="middle">0.0168</entry></row><row><entry valign="middle">A19 total</entry><entry valign="middle">13.8129</entry><entry valign="middle">0.0468</entry><entry valign="middle">28.2593</entry><entry valign="middle">0.1504</entry><entry valign="middle">17.3846</entry><entry valign="middle">0.1555</entry><entry valign="middle">19.5252</entry><entry valign="middle">0.1481</entry><entry valign="middle">15.8358</entry><entry valign="middle">0.2832</entry></row><row><entry valign="middle">AX</entry><entry valign="middle">0.8204</entry><entry valign="middle">0.0297</entry><entry valign="middle">4.9506</entry><entry valign="middle">0.0963</entry><entry valign="middle">2.9916</entry><entry valign="middle">0.1177</entry><entry valign="middle">1.6332</entry><entry valign="middle">0.0979</entry><entry valign="middle">1.8454</entry><entry valign="middle">0.1925</entry></row><row><entry namest="col1" nameend="col11" align="left" valign="middle"><sup>a</sup>Gene frequency</entry></row><row><entry namest="col1" nameend="col11" align="left" valign="middle"><sup>b</sup>Standard error.</entry></row></tbody></tgroup></table></tables><!-- EPO <DP n="63"> -->
<tables id="tabl0009" num="0009"><table frame="all"><title>Table 9</title><tgroup cols="11"><colspec colnum="1" colname="col1" colwidth="16mm"/><colspec colnum="2" colname="col2" colwidth="16mm"/><colspec colnum="3" colname="col3" colwidth="15mm"/><colspec colnum="4" colname="col4" colwidth="16mm"/><colspec colnum="5" colname="col5" colwidth="15mm"/><colspec colnum="6" colname="col6" colwidth="16mm"/><colspec colnum="7" colname="col7" colwidth="15mm"/><colspec colnum="8" colname="col8" colwidth="16mm"/><colspec colnum="9" colname="col9" colwidth="15mm"/><colspec colnum="10" colname="col10" colwidth="16mm"/><colspec colnum="11" colname="col11" colwidth="15mm"/><thead><row><entry namest="col1" nameend="col11" align="center" valign="middle">Estimated gene frequencies for HLA-B antigens</entry></row><row><entry morerows="1" valign="middle">Antigen</entry><entry namest="col2" nameend="col3" align="left" valign="middle">CAU</entry><entry namest="col4" nameend="col5" align="left" valign="middle">Afar</entry><entry namest="col6" nameend="col7" align="left" valign="middle">ASI</entry><entry namest="col8" nameend="col9" align="left" valign="middle">LAT</entry><entry namest="col10" nameend="col11" align="left" valign="middle">NAT</entry></row><row><entry valign="middle">Gf<sup>a</sup></entry><entry valign="middle">SE<sup>b</sup></entry><entry valign="middle">Gf</entry><entry valign="middle">SE</entry><entry valign="middle">Gf</entry><entry valign="middle">SE</entry><entry valign="middle">Gf</entry><entry valign="middle">SE</entry><entry valign="middle">Gf</entry><entry valign="middle">SE</entry></row></thead><tbody><row><entry valign="middle">B7</entry><entry valign="middle">12.1782</entry><entry valign="middle">0.0445</entry><entry valign="middle">10.5960</entry><entry valign="middle">0.1024</entry><entry valign="middle">4.2691</entry><entry valign="middle">0.0827</entry><entry valign="middle">6.4477</entry><entry valign="middle">0.0918</entry><entry valign="middle">10.9845</entry><entry valign="middle">0.2432</entry></row><row><entry valign="middle">B8</entry><entry valign="middle">9.4077</entry><entry valign="middle">0.0397</entry><entry valign="middle">3.8315</entry><entry valign="middle">0.0634</entry><entry valign="middle">1.3322</entry><entry valign="middle">0.0467</entry><entry valign="middle">3.8225</entry><entry valign="middle">0.0715</entry><entry valign="middle">8.5789</entry><entry valign="middle">0.2176</entry></row><row><entry valign="middle">B13</entry><entry valign="middle">2.3061</entry><entry valign="middle">0.0203</entry><entry valign="middle">0.8103</entry><entry valign="middle">0.0295</entry><entry valign="middle">4.9222</entry><entry valign="middle">0.0886</entry><entry valign="middle">1.2699</entry><entry valign="middle">0.0416</entry><entry valign="middle">1.7495</entry><entry valign="middle">0.1013</entry></row><row><entry valign="middle">B14</entry><entry valign="middle">4.3481</entry><entry valign="middle">0.0277</entry><entry valign="middle">3.0331</entry><entry valign="middle">0.0566</entry><entry valign="middle">0.5004</entry><entry valign="middle">0.0287</entry><entry valign="middle">5.4166</entry><entry valign="middle">0.0846</entry><entry valign="middle">2.9823</entry><entry valign="middle">0.1316</entry></row><row><entry valign="middle">B18</entry><entry valign="middle">4.7980</entry><entry valign="middle">0.0290</entry><entry valign="middle">32057</entry><entry valign="middle">0.0582</entry><entry valign="middle">1.1246</entry><entry valign="middle">0.0429</entry><entry valign="middle">4.2349</entry><entry valign="middle">0.0752</entry><entry valign="middle">3.3422</entry><entry valign="middle">0.1391</entry></row><row><entry valign="middle">B27</entry><entry valign="middle">4.383</entry><entry valign="middle">0.0278</entry><entry valign="middle">1.2918</entry><entry valign="middle">0.0372</entry><entry valign="middle">2.2355</entry><entry valign="middle">0.0603</entry><entry valign="middle">2.3724</entry><entry valign="middle">0.0567</entry><entry valign="middle">5.1970</entry><entry valign="middle">0.1721</entry></row><row><entry valign="middle">B35</entry><entry valign="middle">9.6614</entry><entry valign="middle">0.0402</entry><entry valign="middle">8.5172</entry><entry valign="middle">0.0927</entry><entry valign="middle">8.1203</entry><entry valign="middle">0.1122</entry><entry valign="middle">14.6516</entry><entry valign="middle">0.1329</entry><entry valign="middle">10.1198</entry><entry valign="middle">0.2345</entry></row><row><entry valign="middle">B37</entry><entry valign="middle">1.4032</entry><entry valign="middle">0.0159</entry><entry valign="middle">0.5916</entry><entry valign="middle">0.0252</entry><entry valign="middle">1.2327</entry><entry valign="middle">0.0449</entry><entry valign="middle">0.7807</entry><entry valign="middle">0.0327</entry><entry valign="middle">0.9755</entry><entry valign="middle">0.0759</entry></row><row><entry valign="middle">B41</entry><entry valign="middle">0.9211</entry><entry valign="middle">0.0129</entry><entry valign="middle">0.8183</entry><entry valign="middle">0.0296</entry><entry valign="middle">0.1303</entry><entry valign="middle">0.0147</entry><entry valign="middle">1.2818</entry><entry valign="middle">0.0418</entry><entry valign="middle">0.4766</entry><entry valign="middle">0.0531</entry></row><row><entry valign="middle">B42</entry><entry valign="middle">0.0608</entry><entry valign="middle">0.0033</entry><entry valign="middle">5.6991</entry><entry valign="middle">0,0768</entry><entry valign="middle">0.0841</entry><entry valign="middle">0,0118</entry><entry valign="middle">0.5866</entry><entry valign="middle">0.0284</entry><entry valign="middle">0.2856</entry><entry valign="middle">0.0411</entry></row><row><entry valign="middle">B46</entry><entry valign="middle">0.0099</entry><entry valign="middle">0.0013</entry><entry valign="middle">0.0151</entry><entry valign="middle">0.0040</entry><entry valign="middle">4.9292</entry><entry valign="middle">0.0886</entry><entry valign="middle">0.0234</entry><entry valign="middle">0.0057</entry><entry valign="middle">0.0238</entry><entry valign="middle">0.0119</entry></row><row><entry valign="middle">B47</entry><entry valign="middle">0.2069</entry><entry valign="middle">0.0061</entry><entry valign="middle">0.1305</entry><entry valign="middle">0.0119</entry><entry valign="middle">0.0956</entry><entry valign="middle">0.0126</entry><entry valign="middle">0.1832</entry><entry valign="middle">0.0159</entry><entry valign="middle">0.2139</entry><entry valign="middle">0.0356</entry></row><row><entry valign="middle">B49</entry><entry valign="middle">0.0865</entry><entry valign="middle">0.0040</entry><entry valign="middle">0.1316</entry><entry valign="middle">0.0119</entry><entry valign="middle">2.0276</entry><entry valign="middle">0.0575</entry><entry valign="middle">1.5915</entry><entry valign="middle">0.0466</entry><entry valign="middle">1.0267</entry><entry valign="middle">0.0778</entry></row><row><entry valign="middle">B53</entry><entry valign="middle">0.4620</entry><entry valign="middle">0.0092</entry><entry valign="middle">10.9529</entry><entry valign="middle">0.1039</entry><entry valign="middle">0.4315</entry><entry valign="middle">0.0266</entry><entry valign="middle">1.6982</entry><entry valign="middle">0.0481</entry><entry valign="middle">1.0804</entry><entry valign="middle">0.0798</entry></row><row><entry valign="middle">B59</entry><entry valign="middle">0.0020</entry><entry valign="middle">0.0006</entry><entry valign="middle">0.0032</entry><entry valign="middle">0.0019</entry><entry valign="middle">0.4277</entry><entry valign="middle">0.0265</entry><entry valign="middle">0.0055</entry><entry valign="middle">0.0028</entry><entry valign="middle">0<sup>c</sup></entry><entry valign="middle"/></row><row><entry valign="middle">B67</entry><entry valign="middle">0.0040</entry><entry valign="middle">0.0009</entry><entry valign="middle">0.0086</entry><entry valign="middle">0.0030</entry><entry valign="middle">0.2276</entry><entry valign="middle">0.0194</entry><entry valign="middle">0.0055</entry><entry valign="middle">0.0028</entry><entry valign="middle">0.0059</entry><entry valign="middle">0.0059</entry></row><row><entry valign="middle">B70</entry><entry valign="middle">0.3270</entry><entry valign="middle">0.0077</entry><entry valign="middle">7.3571</entry><entry valign="middle">0.0866</entry><entry valign="middle">0.8901</entry><entry valign="middle">0.0382</entry><entry valign="middle">1.9266</entry><entry valign="middle">0.0512</entry><entry valign="middle">0.6901</entry><entry valign="middle">0.0639</entry></row><row><entry valign="middle">B73</entry><entry valign="middle">0.0108</entry><entry valign="middle">0.0014</entry><entry valign="middle">0.0032</entry><entry valign="middle">0.0019</entry><entry valign="middle">0.0132</entry><entry valign="middle">0.0047</entry><entry valign="middle">0.0261</entry><entry valign="middle">0.0060</entry><entry valign="middle">0<sup>c</sup></entry><entry valign="middle"/></row><row><entry valign="middle">B51</entry><entry valign="middle">5.4215</entry><entry valign="middle">0.0307</entry><entry valign="middle">2.5980</entry><entry valign="middle">0.0525</entry><entry valign="middle">7.4751</entry><entry valign="middle">0.1080</entry><entry valign="middle">6.8147</entry><entry valign="middle">0.0943</entry><entry valign="middle">6.9077</entry><entry valign="middle">0.1968</entry></row><row><entry valign="middle">B52</entry><entry valign="middle">0.9658</entry><entry valign="middle">0.0132</entry><entry valign="middle">1.3712</entry><entry valign="middle">0.0383</entry><entry valign="middle">3.5121</entry><entry valign="middle">0.0752</entry><entry valign="middle">2.2447</entry><entry valign="middle">0.0552</entry><entry valign="middle">0.6960</entry><entry valign="middle">0.0641</entry></row><row><entry valign="middle">85 unsplit</entry><entry valign="middle">0.1565</entry><entry valign="middle">0.0053</entry><entry valign="middle">0.1522</entry><entry valign="middle">0.0128</entry><entry valign="middle">0.1288</entry><entry valign="middle">0.0146</entry><entry valign="middle">0.1546</entry><entry valign="middle">0.0146</entry><entry valign="middle">0.1307</entry><entry valign="middle">0.0278</entry></row><row><entry valign="middle">85 total</entry><entry valign="middle">6.5438</entry><entry valign="middle">0.0435</entry><entry valign="middle">4.1214</entry><entry valign="middle">0.0747</entry><entry valign="middle">11.1160</entry><entry valign="middle">0.1504</entry><entry valign="middle">9.2141</entry><entry valign="middle">0.1324</entry><entry valign="middle">7.7344</entry><entry valign="middle">0.2784</entry></row><row><entry valign="middle">B44</entry><entry valign="middle">13.4838</entry><entry valign="middle">0.0465</entry><entry valign="middle">7.0137</entry><entry valign="middle">0.0847</entry><entry valign="middle">5.6807</entry><entry valign="middle">0.0948</entry><entry valign="middle">9.9253</entry><entry valign="middle">0.1121</entry><entry valign="middle">11.8424</entry><entry valign="middle">0.2511</entry></row><row><entry valign="middle">B45</entry><entry valign="middle">0.5771</entry><entry valign="middle">0.0102</entry><entry valign="middle">4.8069</entry><entry valign="middle">0.0708</entry><entry valign="middle">0.1816</entry><entry valign="middle">0.0173</entry><entry valign="middle">1.8812</entry><entry valign="middle">0.0506</entry><entry valign="middle">0.7603</entry><entry valign="middle">0.0670</entry></row><row><entry valign="middle">B12 unsplit</entry><entry valign="middle">0.0788</entry><entry valign="middle">0.0038</entry><entry valign="middle">0.0280</entry><entry valign="middle">0.0055</entry><entry valign="middle">0.0049</entry><entry valign="middle">0.0029</entry><entry valign="middle">0.0193</entry><entry valign="middle">0.0051</entry><entry valign="middle">0.0654</entry><entry valign="middle">0.0197</entry></row><row><entry valign="middle">B12 total</entry><entry valign="middle">14.1440</entry><entry valign="middle">0.0474</entry><entry valign="middle">11.8486</entry><entry valign="middle">0.1072</entry><entry valign="middle">5.8673</entry><entry valign="middle">0.0963</entry><entry valign="middle">11.8258</entry><entry valign="middle">0.1210</entry><entry valign="middle">12.6281</entry><entry valign="middle">0.2584</entry></row><row><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle">6.9421</entry><entry valign="middle"/></row><row><entry valign="middle">B62</entry><entry valign="middle">5.9117</entry><entry valign="middle">0.0320</entry><entry valign="middle">1.5267</entry><entry valign="middle">0.0404</entry><entry valign="middle">9.2249</entry><entry valign="middle">0.1190</entry><entry valign="middle">4.1825</entry><entry valign="middle">0.0747</entry><entry valign="middle"/><entry valign="middle">0.1973</entry></row><!-- EPO <DP n="64"> --><row><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle">0.3738</entry><entry valign="middle"/></row><row><entry valign="middle">B63</entry><entry valign="middle">0.4302</entry><entry valign="middle">0.0088</entry><entry valign="middle">1.8865</entry><entry valign="middle">0.0448</entry><entry valign="middle">0.4438</entry><entry valign="middle">0.0270</entry><entry valign="middle">0.8083</entry><entry valign="middle">0.0333</entry><entry valign="middle"/><entry valign="middle">0.0471</entry></row><row><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle">0.0356</entry><entry valign="middle"/></row><row><entry valign="middle">B75</entry><entry valign="middle">0.0104</entry><entry valign="middle">0.0014</entry><entry valign="middle">0.0226</entry><entry valign="middle">0.0049</entry><entry valign="middle">1.9673</entry><entry valign="middle">0.0566</entry><entry valign="middle">0.1101</entry><entry valign="middle">0.0123</entry><entry valign="middle"/><entry valign="middle">0.0145</entry></row><row><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle">0</entry><entry valign="middle"/></row><row><entry valign="middle">B76</entry><entry valign="middle">0.0026</entry><entry valign="middle">0.0007</entry><entry valign="middle">0.0065</entry><entry valign="middle">0.0026</entry><entry valign="middle">0.0874</entry><entry valign="middle">0.0120</entry><entry valign="middle">0.0055</entry><entry valign="middle">0.0028</entry><entry valign="middle"/><entry valign="middle"/></row><row><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle">0<sup>c</sup></entry><entry valign="middle"/></row><row><entry valign="middle">B77</entry><entry valign="middle">0.0057</entry><entry valign="middle">0.0010</entry><entry valign="middle">0.0119</entry><entry valign="middle">0.0036</entry><entry valign="middle">0.0517</entry><entry valign="middle">0.0098</entry><entry valign="middle">0.0083</entry><entry valign="middle">0.0034</entry><entry valign="middle"/><entry valign="middle">0.0059</entry></row><row><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle">0.0059</entry><entry valign="middle"/></row><row><entry valign="middle">B15 unsplit</entry><entry valign="middle">0.1305</entry><entry valign="middle">0.0049</entry><entry valign="middle">0.0691</entry><entry valign="middle">0.0086</entry><entry valign="middle">0.4301</entry><entry valign="middle">0.0266</entry><entry valign="middle">0.1820</entry><entry valign="middle">0.0158</entry><entry valign="middle"/><entry valign="middle">0.0206</entry></row><row><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle">0.0715</entry><entry valign="middle"/></row><row><entry valign="middle">B15 total</entry><entry valign="middle">6.4910</entry><entry valign="middle">0.0334</entry><entry valign="middle">3.5232</entry><entry valign="middle">0.0608</entry><entry valign="middle">12.2112</entry><entry valign="middle">0.1344</entry><entry valign="middle">5.2967</entry><entry valign="middle">0.0835</entry><entry valign="middle"/><entry valign="middle">0.2035</entry></row><row><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle"/><entry valign="middle">7.4290</entry><entry valign="middle"/></row><row><entry valign="middle">B38</entry><entry valign="middle">2.4413</entry><entry valign="middle">0.0209</entry><entry valign="middle">0.3323</entry><entry valign="middle">0.0189</entry><entry valign="middle">3.2818</entry><entry valign="middle">0.0728</entry><entry valign="middle">1.9662</entry><entry valign="middle">0.0517</entry><entry valign="middle">1.1017</entry><entry valign="middle">0.0806</entry></row><row><entry valign="middle">B39</entry><entry valign="middle">1.9614</entry><entry valign="middle">0.0188</entry><entry valign="middle">1.2893</entry><entry valign="middle">0.0371</entry><entry valign="middle">2.0352</entry><entry valign="middle">0.0576</entry><entry valign="middle">6.3040</entry><entry valign="middle">0.0909</entry><entry valign="middle">4.5527</entry><entry valign="middle">0.1615</entry></row><row><entry valign="middle">B16 unsplit</entry><entry valign="middle">0.0638</entry><entry valign="middle">0.0034</entry><entry valign="middle">0.0237</entry><entry valign="middle">0.0051</entry><entry valign="middle">0.0644</entry><entry valign="middle">0.0103</entry><entry valign="middle">0.1226</entry><entry valign="middle">0.0130</entry><entry valign="middle">0.0593</entry><entry valign="middle">0.0188</entry></row><row><entry valign="middle">B16 total</entry><entry valign="middle">4.4667</entry><entry valign="middle">0.0280</entry><entry valign="middle">1.6453</entry><entry valign="middle">0.0419</entry><entry valign="middle">5.3814</entry><entry valign="middle">0.0921</entry><entry valign="middle">8.3917</entry><entry valign="middle">0.1036</entry><entry valign="middle">5.7137</entry><entry valign="middle">0.1797</entry></row><row><entry valign="middle">B57</entry><entry valign="middle">3.5955</entry><entry valign="middle">0.0252</entry><entry valign="middle">5.6746</entry><entry valign="middle">0.0766</entry><entry valign="middle">2.5782</entry><entry valign="middle">0.0647</entry><entry valign="middle">2.1800</entry><entry valign="middle">0.0544</entry><entry valign="middle">2.7265</entry><entry valign="middle">0.1260</entry></row><row><entry valign="middle">B58</entry><entry valign="middle">0.7152</entry><entry valign="middle">0.0114</entry><entry valign="middle">5.9546</entry><entry valign="middle">0.0784</entry><entry valign="middle">4.0189</entry><entry valign="middle">0.0803</entry><entry valign="middle">1,2481</entry><entry valign="middle">0.0413</entry><entry valign="middle">0.9398</entry><entry valign="middle">0.0745</entry></row><row><entry valign="middle">B17 unsplit</entry><entry valign="middle">0.2845</entry><entry valign="middle">0.0072</entry><entry valign="middle">0.3248 '</entry><entry valign="middle">0.0197</entry><entry valign="middle">0.3751</entry><entry valign="middle">0.0248</entry><entry valign="middle">0.1446</entry><entry valign="middle">0.0141</entry><entry valign="middle">0.2674</entry><entry valign="middle">0.0398</entry></row><row><entry valign="middle">B17 total</entry><entry valign="middle">4.5952</entry><entry valign="middle">0.0284</entry><entry valign="middle">11.9540</entry><entry valign="middle">0.1076</entry><entry valign="middle">.9722</entry><entry valign="middle">0.1041</entry><entry valign="middle">3.5727</entry><entry valign="middle">0.0691</entry><entry valign="middle">3.9338</entry><entry valign="middle">0.1503</entry></row><row><entry valign="middle">B49</entry><entry valign="middle">1.6452</entry><entry valign="middle">0.0172</entry><entry valign="middle">2.6286</entry><entry valign="middle">0.0528</entry><entry valign="middle">0.2440</entry><entry valign="middle">0.0200</entry><entry valign="middle">2.3353</entry><entry valign="middle">0.0562</entry><entry valign="middle">1.5462</entry><entry valign="middle">0.0953</entry></row><row><entry valign="middle">B50</entry><entry valign="middle">1.0580</entry><entry valign="middle">0.0138</entry><entry valign="middle">0.8636</entry><entry valign="middle">0.0304</entry><entry valign="middle">0.4421</entry><entry valign="middle">0.0270</entry><entry valign="middle">1.8883</entry><entry valign="middle">0.0507</entry><entry valign="middle">0.7862</entry><entry valign="middle">0.0681</entry></row><row><entry valign="middle">B21 unsplit</entry><entry valign="middle">0.0702</entry><entry valign="middle">0.0036</entry><entry valign="middle">0.0270</entry><entry valign="middle">0.0054</entry><entry valign="middle">0.0132</entry><entry valign="middle">0.0047</entry><entry valign="middle">0.0771</entry><entry valign="middle">0.0103</entry><entry valign="middle">0.0356</entry><entry valign="middle">0.0145</entry></row><row><entry valign="middle">B21 total</entry><entry valign="middle">2.7733</entry><entry valign="middle">0.0222</entry><entry valign="middle">3.5192</entry><entry valign="middle">0.0608</entry><entry valign="middle">0.6993</entry><entry valign="middle">0.0339</entry><entry valign="middle">4.3007</entry><entry valign="middle">0.0755</entry><entry valign="middle">2.3680</entry><entry valign="middle">0.1174</entry></row><row><entry valign="middle">B54</entry><entry valign="middle">0.0124</entry><entry valign="middle">0.0015</entry><entry valign="middle">0.0183</entry><entry valign="middle">0.0044</entry><entry valign="middle">2.6873</entry><entry valign="middle">0.0660</entry><entry valign="middle">0.0289</entry><entry valign="middle">0.0063</entry><entry valign="middle">0.0534</entry><entry valign="middle">0.0178</entry></row><row><entry valign="middle">B55</entry><entry valign="middle">1.9046</entry><entry valign="middle">0.0185</entry><entry valign="middle">0.4895</entry><entry valign="middle">0.0229</entry><entry valign="middle">2.2444</entry><entry valign="middle">0.0604</entry><entry valign="middle">0.9515</entry><entry valign="middle">0.0361</entry><entry valign="middle">1.4054</entry><entry valign="middle">0.0909</entry></row><row><entry valign="middle">B56</entry><entry valign="middle">0.5527</entry><entry valign="middle">0.0100</entry><entry valign="middle">0.2686</entry><entry valign="middle">0.0170</entry><entry valign="middle">0.8260</entry><entry valign="middle">0.0368</entry><entry valign="middle">0.3596</entry><entry valign="middle">0.0222</entry><entry valign="middle">0.3387</entry><entry valign="middle">0.0448</entry></row><row><entry valign="middle">B22 unsplit</entry><entry valign="middle">0.1682</entry><entry valign="middle">0.0055</entry><entry valign="middle">0.0496</entry><entry valign="middle">0.0073</entry><entry valign="middle">0.2730</entry><entry valign="middle">0.0212</entry><entry valign="middle">0.0372</entry><entry valign="middle">0.0071</entry><entry valign="middle">0.1246</entry><entry valign="middle">0.0272</entry></row><!-- EPO <DP n="65"> --><row><entry valign="middle">B22 total</entry><entry valign="middle">2.0852</entry><entry valign="middle">0.0217</entry><entry valign="middle">0.8261</entry><entry valign="middle">0.0297</entry><entry valign="middle">6.0307</entry><entry valign="middle">0.0971</entry><entry valign="middle">1.3771</entry><entry valign="middle">0.0433</entry><entry valign="middle">1.9221</entry><entry valign="middle">0.1060</entry></row><row><entry valign="middle">B60</entry><entry valign="middle">5.2222</entry><entry valign="middle">0.0302</entry><entry valign="middle">1.5299</entry><entry valign="middle">0.0404</entry><entry valign="middle">8.3254</entry><entry valign="middle">0.1135</entry><entry valign="middle">2.2538</entry><entry valign="middle">0.0553</entry><entry valign="middle">5.7218</entry><entry valign="middle">0.1801</entry></row><row><entry valign="middle">861</entry><entry valign="middle">1.1918</entry><entry valign="middle">0.0147</entry><entry valign="middle">0.4709</entry><entry valign="middle">0.0225</entry><entry valign="middle">6.2072</entry><entry valign="middle">0.0989</entry><entry valign="middle">4.6691</entry><entry valign="middle">0.0788</entry><entry valign="middle">2.6023</entry><entry valign="middle">0.1231</entry></row><row><entry valign="middle">B40 unsplit</entry><entry valign="middle">0.2696</entry><entry valign="middle">0.0070</entry><entry valign="middle">0.0388</entry><entry valign="middle">0.0065</entry><entry valign="middle">0.3205</entry><entry valign="middle">0.0230</entry><entry valign="middle">0.2473</entry><entry valign="middle">0.0184</entry><entry valign="middle">0.2271</entry><entry valign="middle">0.0367</entry></row><row><entry valign="middle">B40 total</entry><entry valign="middle">6.6834</entry><entry valign="middle">0.0338</entry><entry valign="middle">2.0396</entry><entry valign="middle">0.0465</entry><entry valign="middle">14.8531</entry><entry valign="middle">0.1462</entry><entry valign="middle">7.1702</entry><entry valign="middle">0.0963</entry><entry valign="middle">8.5512</entry><entry valign="middle">0.2168</entry></row><row><entry valign="middle">BX</entry><entry valign="middle">1.0922</entry><entry valign="middle">0.0252</entry><entry valign="middle">3.5258</entry><entry valign="middle">0.0802</entry><entry valign="middle">3.8749</entry><entry valign="middle">0.0988</entry><entry valign="middle">2.5266</entry><entry valign="middle">0.0807</entry><entry valign="middle">1.9867</entry><entry valign="middle">0.1634</entry></row><row><entry namest="col1" nameend="col11" align="left" valign="middle"><sup>a</sup>Gene frequency. <sup>b</sup>Standard error. <sup>c</sup>The observed gene count was zero.</entry></row></tbody></tgroup></table></tables><!-- EPO <DP n="66"> -->
<tables id="tabl0010" num="0010"><table frame="all"><title><u>Table 10.</u></title><tgroup cols="11"><colspec colnum="1" colname="col1" colwidth="16mm"/><colspec colnum="2" colname="col2" colwidth="16mm"/><colspec colnum="3" colname="col3" colwidth="15mm"/><colspec colnum="4" colname="col4" colwidth="16mm"/><colspec colnum="5" colname="col5" colwidth="15mm"/><colspec colnum="6" colname="col6" colwidth="16mm"/><colspec colnum="7" colname="col7" colwidth="15mm"/><colspec colnum="8" colname="col8" colwidth="16mm"/><colspec colnum="9" colname="col9" colwidth="15mm"/><colspec colnum="10" colname="col10" colwidth="16mm"/><colspec colnum="11" colname="col11" colwidth="15mm"/><thead><row><entry namest="col1" nameend="col11" align="center" valign="middle">Estimated gene frequencies of HLA-DR antigens</entry></row><row><entry morerows="1" valign="middle">Antigen</entry><entry namest="col2" nameend="col3" align="center" valign="middle">CAU</entry><entry namest="col4" nameend="col5" align="center" valign="middle">AFR</entry><entry namest="col6" nameend="col7" align="center" valign="middle">ASI</entry><entry namest="col8" nameend="col9" align="center" valign="middle">LAT</entry><entry namest="col10" nameend="col11" align="center" valign="middle">NAT</entry></row><row><entry valign="middle">Gf<sup>a</sup></entry><entry valign="middle">SE<sup>b</sup></entry><entry valign="middle">Gf</entry><entry valign="middle">SE</entry><entry valign="middle">Gf</entry><entry valign="middle">SE</entry><entry valign="middle">Gf</entry><entry valign="middle">SE</entry><entry valign="middle">Gf</entry><entry valign="middle">SE</entry></row></thead><tbody><row><entry valign="middle">DR1</entry><entry valign="middle">10.2279</entry><entry valign="middle">0.0413</entry><entry valign="middle">6.8200</entry><entry valign="middle">0.0832</entry><entry valign="middle">3.4628</entry><entry valign="middle">0.0747</entry><entry valign="middle">7.9859</entry><entry valign="middle">0.1013</entry><entry valign="middle">8.2512</entry><entry valign="middle">0.2139</entry></row><row><entry valign="middle">DR2</entry><entry valign="middle">15.2408</entry><entry valign="middle">0.0491</entry><entry valign="middle">16.2373</entry><entry valign="middle">0.1222</entry><entry valign="middle">18.6162</entry><entry valign="middle">0.1608</entry><entry valign="middle">11.2389</entry><entry valign="middle">0.1182</entry><entry valign="middle">15.3932</entry><entry valign="middle">0.2818</entry></row><row><entry valign="middle">DR3</entry><entry valign="middle">10.8708</entry><entry valign="middle">0.0424</entry><entry valign="middle">13.3080</entry><entry valign="middle">0.1124</entry><entry valign="middle">4.7223</entry><entry valign="middle">0.0867</entry><entry valign="middle">7.8998</entry><entry valign="middle">0.1008</entry><entry valign="middle">10.2549</entry><entry valign="middle">0.2361</entry></row><row><entry valign="middle">DR4</entry><entry valign="middle">16.7589</entry><entry valign="middle">0.0511</entry><entry valign="middle">5.7084</entry><entry valign="middle">0.0765</entry><entry valign="middle">15.4623</entry><entry valign="middle">0.1490</entry><entry valign="middle">20.6373</entry><entry valign="middle">0.1520</entry><entry valign="middle">19.8264</entry><entry valign="middle">0.3123</entry></row><row><entry valign="middle">DR6</entry><entry valign="middle">14.3937</entry><entry valign="middle">0.0479</entry><entry valign="middle">18.6117</entry><entry valign="middle">0.1291</entry><entry valign="middle">13.4471</entry><entry valign="middle">0.1404</entry><entry valign="middle">17.0265</entry><entry valign="middle">0.1411</entry><entry valign="middle">14.8021</entry><entry valign="middle">0.2772</entry></row><row><entry valign="middle">DR7</entry><entry valign="middle">13.2807</entry><entry valign="middle">0.0463</entry><entry valign="middle">10.1317</entry><entry valign="middle">0.0997</entry><entry valign="middle">6.9270</entry><entry valign="middle">0.1040</entry><entry valign="middle">10.6726</entry><entry valign="middle">0.1155</entry><entry valign="middle">10.4219</entry><entry valign="middle">0.2378</entry></row><row><entry valign="middle">DRB</entry><entry valign="middle">2.8820</entry><entry valign="middle">0.0227</entry><entry valign="middle">62673</entry><entry valign="middle">0.0800</entry><entry valign="middle">6.5413</entry><entry valign="middle">0.1013</entry><entry valign="middle">9.7731</entry><entry valign="middle">0.1110</entry><entry valign="middle">6.0059</entry><entry valign="middle">0.1844</entry></row><row><entry valign="middle">DR9</entry><entry valign="middle">1.0616</entry><entry valign="middle">0.0139</entry><entry valign="middle">2.9646</entry><entry valign="middle">0.0559</entry><entry valign="middle">9.7527</entry><entry valign="middle">0.1218</entry><entry valign="middle">1.0712</entry><entry valign="middle">0.0383</entry><entry valign="middle">2.8662</entry><entry valign="middle">0.1291</entry></row><row><entry valign="middle">DR10</entry><entry valign="middle">1.4790</entry><entry valign="middle">0.0163</entry><entry valign="middle">2.0397</entry><entry valign="middle">0.0465</entry><entry valign="middle">2.2304</entry><entry valign="middle">0.0602</entry><entry valign="middle">1.8044</entry><entry valign="middle">0.0495</entry><entry valign="middle">1.0898</entry><entry valign="middle">0.0801</entry></row><row><entry valign="middle">DR11</entry><entry valign="middle">9.3180</entry><entry valign="middle">0.0396</entry><entry valign="middle">10.6151</entry><entry valign="middle">0.1018</entry><entry valign="middle">4.7375</entry><entry valign="middle">0.0869</entry><entry valign="middle">7.0411</entry><entry valign="middle">0.0955</entry><entry valign="middle">5.3152</entry><entry valign="middle">0.1740</entry></row><row><entry valign="middle">DR12</entry><entry valign="middle">1.9070</entry><entry valign="middle">0.0185</entry><entry valign="middle">4.1152</entry><entry valign="middle">0.0655</entry><entry valign="middle">10.1365</entry><entry valign="middle">0.1239</entry><entry valign="middle">1.7244</entry><entry valign="middle">0.0484</entry><entry valign="middle">2.0132</entry><entry valign="middle">0.1086</entry></row><row><entry valign="middle">DR5 unsplit</entry><entry valign="middle">1.2199</entry><entry valign="middle">0.0149</entry><entry valign="middle">2.2957</entry><entry valign="middle">0.0493</entry><entry valign="middle">1.4118</entry><entry valign="middle">0.0480</entry><entry valign="middle">1.8225</entry><entry valign="middle">0.0498</entry><entry valign="middle">1.6769</entry><entry valign="middle">0.0992</entry></row><row><entry valign="middle">DR5 total</entry><entry valign="middle">12.4449</entry><entry valign="middle">0.0045</entry><entry valign="middle">17.0260</entry><entry valign="middle">0.1243</entry><entry valign="middle">16.2858</entry><entry valign="middle">0.1316</entry><entry valign="middle">10.5880</entry><entry valign="middle">0.1148</entry><entry valign="middle">9.0052</entry><entry valign="middle">0.2218</entry></row><row><entry valign="middle">DRX</entry><entry valign="middle">1.3598</entry><entry valign="middle">0.0342</entry><entry valign="middle">0.8853</entry><entry valign="middle">0.0760</entry><entry valign="middle">2.5521</entry><entry valign="middle">0.1089</entry><entry valign="middle">1.4023</entry><entry valign="middle">0.0930</entry><entry valign="middle">2.0834</entry><entry valign="middle">0.2037</entry></row><row><entry namest="col1" nameend="col11" align="left" valign="middle"><sup>a</sup>Gene frequency.</entry></row><row><entry namest="col1" nameend="col11" align="left" valign="middle"><sup>b</sup>Standard error.</entry></row></tbody></tgroup></table></tables><!-- EPO <DP n="67"> --></p><p id="p0073" num="0073">It can be desirable to express housekeeping peptides in the context of a larger protein. Processing can be detected even when a small number of amino acids are present beyond the terminus of an epitope. Small peptide hormones are usually proteolytically processed from longer transition products, often In the size range of approximately 60-120 amino acids. This fact has led some to assume that this is the minimum size that can be efficiency translated. In some embodiments, the housekeeping peptide can be embedded in a translation produce of at least about 60 amino acids, in others 70, 80, 90 amino acids, and in still others 100,110 or 120 amino acids, for example. In other embodiments the housekeeping peptide can be embedded in a translation product of at least, about 50, 30, or 15 amino acids.</p><p id="p0074" num="0074">Due to differential proteasomal processing, the immunoprotcasome of the pAPC produces peptides that are different from those produced by the housekeeping proteasome In peripheral body cells. Thus, in expressing a housekeeping peptide in the context of a larger protein, it is preferably expressed in the pAPC in a context other than its full-length native sequence, because, as a housekeeping epitope, it is generally only efficiently processed from the native protein by the housekeeping proteasome, which is not active in the pAPC. In order to encode the housekeeping epitope in a DNA sequence encoding a larger polypeptide, it is useful to find flanking areas on either side of the sequence encoding the epitope that permit appropriate cleavage by the immunoproteasome in order to liberate that housekeeping epitope. Such a sequence promoting appropriate processing is referred to hereinafter as having substrate or liberation sequence function. Altering flanking amino acid residues at the N-terminus and C-terminus of the desired housekeeping epitope: can facilitate appropriate cleavage and generation of the housekeeping epitope in the pAPC. Sequences embedding housekeeping epitopes can be designed <i>de novo</i> and screened to determine which can be successfully processed by immunoproteasomes to liberate housekeeping epitopes.</p><p id="p0075" num="0075">Alternatively, another strategy is very effective for identifying sequences allowing production of housekeeping epitopes in APC. A contiguous sequence of amino acids can be generated from head to tall arrangement, of one or more housekeeping epitopes. A construct expressing this sequence is used to immunize an animal, and the resulting T cell response is evaluated to determine its specificity to one or more of the epitopes in the array. These immune responses indicate housekeeping epitopes that are processed in the pAPC effectively. The necessary flanking areas around this epitopes are thereby defined. The use of flanking regions of about 4-6 amino acids on either side of the desired peptide can provide the necessary information to facilitate proteasome processing of the housekeeping epitope by the immunoproteasome. Therefore, a substrate or liberation sequence of approximately 16-22 amino acids can be inserted into, or fused to, any protein sequence effectively to result in that housekeeping epitope being produced in an APC. In some embodiments, a broader context of a substrate sequence can also influence processing. In such embodiments, comparisons of a liberaton sequence in a variety of contexts can be useful in further optimising a particular substrate sequence. In alternate embodiments the whole head-to-tail array of epitopes, or just the epitopes immediately adjacent, to the correctly processed housekeeping epitope can be similarly transferred from a test construct to a vaccine vector,</p><p id="p0076" num="0076">It is also described herein that, the housekeeping epitopes can be embedded between known immune epitopes, or segments of such, thereby providing an appropriate context for processing. The abutment of housekeeping and immune epitopes can generate the necessary context to enable the immunoproteasome to liberate the housekeeping epitope, or a larger fragment, preferably including a correct C-terminus. It can be useful to screen constructs to verify that the desired epitope is produced. The abutment of housekeeping epitopes can generate a site cleavable by the immunoproteasome. Some embodiments of the invention, employ known epitopes to flank: housekeeping epitopes in test substrates; in others, screening as described below is used, whether the flanking regions are arbitrary sequences or mutants of the natural flanking sequence, and whether or not knowledge of proteasomal cleavage preferences are used in designing the substrates.</p><p id="p0077" num="0077">Cleavage at the mature N-terminus of the epitope, while advantageous, is not required, since a variety of N-terminal trimming activities exist in the cell that can generate the mature N-terminus of the epitope subsequent to proteasomal processing. It is preferred that such N-terminal extension be less than about 25 amino acids in length and it is further preferred that the extension have few or no proline residues. Preferably, in screening, consideration is given not only to cleavage at the ends of the epitope (or at least at its C-terminus), but consideration also can be given to ensure limited cleavage within the epitope.</p><p id="p0078" num="0078">Shotgun approaches can be used in designing test substrates and can increase the efficiency of screening, in one embodiment multiple epitopes can be assembled one after the other, with Individual epitopes possibly appearing more than once. The substrate can be screened to determine which epitopes can be produced. In the case where a particular epitope is of concern, a substrate can be designed in which it appears in multiple different contexts. When a single epitope appearing in more than one context is liberated from the substrate additional secondary test substrates, in which individual instances of the epitope are removed, disabled, or are unique, can be used to determine which are being liberated and truly confer substrate or liberation sequence function.</p><p id="p0079" num="0079">Several readily practicable screens exist A preferred <i>in vitro</i> screen utilizes proteasomal digestion analysis, using purifled immunoproteasomes, to determine the desired housekeeping epitope can be liberated from a synthetic peptide embodying the sequence in question. The position of the cleavages obtained can be determined by techniques<!-- EPO <DP n="68"> --> such as mass spectrometry, HPLC, and N-terminal pool sequencing; as described in greater detail In <patcit id="pcit0107" dnum="US6861234B"><text>U.S. Patent 6,861,234</text></patcit> and US Patent Application No. <patcit id="pcit0108" dnum="US20030220239A"><text>US 2003/0220239</text></patcit>.</p><p id="p0080" num="0080">Alternatively, <i>in vivo</i> and cell-based screens such as immunization or target sensitization can be employed. For immunization a nucleic acid construct capable of expressing the sequence In question is used. Harvested CTL can be tested for their ability to recognize target cells presenting the housekeeping epitope in question. Such targets cells are most readily obtained by pulsing cells expressing the appropriate MHC molecule with synthetic peptide embodying the mature housekeeping epitope. Alternatively, immunization can be carried out using cells known to express housekeeping proteasome and the antigen from which the housekeeping epitope is derived, either endogenously or through genetic engineering. To use target sensitization as a screen, CTL, or preferably a CTL clone, that recognizes the housekeeping epitope can be used, in this case it is the target cell that expresses the embedded housekeeping epitope (instead of the pAPC during immunization) and it must express immunoproteasome. Generally, the cell or target cell can be transformed with an appropriate nucleic acid construct to confer expression of the embedded housekeeping epitope. Loading with a synthetic peptide embodying the embedded epitope using peptide loaded liposomes, or complexed with cationic lipid protein transfer reagents such as BIOPORTER™ (Gene Therapy Systems, San Diego, CA), represents an alternative.</p><p id="p0081" num="0081">Once sequences with substrate or liberation sequence function are identified they can be encoded in nucleic acid vectors, chemically synthesized, or produced recombinantly. In any of these forms they can be incorporated into immunogenic compositions. Such compositions can be used <i>in vitro</i> in vaccine development or in the generation or expansion of CTL to be used in adoptive immunotherapy. <i>In vivo</i> they can be used to induce, amplify or sustain and active immune response. The uptake of polypeptides for processing and presentation can be greatly enhanced by packaging with cationic lipid, the addition of a tract of cationic amino acids such as poly-L-lysine (<nplcit id="ncit0066" npl-type="s"><text>Ryser, H-J, et al., J. Cell Physiol. 113-167-178, 1982</text></nplcit>; <nplcit id="ncit0067" npl-type="s"><text>Shen, W.C. &amp; Ryser, H.J., Proc. Natl. Aced. Sci. USA 75:1872-1876, 1978</text></nplcit>), the incorporation into branched structures with importation signals (<nplcit id="ncit0068" npl-type="s"><text>Sheldon, K. et al., Proc. Natl. Aced. Sci. USA 92: 2056-2060,1995</text></nplcit>), or mixture with or fusion to polypeptides with protein transfer function including peptide carriers such as pep-1 (<nplcit id="ncit0069" npl-type="s"><text>Moms, M.C., et al., Nat. Biotech. 19:1173-1176, 2001</text></nplcit>), the PreS2 translocation motif of hepatitis 13 virus surface antigen, VP22 of herpes viruses, and HIV-TAT protein (<nplcit id="ncit0070" npl-type="s"><text>Oess, S. &amp; Hildt, E., Gene Ther. 7:750.-758,2000</text></nplcit>; <nplcit id="ncit0071" npl-type="s"><text>Ford, K.G., et al., Gene Ther. 8:1-4, 2001</text></nplcit>; <nplcit id="ncit0072" npl-type="s"><text>Hung, C.F. et al.,J. Virol. 76:2676-2682, 2002</text></nplcit>; <nplcit id="ncit0073" npl-type="s"><text>Oliveira, S.C., a;. Hum. Gene Ther. 12:1353-1359, 2001</text></nplcit>; <nplcit id="ncit0074" npl-type="s"><text>Normand, N. et al., J. Biol. Chem. 276: 15042. 15050, 2001</text></nplcit>; <nplcit id="ncit0075" npl-type="s"><text>Schwartz, J.J. &amp; Zhang, S., Curr. Opin Mo/. Ther. 2:162.-167,2000</text></nplcit>; <nplcit id="ncit0076" npl-type="s"><text>Elliot G., 7 Hare, P, Cell 88:223..233,1997</text></nplcit>), among other methodologies. Particularly for fusion proteins the immunogen can be produced in culture and the purified protein administered or, in the alternative, the nucleic acid vector can be administered so that the immunogen is produced and secreted by cells transformed <i>in vivo.</i> In either scenario the transport function of the fusion protein facilitates uptake by pAPC.</p><heading id="h0008">EXAMPLES</heading><heading id="h0009"><u>Example1.</u></heading><p id="p0082" num="0082">A recombinant DNA plasmid vaccine, pMA2M, which encodes one polypeptide with an HLA A2-specific CTL epitope ELAGIGILTV (SEQ ID NO.1) from melan-A (26-35A27L), and a portion (amino acids 31.-96) of melan-A (SEQ ID NO. 2) including the epitope clusters at amino acids 31-48 and 56-69, was constructed. These clusters were previously disclosed in <patcit id="pcit0109" dnum="US561571A"><text>U.S. Patent. Application No. 09/561,571</text></patcit> entitled EPITOPE CLUSTERS. Flanking the defined melan-A CTL epitope are short amino acid sequences derived from human tyrosinase (SEQ ID NO, 3) to facilitate liberation of the melan-A housekeeping epitope by processing by the inmunoproteasome. In addition, these amino acid sequences represent potential CTL epitopes themselves. The CDNA sequence for the polypeptide in the plasmid is under the control of promoter/enhancer sequence from cytomegalovirus (CMVp) (see <figref idrefs="f0001">Figure 1</figref>), which allows efficient transcription of messenger for the polypeptide upon uptake by APCs. The bovine growth hormone polyadenylation signal (BGH poly A) at the 3' end of the encoding sequence provides a signal for polyadenylation of the messenger to increase its stability as well as for translation out of nucleus into the cytoplasm for translation. To facilitate plasmid transport into the nucleus after uptake, a nuclear import sequence (NIS) from simian virus 40 (SV40) has been inserted in the plasmid backbone. The plasmid carries two copies of a CpG immunostimulatory motif, one in the NIS sequence and one in the plasmid backbone. Lastly, two prokaryotic genetic elements in the plasmid are responsible for amplification in <i>E.coli</i>, the kan-amycin resistance gene (Kan R) and the pMB1 bacterial origin of replication.</p><heading id="h0010"><u>SUBSTRATE or LIBERATION sequence</u></heading><p id="p0083" num="0083">The amino acid sequence of the encoded polypeptide (94 amino acid residues in length) (SEQ ID NO. 4) containing a 28 amino acid substrate or liberation sequence at its N-terminus (SEQ ID NO. 5) is given below:<!-- EPO <DP n="69"> --></p><p id="p0084" num="0084">MLLAVLYCL- ELAGIGILTV- YMDGTMSOV- GILTVILGVLLLIGCWYCRRRNGYRALMDKSLHVGTQCAL-TRRCPQEGFDHRDSKVSLQEK NCEPV</p><p id="p0085" num="0085">The first 9 amino acid residues are derived from tyrosinase<sub>1-9</sub> (SEQ ID NO.), the next ten constitute melan-A (26-35A27L) (SEQ ID NO. 1), and amino acid residues 20 to 29 are derived from tyrosinase 369-377 (SEQ ID NO. 7). These two tyrosinase nonamer sequences both represent potential HLA A2-specific CTL, epitopes. Amino acid residues 10-19 constitute melan-A (26-35A27L) an analog of an HLA A2-speciflc CTL epitope from melan-A, EAAGIGILTV (SEQ ID NO. 8), with an elevated potency in inducing CTL responses during <i>in vitro</i> immunization of human PBMC <i>and in vino</i> immunization in mice. The segment of melan-A constituting the rest of the polypeptide (amino add residues 30 to 94) contain a number of predicted HLA A2-specific epitopes, including the epitope clusters cited above, and thus can be useful in generating a response to immune epitopes as described at length in the patent applications 'Epitope Syn-chronization in Antigen Presenting Cells' and'Epitope Clusters'. This regionwas also included to overcome any difficulties that can be associated with the expression of shorter sequences. A drawing of pMA2M is shown in <figref idrefs="f0001">Figure 1</figref>.</p><heading id="h0011"><u>Plasmid construction</u></heading><p id="p0086" num="0086">A pair of long complementary oligonucleotides was synthesized which encoded the first 30 amino acid residues. In addition, upon annealing, these oligonucleotides generated the cohensive ends of <i>Afl</i> II at the 5' end and that of <i>EcoR</i> I at the 3' end. The melan A<sub>31</sub>-<sub>96</sub> region was amplified with PCR using oligonucleotides carrying restriction sites for <i>EcoR</i> I at the 5' end and <i>Not</i> I at the 3' end. The PCR product was digested with <i>EcoR</i> I and <i>Not</i> I and ligated into the vector backbone, described in Example 1, that had been digested with <i>AFL</i> II and <i>Not</i> I, along with the annealed oligonucleotides encoding the amino terminal region in a three-fragment ligation. The entire coding sequence was verified by DNA sequencing. The sequence of the entire insert, from the <i>Afl</i> II site at the 5' end to the <i>Not</i> I site at the 3' end is disclosed as SEQ ID NO, 9, Nucleotides 12-293 encode the polypeptide.</p><heading id="h0012"><u>Example2</u></heading><p id="p0087" num="0087">Three vectors containing melan-A (26-35A27L) (SEQ ID NO.1) as an embedded housekeeping epitope were tested for their ability to induce a CTL response to this epitope in HLA-A2 transgenic HHD mice (<nplcit id="ncit0077" npl-type="s"><text>Pascolo et al. J. Exp. Med.185:2043-2051, 1997</text></nplcit>). One of the vectors was pMA2M described above (called pVAXM3 in <figref idrefs="f0003">Figure 3</figref>). In pVAXM2 the same basic group of 3 epitopes was repeated several times with the flanking epitopes truncated by differing degrees In the various repeats of the array. Specifically the cassette consisted of:</p><p id="p0088" num="0088">M-Tyr(5-9)-ELA-Tyr(369-373)-Tyr(4-9)-ELA-Tyr(369-374)-Tyr(3-9)-ELA-Tyr(369-375)-Tyr(2-9)-ELA (SEQ ID NO, 10)</p><p id="p0089" num="0089">where ELA represents melan-A (26-35A27L) (SEQ ID NO.1). This cassette was inserted in the same plasmid backbone as used for pVAXM3. The third, pVAXMI is identical to pVAXM2 except that the epitope array is followed by an IRES (internal ribosome entry site for encephalomyocarditis virus) linked to a reading frame encoding melan-A 31-70.</p><p id="p0090" num="0090">Four groups of three HHD A2.1 mice were injected intranodally in surgically exposed inguinal lymph nodes with 25 &gt;1 of 1 mg/ml plasmid DNA. in PBS on days 0,3. and 6, each group receiving one of the three vectors or PBS alone. On day 14 the spleens were harvested and restimulated <i>in vitro</i> one time with 3-day LPS blasts pulsed with peptide (melan-A (26-35A27L)(SEQ ID NO. 1)). The <i>in vitro</i> cultures were supplemented with RatT-Stim (Collaborative Biomedical Products) on the 3<sup>rd</sup> day and assayed for cytolytic activity on the 7<sup>th</sup> day using a standard <sup>51</sup>Cr-ralease assay. <figref idrefs="f0002 f0003 f0004 f0005">Figures 2 to 5</figref> show % specific lysis obtained using the cells immunized with PBS, pVAXM1, pVAXM2, and pVAXM3, respectively on T2 target cells and T2 target cells pulsed with melan-A (26-35A27L) (ELA) (SEQ ID NO.1). All three vectors generated strong CTL responses. These data indicated that the plasmids have been taken up by APCs, the encoded polypeptide has been synthesized and proteolytically processed to produce the decamer epitope in question (that is, it had substrate or liberation sequence function), and that the epitopes became HLA-A2 bound for presentation. Also, an isolated variant of pVAXM2, that terminates after the 55<sup>th</sup> amino acid, worked similarly well as the full length version (data not shown). Whether other potential epitopes within the expression cassette can also be produced and be active in inducing CTL responses can be determined by testing for CTL activity against target cells pulsed with corresponding synthetic peptides.</p><heading id="h0013"><u>Example 3</u></heading><heading id="h0014"><u>An NY-ESO-1</u><u>(SEQ ID NO.11) SUBSTRATE/LIBERATION Sequence</u></heading><p id="p0091" num="0091">Six other epitope arrays were tested leading to the identification of a substrate/liberation sequence for the housekeeping epitope NY-ESO-1 <sub>157-165</sub> (SEQ ID NO. 12). The component epitopes of the arrays were:
<ul><li>SSX-2<sub>41-49</sub>: KASEKI FYV (SEQ ID NO. 13) Array element A<!-- EPO <DP n="70"> --></li><li>NY-ESO-1 <sub>157-165</sub>: SLLMWITQC (SEQ ID) NO. 12) Array element B</li><li>NY-ESO-1<sub>163-171</sub>: TQCFLPVFL (SEO ID NO. 14) Array element C</li><li>PSMA<sub>288-297</sub>: GLPSIPVHPI (SEQ ID NO.15) Array element D</li><li>TYR<sub>4-9</sub>: AVLYCL (SEQ ID NO. 16) Array element E</li><li>The six arrays had the following arrangements of elements after starting with an initiator methionine:</li><li>pVAX-PC-A: B-A-D-D-A-B-A-A.</li><li>pVAX-PC-B: D-A-B-A-A-D-B-A</li><li>pVAX-PC-C: E-A-D-B-A-B-E-A-A</li><li>pVAX-BC-A: B-A-C-B-A-A-GA</li><li>pVAX-BC-B: C-A-B-C-A-A-B-A</li><li>pVAX-BC-C: E-A-A-B-C-B-A-A</li></ul></p><p id="p0092" num="0092">These arrays were inserted into the same vector backbone described in the examples above. The plasmid vectors were used to immunize mice essentially as described in Example 2 and the resulting CTL were tested for their ability to specifically lyse target cells pulsed with the peptide NY-ESO-1 157-165, corresponding to element B above. Both pVAX-PC-A and pVAX-BC-A were found to induce specific lytic activity. Comparing the contexts of the epitope (element B) in the various arrays, and particularly between pVAX-PGA and pVAX-BC-A, between pVAX-PC-A and pVAX-PC-B, and between pVAX-BGA and pVAX-BC-C, it was concluded that it was the first occurrence of the epitope In pVAX-PC-A and pVAX-BC-A that was being correctly processed and presented. In otherwords an initiator methionine followed by elements B-A constitute a substrate/liberation sequence for the presentation of element B. On this basis a new expression cassette for use as a vaccine was constructed encoding the following elements:
<ul><li>An Initiatormethionine,</li><li>NY-ESO-1<sub>157-165</sub> (bold) --- a housekeeping epitope,</li><li>SSX2<sub>41-49</sub> (<i>italic</i>) -providing appropriate context for processing, and</li><li>NY-ESO-1<sub>77-180</sub>-to avoid "short sequence" problems and provide immune epitopes,</li><li>Thus the construct encodes the amino acid sequence:</li><li>M-SLLMW[TQC-<i>KASEKIFYV</i>-RCGARGPESRLLEFYLAMPFATPMEAELARRSLAQDAPPLPVPGVLLKEFT-VSGNILTIRLTA ADHRQLQLSISSCLQQLSLLMWHCFLPVFLAQPPSGQRR (SEQ ID NO. 17) and MSLLMWITQCK-ASEKITYV (SEQ ID NO. 18) constitutes the liberation or substrate sequence. A. polynucleotide encoding SEQ ID NO. 17 (SEQ ID NO. 19: nucleotides 12-380) was inserted into the same plasmid backbone as used for pMA2M generating the plasmid pN157.</li></ul></p><heading id="h0015"><u>Example 4</u></heading><p id="p0093" num="0093">A construct similar to pN157 containing the whole epitope array from PVAX-PC-A was also made and designated pBPL. Thus the encoded amino add sequence in pBPL is:
<ul><li>M-SLLMWTQC-<i>KASEKIFYV</i>-GLPSIPVHPI-GLPSIPVHPI-<i>KASEKIFYV</i>-SLLMWITQC-<i>KASEKIFYV</i>- <i>KASE-KIFYV</i>- RCGARGPESRLEFYLAMPFATPMEAELARRSLAQDAPPLPVPGVLLKEFTVSGNLLTIRLTA ADHRQLQLSI-SSCLQQLSLLMWITQCFL,PYFLAQPPSGQRR (SEQ ID NO. 20).</li><li>SEQ ID NO. 21 is the polynucleotide encoding SEQ ID NO. 20 used in pBPL.</li></ul></p><p id="p0094" num="0094">A portion of SEQ ID NO. 20, <i>IKASEKIFYV</i>SLLMWITQC<i>KASEKIFYVK</i> (SEQ ID NO. 22) was made as a synthetic peptide and subjected to <i>In vitro</i> proteasomal digestion analysis with human immunoproteasome, utilizing both mass spectrometry and N-terminal pool sequencing. The identification of a cleavage after the C residue indicates that this segment of the construct can function as a substrate or liberation sequence for NY-ESO-1 157-165 (SEQ ID NO. 12) epitope (see <figref idrefs="f0006">Figure 6</figref>). <figref idrefs="f0007">Figure 7</figref> shows the differential processing of the SLLMWJTQC epitope (SEQ ID NO. 12) in its native context where the cleavage following the C is more efficiently produced by housekeeping than immunoproteasome. The immunoproteasome also produces a major cleavage internal to the epitope, between the T and the Q when the epitope is in its native context, but not in the context of SEQ ID NO. 22 (compare <figref idrefs="f0006">fig. 6</figref> and <figref idrefs="f0007">7</figref>).</p><heading id="h0016"><u>Example_5</u></heading><p id="p0095" num="0095">Screening of further epitope arrays led to the identification of constructs promoting the expression of the epitope SSX-2<sub>41-49</sub> (SEQ ID NO. 13). In addition to some of the array elements defined in Example 3, the following additional elements were also used:
<ul><li>SSX-4<sub>57-65</sub>:VMTKLGFKV (SEQ ID NO. 23) Array element F.</li><li>PSMA-<sub>730-739</sub>: RQIYVAAFTV (SEQ ID NO. 24) Array element G.</li></ul></p><p id="p0096" num="0096">A construct, denoted CTLA02, encoding an initiator methionine and the array F-A-G-D-C-F-G-A, was found to successfully immunize HLA-A2 transgenic mice to generate a CTL response recognizing the peptide SSX-2<sub>41</sub>-<sub>49</sub> (SEQ ID NO. 13).<!-- EPO <DP n="71"> --></p><p id="p0097" num="0097">As described above, it can be desirable to combine a sequence with substrate or liberation sequence function with one that can be processed into immune epitopes. Thus SSX-2<sub>15-183</sub> (SEQ ID NO. 25) was combined with all or part of the array as follows:
<ul><li>CTLSI: F-A-G-D-C-F-G-A- SSX-2<sub>15-183</sub> (SEQ ID NO. 26)</li><li>CTLS2: SSX-2<sub>15-183</sub> - F-A-G-D-C-F-G-A (SBQ ID NO. 27)</li><li>CTLS3: F-A-G-D- SSX-2<sub>15-183</sub> (SEQ ID NO. 28)</li><li>CTLS4: SSX-2<sub>15-183</sub> -G-F-G-A (SEQ ID NO. 29).</li></ul></p><p id="p0098" num="0098">All of the constructs except CTLS3 were able to induce CTL recognizing the peptide SSX-2<sub>41-49</sub> (SEQ ID NO. 13). CTLS3 was the only one of these four constructs which did not include the second element A from CTLA02 suggesting that it was this second occurrence of the element that provided substrate or liberation sequence function. In CTLS2 and CTLS4 the A element is at the C-terminal end of the array, as In CTLA02. In CTLS1 the A element is immediately followed by the SSX-2<sub>15-183</sub> segment which begins with an alanine, a residue often found after proteasomal cleavage sites (<nplcit id="ncit0078" npl-type="s"><text>Toes, R.E.M., et al., J. Exp. Med. 194:1-12, 2001</text></nplcit>). SEQ ID NO. 30 is the polynucleotide sequence encoding SEQ ID NO. 26 used in CTLS1, also called pCBP.</p><p id="p0099" num="0099">A portion of CTLS1 (SEQ ID NO. 26), encompassing array elements F-A-SSX-2<sub>15-23</sub> with the sequence RQI-YVAAFTV-<i>KASEKIFV</i>-AQIPEKIQK (SEQ ID NO. 31), was made as a synthetic peptide and subjected to <i>in vitro</i> proteasomal digestion analysis with human immunoproteasome, utilizing both mass spectrometry and N-terminal pool sequencing. The observation that the C-terminus of the SSX-2<sub>41-49</sub> epitope (SEQ ID NO.13) was generated (see <figref idrefs="f0008 f0009">Figure 8</figref>) provided further evidence In support of substrate or liberation sequence function. The data in <figref idrefs="f0010">Figure 9</figref> showed the differential processing of the SSX-2<sub>41-49</sub> epitope, <i>KASEKlFYV</i>(SEQ ID NO.13), in its native context, where the cleavage following the V was the predominant cleavage produced by housekeeping proteasome, while the immunoproteasome had several major cleavage sites elsewhere in the sequence. By moving this epitope Into the context provided by SEQ ID NO. 31 the desired cleavage became a major one and its relative frequency compared to other immunoproteasome cleavages was Increased (compare <figref idrefs="f0008 f0009">figs. 8</figref> and <figref idrefs="f0010">9</figref>). The data In <figref idrefs="f0009">figure 8B</figref> also showed the similarity in specificity of mouse and human immunoproteasome lending support to the usefulness of the transgente mouse model to predict human antigen processing.</p><heading id="h0017"><u>Example 6</u></heading><p id="p0100" num="0100">Screening also revealed substrate or liberation sequence function for a tyrosinase epitope, Tyr<sub>207-215</sub> (SEQ ID NO. 32), as part of an array consisting of the sequence [Tyr<sub>1-17</sub>- Tyr<sub>207-215]4</sub>, [MLLAVLYCLLWSFQTSA-FLPWHRLFL]<sub>4</sub>, (SEQ ID NO. 33). The same vector backbone described above was used to express this array. This array differs from those of the other examples in that the Tyr<sub>1-17</sub> segment, which was inducled as a source of immune epitopes, is used as a repeated element of the array. This is in contrast with the pattern shown in the other examples where sequence included as a source of immune epitopes and/or length occurred a single time at the beginning or end of the array, the remainder of which was made up of individual epitopes or shorter sequences.</p><heading id="h0018"><u>Plasmid constriction</u></heading><p id="p0101" num="0101">The polynucleotide encoding SEQ ID NO. 33 was generated by assembly of annealed synthetic oligonucleotides. Four pairs of complementary oligonucleotides were synthesized which span the entire coding sequence with cohesive ends of the restriction sites of AfI II and EcoR I at either terminus. Each complementary pair of oligonucleotides were first annealed, the resultant DNA fragments were ligated stepwise, and the assembled DNA fragment was inserted into the same vector backbone described above pre-digested with AfI II/Vector. I. The construct was called CTLT2/pMEL and SEQ ID NO. 34 is the polynucleotide sequence used to encode SEQ ID NO. 33.</p><heading id="h0019"><u>Example 7</u></heading><heading id="h0020"><u>Administration of a DNA-plasmid formulation of a immunotherapeutic for melanoma to humans.</u></heading><p id="p0102" num="0102">An MA2M melanoma vaccine with a sequence as described in Example 1 above, was formulated in 1% Benzyl alcohol, 1% ethyl alcohol, 0.5mM EDTA, citrate-phosphate, pH 7.6. Aliquots of 200, 400, and 600 µg DNA/ml were prepared for loading into MINIMED 407C infusion pumps. The catheter of a SILHOUETTE infusion set was placed into an inguinal lymph node visualized by ultrasound imaging. The pump and infusion set assembly was originally designed forthe delivery of insulin to diabetics. The usual 17mm catheter was substituted with a 31 mm catheter for this application. The infusion set was kept patent for 4 days (approximately 96 hours) with an infusion rate of about 25 µl/hour resulting in a total infused volume of approximately 2.4 ml. Thus the total administered dose per infusion was approximately 500, and 1000 µg; and can be 1500 µg, respectively, for the three concentrations described above. Following an infusion,<!-- EPO <DP n="72"> --> subjects were given a 10 day rest period before starting a subsequent infusion. Given the continued residency of plasmid DNA in the lymph node after administration and the usual kinetics of CTL response following disappearance of antigen. this schedule will be sufficient to maintain the immunologic CTL response.</p><heading id="h0021"><u>Example 8</u></heading><p id="p0103" num="0103">SEQ ID NO. 22 is made as a synthetic peptide and packaged with a cationic lipid protein transfer reagent. The composition is infused directly into the inguinal lymph node (see example 7) at a rate of 200 to 600 µg of peptide per day for seven days, followed by seven days rest An initial treatment, of 3-8 cycles are conducted.</p><heading id="h0022"><u>Example 9</u></heading><p id="p0104" num="0104">A fusion protein is made by adding SEQ ID NO. 34 to the 3' end of a nucleotide sequence encoding herpes simplex virus 1 VP22 (SEQ ID NO. 42) in an appropriate mammalian expression vector; the vector used above is suitable. The vector is used to transform HEK 293 cells and 48 to 72 hours later the cells are pelleted, lysed and a soluble extract prepared. The fusion protein is purified by affinity chromatagraphy using an anti-VP22 monoclonal antibody. The purified fusion protein is administered intranodally at a rate of 10 to 100 µg per day for seven days, followed by seven days rest. An initial treatment of 3-8 cycles are conducted.</p><p id="p0105" num="0105">Further, the present invention can utilize various aspects of the following: <patcit id="pcit0110" dnum="US6994851B"><text>U.S. Patent Nos.6,994,851</text></patcit>. <patcit id="pcit0111" dnum="US6977074B"><text>6,977,074</text></patcit>; <patcit id="pcit0112" dnum="US6709844B"><text>6,709,844</text></patcit>.
<tables id="tabl0011" num="0011"><table frame="all"><title><u>Table 11</u></title><tgroup cols="3"><colspec colnum="1" colname="col1" colwidth="12mm"/><colspec colnum="2" colname="col2" colwidth="126mm"/><colspec colnum="3" colname="col3" colwidth="28mm"/><thead><row><entry namest="col1" nameend="col3" align="center" valign="top"><u>Partial listing of SEQ ID NOS.</u></entry></row></thead><tbody><row><entry align="center">1</entry><entry>ELAGIGILTV</entry><entry>melan-A 26-35 (A27L)</entry></row><row><entry align="center">2</entry><entry>Melan-A protein</entry><entry>Accession number: NP 005502</entry></row><row><entry align="center">3</entry><entry>Tyrosinase protein</entry><entry>Accession number P14679</entry></row><row><entry align="center">4</entry><entry>MLLAVLYCLELAGIGILVYMDGTMSQVGILT</entry><entry morerows="2" rowsep="1">pMA2M expression product</entry></row><row><entry align="center"/><entry>VILGVLLLIGCWYCRRRNGYRALMDKSLHVG</entry></row><row><entry align="center"/><entry>TQCALTRRCPQEGFDHRDSKVSLQEKNCEPV</entry></row><row><entry align="center">5</entry><entry>MLLAVLYCLELAGIGILTVYMDGTMSQV</entry><entry>Liberation or substrate sequence for SEQ ID NO.1 from pMA2M</entry></row><row><entry align="center">6</entry><entry>MLLAVLYCL</entry><entry>tyrosinase 1-9</entry></row><row><entry align="center">7</entry><entry>YMDGTMSQV</entry><entry>tyrosinase 369-377</entry></row><row><entry align="center">8</entry><entry>EAAGIGILTV</entry><entry>melan-A 26-35</entry></row><row><entry align="center">9</entry><entry><img id="ib0118" file="imgb0118.tif" wi="116" he="16" img-content="dna" img-format="tif"/></entry><entry>pMA2M insert</entry></row><!-- EPO <DP n="73"> --><row><entry align="center">10</entry><entry>MVLYCLELAGIGILTVYMDGTAVLYCLELAGI</entry><entry>Epitope array from pVAXM2 and</entry></row><row><entry align="center"/><entry>GILTVYMDGTMLAVLYCLELAGIGILTVYMD GTMSLLAVLYCLELAGIGILTV</entry><entry>pVAXM1</entry></row><row><entry align="center">11</entry><entry>NY-ESO-1 protein.</entry><entry>Accession number: P78358</entry></row><row><entry align="center">12</entry><entry>SLLMWITQC</entry><entry>NY-ESO-1 157-165</entry></row><row><entry align="center">13</entry><entry>KASEKIFYV</entry><entry>SSX-241-49</entry></row><row><entry align="center">14</entry><entry>TQCFLPVFL</entry><entry>NY-ESO-1 163-171</entry></row><row><entry align="center">15</entry><entry>GLPSIPVHPI</entry><entry>PSMA 288-297</entry></row><row><entry align="center">16</entry><entry>AVLYCL</entry><entry>tyrosinase 4-9</entry></row><row><entry align="center">17</entry><entry><img id="ib0119" file="imgb0119.tif" wi="115" he="11" img-content="dna" img-format="tif"/></entry><entry>pN157 expression product</entry></row><row><entry align="center">18</entry><entry>MSLLMWITQCKASEKIFYV</entry><entry>liberation or substrate sequence for SEQ ID NO. 12 from pN157</entry></row><row><entry align="center">19</entry><entry><img id="ib0120" file="imgb0120.tif" wi="112" he="23" img-content="dna" img-format="tif"/></entry><entry>Insert for pN 157</entry></row><row><entry align="center">20</entry><entry><img id="ib0121" file="imgb0121.tif" wi="92" he="19" img-content="dna" img-format="tif"/></entry><entry>pBPL expression product</entry></row><row><entry align="center">21</entry><entry><img id="ib0122" file="imgb0122.tif" wi="116" he="31" img-content="dna" img-format="tif"/></entry><entry>pBPL insert coding region</entry></row><row><entry align="center">22</entry><entry>IKASEKIFYVSLLMWKTQCKASEKIFYVK</entry><entry>Substrate in <figref idrefs="f0006">Fig. 6</figref></entry></row><row><entry align="center">23</entry><entry>VMTKLGFKY</entry><entry>SSX-4<sub>57-65</sub></entry></row><row><entry align="center">24</entry><entry>RQIYVAAFTV</entry><entry>PSMA<sub>730-739</sub></entry></row><!-- EPO <DP n="74"> --><row><entry align="center">25</entry><entry><img id="ib0123" file="imgb0123.tif" wi="86" he="19" img-content="dna" img-format="tif"/></entry><entry>SSX-2<sub>15-183</sub></entry></row><row><entry align="center">26</entry><entry><img id="ib0124" file="imgb0124.tif" wi="118" he="23" img-content="dna" img-format="tif"/></entry><entry>CTLS1/pCBP expression product</entry></row><row><entry align="center">27</entry><entry><img id="ib0125" file="imgb0125.tif" wi="108" he="27" img-content="dna" img-format="tif"/></entry><entry>CTLS2 expression product</entry></row><row><entry align="center">28</entry><entry><img id="ib0126" file="imgb0126.tif" wi="101" he="23" img-content="dna" img-format="tif"/></entry><entry>CTLS3 expression product</entry></row><row><entry align="center">29</entry><entry><img id="ib0127" file="imgb0127.tif" wi="97" he="23" img-content="dna" img-format="tif"/></entry><entry>CTLS4 expression product</entry></row><row><entry align="center">30</entry><entry><img id="ib0128" file="imgb0128.tif" wi="116" he="43" img-content="dna" img-format="tif"/></entry><entry>pCBP insert coding region</entry></row><row><entry align="center">31</entry><entry>RQIYVAAFTVKASEKIFYVAQIPEKIQKIQK</entry><entry><figref idrefs="f0008 f0009">Fig.8</figref> substrate/ CTLS1-2</entry></row><row><entry align="center">32</entry><entry>FLPWHRLFL</entry><entry>TYR.<sub>207-215</sub></entry></row><row><entry align="center">33</entry><entry><img id="ib0129" file="imgb0129.tif" wi="62" he="7" img-content="dna" img-format="tif"/></entry><entry>CTLT2/pMBL expression product</entry></row><row><entry align="center"/><entry>WSFQTSAFLPWI-IRLFLMLLAVLYCLLWSFQT SAFLPWHRLFL</entry><entry/></row><!-- EPO <DP n="75"> --><row><entry align="center">34</entry><entry><img id="ib0130" file="imgb0130.tif" wi="116" he="16" img-content="dna" img-format="tif"/></entry><entry>CTLT2/pMEL insert coding region</entry></row><row><entry align="center"/><entry/><entry/></row><row><entry align="center">35</entry><entry>MELAN-A cDNA</entry><entry>Accession number: NM 005511</entry></row><row><entry align="center">36</entry><entry>Tyrosinase cDNA</entry><entry>Accession number NM 000372</entry></row><row><entry align="center">37</entry><entry>NY-ESO-1 DNA</entry><entry>Accession number: U87459</entry></row><row><entry align="center">38</entry><entry>PSMA protein</entry><entry>Accession number: NP 004467</entry></row><row><entry align="center">39</entry><entry>PSMA cDNA</entry><entry>Accession number NM 004476</entry></row><row><entry align="center">40</entry><entry>SSX-2 protein</entry><entry>Accession number NP 003138</entry></row><row><entry align="center">41</entry><entry>SSX-2 cDNA</entry><entry>Accession number: NM 003147</entry></row><row><entry align="center">42</entry><entry><img id="ib0131" file="imgb0131.tif" wi="72" he="74" img-content="dna" img-format="tif"/></entry><entry>From accession number: D10879 Herpes Simplex virus 1 UL49 coding sequence (VP22)</entry></row><!-- EPO <DP n="76"> --><row><entry align="center">43</entry><entry><img id="ib0132" file="imgb0132.tif" wi="117" he="35" img-content="dna" img-format="tif"/></entry><entry>Accession number P10233 Herpes Simplex virus 1 UL49/VP22 protein sequence</entry></row></tbody></tgroup></table></tables></p><heading id="h0023"><b>Melan-A mRNA sequences</b></heading><p id="p0106" num="0106">LOCUS NM_005511 1524 bp mRNA PRI 14-OCT-2001</p><heading id="h0024">DEFINITION Homo sapiens melan-A (MLANA), mRNA.</heading><p id="p0107" num="0107">ACCESSION NM_005511</p><p id="p0108" num="0108">VERSION NM_005511.1 01:5031912</p><heading id="h0025"><b>(SEQ ID NO. 2)</b></heading><p id="p0109" num="0109">/transladon-'MPREDAHFIYGYPKKGHGHSYTTAEEAAGtGILGVILGVLILIGCWYCRRRNGY RALMDKSLH-VGTQCALTRRCPQEGFDHRDSKVSLQEKNCEPVVPNAPPAYEKLSAEQSPPP YSP'</p><heading id="h0026"><b>(SEQ ID NO. 35)</b></heading><heading id="h0027"><b>ORIGIN</b></heading><p id="p0110" num="0110"><img id="ib0133" file="imgb0133.tif" wi="98" he="94" img-content="dna" img-format="tif"/><!-- EPO <DP n="77"> --><img id="ib0134" file="imgb0134.tif" wi="94" he="8" img-content="dna" img-format="tif"/></p><heading id="h0028"><b>Tyrosinase mRNA sequence</b></heading><p id="p0111" num="0111">LOCUS NM_000372 1964 bp mRNA PRI 31 -OCT-2000</p><heading id="h0029">DEFINITION Homo sapiens tyrosinase (oculocutaneous albinism IA) (TYR), mRNA.</heading><p id="p0112" num="0112">ACCESSION NM_000372</p><p id="p0113" num="0113">VERSION NM_000372.1 GI:4507752</p><heading id="h0030">(SEQ ID NO. 3)</heading><p id="p0114" num="0114"><img id="ib0135" file="imgb0135.tif" wi="153" he="31" img-content="dna" img-format="tif"/></p><heading id="h0031"><b>(SEQ ID NO. 36)</b></heading><heading id="h0032">ORIGIN</heading><p id="p0115" num="0115"><img id="ib0136" file="imgb0136.tif" wi="98" he="114" img-content="dna" img-format="tif"/><!-- EPO <DP n="78"> --><img id="ib0137" file="imgb0137.tif" wi="92" he="16" img-content="dna" img-format="tif"/></p><heading id="h0033">NY-ESO-1 mRNA sequence</heading><p id="p0116" num="0116">LOCUS HSU87459 752 bp mRNA PRI 22-DEC-1999 DEFINITION Human autoimmunogenic cancer/testis antigen NY-ESO-1 mRNA, complete cds.</p><p id="p0117" num="0117">ACCESSION U87459</p><p id="p0118" num="0118">VERSION U87459.1 GI-1890098</p><heading id="h0034"><b>(SEQ ID NO. 11)</b></heading><p id="p0119" num="0119"><img id="ib0138" file="imgb0138.tif" wi="152" he="12" img-content="dna" img-format="tif"/></p><heading id="h0035"><b>(SEQ ID NO. 37)</b></heading><heading id="h0036">ORIGIN</heading><p id="p0120" num="0120"><img id="ib0139" file="imgb0139.tif" wi="104" he="51" img-content="dna" img-format="tif"/></p><heading id="h0037"><b>PSMA cDNA sequence</b></heading><p id="p0121" num="0121">LOCUS NM_004476 2653 bp mRNA PRI 01-NOV-2000</p><heading id="h0038">DEFINITION Homo sapiens folate hydrolese (prostate-specific membrane antigen) 1 (FOLH1), mRNA.</heading><p id="p0122" num="0122">ACCESSION NM_004476</p><p id="p0123" num="0123">VERSION NM_004476.1 GI:4758397</p><heading id="h0039"><b>(SEQ ID NO. 38)</b></heading><p id="p0124" num="0124"><img id="ib0140" file="imgb0140.tif" wi="153" he="35" img-content="dna" img-format="tif"/><!-- EPO <DP n="79"> --><img id="ib0141" file="imgb0141.tif" wi="141" he="4" img-content="dna" img-format="tif"/></p><heading id="h0040"><b>(SEQ ID NO. 39)</b></heading><heading id="h0041">ORIGIN</heading><p id="p0125" num="0125"><img id="ib0142" file="imgb0142.tif" wi="101" he="176" img-content="dna" img-format="tif"/><!-- EPO <DP n="80"> -->
NM 003147 <b>Homo sapiens synovial sarcoma, X breakpoint 2 (SSX2), mRNA</b> LOCUS NM_003147 766 bp mRNA PRI 14-MAR-2001 DEFINITION Homo sapiens synovial sarcoma, X breakpoint 2 (SSX2), mRNA.</p><p id="p0126" num="0126">ACCESSION NM_003147</p><p id="p0127" num="0127">VERSION NM_003147.1 GI:10337b82</p><p id="p0128" num="0128">SEQ ID NO. 40
<img id="ib0143" file="imgb0143.tif" wi="105" he="14" img-content="dna" img-format="tif"/></p><p id="p0129" num="0129"><b>SEQ ID NO 41</b><img id="ib0144" file="imgb0144.tif" wi="124" he="43" img-content="dna" img-format="tif"/><!-- EPO <DP n="81"> --></p><heading id="h0042">SEQUENCE LISTING</heading><p id="p0130" num="0130"><ul><li>&lt;110&gt; Simard, John J. L.<br/>
Diamond, David C.<br/>
Qiu, Zhiyong<br/>
Lei, Xiang-Dong</li><li>&lt;120&gt; EXPRESSION VECTORS ENCODING EPITOPES OF<br/>
TARGET-ASSOCIATED ANTIGENS AND METHODS FOR THEIR DESIGN</li><li>&lt;130&gt; M 9318</li><li>&lt;140&gt; <patcit id="pcit0113" dnum="EP02806695A"><text>EP 02806695.9</text></patcit><br/>
&lt;141&gt; 2002-11-07</li><li>&lt;150&gt; <patcit id="pcit0114" dnum="EP60336968A"><text>60/336,968</text></patcit><br/>
&lt;151&gt; 2001-11-07</li><li>&lt;160&gt; 979</li><li>&lt;170&gt; FastSEQ for Windows Version 4.0</li><li>&lt;210&gt; 1<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 1
<img id="ib0145" file="imgb0145.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 2<br/>
&lt;211&gt; 118<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 2
<img id="ib0146" file="imgb0146.tif" wi="132" he="55" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 3<br/>
&lt;211&gt; 529<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 3
<img id="ib0147" file="imgb0147.tif" wi="132" he="14" img-content="dna" img-format="tif"/><!-- EPO <DP n="82"> -->
<img id="ib0148" file="imgb0148.tif" wi="133" he="213" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 4<br/>
&lt;211&gt; 94<br/>
<!-- EPO <DP n="83"> -->&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; pMA2M expression product</li><li>&lt;400&gt; 4
<img id="ib0149" file="imgb0149.tif" wi="132" he="41" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 5<br/>
&lt;211&gt; 28<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Epitope liberation sequence for SEQ ID NO. 1 from pMA2M</li><li>&lt;400&gt; 5
<img id="ib0150" file="imgb0150.tif" wi="132" he="14" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 6<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 6
<img id="ib0151" file="imgb0151.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 7<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 7
<img id="ib0152" file="imgb0152.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 8<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 8
<img id="ib0153" file="imgb0153.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 9<br/>
<!-- EPO <DP n="84"> -->&lt;211&gt; 307<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; pMA2M insert coding region</li><li>&lt;400&gt; 9
<img id="ib0154" file="imgb0154.tif" wi="144" he="22" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 10<br/>
&lt;211&gt; 85<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Epitope array from pVAXM2 and pVAXM1</li><li>&lt;400&gt; 10
<img id="ib0155" file="imgb0155.tif" wi="132" he="41" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 11<br/>
&lt;211&gt; 180<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo sapien</li><li>&lt;400&gt; 11
<img id="ib0156" file="imgb0156.tif" wi="132" he="82" img-content="dna" img-format="tif"/><!-- EPO <DP n="85"> --></li><li>&lt;210&gt; 12<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 12
<img id="ib0157" file="imgb0157.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 13<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 13
<img id="ib0158" file="imgb0158.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 14<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 14
<img id="ib0159" file="imgb0159.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 15<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 15
<img id="ib0160" file="imgb0160.tif" wi="83" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 16<br/>
&lt;211&gt; 6<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 16
<img id="ib0161" file="imgb0161.tif" wi="50" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 17<br/>
&lt;211&gt; 123<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; pN157 expression product</li><li>&lt;400&gt; 17
<img id="ib0162" file="imgb0162.tif" wi="132" he="25" img-content="dna" img-format="tif"/><!-- EPO <DP n="86"> -->
<img id="ib0163" file="imgb0163.tif" wi="132" he="31" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 18<br/>
&lt;211&gt; 19<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Epitope liberation sequence for SEQ ID No. 12 from pN157</li><li>&lt;400&gt; 18
<img id="ib0164" file="imgb0164.tif" wi="132" he="11" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 19<br/>
&lt;211&gt; 392<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; pN157 insert coding region</li><li>&lt;400&gt; 19
<img id="ib0165" file="imgb0165.tif" wi="144" he="25" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 20<br/>
&lt;211&gt; 179<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; pBPL expression product</li></ul><ul><li>&lt;400&gt; 20
<img id="ib0166" file="imgb0166.tif" wi="132" he="52" img-content="dna" img-format="tif"/><!-- EPO <DP n="87"> -->
<img id="ib0167" file="imgb0167.tif" wi="132" he="29" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 21<br/>
&lt;211&gt; 543<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; pBPL insert coding region</li><li>&lt;400&gt; 21
<img id="ib0168" file="imgb0168.tif" wi="144" he="35" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 22<br/>
&lt;211&gt; 29<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; liberation sequence for SEQ ID NO. 22</li><li>&lt;400&gt; 22
<img id="ib0169" file="imgb0169.tif" wi="132" he="14" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 23<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo sapien</li><li>&lt;400&gt; 23
<img id="ib0170" file="imgb0170.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 24<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 24
<img id="ib0171" file="imgb0171.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 25<br/>
&lt;211&gt; 169<br/>
<!-- EPO <DP n="88"> -->&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 25
<img id="ib0172" file="imgb0172.tif" wi="132" he="75" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 26<br/>
&lt;211&gt; 245<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; CTLS1/pCBP expression product</li><li>&lt;400&gt; 26
<img id="ib0173" file="imgb0173.tif" wi="132" he="106" img-content="dna" img-format="tif"/><!-- EPO <DP n="89"> -->
<img id="ib0174" file="imgb0174.tif" wi="8" he="4" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 27<br/>
&lt;211&gt; 245<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; CTL52 expression product</li><li>&lt;400&gt; 27
<img id="ib0175" file="imgb0175.tif" wi="132" he="109" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 28<br/>
&lt;211&gt; 208<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; CTL53 expression product</li><li>&lt;400&gt; 28
<img id="ib0176" file="imgb0176.tif" wi="132" he="45" img-content="dna" img-format="tif"/><!-- EPO <DP n="90"> -->
<img id="ib0177" file="imgb0177.tif" wi="132" he="45" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 29<br/>
&lt;211&gt; 207<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; CTL54 expression product</li><li>&lt;400&gt; 29
<img id="ib0178" file="imgb0178.tif" wi="132" he="88" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 30<br/>
&lt;211&gt; 741<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; pCBP insert coding region</li><li>&lt;400&gt; 30
<img id="ib0179" file="imgb0179.tif" wi="144" he="25" img-content="dna" img-format="tif"/><!-- EPO <DP n="91"> -->
<img id="ib0180" file="imgb0180.tif" wi="145" he="21" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 31<br/>
&lt;211&gt; 28<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; CTLS11-2 liberation/substrate sequence</li><li>&lt;400&gt; 31
<img id="ib0181" file="imgb0181.tif" wi="132" he="14" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 32<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 32
<img id="ib0182" file="imgb0182.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 33<br/>
&lt;211&gt; 104<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; CTLT2/pMEL expression product</li><li>&lt;400&gt; 33
<img id="ib0183" file="imgb0183.tif" wi="132" he="48" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 34<br/>
&lt;211&gt; 318<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; CTLT2/pMEL insert coding region</li><li>&lt;400&gt; 34
<img id="ib0184" file="imgb0184.tif" wi="144" he="10" img-content="dna" img-format="tif"/><!-- EPO <DP n="92"> -->
<img id="ib0185" file="imgb0185.tif" wi="144" he="15" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 35<br/>
&lt;211&gt; 1524<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 35
<img id="ib0186" file="imgb0186.tif" wi="146" he="88" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 36<br/>
&lt;211&gt; 1964<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 36
<img id="ib0187" file="imgb0187.tif" wi="146" he="82" img-content="dna" img-format="tif"/><!-- EPO <DP n="93"> -->
<img id="ib0188" file="imgb0188.tif" wi="146" he="32" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 37<br/>
&lt;211&gt; 752<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 37
<img id="ib0189" file="imgb0189.tif" wi="144" he="45" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 38<br/>
&lt;211&gt; 750<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 38
<img id="ib0190" file="imgb0190.tif" wi="132" he="109" img-content="dna" img-format="tif"/><!-- EPO <DP n="94"> -->
<img id="ib0191" file="imgb0191.tif" wi="135" he="210" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 39<br/>
&lt;211&gt; 2653<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Homo Sapien<!-- EPO <DP n="95"> --></li><li>&lt;400&gt; 39
<img id="ib0192" file="imgb0192.tif" wi="147" he="152" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 40<br/>
&lt;211&gt; 188<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 40
<img id="ib0193" file="imgb0193.tif" wi="132" he="48" img-content="dna" img-format="tif"/><!-- EPO <DP n="96"> -->
<img id="ib0194" file="imgb0194.tif" wi="132" he="35" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 41<br/>
&lt;211&gt; 766<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 41
<img id="ib0195" file="imgb0195.tif" wi="144" he="45" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 42<br/>
&lt;211&gt; 903<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Herpes Simplex Virus</li><li>&lt;400&gt; 42
<img id="ib0196" file="imgb0196.tif" wi="144" he="55" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 43<br/>
&lt;211&gt; 311<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Herpes Simplex Virus</li><li>&lt;400&gt; 43
<img id="ib0197" file="imgb0197.tif" wi="131" he="25" img-content="dna" img-format="tif"/><!-- EPO <DP n="97"> -->
<img id="ib0198" file="imgb0198.tif" wi="133" he="112" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 44<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Adenovirus 3</li><li>&lt;400&gt; 44
<img id="ib0199" file="imgb0199.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 45<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Adenovirus 5</li><li>&lt;400&gt; 45
<img id="ib0200" file="imgb0200.tif" wi="83" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 46<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Adenovirus 5</li><li>&lt;400&gt; 46
<img id="ib0201" file="imgb0201.tif" wi="66" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 47<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
<!-- EPO <DP n="98"> -->&lt;213&gt; Adenovirus 5</li><li>&lt;400&gt; 47
<img id="ib0202" file="imgb0202.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 48<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; classical Swine Fever Virus</li><li>&lt;400&gt; 4R
<img id="ib0203" file="imgb0203.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 49<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Dengue virus 4</li><li>&lt;400&gt; 49
<img id="ib0204" file="imgb0204.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 50<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 50
<img id="ib0205" file="imgb0205.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 51<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 51
<img id="ib0206" file="imgb0206.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 52<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 52
<img id="ib0207" file="imgb0207.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 53<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 53
<img id="ib0208" file="imgb0208.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 54<br/>
<!-- EPO <DP n="99"> -->&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 54
<img id="ib0209" file="imgb0209.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 55<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 55
<img id="ib0210" file="imgb0210.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 56<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 56
<img id="ib0211" file="imgb0211.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 57<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 57
<img id="ib0212" file="imgb0212.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 58<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 58
<img id="ib0213" file="imgb0213.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 59<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr virus</li><li>&lt;400&gt; 59
<img id="ib0214" file="imgb0214.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 60<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr virus</li><li>&lt;400&gt; 60
<img id="ib0215" file="imgb0215.tif" wi="73" he="7" img-content="dna" img-format="tif"/><!-- EPO <DP n="100"> --></li><li>&lt;210&gt; 61<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 61
<img id="ib0216" file="imgb0216.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 62<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 62
<img id="ib0217" file="imgb0217.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 63<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 63
<img id="ib0218" file="imgb0218.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 64<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr virus</li><li>&lt;400&gt; 64
<img id="ib0219" file="imgb0219.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 65<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li></ul><ul><li>&lt;400&gt; 65
<img id="ib0220" file="imgb0220.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 66<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 66
<img id="ib0221" file="imgb0221.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 67<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr virus</li><li>&lt;400&gt; 67
<img id="ib0222" file="imgb0222.tif" wi="74" he="4" img-content="dna" img-format="tif"/><!-- EPO <DP n="101"> -->
<img id="ib0223" file="imgb0223.tif" wi="37" he="4" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 68<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 68
<img id="ib0224" file="imgb0224.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 69<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 69
<img id="ib0225" file="imgb0225.tif" wi="73" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 70<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 70
<img id="ib0226" file="imgb0226.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 71<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 71
<img id="ib0227" file="imgb0227.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 72<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr virus</li><li>&lt;400&gt; 72
<img id="ib0228" file="imgb0228.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 73<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 73
<img id="ib0229" file="imgb0229.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 74<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus<!-- EPO <DP n="102"> --></li><li>&lt;400&gt; 74
<img id="ib0230" file="imgb0230.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 75<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr virus</li><li>&lt;400&gt; 75
<img id="ib0231" file="imgb0231.tif" wi="73" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 76<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 76
<img id="ib0232" file="imgb0232.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 77<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 77
<img id="ib0233" file="imgb0233.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 78<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 78
<img id="ib0234" file="imgb0234.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 79<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr virus</li><li>&lt;400&gt; 79
<img id="ib0235" file="imgb0235.tif" wi="83" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 80<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 80
<img id="ib0236" file="imgb0236.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 81<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
<!-- EPO <DP n="103"> -->&lt;213&gt; Epstein-Barr virus</li><li>&lt;400&gt; 81
<img id="ib0237" file="imgb0237.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 82<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr virus</li><li>&lt;400&gt; 82
<img id="ib0238" file="imgb0238.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 83<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 83
<img id="ib0239" file="imgb0239.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 84<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 84
<img id="ib0240" file="imgb0240.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 85<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-sarr Virus</li><li>&lt;400&gt; 85
<img id="ib0241" file="imgb0241.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 86<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 86
<img id="ib0242" file="imgb0242.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 87<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr virus</li><li>&lt;400&gt; 87
<img id="ib0243" file="imgb0243.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 88<br/>
<!-- EPO <DP n="104"> -->&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 88
<img id="ib0244" file="imgb0244.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 89<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 89
<img id="ib0245" file="imgb0245.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 90<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 90
<img id="ib0246" file="imgb0246.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 91<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 91
<img id="ib0247" file="imgb0247.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 92<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 92
<img id="ib0248" file="imgb0248.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 93<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 93
<img id="ib0249" file="imgb0249.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 94<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 94
<img id="ib0250" file="imgb0250.tif" wi="82" he="7" img-content="dna" img-format="tif"/><!-- EPO <DP n="105"> --></li><li>&lt;210&gt; 95<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 95
<img id="ib0251" file="imgb0251.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 96<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 96
<img id="ib0252" file="imgb0252.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 97<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr virus</li><li>&lt;400&gt; 97
<img id="ib0253" file="imgb0253.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 98<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 98
<img id="ib0254" file="imgb0254.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 99<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr virus</li><li>&lt;400&gt; 99
<img id="ib0255" file="imgb0255.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 100<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr virus</li><li>&lt;400&gt; 100
<img id="ib0256" file="imgb0256.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 101<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 101
<img id="ib0257" file="imgb0257.tif" wi="74" he="5" img-content="dna" img-format="tif"/><!-- EPO <DP n="106"> -->
<img id="ib0258" file="imgb0258.tif" wi="37" he="4" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 102<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 102
<img id="ib0259" file="imgb0259.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 103<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 103
<img id="ib0260" file="imgb0260.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 104<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 104
<img id="ib0261" file="imgb0261.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 105<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C virus</li><li>&lt;400&gt; 105
<img id="ib0262" file="imgb0262.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 106<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis c Virus</li><li>&lt;400&gt; 106
<img id="ib0263" file="imgb0263.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 107<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 107
<img id="ib0264" file="imgb0264.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 108<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus<!-- EPO <DP n="107"> --></li><li>&lt;400&gt; 108
<img id="ib0265" file="imgb0265.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 109<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 109
<img id="ib0266" file="imgb0266.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 110<br/>
&lt;211&gt; 16<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 110
<img id="ib0267" file="imgb0267.tif" wi="132" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 111<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 111
<img id="ib0268" file="imgb0268.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 112<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus 1</li><li>&lt;400&gt; 112
<img id="ib0269" file="imgb0269.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 113<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis c Virus 1</li><li>&lt;400&gt; 113
<img id="ib0270" file="imgb0270.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 114<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis c virus 1</li><li>&lt;400&gt; 114
<img id="ib0271" file="imgb0271.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 115<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
<!-- EPO <DP n="108"> -->&lt;213&gt; Hepatitis C Virus 1</li><li>&lt;400&gt; 115
<img id="ib0272" file="imgb0272.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 116<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis c Virus 1</li><li>&lt;400&gt; 116
<img id="ib0273" file="imgb0273.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 117<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C virus 1</li><li>&lt;400&gt; 117
<img id="ib0274" file="imgb0274.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 118<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus 1</li><li>&lt;400&gt; 118
<img id="ib0275" file="imgb0275.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 119<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus 1</li><li>&lt;400&gt; 119
<img id="ib0276" file="imgb0276.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 120<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis c virus 1</li><li>&lt;400&gt; 120
<img id="ib0277" file="imgb0277.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 121<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human immunodeficiency Virus</li><li>&lt;400&gt; 121
<img id="ib0278" file="imgb0278.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 122<br/>
<!-- EPO <DP n="109"> -->&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus</li><li>&lt;400&gt; 122
<img id="ib0279" file="imgb0279.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 123<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus</li><li>&lt;400&gt; 123
<img id="ib0280" file="imgb0280.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 124<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus</li><li>&lt;400&gt; 124
<img id="ib0281" file="imgb0281.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 125<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus</li><li>&lt;400&gt; 125
<img id="ib0282" file="imgb0282.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 126<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus</li><li>&lt;400&gt; 126
<img id="ib0283" file="imgb0283.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 127<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus</li><li>&lt;400&gt; 127
<img id="ib0284" file="imgb0284.tif" wi="91" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 128<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human immunodeficiency virus</li><li>&lt;400&gt; 128
<img id="ib0285" file="imgb0285.tif" wi="74" he="7" img-content="dna" img-format="tif"/><!-- EPO <DP n="110"> --></li><li>&lt;210&gt; 129<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus</li><li>&lt;400&gt; 129
<img id="ib0286" file="imgb0286.tif" wi="90" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 130<br/>
&lt;211&gt; 12<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus</li></ul><ul><li>&lt;400&gt; 130
<img id="ib0287" file="imgb0287.tif" wi="98" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 131<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human immunodeficiency virus</li><li>&lt;400&gt; 131
<img id="ib0288" file="imgb0288.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 132<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus</li><li>&lt;400&gt; 132
<img id="ib0289" file="imgb0289.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 133<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus</li><li>&lt;400&gt; 133
<img id="ib0290" file="imgb0290.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 134<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus</li><li>&lt;400&gt; 134
<img id="ib0291" file="imgb0291.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 135<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus</li><li>&lt;400&gt; 135
<img id="ib0292" file="imgb0292.tif" wi="74" he="5" img-content="dna" img-format="tif"/><!-- EPO <DP n="111"> -->
<img id="ib0293" file="imgb0293.tif" wi="37" he="4" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 136<br/>
&lt;211&gt; 12<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus</li><li>&lt;400&gt; 136
<img id="ib0294" file="imgb0294.tif" wi="99" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 137<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus</li><li>&lt;400&gt; 137
<img id="ib0295" file="imgb0295.tif" wi="83" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 138<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus</li><li>&lt;400&gt; 138
<img id="ib0296" file="imgb0296.tif" wi="83" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 139<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunocieficiency virus</li><li>&lt;400&gt; 139
<img id="ib0297" file="imgb0297.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 140<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 140
<img id="ib0298" file="imgb0298.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 141<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 141
<img id="ib0299" file="imgb0299.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 142<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1<!-- EPO <DP n="112"> --></li><li>&lt;400&gt; 142
<img id="ib0300" file="imgb0300.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 143<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1</li><li>&lt;400&gt; 143
<img id="ib0301" file="imgb0301.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 144<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1</li><li>&lt;400&gt; 144
<img id="ib0302" file="imgb0302.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 145<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1</li><li>&lt;400&gt; 145
<img id="ib0303" file="imgb0303.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 146<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 146
<img id="ib0304" file="imgb0304.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 147<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human immunodeficiency Virus 1</li><li>&lt;400&gt; 147
<img id="ib0305" file="imgb0305.tif" wi="91" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 148<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Vi rus 1</li><li>&lt;400&gt; 148
<img id="ib0306" file="imgb0306.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 149<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
<!-- EPO <DP n="113"> -->&lt;213&gt; Human Immunodeficiency virus 1</li><li>&lt;400&gt; 149
<img id="ib0307" file="imgb0307.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 150<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1</li><li>&lt;400&gt; 150
<img id="ib0308" file="imgb0308.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 151<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1</li><li>&lt;400&gt; 151
<img id="ib0309" file="imgb0309.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 152<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1</li><li>&lt;400&gt; 152
<img id="ib0310" file="imgb0310.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 153<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1</li><li>&lt;400&gt; 153
<img id="ib0311" file="imgb0311.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 154<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1</li><li>&lt;400&gt; 154
<img id="ib0312" file="imgb0312.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 155<br/>
&lt;211&gt; 12<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1</li><li>&lt;400&gt; 155
<img id="ib0313" file="imgb0313.tif" wi="99" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 156<br/>
<!-- EPO <DP n="114"> -->&lt;211&gt; 12<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 156
<img id="ib0314" file="imgb0314.tif" wi="99" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 157<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 157
<img id="ib0315" file="imgb0315.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 158<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1</li><li>&lt;400&gt; 158
<img id="ib0316" file="imgb0316.tif" wi="83" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 159<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1</li><li>&lt;400&gt; 159
<img id="ib0317" file="imgb0317.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 160<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1</li><li>&lt;400&gt; 160
<img id="ib0318" file="imgb0318.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 161<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1</li><li>&lt;400&gt; 161
<img id="ib0319" file="imgb0319.tif" wi="74" he="9" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 162<br/>
&lt;211&gt; 16<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1</li><li>&lt;400&gt; 162
<img id="ib0320" file="imgb0320.tif" wi="132" he="8" img-content="dna" img-format="tif"/><!-- EPO <DP n="115"> --></li><li>&lt;210&gt; 163<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1</li><li>&lt;400&gt; 163
<img id="ib0321" file="imgb0321.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 164<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 164
<img id="ib0322" file="imgb0322.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 165<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr virus</li><li>&lt;400&gt; 165
<img id="ib0323" file="imgb0323.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 166<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 166
<img id="ib0324" file="imgb0324.tif" wi="83" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 167<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 167
<img id="ib0325" file="imgb0325.tif" wi="83" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 168<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 168
<img id="ib0326" file="imgb0326.tif" wi="83" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 169<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 169
<img id="ib0327" file="imgb0327.tif" wi="75" he="5" img-content="dna" img-format="tif"/><!-- EPO <DP n="116"> -->
<img id="ib0328" file="imgb0328.tif" wi="37" he="4" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 170<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B Virus</li><li>&lt;400&gt; 170
<img id="ib0329" file="imgb0329.tif" wi="81" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 171<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B virus</li><li>&lt;400&gt; 171
<img id="ib0330" file="imgb0330.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 172<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B virus</li><li>&lt;400&gt; 172
<img id="ib0331" file="imgb0331.tif" wi="81" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 173<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B Virus</li><li>&lt;400&gt; 173
<img id="ib0332" file="imgb0332.tif" wi="81" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 174<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B Virus</li><li>&lt;400&gt; 174
<img id="ib0333" file="imgb0333.tif" wi="81" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 175<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B Virus</li><li>&lt;400&gt; 175
<img id="ib0334" file="imgb0334.tif" wi="81" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 176<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B Virus<!-- EPO <DP n="117"> --></li><li>&lt;400&gt; 176
<img id="ib0335" file="imgb0335.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 177<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B virus</li><li>&lt;400&gt; 177
<img id="ib0336" file="imgb0336.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 178<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B virus</li><li>&lt;400&gt; 178
<img id="ib0337" file="imgb0337.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 179<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B virus</li><li>&lt;400&gt; 179
<img id="ib0338" file="imgb0338.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 180<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B Virus</li><li>&lt;400&gt; 180
<img id="ib0339" file="imgb0339.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 181<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B Virus</li><li>&lt;400&gt; 181
<img id="ib0340" file="imgb0340.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 182<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B Virus</li><li>&lt;400&gt; 182
<img id="ib0341" file="imgb0341.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 183<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
<!-- EPO <DP n="118"> -->&lt;213&gt; Hepatitis B virus</li><li>&lt;400&gt; 183
<img id="ib0342" file="imgb0342.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 184<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B virus</li><li>&lt;400&gt; 184
<img id="ib0343" file="imgb0343.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 185<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B Virus</li><li>&lt;400&gt; 185
<img id="ib0344" file="imgb0344.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 186<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B Virus</li><li>&lt;400&gt; 186
<img id="ib0345" file="imgb0345.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 187<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B Virus</li><li>&lt;400&gt; 187
<img id="ib0346" file="imgb0346.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 188<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B virus</li><li>&lt;400&gt; 188
<img id="ib0347" file="imgb0347.tif" wi="90" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 189<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B Virus</li><li>&lt;400&gt; 189
<img id="ib0348" file="imgb0348.tif" wi="90" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 190<br/>
<!-- EPO <DP n="119"> -->&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B Virus</li><li>&lt;400&gt; 190
<img id="ib0349" file="imgb0349.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 191<br/>
&lt;211&gt; 12<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B virus</li></ul><ul><li>&lt;400&gt; 191
<img id="ib0350" file="imgb0350.tif" wi="99" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 192<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis Virus</li><li>&lt;400&gt; 192
<img id="ib0351" file="imgb0351.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 193<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B Virus</li><li>&lt;220&gt;<br/>
&lt;221&gt; VARIANT<br/>
&lt;222&gt; 4, 8<br/>
&lt;223&gt; xaa = Any Amino Acid</li><li>&lt;400&gt; 193
<img id="ib0352" file="imgb0352.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 194<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Cytomegalovirus</li><li>&lt;400&gt; 194
<img id="ib0353" file="imgb0353.tif" wi="90" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 195<br/>
&lt;211&gt; 12<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Cytomegalovirus</li><li>&lt;400&gt; 195
<img id="ib0354" file="imgb0354.tif" wi="99" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 196<br/>
&lt;211&gt; 15<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Cytomegalovirus<!-- EPO <DP n="120"> --></li><li>&lt;400&gt; 196
<img id="ib0355" file="imgb0355.tif" wi="123" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 197<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Cytomegalovirus</li><li>&lt;400&gt; 197
<img id="ib0356" file="imgb0356.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 198<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Cytomegalovirus</li><li>&lt;400&gt; 198
<img id="ib0357" file="imgb0357.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 199<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human cytomegalovirus</li><li>&lt;400&gt; 199
<img id="ib0358" file="imgb0358.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 200<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C virus</li><li>&lt;400&gt; 200
<img id="ib0359" file="imgb0359.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 201<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 201
<img id="ib0360" file="imgb0360.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 202<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 202
<img id="ib0361" file="imgb0361.tif" wi="65" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 203<br/>
&lt;211&gt; 10<br/>
<!-- EPO <DP n="121"> -->&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C virus</li><li>&lt;400&gt; 203
<img id="ib0362" file="imgb0362.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 204<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 204
<img id="ib0363" file="imgb0363.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 205<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 205
<img id="ib0364" file="imgb0364.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 206<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 206
<img id="ib0365" file="imgb0365.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 207<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 207
<img id="ib0366" file="imgb0366.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 208<br/>
&lt;211&gt; 13<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 208
<img id="ib0367" file="imgb0367.tif" wi="107" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 209<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 209
<img id="ib0368" file="imgb0368.tif" wi="90" he="8" img-content="dna" img-format="tif"/><!-- EPO <DP n="122"> --></li><li>&lt;210&gt; 210<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 210
<img id="ib0369" file="imgb0369.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 211<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 211
<img id="ib0370" file="imgb0370.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 212<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C virus</li><li>&lt;400&gt; 212
<img id="ib0371" file="imgb0371.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 213<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 213
<img id="ib0372" file="imgb0372.tif" wi="81" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 214<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C virus</li><li>&lt;400&gt; 214
<img id="ib0373" file="imgb0373.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 215<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 215
<img id="ib0374" file="imgb0374.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 216<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C virus</li><li>&lt;400&gt; 216
<img id="ib0375" file="imgb0375.tif" wi="73" he="7" img-content="dna" img-format="tif"/><!-- EPO <DP n="123"> --></li><li>&lt;210&gt; 217<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C virus</li><li>&lt;400&gt; 217
<img id="ib0376" file="imgb0376.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 218<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 218
<img id="ib0377" file="imgb0377.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 219<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 219
<img id="ib0378" file="imgb0378.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 220<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 220
<img id="ib0379" file="imgb0379.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 221<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 221
<img id="ib0380" file="imgb0380.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 222<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 222
<img id="ib0381" file="imgb0381.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 223<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 223<!-- EPO <DP n="124"> -->
<img id="ib0382" file="imgb0382.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 224<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 224
<img id="ib0383" file="imgb0383.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 225<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C virus</li><li>&lt;400&gt; 225
<img id="ib0384" file="imgb0384.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 226<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 226
<img id="ib0385" file="imgb0385.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 227<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human immunodeficiency Virus 1</li><li>&lt;400&gt; 227
<img id="ib0386" file="imgb0386.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 228<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 228
<img id="ib0387" file="imgb0387.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 229<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 229
<img id="ib0388" file="imgb0388.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 230<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human immunodeficiency Virus 1<!-- EPO <DP n="125"> --></li><li>&lt;400&gt; 230
<img id="ib0389" file="imgb0389.tif" wi="83" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 231<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 231
<img id="ib0390" file="imgb0390.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 232<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1</li><li>&lt;400&gt; 232
<img id="ib0391" file="imgb0391.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 233<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1</li><li>&lt;400&gt; 233
<img id="ib0392" file="imgb0392.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 234<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 234
<img id="ib0393" file="imgb0393.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 235<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 235
<img id="ib0394" file="imgb0394.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 236<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 236
<img id="ib0395" file="imgb0395.tif" wi="91" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 237<br/>
&lt;211&gt; 9<br/>
<!-- EPO <DP n="126"> -->&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 237
<img id="ib0396" file="imgb0396.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 238<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 238
<img id="ib0397" file="imgb0397.tif" wi="90" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 239<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 239
<img id="ib0398" file="imgb0398.tif" wi="90" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 240<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 240
<img id="ib0399" file="imgb0399.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 241<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 241
<img id="ib0400" file="imgb0400.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 242<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 242
<img id="ib0401" file="imgb0401.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 243<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 243
<img id="ib0402" file="imgb0402.tif" wi="74" he="7" img-content="dna" img-format="tif"/><!-- EPO <DP n="127"> --></li><li>&lt;210&gt; 244<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 244
<img id="ib0403" file="imgb0403.tif" wi="73" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 245<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1</li><li>&lt;400&gt; 245
<img id="ib0404" file="imgb0404.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 246<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 246
<img id="ib0405" file="imgb0405.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 247<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 247
<img id="ib0406" file="imgb0406.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 248<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 248
<img id="ib0407" file="imgb0407.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 249<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 249
<img id="ib0408" file="imgb0408.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 250<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 250
<img id="ib0409" file="imgb0409.tif" wi="66" he="8" img-content="dna" img-format="tif"/><!-- EPO <DP n="128"> --></li><li>&lt;210&gt; 251<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 251
<img id="ib0410" file="imgb0410.tif" wi="66" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 252<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 252
<img id="ib0411" file="imgb0411.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 253<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1</li><li>&lt;400&gt; 253
<img id="ib0412" file="imgb0412.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 254<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 254
<img id="ib0413" file="imgb0413.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 255<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 255
<img id="ib0414" file="imgb0414.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 256<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 256
<img id="ib0415" file="imgb0415.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 257<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 257<!-- EPO <DP n="129"> -->
<img id="ib0416" file="imgb0416.tif" wi="66" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 258<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1</li><li>&lt;400&gt; 258
<img id="ib0417" file="imgb0417.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 259<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 259
<img id="ib0418" file="imgb0418.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 260<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 260
<img id="ib0419" file="imgb0419.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 261<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 261
<img id="ib0420" file="imgb0420.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 262<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 262
<img id="ib0421" file="imgb0421.tif" wi="91" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 263<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1</li><li>&lt;400&gt; 263
<img id="ib0422" file="imgb0422.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 264<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1<!-- EPO <DP n="130"> --></li><li>&lt;400&gt; 264
<img id="ib0423" file="imgb0423.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 265<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 265
<img id="ib0424" file="imgb0424.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 266<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 266
<img id="ib0425" file="imgb0425.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 267<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li></ul><ul><li>&lt;400&gt; 267
<img id="ib0426" file="imgb0426.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 268<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 268
<img id="ib0427" file="imgb0427.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 269<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 269
<img id="ib0428" file="imgb0428.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 270<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 270
<img id="ib0429" file="imgb0429.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 271<br/>
&lt;211&gt; 9<br/>
<!-- EPO <DP n="131"> -->&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 271
<img id="ib0430" file="imgb0430.tif" wi="75" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 272<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 272
<img id="ib0431" file="imgb0431.tif" wi="83" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 273<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 273
<img id="ib0432" file="imgb0432.tif" wi="75" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 274<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 274
<img id="ib0433" file="imgb0433.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 275<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 275
<img id="ib0434" file="imgb0434.tif" wi="83" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 276<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 276
<img id="ib0435" file="imgb0435.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 277<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 277
<img id="ib0436" file="imgb0436.tif" wi="83" he="8" img-content="dna" img-format="tif"/><!-- EPO <DP n="132"> --></li><li>&lt;210&gt; 278<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1</li><li>&lt;400&gt; 278
<img id="ib0437" file="imgb0437.tif" wi="90" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 279<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1</li><li>&lt;400&gt; 279
<img id="ib0438" file="imgb0438.tif" wi="76" he="10" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 280<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1</li><li>&lt;400&gt; 280
<img id="ib0439" file="imgb0439.tif" wi="75" he="9" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 281<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 281
<img id="ib0440" file="imgb0440.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 282<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 282
<img id="ib0441" file="imgb0441.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 283<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 283
<img id="ib0442" file="imgb0442.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 284<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 284
<img id="ib0443" file="imgb0443.tif" wi="82" he="7" img-content="dna" img-format="tif"/><!-- EPO <DP n="133"> --></li><li>&lt;210&gt; 285<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 285
<img id="ib0444" file="imgb0444.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 286<br/>
&lt;211&gt; 12<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Inmmunodeficiency Virus 1</li><li>&lt;400&gt; 286
<img id="ib0445" file="imgb0445.tif" wi="99" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 287<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 287
<img id="ib0446" file="imgb0446.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 288<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 288
<img id="ib0447" file="imgb0447.tif" wi="91" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 289<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunonodeficiency Virus 1</li><li>&lt;400&gt; 289
<img id="ib0448" file="imgb0448.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 290<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 290
<img id="ib0449" file="imgb0449.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 291<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 291<!-- EPO <DP n="134"> -->
<img id="ib0450" file="imgb0450.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 292<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 292
<img id="ib0451" file="imgb0451.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 293<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1</li><li>&lt;400&gt; 293
<img id="ib0452" file="imgb0452.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 294<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 294
<img id="ib0453" file="imgb0453.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 295<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 295
<img id="ib0454" file="imgb0454.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 296<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 296
<img id="ib0455" file="imgb0455.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 297<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 297
<img id="ib0456" file="imgb0456.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 298<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1 IIIB<!-- EPO <DP n="135"> --></li><li>&lt;400&gt; 298
<img id="ib0457" file="imgb0457.tif" wi="83" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 299<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1 IIIB</li><li>&lt;400&gt; 299
<img id="ib0458" file="imgb0458.tif" wi="75" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 300<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1 IIIB</li><li>&lt;400&gt; 300
<img id="ib0459" file="imgb0459.tif" wi="75" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 301<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1 IIIB</li><li>&lt;400&gt; 301
<img id="ib0460" file="imgb0460.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 302<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1 IIIB</li><li>&lt;400&gt; 302
<img id="ib0461" file="imgb0461.tif" wi="83" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 303<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1 IIIB</li><li>&lt;400&gt; 303
<img id="ib0462" file="imgb0462.tif" wi="83" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 304<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1 IIIB</li><li>&lt;400&gt; 304
<img id="ib0463" file="imgb0463.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 305<br/>
&lt;211&gt; 9<br/>
<!-- EPO <DP n="136"> -->&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1 5F2</li><li>&lt;400&gt; 305
<img id="ib0464" file="imgb0464.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 306<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1 5F2</li><li>&lt;400&gt; 306
<img id="ib0465" file="imgb0465.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 307<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1 5F2</li><li>&lt;400&gt; 307
<img id="ib0466" file="imgb0466.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 308<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1 5F2</li><li>&lt;400&gt; 308
<img id="ib0467" file="imgb0467.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 309<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1 5F2</li><li>&lt;400&gt; 309
<img id="ib0468" file="imgb0468.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 310<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1 5F2</li><li>&lt;400&gt; 310
<img id="ib0469" file="imgb0469.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 311<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1 5F2</li><li>&lt;400&gt; 311
<img id="ib0470" file="imgb0470.tif" wi="74" he="7" img-content="dna" img-format="tif"/><!-- EPO <DP n="137"> --></li><li>&lt;210&gt; 312<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1 5F2</li><li>&lt;400&gt; 312
<img id="ib0471" file="imgb0471.tif" wi="91" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 313<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1 5F2</li><li>&lt;400&gt; 313
<img id="ib0472" file="imgb0472.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 314<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1 5F2</li><li>&lt;400&gt; 314
<img id="ib0473" file="imgb0473.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 315<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1 5F2</li><li>&lt;400&gt; 315
<img id="ib0474" file="imgb0474.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 316<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1 5F2</li><li>&lt;400&gt; 316
<img id="ib0475" file="imgb0475.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 317<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1 5F2</li><li>&lt;400&gt; 317
<img id="ib0476" file="imgb0476.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 318<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1 5F2</li><li>&lt;400&gt; 318
<img id="ib0477" file="imgb0477.tif" wi="74" he="8" img-content="dna" img-format="tif"/><!-- EPO <DP n="138"> --></li><li>&lt;210&gt; 319<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 2</li><li>&lt;400&gt; 319
<img id="ib0478" file="imgb0478.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 320<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 2</li><li>&lt;400&gt; 320
<img id="ib0479" file="imgb0479.tif" wi="90" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 321<br/>
&lt;211&gt; 15<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1 5F2</li><li>&lt;400&gt; 321
<img id="ib0480" file="imgb0480.tif" wi="123" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 322<br/>
&lt;211&gt; 15<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1 5F2</li><li>&lt;400&gt; 322
<img id="ib0481" file="imgb0481.tif" wi="123" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 323<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Papillomavirus 6b</li><li>&lt;400&gt; 323
<img id="ib0482" file="imgb0482.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 324<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human papillomavirus 6b</li><li>&lt;400&gt; 324
<img id="ib0483" file="imgb0483.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 325<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Papillomavirus 11</li><li>&lt;400&gt; 325<!-- EPO <DP n="139"> -->
<img id="ib0484" file="imgb0484.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 326<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Papillomavirus 16</li><li>&lt;400&gt; 326
<img id="ib0485" file="imgb0485.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 327<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human papillomavirus 16</li><li>&lt;400&gt; 327
<img id="ib0486" file="imgb0486.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 328<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Papillomavirus 16</li><li>&lt;400&gt; 328
<img id="ib0487" file="imgb0487.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 329<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human papillomavirus 16</li><li>&lt;400&gt; 329
<img id="ib0488" file="imgb0488.tif" wi="83" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 330<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Papillomavirus 16</li><li>&lt;400&gt; 330
<img id="ib0489" file="imgb0489.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 331<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human papillomavirus 16</li><li>&lt;400&gt; 331
<img id="ib0490" file="imgb0490.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 332<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Herpes simplex virus<!-- EPO <DP n="140"> --></li><li>&lt;400&gt; 332
<img id="ib0491" file="imgb0491.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 333<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Herpes Simplex Virus 1</li><li>&lt;400&gt; 333
<img id="ib0492" file="imgb0492.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 334<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Herpes simplex virus 1</li><li>&lt;400&gt; 334
<img id="ib0493" file="imgb0493.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 335<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Herpes simplex Virus 1</li><li>&lt;400&gt; 335
<img id="ib0494" file="imgb0494.tif" wi="90" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 336<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Herpes simplex Virus 1</li><li>&lt;400&gt; 336
<img id="ib0495" file="imgb0495.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 337<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Herpes simplex virus 2</li><li>&lt;400&gt; 337
<img id="ib0496" file="imgb0496.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 338<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human T-lymphotropic Virus 1</li><li>&lt;400&gt; 338
<img id="ib0497" file="imgb0497.tif" wi="73" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 339<br/>
&lt;211&gt; 9<br/>
<!-- EPO <DP n="141"> -->&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 339
<img id="ib0498" file="imgb0498.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 340<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 340
<img id="ib0499" file="imgb0499.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 341<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 341
<img id="ib0500" file="imgb0500.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 342<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 342
<img id="ib0501" file="imgb0501.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 343<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 343
<img id="ib0502" file="imgb0502.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 344<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 344
<img id="ib0503" file="imgb0503.tif" wi="66" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 345<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 345
<img id="ib0504" file="imgb0504.tif" wi="74" he="8" img-content="dna" img-format="tif"/><!-- EPO <DP n="142"> --></li><li>&lt;210&gt; 346<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 346
<img id="ib0505" file="imgb0505.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 347<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 347
<img id="ib0506" file="imgb0506.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 348<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 348
<img id="ib0507" file="imgb0507.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 349<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 349
<img id="ib0508" file="imgb0508.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 350<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 350
<img id="ib0509" file="imgb0509.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 351</li><li>&lt;271&gt; 9</li><li>&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza A</li><li>&lt;400&gt; 351
<img id="ib0510" file="imgb0510.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;270&gt; 352</li><li>&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 352
<img id="ib0511" file="imgb0511.tif" wi="74" he="7" img-content="dna" img-format="tif"/><!-- EPO <DP n="143"> --></li><li>&lt;210&gt; 353<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza A</li><li>&lt;400&gt; 353
<img id="ib0512" file="imgb0512.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 354<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza A</li><li>&lt;400&gt; 354
<img id="ib0513" file="imgb0513.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 355<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza A</li><li>&lt;400&gt; 355
<img id="ib0514" file="imgb0514.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 356<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza A</li><li>&lt;400&gt; 356
<img id="ib0515" file="imgb0515.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 357<br/>
&lt;271&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza A</li><li>&lt;400&gt; 357
<img id="ib0516" file="imgb0516.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 358<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza A</li><li>&lt;400&gt; 358
<img id="ib0517" file="imgb0517.tif" wi="66" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 359<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza A</li></ul><ul><li>&lt;400&gt; 359<!-- EPO <DP n="144"> -->
<img id="ib0518" file="imgb0518.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 360<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza A</li><li>&lt;400&gt; 360
<img id="ib0519" file="imgb0519.tif" wi="66" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 361<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza A</li><li>&lt;400&gt; 361
<img id="ib0520" file="imgb0520.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 362<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza A34</li><li>&lt;400&gt; 362
<img id="ib0521" file="imgb0521.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 363<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza A68</li><li>&lt;400&gt; 363
<img id="ib0522" file="imgb0522.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 364<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza B</li><li>&lt;400&gt; 364
<img id="ib0523" file="imgb0523.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 365<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza B</li><li>&lt;400&gt; 365
<img id="ib0524" file="imgb0524.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 366<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza JAP<!-- EPO <DP n="145"> --></li><li>&lt;400&gt; 366
<img id="ib0525" file="imgb0525.tif" wi="73" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 367<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza JAP</li><li>&lt;400&gt; 367
<img id="ib0526" file="imgb0526.tif" wi="83" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 368<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza JAP</li><li>&lt;400&gt; 368
<img id="ib0527" file="imgb0527.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 369<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza JAP</li><li>&lt;400&gt; 369
<img id="ib0528" file="imgb0528.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 370<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza JAP</li><li>&lt;400&gt; 370
<img id="ib0529" file="imgb0529.tif" wi="83" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 371<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza JAP</li><li>&lt;400&gt; 371
<img id="ib0530" file="imgb0530.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 372<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Mouse Hepatitis Virus Strain JHM</li><li>&lt;400&gt; 372
<img id="ib0531" file="imgb0531.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 373<br/>
&lt;211&gt; 9<br/>
<!-- EPO <DP n="146"> -->&lt;212&gt; PRT<br/>
&lt;213&gt; Lymphocytic Choriomeningitis virus</li><li>&lt;400&gt; 373
<img id="ib0532" file="imgb0532.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 374<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Lymphocytic Choriomeningitis virus</li><li>&lt;400&gt; 374
<img id="ib0533" file="imgb0533.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 375<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Lymphocytic choriomeningitis virus</li><li>&lt;400&gt; 375
<img id="ib0534" file="imgb0534.tif" wi="90" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 376<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Lymphocytic Choriomeningitis virus</li><li>&lt;400&gt; 376
<img id="ib0535" file="imgb0535.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 377<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Murine cytomegalovirus</li><li>&lt;400&gt; 377
<img id="ib0536" file="imgb0536.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 378<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Mouse Hepatitis virus</li><li>&lt;400&gt; 378
<img id="ib0537" file="imgb0537.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 379<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Mouse Mammarytumor Virus</li><li>&lt;400&gt; 379
<img id="ib0538" file="imgb0538.tif" wi="74" he="7" img-content="dna" img-format="tif"/><!-- EPO <DP n="147"> --></li><li>&lt;210&gt; 380<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Mouse Mammarytumor virus</li><li>&lt;400&gt; 380
<img id="ib0539" file="imgb0539.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 381<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Mouse Mammarytumor virus</li><li>&lt;400&gt; 381
<img id="ib0540" file="imgb0540.tif" wi="66" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 382<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Murine Leukemia virus</li><li>&lt;400&gt; 382
<img id="ib0541" file="imgb0541.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 383<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Murine Leukemia virus</li><li>&lt;400&gt; 383
<img id="ib0542" file="imgb0542.tif" wi="65" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 384<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Murine Leukemia Virus</li><li>&lt;400&gt; 384
<img id="ib0543" file="imgb0543.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 385<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Murine Leukemia Virus</li><li>&lt;400&gt; 385
<img id="ib0544" file="imgb0544.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 386<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Measles Virus</li><li>&lt;400&gt; 386
<img id="ib0545" file="imgb0545.tif" wi="91" he="7" img-content="dna" img-format="tif"/><!-- EPO <DP n="148"> --></li><li>&lt;210&gt; 387<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Measles Virus</li><li>&lt;400&gt; 387
<img id="ib0546" file="imgb0546.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 388<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Measles Virus</li><li>&lt;400&gt; 388
<img id="ib0547" file="imgb0547.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 389<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Measles Virus</li><li>&lt;400&gt; 389
<img id="ib0548" file="imgb0548.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 390<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Measles Virus</li><li>&lt;400&gt; 390
<img id="ib0549" file="imgb0549.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 391<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Poliovirus</li><li>&lt;400&gt; 391
<img id="ib0550" file="imgb0550.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 392<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; poliovirus</li><li>&lt;400&gt; 392
<img id="ib0551" file="imgb0551.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 393<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Pseudorabies virus gp</li><li>&lt;400&gt; 393<!-- EPO <DP n="149"> -->
<img id="ib0552" file="imgb0552.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 394<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Rabiesvirus</li><li>&lt;400&gt; 394
<img id="ib0553" file="imgb0553.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 395<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Rotavirus</li><li>&lt;400&gt; 395
<img id="ib0554" file="imgb0554.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 396<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Rotavirus</li><li>&lt;400&gt; 396
<img id="ib0555" file="imgb0555.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 397<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Rotavirus</li><li>&lt;400&gt; 397
<img id="ib0556" file="imgb0556.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 398<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Respiratory Syncytial virus</li><li>&lt;400&gt; 398
<img id="ib0557" file="imgb0557.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 399<br/>
&lt;211&gt; 12<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; simian Immunodeficiency virus</li><li>&lt;400&gt; 399
<img id="ib0558" file="imgb0558.tif" wi="99" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 400<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Sendai Virus<!-- EPO <DP n="150"> --></li><li>&lt;400&gt; 400
<img id="ib0559" file="imgb0559.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 401<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; sendai virus</li><li>&lt;400&gt; 401
<img id="ib0560" file="imgb0560.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 402<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Sendai Virus 40</li><li>&lt;400&gt; 402
<img id="ib0561" file="imgb0561.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 403<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Sendai Virus 40</li><li>&lt;400&gt; 403
<img id="ib0562" file="imgb0562.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 404<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Sendai Virus 40</li><li>&lt;400&gt; 404
<img id="ib0563" file="imgb0563.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 405<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Sendai Virus 40</li><li>&lt;400&gt; 405
<img id="ib0564" file="imgb0564.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 406<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Sendai Virus 40</li><li>&lt;400&gt; 406
<img id="ib0565" file="imgb0565.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 407<br/>
&lt;211&gt; 9<br/>
<!-- EPO <DP n="151"> -->&lt;212&gt; PRT<br/>
&lt;213&gt; Sendai virus 40</li><li>&lt;400&gt; 407
<img id="ib0566" file="imgb0566.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 408<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Vesicular Stomatitis Virus</li><li>&lt;400&gt; 408
<img id="ib0567" file="imgb0567.tif" wi="66" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 409<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapiens</li><li>&lt;400&gt; 409
<img id="ib0568" file="imgb0568.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 410<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 410
<img id="ib0569" file="imgb0569.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 411<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 411
<img id="ib0570" file="imgb0570.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 412<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapiens</li><li>&lt;400&gt; 412
<img id="ib0571" file="imgb0571.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 413<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien (calreticulin)</li><li>&lt;400&gt; 413
<img id="ib0572" file="imgb0572.tif" wi="83" he="7" img-content="dna" img-format="tif"/><!-- EPO <DP n="152"> --></li><li>&lt;210&gt; 414<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B Virus</li><li>&lt;220&gt;<br/>
&lt;221&gt; VARIANT<br/>
&lt;222&gt; 4, 8<br/>
&lt;223&gt; Xaa = Any Amino acid</li><li>&lt;400&gt; 414
<img id="ib0573" file="imgb0573.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 415<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapiens</li><li>&lt;400&gt; 415
<img id="ib0574" file="imgb0574.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 416<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human immunodeficiency Virus 1</li><li>&lt;400&gt; 416
<img id="ib0575" file="imgb0575.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 417<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza MP</li><li>&lt;400&gt; 417
<img id="ib0576" file="imgb0576.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 418<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human T-lymphotropic Virus 1</li><li>&lt;400&gt; 418
<img id="ib0577" file="imgb0577.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 419<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B Virus</li><li>&lt;400&gt; 419
<img id="ib0578" file="imgb0578.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 420<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
<!-- EPO <DP n="153"> -->&lt;213&gt; Hepatitis B virus</li><li>&lt;400&gt; 420
<img id="ib0579" file="imgb0579.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 421<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B virus</li><li>&lt;400&gt; 421
<img id="ib0580" file="imgb0580.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 422<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus</li><li>&lt;400&gt; 422
<img id="ib0581" file="imgb0581.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 423<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human cytomegalovirus</li><li>&lt;400&gt; 423
<img id="ib0582" file="imgb0582.tif" wi="90" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 424<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 424
<img id="ib0583" file="imgb0583.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 425<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus 1</li><li>&lt;400&gt; 425
<img id="ib0584" file="imgb0584.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 426<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 426
<img id="ib0585" file="imgb0585.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 427<br/>
<!-- EPO <DP n="154"> -->&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Papillomavirus</li><li>&lt;400&gt; 427
<img id="ib0586" file="imgb0586.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 428<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 428
<img id="ib0587" file="imgb0587.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 429<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 429
<img id="ib0588" file="imgb0588.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 430<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 430
<img id="ib0589" file="imgb0589.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 431<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 431
<img id="ib0590" file="imgb0590.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 432<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 432
<img id="ib0591" file="imgb0591.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 433<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 433
<img id="ib0592" file="imgb0592.tif" wi="73" he="8" img-content="dna" img-format="tif"/><!-- EPO <DP n="155"> --></li><li>&lt;210&gt; 434<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 434
<img id="ib0593" file="imgb0593.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 435<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 435
<img id="ib0594" file="imgb0594.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 436<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeviciency Virus 1</li><li>&lt;400&gt; 436
<img id="ib0595" file="imgb0595.tif" wi="83" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 437<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Plasmodium Falciparum</li><li>&lt;400&gt; 437
<img id="ib0596" file="imgb0596.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 438<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Plasmodium Falciparum</li><li>&lt;400&gt; 438
<img id="ib0597" file="imgb0597.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 439<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 439
<img id="ib0598" file="imgb0598.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 440<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr virus (EBNA)</li><li>&lt;400&gt; 440
<img id="ib0599" file="imgb0599.tif" wi="74" he="5" img-content="dna" img-format="tif"/><!-- EPO <DP n="156"> -->
<img id="ib0600" file="imgb0600.tif" wi="37" he="4" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 441<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus (EBN<sub>A</sub>)</li><li>&lt;400&gt; 441
<img id="ib0601" file="imgb0601.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 442<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr virus (EBNA)</li><li>&lt;400&gt; 442
<img id="ib0602" file="imgb0602.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 443<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus (EBNA)</li><li>&lt;400&gt; 443
<img id="ib0603" file="imgb0603.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 444<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus (EBNA)</li><li>&lt;400&gt; 444
<img id="ib0604" file="imgb0604.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 445<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus (EBNA)</li><li>&lt;400&gt; 445
<img id="ib0605" file="imgb0605.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 446<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus (EBNA)</li><li>&lt;400&gt; 446
<img id="ib0606" file="imgb0606.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 447<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus (EBNA)</li></ul><!-- EPO <DP n="157"> --><ul><li>&lt;400&gt; 447
<img id="ib0607" file="imgb0607.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 448<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus (EBNA)</li><li>&lt;400&gt; 448
<img id="ib0608" file="imgb0608.tif" wi="75" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 449<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus (EBNA)</li><li>&lt;400&gt; 449
<img id="ib0609" file="imgb0609.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 450<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus (EBNA)</li><li>&lt;400&gt; 450
<img id="ib0610" file="imgb0610.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 451<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus (EBNA)</li><li>&lt;400&gt; 451
<img id="ib0611" file="imgb0611.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 452<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus (EBNA)</li><li>&lt;400&gt; 452
<img id="ib0612" file="imgb0612.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 453<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus (EBNA)</li><li>&lt;400&gt; 453
<img id="ib0613" file="imgb0613.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 454<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
<!-- EPO <DP n="158"> -->&lt;213&gt; Epstein-Barr Virus (EBNA)</li><li>&lt;400&gt; 454
<img id="ib0614" file="imgb0614.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 455<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus (EBNA)</li><li>&lt;400&gt; 455
<img id="ib0615" file="imgb0615.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 456<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus (EBNA)</li><li>&lt;400&gt; 456
<img id="ib0616" file="imgb0616.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 457<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus (EBNA)</li><li>&lt;400&gt; 457
<img id="ib0617" file="imgb0617.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 458<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus (EBNA)</li><li>&lt;400&gt; 458
<img id="ib0618" file="imgb0618.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 459<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstain-Barr Virus (EBNA)</li><li>&lt;400&gt; 459
<img id="ib0619" file="imgb0619.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 460<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus (EBNA)</li><li>&lt;400&gt; 460
<img id="ib0620" file="imgb0620.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 461<br/>
<!-- EPO <DP n="159"> -->&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus (EBNA)</li><li>&lt;400&gt; 461
<img id="ib0621" file="imgb0621.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 462<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus (EBNA)</li><li>&lt;400&gt; 462
<img id="ib0622" file="imgb0622.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 463<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus (EBNA)</li><li>&lt;400&gt; 463
<img id="ib0623" file="imgb0623.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 464<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus (EBNA)</li><li>&lt;400&gt; 464
<img id="ib0624" file="imgb0624.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 465<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza A</li><li>&lt;400&gt; 465
<img id="ib0625" file="imgb0625.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 466<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza A</li><li>&lt;400&gt; 466
<img id="ib0626" file="imgb0626.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 467<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 467
<img id="ib0627" file="imgb0627.tif" wi="82" he="8" img-content="dna" img-format="tif"/><!-- EPO <DP n="160"> --></li><li>&lt;210&gt; 468<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 468
<img id="ib0628" file="imgb0628.tif" wi="65" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 469<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 469
<img id="ib0629" file="imgb0629.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 470<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatites C Virus</li><li>&lt;400&gt; 470
<img id="ib0630" file="imgb0630.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 471<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 471
<img id="ib0631" file="imgb0631.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 472<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 472
<img id="ib0632" file="imgb0632.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 473<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 473
<img id="ib0633" file="imgb0633.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 474<br/>
&lt;211&gt; 13<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 474
<img id="ib0634" file="imgb0634.tif" wi="106" he="5" img-content="dna" img-format="tif"/><!-- EPO <DP n="161"> -->
<img id="ib0635" file="imgb0635.tif" wi="78" he="4" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 475<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 475
<img id="ib0636" file="imgb0636.tif" wi="90" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 476<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 476
<img id="ib0637" file="imgb0637.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 477<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B Virus</li><li>&lt;400&gt; 477
<img id="ib0638" file="imgb0638.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 478<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B Virus</li><li>&lt;400&gt; 478
<img id="ib0639" file="imgb0639.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 479<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B Virus</li><li>&lt;400&gt; 479
<img id="ib0640" file="imgb0640.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 480<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 480
<img id="ib0641" file="imgb0641.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 481<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien<!-- EPO <DP n="162"> --></li><li>&lt;400&gt; 481
<img id="ib0642" file="imgb0642.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 482<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human immunodeficiency Virus 1</li><li>&lt;400&gt; 482
<img id="ib0643" file="imgb0643.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 483<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 483
<img id="ib0644" file="imgb0644.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 484<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 484
<img id="ib0645" file="imgb0645.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 485<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 485
<img id="ib0646" file="imgb0646.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 486<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C virus</li><li>&lt;400&gt; 486
<img id="ib0647" file="imgb0647.tif" wi="81" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 487<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B Virus</li><li>&lt;400&gt; 487
<img id="ib0648" file="imgb0648.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 488<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
<!-- EPO <DP n="163"> -->&lt;213&gt; Hepatitis B virus</li><li>&lt;400&gt; 488
<img id="ib0649" file="imgb0649.tif" wi="81" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 489<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 489
<img id="ib0650" file="imgb0650.tif" wi="73" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 490<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Himetobi P Virus (HiPV)</li><li>&lt;400&gt; 490
<img id="ib0651" file="imgb0651.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 491<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 491
<img id="ib0652" file="imgb0652.tif" wi="83" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 492<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B Virus</li><li>&lt;400&gt; 492
<img id="ib0653" file="imgb0653.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 493<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatites B virus</li><li>&lt;400&gt; 493
<img id="ib0654" file="imgb0654.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 494<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human papillomavirus</li><li>&lt;400&gt; 494
<img id="ib0655" file="imgb0655.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 495<br/>
<!-- EPO <DP n="164"> -->&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 495
<img id="ib0656" file="imgb0656.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 496<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Papillomavirus</li><li>&lt;400&gt; 496
<img id="ib0657" file="imgb0657.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 497<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C virus</li><li>&lt;400&gt; 497
<img id="ib0658" file="imgb0658.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 498<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C virus</li><li>&lt;400&gt; 498
<img id="ib0659" file="imgb0659.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 499<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 499
<img id="ib0660" file="imgb0660.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 500<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 500
<img id="ib0661" file="imgb0661.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 501<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 501
<img id="ib0662" file="imgb0662.tif" wi="73" he="7" img-content="dna" img-format="tif"/><!-- EPO <DP n="165"> --></li><li>&lt;210&gt; 502<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C virus</li><li>&lt;400&gt; 502
<img id="ib0663" file="imgb0663.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 503<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C virus</li><li>&lt;400&gt; 503
<img id="ib0664" file="imgb0664.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 504<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B Virus</li><li>&lt;400&gt; 504
<img id="ib0665" file="imgb0665.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 505<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B virus</li><li>&lt;400&gt; 505
<img id="ib0666" file="imgb0666.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 506<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B Virus</li><li>&lt;400&gt; 506
<img id="ib0667" file="imgb0667.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 507<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B Virus</li><li>&lt;400&gt; 507
<img id="ib0668" file="imgb0668.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 508<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Plasmodium Faciparum</li><li>&lt;400&gt; 508
<img id="ib0669" file="imgb0669.tif" wi="74" he="5" img-content="dna" img-format="tif"/><!-- EPO <DP n="166"> -->
<img id="ib0670" file="imgb0670.tif" wi="36" he="4" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 509<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Plasmodium Faciparum</li><li>&lt;400&gt; 509
<img id="ib0671" file="imgb0671.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 510<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 510
<img id="ib0672" file="imgb0672.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 511<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li></ul><ul><li>&lt;400&gt; 511
<img id="ib0673" file="imgb0673.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 512<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 512
<img id="ib0674" file="imgb0674.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 513<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 513
<img id="ib0675" file="imgb0675.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 514<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 514
<img id="ib0676" file="imgb0676.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 515<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien<!-- EPO <DP n="167"> --></li><li>&lt;400&gt; 515
<img id="ib0677" file="imgb0677.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 516<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 516
<img id="ib0678" file="imgb0678.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 517<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 517
<img id="ib0679" file="imgb0679.tif" wi="73" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 518<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 518
<img id="ib0680" file="imgb0680.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 519<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Herpes Simplex Virus I</li><li>&lt;400&gt; 519
<img id="ib0681" file="imgb0681.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 520<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Herpes Simplex Virus 2</li><li>&lt;400&gt; 520
<img id="ib0682" file="imgb0682.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 521<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Pseudorabies Virus</li><li>&lt;400&gt; 521
<img id="ib0683" file="imgb0683.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 522<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
<!-- EPO <DP n="168"> -->&lt;213&gt; Adenovirus</li><li>&lt;400&gt; 522
<img id="ib0684" file="imgb0684.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 523<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Streptomyces Lincolnensis</li><li>&lt;400&gt; 523
<img id="ib0685" file="imgb0685.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 524<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Yeast (YSA-1)</li><li>&lt;400&gt; 524
<img id="ib0686" file="imgb0686.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 525<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Bacillus Polymyxa</li><li>&lt;400&gt; 525
<img id="ib0687" file="imgb0687.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 526<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Escherichia coli</li><li>&lt;400&gt; 526
<img id="ib0688" file="imgb0688.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 527<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Escherichia coli</li><li>&lt;400&gt; 527
<img id="ib0689" file="imgb0689.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 528<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 528
<img id="ib0690" file="imgb0690.tif" wi="90" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 529<br/>
<!-- EPO <DP n="169"> -->&lt;211&gt; 13<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 529
<img id="ib0691" file="imgb0691.tif" wi="107" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 530<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 530
<img id="ib0692" file="imgb0692.tif" wi="90" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 531<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus I</li><li>&lt;400&gt; 531
<img id="ib0693" file="imgb0693.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 532<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 532
<img id="ib0694" file="imgb0694.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 533<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus I</li><li>&lt;400&gt; 533
<img id="ib0695" file="imgb0695.tif" wi="83" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 534<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 534
<img id="ib0696" file="imgb0696.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 535<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Cytomegalovirus</li><li>&lt;400&gt; 535
<img id="ib0697" file="imgb0697.tif" wi="83" he="7" img-content="dna" img-format="tif"/><!-- EPO <DP n="170"> --></li><li>&lt;210&gt; 536<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Papillomavirus</li><li>&lt;400&gt; 536
<img id="ib0698" file="imgb0698.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 537<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Papillomavirus</li><li>&lt;400&gt; 537
<img id="ib0699" file="imgb0699.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 538<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus (EBNA)</li><li>&lt;400&gt; 538
<img id="ib0700" file="imgb0700.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 539<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 539
<img id="ib0701" file="imgb0701.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 540<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Plasmodium Falciparum</li><li>&lt;400&gt; 540
<img id="ib0702" file="imgb0702.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 541<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Plasmodium Falciparum</li><li>&lt;400&gt; 541
<img id="ib0703" file="imgb0703.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 542<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Papillomavirus</li><li>&lt;400&gt; 542
<img id="ib0704" file="imgb0704.tif" wi="82" he="5" img-content="dna" img-format="tif"/><!-- EPO <DP n="171"> -->
<img id="ib0705" file="imgb0705.tif" wi="78" he="4" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 543<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Papillomavirus</li><li>&lt;400&gt; 543
<img id="ib0706" file="imgb0706.tif" wi="73" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 544<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Papillomavirus</li><li>&lt;400&gt; 544
<img id="ib0707" file="imgb0707.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 545<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 545
<img id="ib0708" file="imgb0708.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 546<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Papillomavirus</li><li>&lt;400&gt; 546
<img id="ib0709" file="imgb0709.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 547<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Papillomavirus 16</li><li>&lt;400&gt; 547
<img id="ib0710" file="imgb0710.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 548<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Papillomavirus 16</li><li>&lt;400&gt; 548
<img id="ib0711" file="imgb0711.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 549<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien<!-- EPO <DP n="172"> --></li><li>&lt;400&gt; 549
<img id="ib0712" file="imgb0712.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 550<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 550
<img id="ib0713" file="imgb0713.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 551<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 551
<img id="ib0714" file="imgb0714.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 552<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Plasmodium Falciparum</li><li>&lt;400&gt; 552
<img id="ib0715" file="imgb0715.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 553<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 553
<img id="ib0716" file="imgb0716.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 554<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B Virus</li><li>&lt;400&gt; 554
<img id="ib0717" file="imgb0717.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 555<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus (EBNA)</li><li>&lt;400&gt; 555
<img id="ib0718" file="imgb0718.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 556<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
<!-- EPO <DP n="173"> -->&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 556
<img id="ib0719" file="imgb0719.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 557<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 557
<img id="ib0720" file="imgb0720.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 558<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 558
<img id="ib0721" file="imgb0721.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 559<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B Virus</li><li>&lt;400&gt; 559
<img id="ib0722" file="imgb0722.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 560<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 560
<img id="ib0723" file="imgb0723.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 561<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B Virus</li><li>&lt;400&gt; 561
<img id="ib0724" file="imgb0724.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 562<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 562
<img id="ib0725" file="imgb0725.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 563<br/>
<!-- EPO <DP n="174"> -->&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 563
<img id="ib0726" file="imgb0726.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 564<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 564
<img id="ib0727" file="imgb0727.tif" wi="91" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 565<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 565
<img id="ib0728" file="imgb0728.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 566<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 566
<img id="ib0729" file="imgb0729.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 567<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 567
<img id="ib0730" file="imgb0730.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 568<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 568
<img id="ib0731" file="imgb0731.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 569<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus (EBNA)</li><li>&lt;400&gt; 569
<img id="ib0732" file="imgb0732.tif" wi="74" he="8" img-content="dna" img-format="tif"/><!-- EPO <DP n="175"> --></li><li>&lt;210&gt; 570<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1</li><li>&lt;400&gt; 570
<img id="ib0733" file="imgb0733.tif" wi="91" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 571<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 571
<img id="ib0734" file="imgb0734.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 572<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis C Virus</li><li>&lt;400&gt; 572
<img id="ib0735" file="imgb0735.tif" wi="75" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 573<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 573
<img id="ib0736" file="imgb0736.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 574<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B Virus</li><li>&lt;400&gt; 574
<img id="ib0737" file="imgb0737.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 575<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus (EBNA)</li><li>&lt;400&gt; 575
<img id="ib0738" file="imgb0738.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 576<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 576
<img id="ib0739" file="imgb0739.tif" wi="74" he="5" img-content="dna" img-format="tif"/><!-- EPO <DP n="176"> -->
<img id="ib0740" file="imgb0740.tif" wi="37" he="4" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 577<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1</li><li>&lt;400&gt; 577
<img id="ib0741" file="imgb0741.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 578<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 578
<img id="ib0742" file="imgb0742.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 579<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 579
<img id="ib0743" file="imgb0743.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 580<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 580
<img id="ib0744" file="imgb0744.tif" wi="90" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 581<br/>
&lt;211&gt; 12<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 581
<img id="ib0745" file="imgb0745.tif" wi="98" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 582<br/>
&lt;211&gt; 12<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 582
<img id="ib0746" file="imgb0746.tif" wi="98" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 583<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien<!-- EPO <DP n="177"> --></li><li>&lt;400&gt; 583
<img id="ib0747" file="imgb0747.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 584<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus 1</li><li>&lt;400&gt; 584
<img id="ib0748" file="imgb0748.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 585<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 585
<img id="ib0749" file="imgb0749.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 586<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 586
<img id="ib0750" file="imgb0750.tif" wi="83" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 587<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 587
<img id="ib0751" file="imgb0751.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 588<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Epstein-Barr Virus (EBNA)</li><li>&lt;400&gt; 588
<img id="ib0752" file="imgb0752.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 589<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus 1</li><li>&lt;400&gt; 589
<img id="ib0753" file="imgb0753.tif" wi="83" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 590<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
<!-- EPO <DP n="178"> -->&lt;213&gt; Hepatitis B Virus</li><li>&lt;400&gt; 590
<img id="ib0754" file="imgb0754.tif" wi="90" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 591<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 591
<img id="ib0755" file="imgb0755.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 592<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 592
<img id="ib0756" file="imgb0756.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 593<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus</li><li>&lt;400&gt; 593
<img id="ib0757" file="imgb0757.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 594<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 594
<img id="ib0758" file="imgb0758.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 595<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 595
<img id="ib0759" file="imgb0759.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 596<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 596
<img id="ib0760" file="imgb0760.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 597<br/>
<!-- EPO <DP n="179"> -->&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 597
<img id="ib0761" file="imgb0761.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 598<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 598
<img id="ib0762" file="imgb0762.tif" wi="75" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 599<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 599
<img id="ib0763" file="imgb0763.tif" wi="83" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 600<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 600
<img id="ib0764" file="imgb0764.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 601<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 601
<img id="ib0765" file="imgb0765.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 602<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 602
<img id="ib0766" file="imgb0766.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 603<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;220&gt;<br/>
&lt;221&gt; VARIANT<br/>
&lt;222&gt; 1<br/>
&lt;223&gt; Xaa = Any Amino Acid<!-- EPO <DP n="180"> --></li><li>&lt;400&gt; 603
<img id="ib0767" file="imgb0767.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 604<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 604
<img id="ib0768" file="imgb0768.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 605<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 605
<img id="ib0769" file="imgb0769.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 606<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 606
<img id="ib0770" file="imgb0770.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 607<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li></ul><ul><li>&lt;400&gt; 607
<img id="ib0771" file="imgb0771.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 608<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 608
<img id="ib0772" file="imgb0772.tif" wi="90" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 609<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 609
<img id="ib0773" file="imgb0773.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 610<br/>
&lt;211&gt; 9<br/>
<!-- EPO <DP n="181"> -->&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 610
<img id="ib0774" file="imgb0774.tif" wi="73" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 611<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 611
<img id="ib0775" file="imgb0775.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 612<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 612
<img id="ib0776" file="imgb0776.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 613<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 613
<img id="ib0777" file="imgb0777.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 614<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 614
<img id="ib0778" file="imgb0778.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 615<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;220&gt;<br/>
&lt;221&gt; VARIANT<br/>
&lt;222&gt; 2, 4, 5, 6, 7, 8<br/>
&lt;223&gt; Xaa = Any Amino Acid</li><li>&lt;400&gt; 615
<img id="ib0779" file="imgb0779.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 616<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien<!-- EPO <DP n="182"> --></li><li>&lt;400&gt; 616
<img id="ib0780" file="imgb0780.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 617<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;220&gt;<br/>
&lt;221&gt; VARIANT<br/>
&lt;222&gt; 4, 5, 6, 7, 8<br/>
&lt;223&gt; Xaa = Any Amino Acid</li><li>&lt;221&gt; VARIANT<br/>
&lt;222&gt; 2<br/>
&lt;223&gt; Xaa = A or V</li><li>&lt;400&gt; 617
<img id="ib0781" file="imgb0781.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 618<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;220&gt;<br/>
&lt;221&gt; VARIANT<br/>
&lt;222&gt; 5, 6, 7, 8<br/>
&lt;223&gt; Xaa = Any Amino Acid</li><li>&lt;221&gt; VARIANT<br/>
&lt;222&gt; 2<br/>
&lt;223&gt; Xaa = A or V</li><li>&lt;400&gt; 618
<img id="ib0782" file="imgb0782.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 619<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;220&gt;<br/>
&lt;221&gt; VARIANT<br/>
&lt;222&gt; 6, 7, 8<br/>
&lt;223&gt; Xaa = Any Amino Acid</li><li>&lt;221&gt; VARIANT<br/>
&lt;222&gt; 2<br/>
&lt;223&gt; Xaa = A or V</li><li>&lt;221&gt; VARIANT<br/>
&lt;222&gt; 5<br/>
&lt;223&gt; Xaa = I or A or T</li><li>&lt;400&gt; 619
<img id="ib0783" file="imgb0783.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 620<br/>
&lt;211&gt; 9<br/>
<!-- EPO <DP n="183"> -->&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;220&gt;<br/>
&lt;221&gt; VARIANT<br/>
&lt;222&gt; 7, 8<br/>
&lt;223&gt; Xaa = Any Amino Acid</li><li>&lt;221&gt; VARIANT<br/>
&lt;222&gt; 2<br/>
&lt;223&gt; Xaa = A or V</li><li>&lt;221&gt; VARIANT<br/>
&lt;222&gt; 5<br/>
&lt;223&gt; Xaa = I or A or T</li><li>&lt;221&gt; VARIANT<br/>
&lt;222&gt; 6<br/>
&lt;223&gt; Xaa = G or S</li><li>&lt;400&gt; 620
<img id="ib0784" file="imgb0784.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 621<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;220&gt;<br/>
&lt;221&gt; VARIANT<br/>
&lt;222&gt; 8<br/>
&lt;223&gt; Xaa = Any Amino Acid</li><li>&lt;221&gt; VARIANT<br/>
&lt;222&gt; 2<br/>
&lt;223&gt; Xaa = A or V</li><li>&lt;221&gt; VARIANT<br/>
&lt;222&gt; 5<br/>
&lt;223&gt; Xaa = I or A or T</li><li>&lt;221&gt; VARIANT<br/>
&lt;222&gt; 6<br/>
&lt;223&gt; Xaa = G or S</li><li>&lt;221&gt; VARIANT<br/>
&lt;222&gt; 7<br/>
&lt;223&gt; Xaa = H or N</li></ul><ul><li>&lt;400&gt; 621
<img id="ib0785" file="imgb0785.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 622<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;220&gt;<br/>
&lt;221&gt; VARIANT<br/>
&lt;222&gt; 2<br/>
&lt;223&gt; Xaa = A or V</li><li>&lt;221&gt; VARIANT<br/>
&lt;222&gt; 5<br/>
<!-- EPO <DP n="184"> -->&lt;223&gt; Xaa = I or A or T</li><li>&lt;221&gt; VARIANT<br/>
&lt;222&gt; 6<br/>
&lt;223&gt; Xaa = G or S</li><li>&lt;221&gt; VARIANT<br/>
&lt;222&gt; 7<br/>
&lt;223&gt; Xaa = H or N</li><li>&lt;221&gt; VARIANT<br/>
&lt;222&gt; 8<br/>
&lt;223&gt; Xaa = L or T or V</li><li>&lt;400&gt; 622
<img id="ib0786" file="imgb0786.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 623<br/>
&lt;211&gt; 16<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 623
<img id="ib0787" file="imgb0787.tif" wi="132" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 624<br/>
&lt;211&gt; 12<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo sapien</li><li>&lt;400&gt; 624
<img id="ib0788" file="imgb0788.tif" wi="99" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 625<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 625
<img id="ib0789" file="imgb0789.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 626<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 626
<img id="ib0790" file="imgb0790.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 627<br/>
&lt;211&gt; 22<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 627
<img id="ib0791" file="imgb0791.tif" wi="132" he="11" img-content="dna" img-format="tif"/><!-- EPO <DP n="185"> -->
<img id="ib0792" file="imgb0792.tif" wi="6" he="4" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 628<br/>
&lt;211&gt; 16<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 628
<img id="ib0793" file="imgb0793.tif" wi="132" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 629<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 629
<img id="ib0794" file="imgb0794.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 630<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 630
<img id="ib0795" file="imgb0795.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 631<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 631
<img id="ib0796" file="imgb0796.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 632<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 632
<img id="ib0797" file="imgb0797.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 633<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 633<!-- EPO <DP n="186"> -->
<img id="ib0798" file="imgb0798.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 634<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 634
<img id="ib0799" file="imgb0799.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 635<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 635
<img id="ib0800" file="imgb0800.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 636<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 636
<img id="ib0801" file="imgb0801.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 637<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 637
<img id="ib0802" file="imgb0802.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 638<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 638
<img id="ib0803" file="imgb0803.tif" wi="74" he="7" img-content="dna" img-format="tif"/><!-- EPO <DP n="187"> --></li><li>&lt;210&gt; 639<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 639
<img id="ib0804" file="imgb0804.tif" wi="73" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 640<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 640
<img id="ib0805" file="imgb0805.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 641<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 641
<img id="ib0806" file="imgb0806.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 642<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 642
<img id="ib0807" file="imgb0807.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 643<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 643
<img id="ib0808" file="imgb0808.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 644<br/>
&lt;211&gt; 9<br/>
<!-- EPO <DP n="188"> -->&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 644
<img id="ib0809" file="imgb0809.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 645<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 645
<img id="ib0810" file="imgb0810.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 646<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 646
<img id="ib0811" file="imgb0811.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 647<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 647
<img id="ib0812" file="imgb0812.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 648<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 648
<img id="ib0813" file="imgb0813.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 649<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence<!-- EPO <DP n="189"> --></li><li>&lt;220&gt;<br/>
&lt;223&gt; synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 649
<img id="ib0814" file="imgb0814.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 650<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 650
<img id="ib0815" file="imgb0815.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 651<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 651
<img id="ib0816" file="imgb0816.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 652<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 652
<img id="ib0817" file="imgb0817.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 653<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 653
<img id="ib0818" file="imgb0818.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 654<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide<!-- EPO <DP n="190"> --></li><li>&lt;400&gt; 654
<img id="ib0819" file="imgb0819.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 655<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li></ul><ul><li>&lt;400&gt; 655
<img id="ib0820" file="imgb0820.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 656<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial sequence</li><li><i>&lt;220&gt;</i><br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 656
<img id="ib0821" file="imgb0821.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 657<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 657
<img id="ib0822" file="imgb0822.tif" wi="75" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 658<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 658
<img id="ib0823" file="imgb0823.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 659<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 659
<img id="ib0824" file="imgb0824.tif" wi="74" he="7" img-content="dna" img-format="tif"/><!-- EPO <DP n="191"> --></li><li>&lt;210&gt; 660<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 660
<img id="ib0825" file="imgb0825.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 661<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 661
<img id="ib0826" file="imgb0826.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 662<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 662
<img id="ib0827" file="imgb0827.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 663<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 663
<img id="ib0828" file="imgb0828.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 664<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 664
<img id="ib0829" file="imgb0829.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 665<br/>
<!-- EPO <DP n="192"> -->&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 665
<img id="ib0830" file="imgb0830.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 666<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 666
<img id="ib0831" file="imgb0831.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 667<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 667
<img id="ib0832" file="imgb0832.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 668<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 668
<img id="ib0833" file="imgb0833.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 669<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 669
<img id="ib0834" file="imgb0834.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 670<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence<!-- EPO <DP n="193"> --></li><li>&lt;220&gt;<br/>
&lt;223&gt; synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 670
<img id="ib0835" file="imgb0835.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 671<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 671
<img id="ib0836" file="imgb0836.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 672<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 672
<img id="ib0837" file="imgb0837.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 673<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 673
<img id="ib0838" file="imgb0838.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 674<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 674
<img id="ib0839" file="imgb0839.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 675<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide<!-- EPO <DP n="194"> --></li><li>&lt;400&gt; 675
<img id="ib0840" file="imgb0840.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 676<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 676
<img id="ib0841" file="imgb0841.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 677<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 677
<img id="ib0842" file="imgb0842.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 678<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 678
<img id="ib0843" file="imgb0843.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 679<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 679
<img id="ib0844" file="imgb0844.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 680<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 680
<img id="ib0845" file="imgb0845.tif" wi="74" he="5" img-content="dna" img-format="tif"/><!-- EPO <DP n="195"> -->
<img id="ib0846" file="imgb0846.tif" wi="37" he="4" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 681<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 681
<img id="ib0847" file="imgb0847.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 682<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 682
<img id="ib0848" file="imgb0848.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 683<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 683
<img id="ib0849" file="imgb0849.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 684<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 684
<img id="ib0850" file="imgb0850.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 685<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 685
<img id="ib0851" file="imgb0851.tif" wi="74" he="8" img-content="dna" img-format="tif"/><!-- EPO <DP n="196"> --></li><li>&lt;210&gt; 686<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 686
<img id="ib0852" file="imgb0852.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 687<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 687
<img id="ib0853" file="imgb0853.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 688<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 688
<img id="ib0854" file="imgb0854.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 689<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 689
<img id="ib0855" file="imgb0855.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 690<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 690
<img id="ib0856" file="imgb0856.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 691<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
<!-- EPO <DP n="197"> -->&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 691
<img id="ib0857" file="imgb0857.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 692<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nanamer peptide</li><li>&lt;400&gt; 692
<img id="ib0858" file="imgb0858.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 693<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 693
<img id="ib0859" file="imgb0859.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 694<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 694
<img id="ib0860" file="imgb0860.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 695<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 695
<img id="ib0861" file="imgb0861.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 696<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li></ul><ul><li>&lt;220&gt;<br/>
<!-- EPO <DP n="198"> -->&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 696
<img id="ib0862" file="imgb0862.tif" wi="73" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 697<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 697
<img id="ib0863" file="imgb0863.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 698<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 698
<img id="ib0864" file="imgb0864.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 699<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 699
<img id="ib0865" file="imgb0865.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 700<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 700
<img id="ib0866" file="imgb0866.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 701<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 701<!-- EPO <DP n="199"> -->
<img id="ib0867" file="imgb0867.tif" wi="65" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 702<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 702
<img id="ib0868" file="imgb0868.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 703<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 703
<img id="ib0869" file="imgb0869.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 704<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 704
<img id="ib0870" file="imgb0870.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 705<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 705
<img id="ib0871" file="imgb0871.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 706<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 706
<img id="ib0872" file="imgb0872.tif" wi="74" he="7" img-content="dna" img-format="tif"/><!-- EPO <DP n="200"> --></li><li>&lt;210&gt; 707<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 707
<img id="ib0873" file="imgb0873.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 708<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Syntheti HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 708
<img id="ib0874" file="imgb0874.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 709<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 709
<img id="ib0875" file="imgb0875.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 710<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 710
<img id="ib0876" file="imgb0876.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 711<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 711
<img id="ib0877" file="imgb0877.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 712<br/>
&lt;211&gt; 9<br/>
<!-- EPO <DP n="201"> -->&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 712
<img id="ib0878" file="imgb0878.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 713<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 713
<img id="ib0879" file="imgb0879.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 714<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 714
<img id="ib0880" file="imgb0880.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 715<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 715
<img id="ib0881" file="imgb0881.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 716<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 716
<img id="ib0882" file="imgb0882.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 717<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial sequence<!-- EPO <DP n="202"> --></li><li>&lt;220&gt;<br/>
&lt;223&gt; synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 717
<img id="ib0883" file="imgb0883.tif" wi="73" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 718<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 718
<img id="ib0884" file="imgb0884.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 719<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic. HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 719
<img id="ib0885" file="imgb0885.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 720<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 720
<img id="ib0886" file="imgb0886.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 721<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 721
<img id="ib0887" file="imgb0887.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 722<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; synthetic HLA-A2 binding nonamer peptide<!-- EPO <DP n="203"> --></li><li>&lt;400&gt; 722
<img id="ib0888" file="imgb0888.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 723<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 723
<img id="ib0889" file="imgb0889.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 724<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 724
<img id="ib0890" file="imgb0890.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 725<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 725
<img id="ib0891" file="imgb0891.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 726<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 726 Gly Leu Phe Gly Gly Gly Gly Gly Thr 1 5</li><li>&lt;210&gt; 727<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 727
<img id="ib0892" file="imgb0892.tif" wi="74" he="7" img-content="dna" img-format="tif"/><!-- EPO <DP n="204"> --></li><li>&lt;210&gt; 728<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 728
<img id="ib0893" file="imgb0893.tif" wi="73" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 729<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 729
<img id="ib0894" file="imgb0894.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 730<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 730
<img id="ib0895" file="imgb0895.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 731<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 731
<img id="ib0896" file="imgb0896.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 732<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 732
<img id="ib0897" file="imgb0897.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 733<br/>
<!-- EPO <DP n="205"> -->&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 733
<img id="ib0898" file="imgb0898.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 734<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 734
<img id="ib0899" file="imgb0899.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 735<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li></ul><ul><li>&lt;400&gt; 735
<img id="ib0900" file="imgb0900.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 736<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic III-A A2 binding nonamer peptide</li><li>&lt;400&gt; 736
<img id="ib0901" file="imgb0901.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 737<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 737
<img id="ib0902" file="imgb0902.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 738<br/>
&lt;221&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence<!-- EPO <DP n="206"> --></li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 738
<img id="ib0903" file="imgb0903.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 739<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 739
<img id="ib0904" file="imgb0904.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 740<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 740
<img id="ib0905" file="imgb0905.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 741<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 741
<img id="ib0906" file="imgb0906.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 742<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 742
<img id="ib0907" file="imgb0907.tif" wi="73" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 743<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide<!-- EPO <DP n="207"> --></li><li>&lt;400&gt; 743
<img id="ib0908" file="imgb0908.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 744<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 744
<img id="ib0909" file="imgb0909.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 745<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 745
<img id="ib0910" file="imgb0910.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 746<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide.</li><li>&lt;400&gt; 746
<img id="ib0911" file="imgb0911.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 747<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 747
<img id="ib0912" file="imgb0912.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 748<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 748
<img id="ib0913" file="imgb0913.tif" wi="74" he="5" img-content="dna" img-format="tif"/><!-- EPO <DP n="208"> -->
<img id="ib0914" file="imgb0914.tif" wi="37" he="4" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 749<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 749
<img id="ib0915" file="imgb0915.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 750<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 750
<img id="ib0916" file="imgb0916.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 751<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 751
<img id="ib0917" file="imgb0917.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 752<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 752
<img id="ib0918" file="imgb0918.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 753<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 753
<img id="ib0919" file="imgb0919.tif" wi="74" he="7" img-content="dna" img-format="tif"/><!-- EPO <DP n="209"> --></li><li>&lt;210&gt; 754<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 754
<img id="ib0920" file="imgb0920.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 755<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 755
<img id="ib0921" file="imgb0921.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 756<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 756
<img id="ib0922" file="imgb0922.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 757<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 757
<img id="ib0923" file="imgb0923.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 758<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 758
<img id="ib0924" file="imgb0924.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 759<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
<!-- EPO <DP n="210"> -->&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 759
<img id="ib0925" file="imgb0925.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 760<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 760
<img id="ib0926" file="imgb0926.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 761<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 761
<img id="ib0927" file="imgb0927.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 762<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 762
<img id="ib0928" file="imgb0928.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 763<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 763
<img id="ib0929" file="imgb0929.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 764<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Yersenia pestis</li><li>&lt;400&gt; 764
<img id="ib0930" file="imgb0930.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 765<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Yersenia Pestis<!-- EPO <DP n="211"> --></li><li>&lt;400&gt; 765
<img id="ib0931" file="imgb0931.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 766<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Yersenia Pestis</li><li>&lt;400&gt; 766
<img id="ib0932" file="imgb0932.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 767<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Yersenia Pestis</li><li>&lt;400&gt; 767
<img id="ib0933" file="imgb0933.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 768<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Plasmodium Falciparum</li><li>&lt;400&gt; 768
<img id="ib0934" file="imgb0934.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 769<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; influenza</li><li>&lt;400&gt; 769
<img id="ib0935" file="imgb0935.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 770<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 770
<img id="ib0936" file="imgb0936.tif" wi="83" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 771<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Rotavirus</li><li>&lt;400&gt; 771
<img id="ib0937" file="imgb0937.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 772<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
<!-- EPO <DP n="212"> -->&lt;213&gt; Homo sapien</li><li>&lt;400&gt; 772
<img id="ib0938" file="imgb0938.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 773<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo sapien</li><li>&lt;400&gt; 773
<img id="ib0939" file="imgb0939.tif" wi="66" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 774<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 774
<img id="ib0940" file="imgb0940.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 775<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Rotavirus</li><li>&lt;400&gt; 775
<img id="ib0941" file="imgb0941.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 776<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Epitope mimic of natural tumor Ag</li><li>&lt;400&gt; 776
<img id="ib0942" file="imgb0942.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 777<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Epitope mimic of natural tumor Ag</li><li>&lt;400&gt; 777
<img id="ib0943" file="imgb0943.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 778<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence<!-- EPO <DP n="213"> --></li><li>&lt;220&gt;<br/>
&lt;223&gt; Epitope Mimic of H-3 miHAg</li><li>&lt;400&gt; 778
<img id="ib0944" file="imgb0944.tif" wi="66" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 779<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Epitope Mimic of H-3 miHAg</li><li>&lt;400&gt; 779
<img id="ib0945" file="imgb0945.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 780<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Epitope Mimic of H-3 miHAg</li><li>&lt;400&gt; 780
<img id="ib0946" file="imgb0946.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 781<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Epitope Mimic of H-3 miHAg</li></ul><ul><li>&lt;400&gt; 781
<img id="ib0947" file="imgb0947.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 782<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Epitope Mimic of H-3 miHAg</li><li>&lt;400&gt; 782
<img id="ib0948" file="imgb0948.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 783<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hepatitis B Virus</li><li>&lt;400&gt; 783
<img id="ib0949" file="imgb0949.tif" wi="66" he="7" img-content="dna" img-format="tif"/><!-- EPO <DP n="214"> --></li><li>&lt;210&gt; 784<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 784
<img id="ib0950" file="imgb0950.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 785<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Mus Musculus</li><li>&lt;400&gt; 785
<img id="ib0951" file="imgb0951.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 786<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Mus Musculus</li><li>&lt;400&gt; 786
<img id="ib0952" file="imgb0952.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 787<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Mus Musculus</li><li>&lt;400&gt; 787
<img id="ib0953" file="imgb0953.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 788<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Epitope mimic of natural tumor Ag</li><li>&lt;400&gt; 788
<img id="ib0954" file="imgb0954.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 789<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;273&gt; Murine Leukemia virus</li><li>&lt;400&gt; 789
<img id="ib0955" file="imgb0955.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 790<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
<!-- EPO <DP n="215"> -->&lt;213&gt; plasmodium Falciparum</li><li>&lt;400&gt; 790
<img id="ib0956" file="imgb0956.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 791<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Plasmodium Falciparum</li><li>&lt;400&gt; 791
<img id="ib0957" file="imgb0957.tif" wi="75" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 792<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus</li><li>&lt;400&gt; 792
<img id="ib0958" file="imgb0958.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 793<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Rabies</li><li>&lt;400&gt; 793
<img id="ib0959" file="imgb0959.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 794<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza A</li><li>&lt;400&gt; 794
<img id="ib0960" file="imgb0960.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 795<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Mus Musculus</li><li>&lt;400&gt; 795
<img id="ib0961" file="imgb0961.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 796<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; MHC Class I Leader</li><li>&lt;400&gt; 796
<img id="ib0962" file="imgb0962.tif" wi="75" he="7" img-content="dna" img-format="tif"/><!-- EPO <DP n="216"> --></li><li>&lt;210&gt; 797<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 797
<img id="ib0963" file="imgb0963.tif" wi="90" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 798<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 798
<img id="ib0964" file="imgb0964.tif" wi="90" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 799<br/>
&lt;211&gt; 16<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 799
<img id="ib0965" file="imgb0965.tif" wi="131" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 800<br/>
&lt;211&gt; 16<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 800
<img id="ib0966" file="imgb0966.tif" wi="131" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 801<br/>
&lt;211&gt; 5<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 801
<img id="ib0967" file="imgb0967.tif" wi="41" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 802<br/>
&lt;211&gt; 5<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Listeria Monocytogenes</li><li>&lt;400&gt; 802
<img id="ib0968" file="imgb0968.tif" wi="41" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 803<br/>
&lt;211&gt; 12<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; simian Immunodeficiency Virus</li><li>&lt;400&gt; 803<!-- EPO <DP n="217"> -->
<img id="ib0969" file="imgb0969.tif" wi="99" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 804<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 804
<img id="ib0970" file="imgb0970.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 805<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo sapien</li><li>&lt;400&gt; 805
<img id="ib0971" file="imgb0971.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 806<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 806
<img id="ib0972" file="imgb0972.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 807<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 807
<img id="ib0973" file="imgb0973.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 808<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 808
<img id="ib0974" file="imgb0974.tif" wi="81" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 809<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 809
<img id="ib0975" file="imgb0975.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 810<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien<!-- EPO <DP n="218"> --></li><li>&lt;400&gt; 810
<img id="ib0976" file="imgb0976.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 811<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 811
<img id="ib0977" file="imgb0977.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 812<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo sapien</li><li>&lt;400&gt; 812
<img id="ib0978" file="imgb0978.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 813<br/>
&lt;211&gt; 12<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 813
<img id="ib0979" file="imgb0979.tif" wi="98" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 814<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 814
<img id="ib0980" file="imgb0980.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 815<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 815
<img id="ib0981" file="imgb0981.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 816<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 816
<img id="ib0982" file="imgb0982.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 817<br/>
&lt;211&gt; 9<br/>
<!-- EPO <DP n="219"> -->&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 817
<img id="ib0983" file="imgb0983.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 818<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;220&gt;<br/>
&lt;221&gt; VARIANT<br/>
&lt;222&gt; 1, 2, 5, 6, 9<br/>
&lt;223&gt; Xaa = Any Amino Acid</li><li>&lt;400&gt; 818
<img id="ib0984" file="imgb0984.tif" wi="75" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 819<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 819
<img id="ib0985" file="imgb0985.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 820<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 820
<img id="ib0986" file="imgb0986.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 821<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 821
<img id="ib0987" file="imgb0987.tif" wi="83" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 822<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 822
<img id="ib0988" file="imgb0988.tif" wi="91" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 823<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien<!-- EPO <DP n="220"> --></li><li>&lt;400&gt; 823
<img id="ib0989" file="imgb0989.tif" wi="73" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 824<br/>
&lt;211&gt; 16<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 824
<img id="ib0990" file="imgb0990.tif" wi="131" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 825<br/>
&lt;211&gt; 12<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 825
<img id="ib0991" file="imgb0991.tif" wi="98" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 826<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 826
<img id="ib0992" file="imgb0992.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 827<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 827
<img id="ib0993" file="imgb0993.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 828<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 828
<img id="ib0994" file="imgb0994.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 829<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 829
<img id="ib0995" file="imgb0995.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 830<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
<!-- EPO <DP n="221"> -->&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 830
<img id="ib0996" file="imgb0996.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 831<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 831
<img id="ib0997" file="imgb0997.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 832<br/>
&lt;211&gt; 15<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 832
<img id="ib0998" file="imgb0998.tif" wi="124" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 833<br/>
&lt;211&gt; 16<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 833
<img id="ib0999" file="imgb0999.tif" wi="132" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 834<br/>
&lt;211&gt; 3<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 834 Glu Asp Tyr 1</li><li>&lt;210&gt; 835<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 835
<img id="ib1000" file="imgb1000.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 836<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 836
<img id="ib1001" file="imgb1001.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 837<br/>
<!-- EPO <DP n="222"> -->&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 837
<img id="ib1002" file="imgb1002.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 838<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 838
<img id="ib1003" file="imgb1003.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 839<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 839
<img id="ib1004" file="imgb1004.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 840<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 840
<img id="ib1005" file="imgb1005.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 841<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 841
<img id="ib1006" file="imgb1006.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 842<br/>
&lt;211&gt; 27<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 842<br/>
gaagtggtcc ccatcagcca cttgtac    27</li><li>&lt;210&gt; 843<br/>
&lt;211&gt; 27<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 843<br/>
gaagtggtcc gcatcggcca cttgtac    27</li><li>&lt;210&gt; 844<br/>
&lt;211&gt; 27<br/>
&lt;212&gt; DNA<br/>
<!-- EPO <DP n="223"> -->&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 844<br/>
gaagtggacc ccatcggcca cttgtac    27</li><li>&lt;210&gt; 845<br/>
&lt;211&gt; 27<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 845<br/>
gaagtggacc ccgccagcaa cacctac    27</li><li>&lt;210&gt; 846<br/>
&lt;211&gt; 27<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 846<br/>
gaagtggacc ccaccagcaa cacctac    27</li><li>&lt;210&gt; 847<br/>
&lt;211&gt; 27<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 847<br/>
gaagcggacc ccaccagcaa cacctac    27</li><li>&lt;210&gt; 848<br/>
&lt;211&gt; 27<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Homo sapien</li><li>&lt;400&gt; 848<br/>
gaagcggacc ccaccagcaa cacctac    27</li></ul><ul><li>&lt;210&gt; 849<br/>
&lt;211&gt; 27<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Homo sapien</li><li>&lt;400&gt; 849<br/>
gaagtggacc ccatcggcca cgtgtac    27</li><li>&lt;210&gt; 850<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 850
<img id="ib1007" file="imgb1007.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 851<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 851
<img id="ib1008" file="imgb1008.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 852<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
<!-- EPO <DP n="224"> -->&lt;213&gt; Homo sapien</li><li>&lt;400&gt; 852
<img id="ib1009" file="imgb1009.tif" wi="90" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 853<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 853
<img id="ib1010" file="imgb1010.tif" wi="73" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 854<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 854
<img id="ib1011" file="imgb1011.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 855<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 855
<img id="ib1012" file="imgb1012.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 856<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 856
<img id="ib1013" file="imgb1013.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 857<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 857
<img id="ib1014" file="imgb1014.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 858<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 858
<img id="ib1015" file="imgb1015.tif" wi="90" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 859<br/>
<!-- EPO <DP n="225"> -->&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 859
<img id="ib1016" file="imgb1016.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 860<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 860
<img id="ib1017" file="imgb1017.tif" wi="90" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 861<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 861
<img id="ib1018" file="imgb1018.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 862<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 862
<img id="ib1019" file="imgb1019.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 863<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 863
<img id="ib1020" file="imgb1020.tif" wi="91" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 864<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 864
<img id="ib1021" file="imgb1021.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 865<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 865
<img id="ib1022" file="imgb1022.tif" wi="75" he="7" img-content="dna" img-format="tif"/><!-- EPO <DP n="226"> --></li><li>&lt;210&gt; 866<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo sapien</li><li>&lt;400&gt; 866
<img id="ib1023" file="imgb1023.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 867<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 867
<img id="ib1024" file="imgb1024.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 868<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 868
<img id="ib1025" file="imgb1025.tif" wi="83" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 869<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 869
<img id="ib1026" file="imgb1026.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 870<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 870
<img id="ib1027" file="imgb1027.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 871<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 871
<img id="ib1028" file="imgb1028.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 872<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 872
<img id="ib1029" file="imgb1029.tif" wi="91" he="5" img-content="dna" img-format="tif"/><!-- EPO <DP n="227"> -->
<img id="ib1030" file="imgb1030.tif" wi="78" he="4" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 873<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 873
<img id="ib1031" file="imgb1031.tif" wi="90" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 874<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 874
<img id="ib1032" file="imgb1032.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 875<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 875
<img id="ib1033" file="imgb1033.tif" wi="90" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 876<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 876
<img id="ib1034" file="imgb1034.tif" wi="91" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 877<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 877
<img id="ib1035" file="imgb1035.tif" wi="83" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 878<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 878
<img id="ib1036" file="imgb1036.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 879<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien<!-- EPO <DP n="228"> --></li><li>&lt;400&gt; 879
<img id="ib1037" file="imgb1037.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 880<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 880
<img id="ib1038" file="imgb1038.tif" wi="90" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 881<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 881
<img id="ib1039" file="imgb1039.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 882<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 882
<img id="ib1040" file="imgb1040.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 883<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 883
<img id="ib1041" file="imgb1041.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 884<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 884
<img id="ib1042" file="imgb1042.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 885<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 885
<img id="ib1043" file="imgb1043.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 886<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
<!-- EPO <DP n="229"> -->&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 886
<img id="ib1044" file="imgb1044.tif" wi="90" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 887<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 887
<img id="ib1045" file="imgb1045.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 888<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 888
<img id="ib1046" file="imgb1046.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 889<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 889
<img id="ib1047" file="imgb1047.tif" wi="91" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 890<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 890
<img id="ib1048" file="imgb1048.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 891<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 891
<img id="ib1049" file="imgb1049.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 892<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 892
<img id="ib1050" file="imgb1050.tif" wi="90" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 893<br/>
<!-- EPO <DP n="230"> -->&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 893
<img id="ib1051" file="imgb1051.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 894<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 894
<img id="ib1052" file="imgb1052.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 895<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 895
<img id="ib1053" file="imgb1053.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 896<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 896
<img id="ib1054" file="imgb1054.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 897<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 897
<img id="ib1055" file="imgb1055.tif" wi="90" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 898<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li></ul><ul><li>&lt;400&gt; 898
<img id="ib1056" file="imgb1056.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 899<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 899
<img id="ib1057" file="imgb1057.tif" wi="74" he="7" img-content="dna" img-format="tif"/><!-- EPO <DP n="231"> --></li><li>&lt;210&gt; 900<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 900
<img id="ib1058" file="imgb1058.tif" wi="91" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 901<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 901
<img id="ib1059" file="imgb1059.tif" wi="83" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 902<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 902.
<img id="ib1060" file="imgb1060.tif" wi="91" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 903<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 903
<img id="ib1061" file="imgb1061.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 904<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 904
<img id="ib1062" file="imgb1062.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 905<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 905
<img id="ib1063" file="imgb1063.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 906<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 906
<img id="ib1064" file="imgb1064.tif" wi="82" he="5" img-content="dna" img-format="tif"/><!-- EPO <DP n="232"> -->
<img id="ib1065" file="imgb1065.tif" wi="78" he="4" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 907<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 907
<img id="ib1066" file="imgb1066.tif" wi="90" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 908<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 908
<img id="ib1067" file="imgb1067.tif" wi="90" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 909<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 909
<img id="ib1068" file="imgb1068.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 910<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 910
<img id="ib1069" file="imgb1069.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 911<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 911
<img id="ib1070" file="imgb1070.tif" wi="90" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 912<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 912
<img id="ib1071" file="imgb1071.tif" wi="90" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 913<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien<!-- EPO <DP n="233"> --></li><li>&lt;400&gt; 913
<img id="ib1072" file="imgb1072.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 914<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 914
<img id="ib1073" file="imgb1073.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 915<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo sapien</li><li>&lt;400&gt; 915
<img id="ib1074" file="imgb1074.tif" wi="75" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 916<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 916
<img id="ib1075" file="imgb1075.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 917<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 917
<img id="ib1076" file="imgb1076.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 918<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 918
<img id="ib1077" file="imgb1077.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 919<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 919
<img id="ib1078" file="imgb1078.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 920<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
<!-- EPO <DP n="234"> -->&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 920
<img id="ib1079" file="imgb1079.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 921<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 921
<img id="ib1080" file="imgb1080.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 922<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 922
<img id="ib1081" file="imgb1081.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 923<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 923
<img id="ib1082" file="imgb1082.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 924<br/>
&lt;211&gt; 13<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 924
<img id="ib1083" file="imgb1083.tif" wi="107" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 925<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 925
<img id="ib1084" file="imgb1084.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 926<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 926
<img id="ib1085" file="imgb1085.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 927<br/>
<!-- EPO <DP n="235"> -->&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 927
<img id="ib1086" file="imgb1086.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 928<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 928
<img id="ib1087" file="imgb1087.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 929<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo sapien</li><li>&lt;400&gt; 929
<img id="ib1088" file="imgb1088.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 930<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 930
<img id="ib1089" file="imgb1089.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 931<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 931
<img id="ib1090" file="imgb1090.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 932<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 932
<img id="ib1091" file="imgb1091.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 933<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 933
<img id="ib1092" file="imgb1092.tif" wi="74" he="7" img-content="dna" img-format="tif"/><!-- EPO <DP n="236"> --></li><li>&lt;210&gt; 934<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 934
<img id="ib1093" file="imgb1093.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 935<br/>
&lt;211&gt; 22<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 935
<img id="ib1094" file="imgb1094.tif" wi="131" he="14" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 936<br/>
&lt;211&gt; 16<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 936
<img id="ib1095" file="imgb1095.tif" wi="131" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 937<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 937
<img id="ib1096" file="imgb1096.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 938<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 938
<img id="ib1097" file="imgb1097.tif" wi="73" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 939<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 939
<img id="ib1098" file="imgb1098.tif" wi="73" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 940<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza<!-- EPO <DP n="237"> --></li><li>&lt;400&gt; 940
<img id="ib1099" file="imgb1099.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 941<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 941
<img id="ib1100" file="imgb1100.tif" wi="75" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 942<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 942
<img id="ib1101" file="imgb1101.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 943<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 943
<img id="ib1102" file="imgb1102.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 944<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 944
<img id="ib1103" file="imgb1103.tif" wi="75" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 945<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 945
<img id="ib1104" file="imgb1104.tif" wi="75" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 946<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 946
<img id="ib1105" file="imgb1105.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 947<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
<!-- EPO <DP n="238"> -->&lt;213&gt; Plasmodium Berghei</li><li>&lt;400&gt; 947
<img id="ib1106" file="imgb1106.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 948<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Plasmodium Yoelii</li><li>&lt;400&gt; 948
<img id="ib1107" file="imgb1107.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 949<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Vesicular Stomatitis virus</li><li>&lt;400&gt; 949
<img id="ib1108" file="imgb1108.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 950<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Gallus Domesticus</li><li>&lt;400&gt; 950
<img id="ib1109" file="imgb1109.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 951<br/>
&lt;211&gt; 8<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Sendai virus</li><li>&lt;400&gt; 951
<img id="ib1110" file="imgb1110.tif" wi="66" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 952<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 952
<img id="ib1111" file="imgb1111.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 953<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 953
<img id="ib1112" file="imgb1112.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 954<br/>
<!-- EPO <DP n="239"> -->&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 954
<img id="ib1113" file="imgb1113.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 955<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 955
<img id="ib1114" file="imgb1114.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 956<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 956
<img id="ib1115" file="imgb1115.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 957<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 957
<img id="ib1116" file="imgb1116.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 958<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 958
<img id="ib1117" file="imgb1117.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 959<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo sapien</li><li>&lt;400&gt; 959
<img id="ib1118" file="imgb1118.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 960<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 960
<img id="ib1119" file="imgb1119.tif" wi="83" he="8" img-content="dna" img-format="tif"/><!-- EPO <DP n="240"> --></li><li>&lt;210&gt; 961<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo Sapien</li><li>&lt;400&gt; 961
<img id="ib1120" file="imgb1120.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 962<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Plasmodium Berghei</li><li>&lt;400&gt; 962
<img id="ib1121" file="imgb1121.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 963<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Plasmodiuin Yoelii</li><li>&lt;400&gt; 963
<img id="ib1122" file="imgb1122.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 964<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 964
<img id="ib1123" file="imgb1123.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 965<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Adenovirus</li><li>&lt;400&gt; 965
<img id="ib1124" file="imgb1124.tif" wi="82" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 966<br/>
&lt;211&gt; 11<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Lymphocytic choriomeningitis virus</li><li>&lt;400&gt; 966
<img id="ib1125" file="imgb1125.tif" wi="90" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 967<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Simian virus</li><li>&lt;220&gt;<br/>
&lt;221&gt; VARIANT<br/>
<!-- EPO <DP n="241"> -->&lt;222&gt; 7, 8, 9<br/>
&lt;223&gt; Xaa = Any Amino Acid</li><li>&lt;400&gt; 967
<img id="ib1126" file="imgb1126.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 968<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus</li><li>&lt;400&gt; 968
<img id="ib1127" file="imgb1127.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 969<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li></ul><ul><li>&lt;400&gt; 969
<img id="ib1128" file="imgb1128.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 970<br/>
&lt;211&gt; 10<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Influenza</li><li>&lt;400&gt; 970
<img id="ib1129" file="imgb1129.tif" wi="82" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 971<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus</li><li>&lt;400&gt; 971
<img id="ib1130" file="imgb1130.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 972<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human immunodeficiency virus</li><li>&lt;220&gt;<br/>
&lt;221&gt; VARIANT<br/>
&lt;222&gt; 8, 9<br/>
&lt;223&gt; Xaa = Any Amino Acid</li><li>&lt;400&gt; 972
<img id="ib1131" file="imgb1131.tif" wi="75" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 973<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus<!-- EPO <DP n="242"> --></li><li>&lt;400&gt; 973
<img id="ib1132" file="imgb1132.tif" wi="74" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 974<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency Virus</li><li>&lt;400&gt; 974
<img id="ib1133" file="imgb1133.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 975<br/>
&lt;211&gt; 7<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Human Immunodeficiency virus</li><li>&lt;400&gt; 975
<img id="ib1134" file="imgb1134.tif" wi="57" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 976<br/>
&lt;211&gt; 12<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Synthetic HLA-A2 binding nonamer peptide</li><li>&lt;400&gt; 976
<img id="ib1135" file="imgb1135.tif" wi="98" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 977<br/>
&lt;211&gt; 15<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Epitope mimic of natural tumor Ag</li><li>&lt;400&gt; 977
<img id="ib1136" file="imgb1136.tif" wi="123" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 978<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial Sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; Epitope mimic of natural tumor Ag</li><li>&lt;400&gt; 978
<img id="ib1137" file="imgb1137.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 979<br/>
&lt;211&gt; 9<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Homo sapien<!-- EPO <DP n="243"> --></li><li>&lt;400&gt; 979
<img id="ib1138" file="imgb1138.tif" wi="74" he="7" img-content="dna" img-format="tif"/></li></ul></p></description><claims mxw-id="PCLM56985899" lang="DE" load-source="patent-office"><!-- EPO <DP n="245"> --><claim id="c-de-01-0001" num="0001"><claim-text>Vektor kodierend für ein Polypeptid, das ein Initiatormethionin gefolgt von den Elementen B-A umfasst, wobei B die Sequenz gemäß SEQ ID Nr. 12 und A die Sequenz gemäß SEQ ID Nr. 13 ist.</claim-text></claim><claim id="c-de-01-0002" num="0002"><claim-text>Vektor nach Anspruch 1, wobei der Vektor eine kodierende Sequenz umfasst, die aus der Sequenz gemäß SEQ ID Nr. 21 besteht.</claim-text></claim><claim id="c-de-01-0003" num="0003"><claim-text>Vektor nach Anspruch 1 umfassend eine Sequenz, die für SEQ ID Nr. 17 kodiert.</claim-text></claim><claim id="c-de-01-0004" num="0004"><claim-text>Vektor nach Anspruch 1, wobei der Vektor eine Sequenz umfasst, die für die Sequenz m-(B-A-D-D-A-B-A-A) kodiert, wobei m ein Initiatormethionin ist, B die Sequenz gemäß SEQ ID Nr. 12 ist, A die Sequenz gemäß SEQ ID Nr. 13 ist und D die Sequenz gemäß SEQ ID Nr. 15 ist.</claim-text></claim><claim id="c-de-01-0005" num="0005"><claim-text>Vektor nach Anspruch 1, wobei der Vektor eine Sequenz umfasst, die für SEQ ID Nr. 20 kodiert.</claim-text></claim><claim id="c-de-01-0006" num="0006"><claim-text>Vektor nach Anspruch 1, umfassend eine Sequenz, die für SEQ ID Nr. 22 kodiert.</claim-text></claim><claim id="c-de-01-0007" num="0007"><claim-text>Vektor nach Anspruch 1, wobei der Vektor eine Sequenz umfasst, die für die Sequenz m-(B-A-C-B-A-A-C-A) kodiert, wobei m ein Initiatormethionin ist, B die Sequenz gemäß SEQ ID Nr. 12 ist, A die Sequenz gemäß SEQ ID Nr. 13 ist und C die Sequenz gemäß SEQ ID Nr. 14 ist.</claim-text></claim><claim id="c-de-01-0008" num="0008"><claim-text>Polypeptid, das durch den Vektor nach einem der vorhergehenden Ansprüche kodiert wird, wobei das Polypeptid ein Initiatormethionin gefolgt von den Elementen B-A umfasst, wobei B die Sequenz gemäß SEQ ID Nr. 12 ist und A die Sequenz gemäß SEQ ID Nr. 13 ist.</claim-text></claim></claims><claims mxw-id="PCLM56985900" lang="EN" load-source="patent-office"><!-- EPO <DP n="244"> --><claim id="c-en-01-0001" num="0001"><claim-text>A vector encoding a polypeptide comprising an initiator methionine followed by elements B-A, wherein B is the sequence of SEQ ID No. 12 and A is the sequence of SEQ ID No. 13.</claim-text></claim><claim id="c-en-01-0002" num="0002"><claim-text>Vector of claim 1, wherein the vector comprises a coding sequence consisting of the sequence of SEQ ID No. 21.</claim-text></claim><claim id="c-en-01-0003" num="0003"><claim-text>Vector of claim 1 comprising a sequence encoding SEQ ID No. 17.</claim-text></claim><claim id="c-en-01-0004" num="0004"><claim-text>Vector of claim 1, wherein the vector comprises a sequence encoding the sequence m-(B-A-D-D-A-B-A-A), wherein m is an initiator methionine, B is the sequence according to SEQ ID No. 12, A is the sequence according to SEQ ID No. 13 and D is the sequence according to SEQ ID No. 15.</claim-text></claim><claim id="c-en-01-0005" num="0005"><claim-text>Vector of claim 1, wherein the vector comprises a sequence encoding SEQ ID No. 20.</claim-text></claim><claim id="c-en-01-0006" num="0006"><claim-text>Vector of claim 1 comprising a sequence encoding SEQ ID No. 22.</claim-text></claim><claim id="c-en-01-0007" num="0007"><claim-text>Vector of claim 1, wherein the vector comprises a sequence encoding the sequence m-(B-A-C-B-A-A-C-A), wherein m is an initiator methionine, B is the sequence according to SEQ ID No. 12, A is the sequence according to SEQ ID No. 13 and C is the sequence according to SEQ ID No. 14.</claim-text></claim><claim id="c-en-01-0008" num="0008"><claim-text>A polypeptide encoded by the vector according to any one of the preceding claims, wherein the polypeptide comprises an initiator methionine followed by elements B-A, wherein B is the sequence of SEQ ID No. 12 and A is the sequence of SEQ ID No. 13.</claim-text></claim></claims><claims mxw-id="PCLM56985901" lang="FR" load-source="patent-office"><!-- EPO <DP n="246"> --><claim id="c-fr-01-0001" num="0001"><claim-text>Vecteur codant un polypeptide comprenant une méthionine initiatrice suivie par des éléments B-A, où B est la séquence de SEQ ID N° 12 et A est la séquence de SEQ ID N° 13.</claim-text></claim><claim id="c-fr-01-0002" num="0002"><claim-text>Vecteur de la revendication 1, le vecteur comprenant une séquence de codage constituée par la séquence de SEQ ID N° 21.</claim-text></claim><claim id="c-fr-01-0003" num="0003"><claim-text>Vecteur de la revendication 1, comprenant une séquence codant SEQ ID N° 17.</claim-text></claim><claim id="c-fr-01-0004" num="0004"><claim-text>Vecteur de la revendication 1, le vecteur comprenant une séquence codant la séquence m-(B-A-D-D-A-B-A-A), où m est une méthionine initiatrice, B est la séquence selon SEQ ID N° 12, A est la séquence selon SEQ ID N° 13 et D est la séquence selon SEQ ID N° 15.</claim-text></claim><claim id="c-fr-01-0005" num="0005"><claim-text>Vecteur de la revendication 1, le vecteur comprenant une séquence codant SEQ ID N° 20.</claim-text></claim><claim id="c-fr-01-0006" num="0006"><claim-text>Vecteur de la revendication 1, comprenant une séquence codant SEQ ID N° 22.</claim-text></claim><claim id="c-fr-01-0007" num="0007"><claim-text>Vecteur de la revendication 1, le vecteur comprenant une séquence codant la séquence m-(B-A-C-B-A-A-C-A), où m est une méthionine initiatrice, B est la séquence selon SEQ ID N° 12, A est la séquence selon SEQ ID N° 13 et C est la séquence selon SEQ ID N° 14.<!-- EPO <DP n="247"> --></claim-text></claim><claim id="c-fr-01-0008" num="0008"><claim-text>Polypeptide codé par le vecteur selon l'une quelconque des revendications précédentes, le polypeptide comprenant une méthionine initiatrice suivie par des éléments B-A, où B est la séquence de SEQ ID N° 12 et A est la séquence de SEQ ID N° 13.</claim-text></claim></claims><drawings mxw-id="PDW16672296" load-source="patent-office"><!-- EPO <DP n="248"> --><figure id="f0001" num="1"><img id="if0001" file="imgf0001.tif" wi="165" he="189" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="249"> --><figure id="f0002" num="2"><img id="if0002" file="imgf0002.tif" wi="125" he="214" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="250"> --><figure id="f0003" num="3"><img id="if0003" file="imgf0003.tif" wi="130" he="213" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="251"> --><figure id="f0004" num="4"><img id="if0004" file="imgf0004.tif" wi="133" he="210" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="252"> --><figure id="f0005" num="5"><img id="if0005" file="imgf0005.tif" wi="130" he="210" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="253"> --><figure id="f0006" num="6"><img id="if0006" file="imgf0006.tif" wi="165" he="214" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="254"> --><figure id="f0007" num="7"><img id="if0007" file="imgf0007.tif" wi="147" he="225" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="255"> --><figure id="f0008" num="8A"><img id="if0008" file="imgf0008.tif" wi="165" he="210" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="256"> --><figure id="f0009" num="8B"><img id="if0009" file="imgf0009.tif" wi="141" he="229" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="257"> --><figure id="f0010" num="9"><img id="if0010" file="imgf0010.tif" wi="156" he="215" img-content="drawing" img-format="tif"/></figure></drawings><copyright>User acknowledges that Fairview Research LLC and its third party providers retain all right, title and interest in and to this xml under applicable copyright laws.  User acquires no ownership rights to this xml including but not limited to its format.  User hereby accepts the terms and conditions of the Licence Agreement</copyright></patent-document>
